https://www.spreaker.com/podcast/medical-experiments-exposed--7195845
Join us as we meticulously research and narrate the untold accounts of human experimentation, from ancient practices to 20th-century scientific trials. Each episode brings to light the forgotten patients and the pioneering, often morally ambiguous, doctors who shaped modern medicine. This podcast offers a critical look at the evolution of medical ethics and the boundaries pushed in the name of science.

New episodes are released daily, Monday through Sunday, at 4:00 AM, ensuring a fresh, compelling story awaits you every day. Prepare for deep dives into historical medical practices, groundbreaking but often horrifying research, and the fascinating origins of contemporary treatments. We provide a thorough, accessible exploration of these complex topics.

Medical Experiments Exposed is for anyone fascinated by the intersection of science, ethics, and human history. If you're curious about medical history, the darker side of science, or the origins of modern medicine, this is your essential listen. Subscribe now and confront the past.]]>enMedicine© 2026 OBOMEDIA Creatorshttps://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/94fc55037ac902f725536ecd09d77e4c.jpghttps://www.spreaker.com/podcast/medical-experiments-exposed--7195845Mon, 26 Oct 2026 00:39:12 +0000Creator at ObomediaCreator at Obomediacreators@obomedia.comEver wondered about the dark side of medical history? Medical Experiments Exposed uncovers the hidden truths behind the most shocking and controversial medical experiments throughout time. We delve into the ethical quandaries, scientific...
Join us as we meticulously research and narrate the untold accounts of human experimentation, from ancient practices to 20th-century scientific trials. Each episode brings to light the forgotten patients and the pioneering, often morally ambiguous, doctors who shaped modern medicine. This podcast offers a critical look at the evolution of medical ethics and the boundaries pushed in the name of science.

New episodes are released daily, Monday through Sunday, at 4:00 AM, ensuring a fresh, compelling story awaits you every day. Prepare for deep dives into historical medical practices, groundbreaking but often horrifying research, and the fascinating origins of contemporary treatments. We provide a thorough, accessible exploration of these complex topics.

Medical Experiments Exposed is for anyone fascinated by the intersection of science, ethics, and human history. If you're curious about medical history, the darker side of science, or the origins of modern medicine, this is your essential listen. Subscribe now and confront the past.]]>falsec2af08f2-1579-5ace-9ce9-5516fad3456aepisodichttps://www.spreaker.com/episode/the-thumb-sized-tissue-that-unmasked-a-fatal-surgical-lie--73090452
A thumbnail‑sized fragment of gland preserved in a jar became the only physical trace that proved a twenty‑two‑year‑old Singaporean had been operated on for a disease she did not have. That tiny tissue travelled between pathologists and across countries to expose discrepancies between hormonal tests, scans, and a surgeon’s claims-so how did routine medical care become a fatal deception?

In this episode, we tell the sequence of events from the collapse on 24 March 1985 through the surgery on 6 June 1985 and the months that followed, laying out the medical details, family actions, and expert testimony that raised the central question: why was surgery performed when hormone levels and imaging did not support a pituitary tumor?

Person: Chong Yun Jing
Date: 6 June 1985
Location: Mount Elizabeth Medical Centre, Singapore
Surgeon: Dr. Lim Djoe Phing
Pathologist: Dr. Seah Han Cheow

- A tissue fragment the size of a thumbnail was the only physical evidence remaining after the rest of the body had been cremated.
- Chong collapsed on 24 March 1985 and remained under medical attention until surgery in June 1985.
- Surgeon Dr. Lim removed a pituitary gland fragment and recorded the diagnosis as pituitary tumor post‑operation.
- Endocrinologist Dr. John A. Tambyah later testified that Chong’s hormonal readings were normal, not abnormal as claimed.
- Radiologist Dr. Low Chen Hoong testified that one scan is insufficient and at least four radiological assessments are required to confirm a brain tumor.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090452Mon, 26 Oct 2026 08:00:03 +0000Creator at ObomediaThe Thumb‑Sized Tissue That Unmasked a Fatal Surgical Lie A thumbnail‑sized fragment of gland preserved in a jar became the only physical trace that proved a twenty‑two‑year‑old Singaporean had been operated on for a disease she did not have. That...
A thumbnail‑sized fragment of gland preserved in a jar became the only physical trace that proved a twenty‑two‑year‑old Singaporean had been operated on for a disease she did not have. That tiny tissue travelled between pathologists and across countries to expose discrepancies between hormonal tests, scans, and a surgeon’s claims-so how did routine medical care become a fatal deception?

In this episode, we tell the sequence of events from the collapse on 24 March 1985 through the surgery on 6 June 1985 and the months that followed, laying out the medical details, family actions, and expert testimony that raised the central question: why was surgery performed when hormone levels and imaging did not support a pituitary tumor?

Person: Chong Yun Jing
Date: 6 June 1985
Location: Mount Elizabeth Medical Centre, Singapore
Surgeon: Dr. Lim Djoe Phing
Pathologist: Dr. Seah Han Cheow

- A tissue fragment the size of a thumbnail was the only physical evidence remaining after the rest of the body had been cremated.
- Chong collapsed on 24 March 1985 and remained under medical attention until surgery in June 1985.
- Surgeon Dr. Lim removed a pituitary gland fragment and recorded the diagnosis as pituitary tumor post‑operation.
- Endocrinologist Dr. John A. Tambyah later testified that Chong’s hormonal readings were normal, not abnormal as claimed.
- Radiologist Dr. Low Chen Hoong testified that one scan is insufficient and at least four radiological assessments are required to confirm a brain tumor.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1745falsefullhttps://www.spreaker.com/episode/born-a-harm-the-court-that-said-existence-was-an-injury--73090450
Existence as injury: in 1980 a California appeals court allowed a wrongful life suit on behalf of a child with Tay-Sachs, ruling that "such a plaintiff both exists and suffers, due to the negligence of others." Could a court really treat being born as the legal harm, and what did that mean for medicine and law?

In this episode, we walk through the facts of Curlender v. Bio-Science Laboratories, the medical realities of Tay-Sachs, and the legal leap that asked whether nonexistence could be preferable to life. How did a single genetic test, a skipped amniocentesis, and a laboratory's assurances produce a case that reshaped legal thinking about who can be wronged?

Person: child-plaintiff represented by legal guardian
Date: 1980 (California Court of Appeal decision)
Case: Curlender v. Bio-Science Laboratories
Disease: Tay-Sachs (infantile form)
Medical test: genetic screening and missed detection leading parents to skip amniocentesis

- The court's key sentence: "such a plaintiff both exists and suffers, due to the negligence of others." (seven words)
- Tay-Sachs leads to death usually before age five in the classic infantile form.
- If both parents carry the Tay-Sachs mutation, each pregnancy has a 1-in-4 chance of producing an affected child.
- The parents relied on Bio-Science Laboratories' representation that its genetic test was reliable and therefore did not pursue amniocentesis.
- Before Curlender in 1980, no American high court had held that existence itself could be the legal injury.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090450Sun, 25 Oct 2026 08:00:02 +0000Creator at ObomediaBorn a Harm: The Court That Said Existence Was an Injury Existence as injury: in 1980 a California appeals court allowed a wrongful life suit on behalf of a child with Tay-Sachs, ruling that "such a plaintiff both exists and suffers, due to the...
Existence as injury: in 1980 a California appeals court allowed a wrongful life suit on behalf of a child with Tay-Sachs, ruling that "such a plaintiff both exists and suffers, due to the negligence of others." Could a court really treat being born as the legal harm, and what did that mean for medicine and law?

In this episode, we walk through the facts of Curlender v. Bio-Science Laboratories, the medical realities of Tay-Sachs, and the legal leap that asked whether nonexistence could be preferable to life. How did a single genetic test, a skipped amniocentesis, and a laboratory's assurances produce a case that reshaped legal thinking about who can be wronged?

Person: child-plaintiff represented by legal guardian
Date: 1980 (California Court of Appeal decision)
Case: Curlender v. Bio-Science Laboratories
Disease: Tay-Sachs (infantile form)
Medical test: genetic screening and missed detection leading parents to skip amniocentesis

- The court's key sentence: "such a plaintiff both exists and suffers, due to the negligence of others." (seven words)
- Tay-Sachs leads to death usually before age five in the classic infantile form.
- If both parents carry the Tay-Sachs mutation, each pregnancy has a 1-in-4 chance of producing an affected child.
- The parents relied on Bio-Science Laboratories' representation that its genetic test was reliable and therefore did not pursue amniocentesis.
- Before Curlender in 1980, no American high court had held that existence itself could be the legal injury.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1560falsefullhttps://www.spreaker.com/episode/when-a-doctor-s-silence-decides-a-child-s-fate--73090448
A pregnant woman contracted rubella in 1975 and left her physician’s office without a single warning; her child was born with severe disabilities that the medical community already linked to prenatal rubella exposure. Could a doctor’s silence - not an act, but an omission - be the legal injury that reshapes informed consent and medical duty?

In this episode, we tell the story of Dortha Jean Jacobs, her daughter Lesli, and the Texas Supreme Court decision on February 19, 1975 that held a doctor’s silence could constitute malpractice. We trace how the case reframed what patients are owed, what doctors must disclose, and who decides whether a family is warned in time.

Person: Dortha Jean Jacobs
Person: Lesli Jacobs
Event: Texas Supreme Court decision
Date: February 19, 1975
Topic: Doctor’s silence as legal injury

- Dortha Jean Jacobs contracted rubella during pregnancy and received no warning or documented disclosure from her physician.
- Rubella in the first trimester was known in 1975 to cause deafness, blindness, heart defects, and intellectual disabilities.
- Lesli was born severely disabled and the legal record traced her condition to prenatal rubella exposure.
- The Jacobs family sued arguing the physician’s omission deprived them of the ability to choose whether to continue the pregnancy.
- On February 19, 1975, the Texas Supreme Court ruled that a doctor’s silence could be a legal injury, altering the standard for medical negligence.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090448Sat, 24 Oct 2026 08:00:03 +0000Creator at ObomediaWhen a Doctor's Silence Decides a Child's Fate A pregnant woman contracted rubella in 1975 and left her physician’s office without a single warning; her child was born with severe disabilities that the medical community already linked to prenatal...
A pregnant woman contracted rubella in 1975 and left her physician’s office without a single warning; her child was born with severe disabilities that the medical community already linked to prenatal rubella exposure. Could a doctor’s silence - not an act, but an omission - be the legal injury that reshapes informed consent and medical duty?

In this episode, we tell the story of Dortha Jean Jacobs, her daughter Lesli, and the Texas Supreme Court decision on February 19, 1975 that held a doctor’s silence could constitute malpractice. We trace how the case reframed what patients are owed, what doctors must disclose, and who decides whether a family is warned in time.

Person: Dortha Jean Jacobs
Person: Lesli Jacobs
Event: Texas Supreme Court decision
Date: February 19, 1975
Topic: Doctor’s silence as legal injury

- Dortha Jean Jacobs contracted rubella during pregnancy and received no warning or documented disclosure from her physician.
- Rubella in the first trimester was known in 1975 to cause deafness, blindness, heart defects, and intellectual disabilities.
- Lesli was born severely disabled and the legal record traced her condition to prenatal rubella exposure.
- The Jacobs family sued arguing the physician’s omission deprived them of the ability to choose whether to continue the pregnancy.
- On February 19, 1975, the Texas Supreme Court ruled that a doctor’s silence could be a legal injury, altering the standard for medical negligence.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1567falsefullhttps://www.spreaker.com/episode/the-silence-that-cost-a-choice-birth-law-born-in-rubella-case--73090446
A single unremarkable silence in 1971 - a doctor who failed to warn a pregnant patient after a rubella infection - forced the Texas Supreme Court to answer a question no U.S. court had before: can a physician be liable for failing to inform a patient what a disease might do? How did that quiet omission reshape informed consent and give birth to the wrongful birth doctrine?

In this episode, we tell the story of Dortha Jean Jean, the clinical encounter she experienced, and the legal path she and her husband took to the Texas Supreme Court; we describe the ruling that recognized a cause of action for wrongful birth and ask what it meant for parents, doctors, and the law.

Person: Dortha Jean Jean
Date: 1971 (illness), February 19, 1975 (ruling)
Event: Rubella infection during pregnancy leading to birth of Lesli
Court: Texas Supreme Court
Outcome: Recognized a cause of action for wrongful birth

- The patient contracted rubella in 1971 and was pregnant at the time.
- The doctor examined Dortha, did not diagnose rubella correctly, and did not warn her of risks to the fetus.
- Lesli was born severely disabled as a result of congenital rubella.
- On February 19, 1975, the Texas Supreme Court wrote: "We hold that a cause of action for wrongful birth exists in Texas."
- The court allowed recovery for costs tied to the disability (specialized care and medical expenses) but not ordinary child-rearing costs.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090446Fri, 23 Oct 2026 08:00:02 +0000Creator at ObomediaThe Silence That Cost a Choice: Birth Law Born in Rubella Case A single unremarkable silence in 1971 - a doctor who failed to warn a pregnant patient after a rubella infection - forced the Texas Supreme Court to answer a question no U.S. court had...
A single unremarkable silence in 1971 - a doctor who failed to warn a pregnant patient after a rubella infection - forced the Texas Supreme Court to answer a question no U.S. court had before: can a physician be liable for failing to inform a patient what a disease might do? How did that quiet omission reshape informed consent and give birth to the wrongful birth doctrine?

In this episode, we tell the story of Dortha Jean Jean, the clinical encounter she experienced, and the legal path she and her husband took to the Texas Supreme Court; we describe the ruling that recognized a cause of action for wrongful birth and ask what it meant for parents, doctors, and the law.

Person: Dortha Jean Jean
Date: 1971 (illness), February 19, 1975 (ruling)
Event: Rubella infection during pregnancy leading to birth of Lesli
Court: Texas Supreme Court
Outcome: Recognized a cause of action for wrongful birth

- The patient contracted rubella in 1971 and was pregnant at the time.
- The doctor examined Dortha, did not diagnose rubella correctly, and did not warn her of risks to the fetus.
- Lesli was born severely disabled as a result of congenital rubella.
- On February 19, 1975, the Texas Supreme Court wrote: "We hold that a cause of action for wrongful birth exists in Texas."
- The court allowed recovery for costs tied to the disability (specialized care and medical expenses) but not ordinary child-rearing costs.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1773falsefullhttps://www.spreaker.com/episode/does-a-doctor-owe-a-patient-truthful-information-about-pregnancy-risks--73090444
Fear that silence can steal a decision: a Texas ruling in 1975 made it possible to sue not for causing a child's disability but for depriving parents of information about maternal rubella-could withholding a diagnosis be a legal harm? What did courts mean when they recognized "wrongful birth," and how could a lost choice ever be proved?

In this episode, we tell the story of Dortha Jean Jacobs, the Texas Supreme Court's February 19, 1975 decision, and the doctrine that followed; we trace how a physician’s failure to disclose a rubella infection led to a novel legal claim and the unresolved questions it raised about causation and the implications for children and parents.

Person: Dortha Jean Jacobs
Person: Lesli Jacobs
Date: February 19, 1975
Event: Texas Supreme Court ruling recognizing wrongful birth
Topic: Failure to disclose maternal rubella diagnosis

- Dortha Jean Jacobs became ill with rubella during pregnancy and received no diagnosis or warning from her doctor.
- Lesli Jacobs was born severely disabled as a result of congenital rubella.
- The Texas Supreme Court held there was a patient-doctor relationship and negligent failure to disclose risk, creating a new cause of action.
- The ruling framed the harm as the foreclosure of the parents’ choice, not as the child’s existence being a harm.
- Plaintiffs must prove what decision they would have made if given truthful information, requiring testimony about whether they would have terminated the pregnancy.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090444Thu, 22 Oct 2026 08:00:03 +0000Creator at ObomediaDoes a doctor owe a patient truthful information about pregnancy risks? Fear that silence can steal a decision: a Texas ruling in 1975 made it possible to sue not for causing a child's disability but for depriving parents of information about...
Fear that silence can steal a decision: a Texas ruling in 1975 made it possible to sue not for causing a child's disability but for depriving parents of information about maternal rubella-could withholding a diagnosis be a legal harm? What did courts mean when they recognized "wrongful birth," and how could a lost choice ever be proved?

In this episode, we tell the story of Dortha Jean Jacobs, the Texas Supreme Court's February 19, 1975 decision, and the doctrine that followed; we trace how a physician’s failure to disclose a rubella infection led to a novel legal claim and the unresolved questions it raised about causation and the implications for children and parents.

Person: Dortha Jean Jacobs
Person: Lesli Jacobs
Date: February 19, 1975
Event: Texas Supreme Court ruling recognizing wrongful birth
Topic: Failure to disclose maternal rubella diagnosis

- Dortha Jean Jacobs became ill with rubella during pregnancy and received no diagnosis or warning from her doctor.
- Lesli Jacobs was born severely disabled as a result of congenital rubella.
- The Texas Supreme Court held there was a patient-doctor relationship and negligent failure to disclose risk, creating a new cause of action.
- The ruling framed the harm as the foreclosure of the parents’ choice, not as the child’s existence being a harm.
- Plaintiffs must prove what decision they would have made if given truthful information, requiring testimony about whether they would have terminated the pregnancy.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1617falsefullhttps://www.spreaker.com/episode/the-unprecedented-legal-act--73090443
A Texas court used a single sentence to create a new legal right: on February 19, 1975 the Texas Supreme Court held that a woman could sue her doctor for wrongful birth - the first ruling of its kind in the United States. How did an ordinary prenatal visit and an undiagnosed rubella infection become the hinge for a national debate about information, choice, and legal harm?

In this episode, we follow the case Jacobs v. Theimer and the family at its center to explain what happened, what the court decided, and why courts across America are still wrestling with the consequences: what does a physician owe a patient at the moment information matters, and how should the law measure the loss when that moment is lost?

Person: Dortha Jean Jacobs
Person: Dr. Theimer
Person: Lesli Jacobs
Date: February 19, 1975
Case: Jacobs v. Theimer

- The Texas Supreme Court issued its ruling on February 19, 1975.
- The court held that a woman could bring a cause of action for wrongful birth.
- Dortha contracted rubella during pregnancy; the infection was not diagnosed by Dr. Theimer.
- Lesli Jacobs was born severely disabled due to prenatal rubella exposure.
- The ruling was the first of its kind in the United States and left open how to measure the legal harm.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090443Wed, 21 Oct 2026 08:00:03 +0000Creator at Obomedia- the unprecedented legal act A Texas court used a single sentence to create a new legal right: on February 19, 1975 the Texas Supreme Court held that a woman could sue her doctor for wrongful birth - the first ruling of its kind in the United...
A Texas court used a single sentence to create a new legal right: on February 19, 1975 the Texas Supreme Court held that a woman could sue her doctor for wrongful birth - the first ruling of its kind in the United States. How did an ordinary prenatal visit and an undiagnosed rubella infection become the hinge for a national debate about information, choice, and legal harm?

In this episode, we follow the case Jacobs v. Theimer and the family at its center to explain what happened, what the court decided, and why courts across America are still wrestling with the consequences: what does a physician owe a patient at the moment information matters, and how should the law measure the loss when that moment is lost?

Person: Dortha Jean Jacobs
Person: Dr. Theimer
Person: Lesli Jacobs
Date: February 19, 1975
Case: Jacobs v. Theimer

- The Texas Supreme Court issued its ruling on February 19, 1975.
- The court held that a woman could bring a cause of action for wrongful birth.
- Dortha contracted rubella during pregnancy; the infection was not diagnosed by Dr. Theimer.
- Lesli Jacobs was born severely disabled due to prenatal rubella exposure.
- The ruling was the first of its kind in the United States and left open how to measure the legal harm.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1645falsefullhttps://www.spreaker.com/episode/when-a-doctor-s-silence-steals-your-right-to-choose--73090442
The idea that a physician’s silence could erase a parent’s right to decide still shocks: a Texas Supreme Court ruling in 1975 named a new cause of action after a doctor failed to tell a pregnant patient the risks of rubella and her child was born severely disabled. How did a single withheld conversation create a legal doctrine that now divides 25 states and reshapes reproductive decision-making?

In this episode, we trace the case of Dortha Jean Jacobs and the medical and legal changes that followed, from prenatal advances like amniocentesis and genetic counseling to the Texas decision that created wrongful birth; what did courts decide about harm, causation, and the value of a child when a doctor never spoke?

Person: Dortha Jean Jacobs
Person: Lesli Jacobs
Event: Texas Supreme Court ruling on February 19, 1975
Condition: Rubella exposure during first trimester
Legal doctrine: Wrongful birth

- Dortha Jean Jacobs contracted rubella during pregnancy and was not informed by her physician, identified in court records as Theimer.
- Lesli Jacobs was born severely disabled as a result of prenatal rubella exposure.
- The Texas Supreme Court recognized wrongful birth on February 19, 1975, creating a civil cause of action for parents.
- By the time of the episode, 25 states allow parents to sue for wrongful birth while others have enacted laws to block such suits.
- Early wrongful birth rulings required plaintiffs to prove a child would have been born healthy, a causation standard later replaced by whether the parent would have made a different reproductive decision if informed.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090442Tue, 20 Oct 2026 08:00:02 +0000Creator at ObomediaWhen a Doctor's Silence Steals Your Right to Choose The idea that a physician’s silence could erase a parent’s right to decide still shocks: a Texas Supreme Court ruling in 1975 named a new cause of action after a doctor failed to tell a pregnant...
The idea that a physician’s silence could erase a parent’s right to decide still shocks: a Texas Supreme Court ruling in 1975 named a new cause of action after a doctor failed to tell a pregnant patient the risks of rubella and her child was born severely disabled. How did a single withheld conversation create a legal doctrine that now divides 25 states and reshapes reproductive decision-making?

In this episode, we trace the case of Dortha Jean Jacobs and the medical and legal changes that followed, from prenatal advances like amniocentesis and genetic counseling to the Texas decision that created wrongful birth; what did courts decide about harm, causation, and the value of a child when a doctor never spoke?

Person: Dortha Jean Jacobs
Person: Lesli Jacobs
Event: Texas Supreme Court ruling on February 19, 1975
Condition: Rubella exposure during first trimester
Legal doctrine: Wrongful birth

- Dortha Jean Jacobs contracted rubella during pregnancy and was not informed by her physician, identified in court records as Theimer.
- Lesli Jacobs was born severely disabled as a result of prenatal rubella exposure.
- The Texas Supreme Court recognized wrongful birth on February 19, 1975, creating a civil cause of action for parents.
- By the time of the episode, 25 states allow parents to sue for wrongful birth while others have enacted laws to block such suits.
- Early wrongful birth rulings required plaintiffs to prove a child would have been born healthy, a causation standard later replaced by whether the parent would have made a different reproductive decision if informed.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1649falsefullhttps://www.spreaker.com/episode/the-surgeon-s-acid-how-medicine-destroyed-a-child-s-face--73090441
A four-year-old’s face, tongue and teeth were destroyed by daily doses of calomel and two applications of nitric acid; she lived seventy-four years with chronic pain and a tin to eat through. How did a trusted surgeon’s treatment become lifelong ruin, and why did the court’s one-thousand-pound judgment change nothing?

In this episode, we tell the documented life of Elizabeth Storie from Glasgow, the medical treatments she received as a child, the legal case her family won, and the decades of consequences that followed - why did the surgeon refuse to pay the awarded compensation?

Person: Elizabeth Storie
Date of birth: July 1818
Location: Glasgow
Treatment: Calomel daily for three weeks; two applications of aquafortis (nitric acid) by syringe
Judgment: £1,000 awarded to the family

- Age when injured: 4 years old
- Number of surgeries endured: more than 20
- Duration she used a feeding tin: 74 years
- Year she recorded living independently as a dressmaker in census: 1871
- Year her father buried and later moved: mother buried in 1849

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090441Mon, 19 Oct 2026 08:00:03 +0000Creator at ObomediaThe Surgeon's Acid: How Medicine Destroyed a Child's Face A four-year-old’s face, tongue and teeth were destroyed by daily doses of calomel and two applications of nitric acid; she lived seventy-four years with chronic pain and a tin to eat...
A four-year-old’s face, tongue and teeth were destroyed by daily doses of calomel and two applications of nitric acid; she lived seventy-four years with chronic pain and a tin to eat through. How did a trusted surgeon’s treatment become lifelong ruin, and why did the court’s one-thousand-pound judgment change nothing?

In this episode, we tell the documented life of Elizabeth Storie from Glasgow, the medical treatments she received as a child, the legal case her family won, and the decades of consequences that followed - why did the surgeon refuse to pay the awarded compensation?

Person: Elizabeth Storie
Date of birth: July 1818
Location: Glasgow
Treatment: Calomel daily for three weeks; two applications of aquafortis (nitric acid) by syringe
Judgment: £1,000 awarded to the family

- Age when injured: 4 years old
- Number of surgeries endured: more than 20
- Duration she used a feeding tin: 74 years
- Year she recorded living independently as a dressmaker in census: 1871
- Year her father buried and later moved: mother buried in 1849

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1548falsefullhttps://www.spreaker.com/episode/the-surgeon-the-tin-and-the-1-000-he-refused-to-pay--73090440
A trusted neighbour and surgeon turned a four-year-old's harmless nettle-rash into a lifetime of disfigurement with three weeks of mercury, two injections of nitric acid and a powder later shown to contain arsenic - and the court ordered the surgeon to pay £1,000, which he refused. How did a working-class family in 1820s Glasgow end up with a child who ate from a metal feeding tin for the next seventy-four years, and why was justice never fully delivered?

In this episode, we tell the documented life of Elizabeth Storie from birth in July 1818 through the treatments that destroyed her mouth, the medical and legal responses that followed, and the small, precise legacy she left at her death in 1897. What does the arithmetic of this case - treatments, testimony, a civil award that was never paid - reveal about medicine and power in nineteenth-century Scotland?

Person: Elizabeth Storie
Date of birth: July 1818
Event: Three weeks of calomel followed by two nitric acid injections
Evidence: Powder analysed by Lorimer Corbett and James Corkindale found to contain a large quantity of arsenic
Date of death: 1897, aged 78

- She was four years old in 1822 when nettle-rash led her parents to accept treatment from neighbour surgeon Robert Falconer.
- She received calomel daily for three weeks, a mercurous chloride treatment that caused mercury poisoning and blackened, ulcerated gums.
- Falconer injected aquafortis (nitric acid) into her mouth twice, after which her tongue and teeth fell out and part of her jawbone gave way.
- Two independent physicians, Lorimer Corbett and James Corkindale, confirmed the powder Falconer provided contained a large quantity of arsenic.
- The Scottish court ordered the surgeon to pay £1,000, but he refused payment; Elizabeth lived until 1897 and left £39 to the Royal Association of Incurables in Edinburgh.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090440Sun, 18 Oct 2026 08:00:03 +0000Creator at ObomediaThe Surgeon, The Tin, and the £1,000 He Refused to Pay A trusted neighbour and surgeon turned a four-year-old's harmless nettle-rash into a lifetime of disfigurement with three weeks of mercury, two injections of nitric acid and a powder later...
A trusted neighbour and surgeon turned a four-year-old's harmless nettle-rash into a lifetime of disfigurement with three weeks of mercury, two injections of nitric acid and a powder later shown to contain arsenic - and the court ordered the surgeon to pay £1,000, which he refused. How did a working-class family in 1820s Glasgow end up with a child who ate from a metal feeding tin for the next seventy-four years, and why was justice never fully delivered?

In this episode, we tell the documented life of Elizabeth Storie from birth in July 1818 through the treatments that destroyed her mouth, the medical and legal responses that followed, and the small, precise legacy she left at her death in 1897. What does the arithmetic of this case - treatments, testimony, a civil award that was never paid - reveal about medicine and power in nineteenth-century Scotland?

Person: Elizabeth Storie
Date of birth: July 1818
Event: Three weeks of calomel followed by two nitric acid injections
Evidence: Powder analysed by Lorimer Corbett and James Corkindale found to contain a large quantity of arsenic
Date of death: 1897, aged 78

- She was four years old in 1822 when nettle-rash led her parents to accept treatment from neighbour surgeon Robert Falconer.
- She received calomel daily for three weeks, a mercurous chloride treatment that caused mercury poisoning and blackened, ulcerated gums.
- Falconer injected aquafortis (nitric acid) into her mouth twice, after which her tongue and teeth fell out and part of her jawbone gave way.
- Two independent physicians, Lorimer Corbett and James Corkindale, confirmed the powder Falconer provided contained a large quantity of arsenic.
- The Scottish court ordered the surgeon to pay £1,000, but he refused payment; Elizabeth lived until 1897 and left £39 to the Royal Association of Incurables in Edinburgh.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1499falsefullhttps://www.spreaker.com/episode/the-surgeon-s-syringe-the-arsenic-tin-and-a-father-s-uncollected-1-000--73090439
A four-year-old girl in 1820s Glasgow had her jaw destroyed by mercury and then was injected twice with nitric acid by the family surgeon; her parents later found a powder containing a large quantity of arsenic and a court ordered the surgeon to pay £1,000 - but he never did. How did a documented medical catastrophe, physical evidence, and an explicit court order fail to deliver justice?

In this episode, we tell the documented life story of Elizabeth Storie from contemporary physicians' letters, court transcripts, and her own autobiography, outlining the medical treatments, the arsenic powder, and the missed compensation - and we ask why the court’s order was never enforced.

Person: Elizabeth Storie
Date of birth: July 1818
Location: Glasgow
Treatment substances: calomel (mercurous chloride), aquafortis (nitric acid)
Court order: £1,000 compensation ordered but never collected

- Elizabeth Storie was four years old when Robert Falconer prescribed daily calomel for three weeks.
- After three weeks of calomel, Elizabeth’s face and mouth showed mercury poisoning signs: blackening gums and tissue destruction.
- Falconer returned and injected nitric acid into Elizabeth’s mouth twice, resulting in loss of tongue, teeth, and part of her jaw.
- Falconer left a powder with the family; later analysis by Lorimer Corbett and James Corkindale found it contained a large quantity of arsenic.
- A court ordered Falconer to pay £1,000 in compensation, but he refused and no payment was ever collected.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090439Sat, 17 Oct 2026 08:00:03 +0000Creator at ObomediaThe Surgeon's Syringe, the Arsenic Tin, and a Father's Uncollected £1,000 A four-year-old girl in 1820s Glasgow had her jaw destroyed by mercury and then was injected twice with nitric acid by the family surgeon; her parents later found a powder...
A four-year-old girl in 1820s Glasgow had her jaw destroyed by mercury and then was injected twice with nitric acid by the family surgeon; her parents later found a powder containing a large quantity of arsenic and a court ordered the surgeon to pay £1,000 - but he never did. How did a documented medical catastrophe, physical evidence, and an explicit court order fail to deliver justice?

In this episode, we tell the documented life story of Elizabeth Storie from contemporary physicians' letters, court transcripts, and her own autobiography, outlining the medical treatments, the arsenic powder, and the missed compensation - and we ask why the court’s order was never enforced.

Person: Elizabeth Storie
Date of birth: July 1818
Location: Glasgow
Treatment substances: calomel (mercurous chloride), aquafortis (nitric acid)
Court order: £1,000 compensation ordered but never collected

- Elizabeth Storie was four years old when Robert Falconer prescribed daily calomel for three weeks.
- After three weeks of calomel, Elizabeth’s face and mouth showed mercury poisoning signs: blackening gums and tissue destruction.
- Falconer returned and injected nitric acid into Elizabeth’s mouth twice, resulting in loss of tongue, teeth, and part of her jaw.
- Falconer left a powder with the family; later analysis by Lorimer Corbett and James Corkindale found it contained a large quantity of arsenic.
- A court ordered Falconer to pay £1,000 in compensation, but he refused and no payment was ever collected.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1682falsefullhttps://www.spreaker.com/episode/he-cut-without-consent-the-surgeon-who-evaded-accountability--73090438
A woman went under anesthesia in winter 2002 expecting a small lesion removed - but woke to find her clitoris had been cut; the surgeon had already amassed thirty-five complaints and a formal restriction, yet he continued practicing in the public system. How did a doctor with documented abuses, a suspended practice, and psychiatric evaluations still gain new hospital roles and operate on vulnerable patients?

In this episode, we tell the sequence of events that placed Graeme Stephen Reeves back into public hospitals despite prior adverse findings and suspensions, and trace the internal memos, unread referrals, and missed verifications that allowed him to work on the South Coast. Where did the chain of responsibility break, and who ignored the warnings that could have stopped him?

Person: Graeme Stephen Reeves
Date of birth: 1949
Period: 1985-2008 (career events documented)
Complaints: 35 formal complaints before 2002
Investigations: deaths of 10 babies and 7 women under review by Feb 2008

- Appointed visiting medical officer at Hornsby Ku-ring-gai Hospital on 20 December 1985.
- First formal complaint arrived six months after his 1985 appointment.
- In May 1996 a patient died of septicemia after he refused to prescribe antibiotics; the hospital suspended his privileges.
- Professional Standards Committee imposed a formal restriction on his obstetric practice by August 1997.
- Reeves began working for the Greater Southern Area Health Service in April 2002 without disclosing the Professional Standards Committee restriction.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090438Fri, 16 Oct 2026 08:00:03 +0000Creator at ObomediaHe Cut Without Consent: The Surgeon Who Evaded Accountability A woman went under anesthesia in winter 2002 expecting a small lesion removed - but woke to find her clitoris had been cut; the surgeon had already amassed thirty-five complaints and a...
A woman went under anesthesia in winter 2002 expecting a small lesion removed - but woke to find her clitoris had been cut; the surgeon had already amassed thirty-five complaints and a formal restriction, yet he continued practicing in the public system. How did a doctor with documented abuses, a suspended practice, and psychiatric evaluations still gain new hospital roles and operate on vulnerable patients?

In this episode, we tell the sequence of events that placed Graeme Stephen Reeves back into public hospitals despite prior adverse findings and suspensions, and trace the internal memos, unread referrals, and missed verifications that allowed him to work on the South Coast. Where did the chain of responsibility break, and who ignored the warnings that could have stopped him?

Person: Graeme Stephen Reeves
Date of birth: 1949
Period: 1985-2008 (career events documented)
Complaints: 35 formal complaints before 2002
Investigations: deaths of 10 babies and 7 women under review by Feb 2008

- Appointed visiting medical officer at Hornsby Ku-ring-gai Hospital on 20 December 1985.
- First formal complaint arrived six months after his 1985 appointment.
- In May 1996 a patient died of septicemia after he refused to prescribe antibiotics; the hospital suspended his privileges.
- Professional Standards Committee imposed a formal restriction on his obstetric practice by August 1997.
- Reeves began working for the Greater Southern Area Health Service in April 2002 without disclosing the Professional Standards Committee restriction.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1536falsefullhttps://www.spreaker.com/episode/he-cut-without-consent-the-australian-surgeon-women-warned-about--73090437
When a routine operation turned into an unexpected clitoridectomy, an ordinary woman woke up missing a body part she never consented to - and her case was only the tip of a crisis spanning nearly two decades. Thirty-five complaints, seventeen criminal charges, and the deaths of ten infants and seven women followed one surgeon’s path through hospitals that repeatedly renewed his access; how did the system let this happen?

In this episode, we trace the sequence of events, hospital decisions, and missing paperwork that allowed Graeme Stephen Reeves to keep practicing despite formal restrictions, and ask how institutional blindness enabled harm that might have been prevented.

Person: Graeme Stephen Reeves
Date: 2002 (Carolyn Dewaegeneire's operation)
Location: Bega Hospital, New South Wales
Period: mid-1980s to 2004 (career span covered)
Case: 35 documented complaints; 17 criminal charges

- Carolyn Dewaegeneire underwent surgery in 2002 and woke up having had a clitoridectomy without informed consent.
- Investigators later counted 35 separate complaints lodged against Reeves over fifteen years.
- Reeves faced 17 criminal charges and was connected to the deaths of 10 infants and 7 women.
- A Professional Standards Committee in August 1997 explicitly prohibited Reeves from practicing obstetrics.
- In April 2002, an application to the Greater Southern Area Health Service omitted the 1997 restriction and Reeves was hired without the Medical Board being contacted.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090437Thu, 15 Oct 2026 08:00:02 +0000Creator at ObomediaHe Cut Without Consent: The Australian Surgeon Women Warned About When a routine operation turned into an unexpected clitoridectomy, an ordinary woman woke up missing a body part she never consented to - and her case was only the tip of a crisis...
When a routine operation turned into an unexpected clitoridectomy, an ordinary woman woke up missing a body part she never consented to - and her case was only the tip of a crisis spanning nearly two decades. Thirty-five complaints, seventeen criminal charges, and the deaths of ten infants and seven women followed one surgeon’s path through hospitals that repeatedly renewed his access; how did the system let this happen?

In this episode, we trace the sequence of events, hospital decisions, and missing paperwork that allowed Graeme Stephen Reeves to keep practicing despite formal restrictions, and ask how institutional blindness enabled harm that might have been prevented.

Person: Graeme Stephen Reeves
Date: 2002 (Carolyn Dewaegeneire's operation)
Location: Bega Hospital, New South Wales
Period: mid-1980s to 2004 (career span covered)
Case: 35 documented complaints; 17 criminal charges

- Carolyn Dewaegeneire underwent surgery in 2002 and woke up having had a clitoridectomy without informed consent.
- Investigators later counted 35 separate complaints lodged against Reeves over fifteen years.
- Reeves faced 17 criminal charges and was connected to the deaths of 10 infants and 7 women.
- A Professional Standards Committee in August 1997 explicitly prohibited Reeves from practicing obstetrics.
- In April 2002, an application to the Greater Southern Area Health Service omitted the 1997 restriction and Reeves was hired without the Medical Board being contacted.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1740falsefullhttps://www.spreaker.com/episode/the-molecule-that-nearly-became-lsd-silenced-by-nausea--73090435
In this episode, we tell the story of quipazine from its 1966 discovery through human trials and animal experiments, tracing why it was classified as antidepressant-like and then abandoned - and asking whether the nausea problem closed a door science has not yet reopened.

Person: anonymous human volunteers
Date: 1966 (first description)
Compound: quipazine (one-2-quinolinyl-piperazine; “two-QP”)
Dose: 25 mg oral caused significant gastrointestinal distress
Receptor profile: potent 5-HT3 agonist; agonist at 5-HT2A/2B/2C; inhibits serotonin reuptake

- Quipazine was first described in 1966 and later labeled antidepressant-like by 1971.
- Oral doses of 25 mg in humans produced significant nausea, vomiting, cramping, flatulence and diarrhea.
- Quipazine is a 1-(2-quinolinyl)-piperazine (also called two-QP) synthesized from 2-chloroquinoline and piperazine.
- In rodents and monkeys quipazine produced the head-twitch response characteristic of classical psychedelics.
- In drug discrimination studies, rats fully substituted quipazine for LSD, indicating indistinguishable drug-state effects in that model.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090435Wed, 14 Oct 2026 08:00:03 +0000Creator at ObomediaThe Molecule That Nearly Became LSD - Silenced by Nausea In this episode, we tell the story of quipazine from its 1966 discovery through human trials and animal experiments, tracing why it was classified as antidepressant-like and then abandoned -...
In this episode, we tell the story of quipazine from its 1966 discovery through human trials and animal experiments, tracing why it was classified as antidepressant-like and then abandoned - and asking whether the nausea problem closed a door science has not yet reopened.

Person: anonymous human volunteers
Date: 1966 (first description)
Compound: quipazine (one-2-quinolinyl-piperazine; “two-QP”)
Dose: 25 mg oral caused significant gastrointestinal distress
Receptor profile: potent 5-HT3 agonist; agonist at 5-HT2A/2B/2C; inhibits serotonin reuptake

- Quipazine was first described in 1966 and later labeled antidepressant-like by 1971.
- Oral doses of 25 mg in humans produced significant nausea, vomiting, cramping, flatulence and diarrhea.
- Quipazine is a 1-(2-quinolinyl)-piperazine (also called two-QP) synthesized from 2-chloroquinoline and piperazine.
- In rodents and monkeys quipazine produced the head-twitch response characteristic of classical psychedelics.
- In drug discrimination studies, rats fully substituted quipazine for LSD, indicating indistinguishable drug-state effects in that model.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1950falsefullhttps://www.spreaker.com/episode/the-sic-dose-how-quipazine-haunted-psychiatry-s-psychedelic-moment--73090434
A tiny notation in a scientific paper - “0.5 mg (sic)” - froze researchers because the number was real and inexplicable, and the compound it described was never meant to be a psychedelic. Quipazine activated both the 5‑HT2A receptor linked to hallucinogens and the 5‑HT3 receptor that causes severe nausea, leaving animal studies screaming psychedelic signals while human trials reported only sickness; how could the same molecule tell such different stories?

In this episode, we lay out the sequence of experiments, results, and interpretations that turned quipazine into a scientific paradox, from rodent head‑twitches and LSD substitution to primate vomiting and a discontinued 25 mg human trial; can receptor overlap explain why quipazine’s psychedelic promise never reached people?

Person: James Winter
Date: 1994
Dose in publication: 0.5 mg (sic)
Human trial dose: 25 mg
Animal result: full substitution for LSD in drug discrimination studies

- Rodents given quipazine produced a rapid repetitive head‑twitch response matching LSD and mescaline patterns.
- In drug discrimination experiments rodents trained on LSD could not distinguish quipazine from LSD, indicating full substitution.
- Monkey trials at psychedelic‑range doses produced projectile vomiting described as severe, linked to 5‑HT3 activation.
- Human volunteer trial at 25 mg resulted in nausea with no reported LSD‑like subjective effects and was discontinued.
- James Winter proposed in 1994 that 5‑HT3 receptor activation prevented reaching 5‑HT2A‑mediated effects at tolerable doses.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090434Tue, 13 Oct 2026 08:00:03 +0000Creator at ObomediaThe "(sic)" Dose: How Quipazine Haunted Psychiatry's Psychedelic Moment A tiny notation in a scientific paper - “0.5 mg (sic)” - froze researchers because the number was real and inexplicable, and the compound it described was never meant to be a...
A tiny notation in a scientific paper - “0.5 mg (sic)” - froze researchers because the number was real and inexplicable, and the compound it described was never meant to be a psychedelic. Quipazine activated both the 5‑HT2A receptor linked to hallucinogens and the 5‑HT3 receptor that causes severe nausea, leaving animal studies screaming psychedelic signals while human trials reported only sickness; how could the same molecule tell such different stories?

In this episode, we lay out the sequence of experiments, results, and interpretations that turned quipazine into a scientific paradox, from rodent head‑twitches and LSD substitution to primate vomiting and a discontinued 25 mg human trial; can receptor overlap explain why quipazine’s psychedelic promise never reached people?

Person: James Winter
Date: 1994
Dose in publication: 0.5 mg (sic)
Human trial dose: 25 mg
Animal result: full substitution for LSD in drug discrimination studies

- Rodents given quipazine produced a rapid repetitive head‑twitch response matching LSD and mescaline patterns.
- In drug discrimination experiments rodents trained on LSD could not distinguish quipazine from LSD, indicating full substitution.
- Monkey trials at psychedelic‑range doses produced projectile vomiting described as severe, linked to 5‑HT3 activation.
- Human volunteer trial at 25 mg resulted in nausea with no reported LSD‑like subjective effects and was discontinued.
- James Winter proposed in 1994 that 5‑HT3 receptor activation prevented reaching 5‑HT2A‑mediated effects at tolerable doses.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1479falsefullhttps://www.spreaker.com/episode/when-a-trusted-doctor-used-trust-to-mutilate-the-reeves-betrayal--73090433
A trusted specialist performed a clitoridectomy on a patient who had asked only for a small lesion to be removed, after telling her in the seconds before anaesthesia what he intended to do. How could a man with thirty-five complaints, a formal obstetrics ban and prior patient deaths be hired and allowed to operate in plain sight for years?

In this episode, we lay out the sequence of events, the institutional records, and the personal harm that followed, showing how warnings and restrictions appeared on paper yet were ignored - how did that happen, and who carried the cost?

Person: Graeme Stephen Reeves
Date: 2002 (Carolyn Dewaegeneire appointment)
Location: New South Wales South Coast
Event: Clitoridectomy performed without consent
Period: Complaints logged 1985-2000

- Reeves had 35 complaints logged between 1985 and 2000.
- He faced 17 criminal counts and was linked to 10 dead babies and 7 dead women whose cases were reopened.
- In August 1997 the Professional Standards Committee banned Reeves from practising obstetrics.
- A 2002 April reference check by Greater Southern Area Health Service recorded the obstetrics restriction but Reeves was hired anyway that month.
- Carolyn Dewaegeneire was told in the seconds before anaesthesia that a clitoridectomy would be performed and woke up having had that procedure without consent.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090433Mon, 12 Oct 2026 08:00:03 +0000Creator at ObomediaWhen a Trusted Doctor Used Trust to Mutilate: The Reeves Betrayal A trusted specialist performed a clitoridectomy on a patient who had asked only for a small lesion to be removed, after telling her in the seconds before anaesthesia what he intended...
A trusted specialist performed a clitoridectomy on a patient who had asked only for a small lesion to be removed, after telling her in the seconds before anaesthesia what he intended to do. How could a man with thirty-five complaints, a formal obstetrics ban and prior patient deaths be hired and allowed to operate in plain sight for years?

In this episode, we lay out the sequence of events, the institutional records, and the personal harm that followed, showing how warnings and restrictions appeared on paper yet were ignored - how did that happen, and who carried the cost?

Person: Graeme Stephen Reeves
Date: 2002 (Carolyn Dewaegeneire appointment)
Location: New South Wales South Coast
Event: Clitoridectomy performed without consent
Period: Complaints logged 1985-2000

- Reeves had 35 complaints logged between 1985 and 2000.
- He faced 17 criminal counts and was linked to 10 dead babies and 7 dead women whose cases were reopened.
- In August 1997 the Professional Standards Committee banned Reeves from practising obstetrics.
- A 2002 April reference check by Greater Southern Area Health Service recorded the obstetrics restriction but Reeves was hired anyway that month.
- Carolyn Dewaegeneire was told in the seconds before anaesthesia that a clitoridectomy would be performed and woke up having had that procedure without consent.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1058falsefullhttps://www.spreaker.com/episode/the-drug-that-restored-deep-sleep-and-then-vanished-forever--73090432
Sleep turned lethal: a surgical anesthetic meant for operating rooms was given by IV in a private bedroom, night after night for weeks, to a fifty-year-old preparing a comeback. The coroner ruled acute propofol intoxication and listed the manner of death as homicide - so how did a cardiologist end up administering propofol as a sleep aid in a home with no monitoring protocol?

In this episode, we tell the episode’s narrative from the bedroom on Carolwood Drive to the courtroom questions that followed, covering the medical background, the financial pressures, and the sequence of events that led to a physician’s custody of a surgical drug for home use - and ask how that combination produced a fatal outcome.

Person: Conrad Robert Murray
Date: June 25, 2009
Cause of death: Acute propofol intoxication with benzodiazepines as contributing factor
Manner of death: Homicide
Patient age: 50

- Propofol was administered intravenously in Michael Jackson’s bedroom repeatedly over weeks, according to Murray’s sworn statement.
- Michael Jackson died on the morning of June 25, 2009, and the coroner found propofol as the cause.
- Conrad Murray was born February 19, 1953, in Grenada and completed cardiology fellowship at the University of Arizona.
- Court records showed Murray had over $600,000 in outstanding judgments and owed $71,000 in student loans to Meharry.
- Murray was hired for $150,000 per month to serve as Michael Jackson’s personal physician during the London residency concerts.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090432Sun, 11 Oct 2026 08:00:03 +0000Creator at ObomediaThe Drug That Restored Deep Sleep-and Then Vanished Forever Sleep turned lethal: a surgical anesthetic meant for operating rooms was given by IV in a private bedroom, night after night for weeks, to a fifty-year-old preparing a comeback. The...
Sleep turned lethal: a surgical anesthetic meant for operating rooms was given by IV in a private bedroom, night after night for weeks, to a fifty-year-old preparing a comeback. The coroner ruled acute propofol intoxication and listed the manner of death as homicide - so how did a cardiologist end up administering propofol as a sleep aid in a home with no monitoring protocol?

In this episode, we tell the episode’s narrative from the bedroom on Carolwood Drive to the courtroom questions that followed, covering the medical background, the financial pressures, and the sequence of events that led to a physician’s custody of a surgical drug for home use - and ask how that combination produced a fatal outcome.

Person: Conrad Robert Murray
Date: June 25, 2009
Cause of death: Acute propofol intoxication with benzodiazepines as contributing factor
Manner of death: Homicide
Patient age: 50

- Propofol was administered intravenously in Michael Jackson’s bedroom repeatedly over weeks, according to Murray’s sworn statement.
- Michael Jackson died on the morning of June 25, 2009, and the coroner found propofol as the cause.
- Conrad Murray was born February 19, 1953, in Grenada and completed cardiology fellowship at the University of Arizona.
- Court records showed Murray had over $600,000 in outstanding judgments and owed $71,000 in student loans to Meharry.
- Murray was hired for $150,000 per month to serve as Michael Jackson’s personal physician during the London residency concerts.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1638falsefullhttps://www.spreaker.com/episode/when-doctors-become-weapons-the-notebook-that-witnessed-torture--73090431
Grim proof that medicine can be twisted into an instrument of destruction: a small clinical notebook from Tuol Sleng records procedures and outcomes on at least seventeen people labeled as human experiments. How did professional medical practice become state-sanctioned torture, and what can one battered exercise-book tell us about the structures that made it possible?

In this episode, we follow a single object - the Tuol Sleng notebook - and trace the recurring mechanism by which physicians, institutions, and states convert care into harm across the twentieth century and beyond. From Phnom Penh to Manchuria, from Nazi death camps to Soviet psychiatric wards, the episode maps the legal and ethical responses and asks whether declarations and codes ever stopped the practice.

Person: Dietrich Bonhoeffer
Location: Tuol Sleng, Phnom Penh
Period: 1937-1945 (Unit 731); 1975-1979 (Tuol Sleng)
Event: Human experiments recorded as pisaot menuh
Document: Declaration of Tokyo, 1975

- The notebook documents clinical procedures and outcomes on at least 17 detainees labeled as human experiments.
- Tuol Sleng, converted from a secondary school into Security Prison Twenty-One, detained an estimated 17,000 people between 1975 and 1979.
- Unit 731 operated from 1937 to 1945 in Japanese-occupied Manchuria, with historians estimating up to 10,000 deaths directly from its experiments.
- Nuremberg, the Declaration of Geneva, and the Geneva Conventions produced legal and ethical limits on human experimentation after World War II.
- The Declaration of Tokyo in 1975 explicitly stated that physicians may not participate in torture.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090431Sat, 10 Oct 2026 08:00:03 +0000Creator at ObomediaWhen Doctors Become Weapons: The Notebook That Witnessed Torture Grim proof that medicine can be twisted into an instrument of destruction: a small clinical notebook from Tuol Sleng records procedures and outcomes on at least seventeen people...
Grim proof that medicine can be twisted into an instrument of destruction: a small clinical notebook from Tuol Sleng records procedures and outcomes on at least seventeen people labeled as human experiments. How did professional medical practice become state-sanctioned torture, and what can one battered exercise-book tell us about the structures that made it possible?

In this episode, we follow a single object - the Tuol Sleng notebook - and trace the recurring mechanism by which physicians, institutions, and states convert care into harm across the twentieth century and beyond. From Phnom Penh to Manchuria, from Nazi death camps to Soviet psychiatric wards, the episode maps the legal and ethical responses and asks whether declarations and codes ever stopped the practice.

Person: Dietrich Bonhoeffer
Location: Tuol Sleng, Phnom Penh
Period: 1937-1945 (Unit 731); 1975-1979 (Tuol Sleng)
Event: Human experiments recorded as pisaot menuh
Document: Declaration of Tokyo, 1975

- The notebook documents clinical procedures and outcomes on at least 17 detainees labeled as human experiments.
- Tuol Sleng, converted from a secondary school into Security Prison Twenty-One, detained an estimated 17,000 people between 1975 and 1979.
- Unit 731 operated from 1937 to 1945 in Japanese-occupied Manchuria, with historians estimating up to 10,000 deaths directly from its experiments.
- Nuremberg, the Declaration of Geneva, and the Geneva Conventions produced legal and ethical limits on human experimentation after World War II.
- The Declaration of Tokyo in 1975 explicitly stated that physicians may not participate in torture.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1719falsefullhttps://www.spreaker.com/episode/when-doctors-became-executioners-the-notebook-that-proves-it--73090428
The notebook found in 1978 at a former prison in Phnom Penh records clinical procedures on at least seventeen detainees and names the Khmer Rouge term pisaot menuh - human experiments - raising the chilling possibility that medical training was repurposed as a tool of systematic harm. How did professionals sworn to care become architects or enablers of torture and experimentation across the twentieth century?

In this episode, we trace a line from the Tuol Sleng notebook through Unit Seven Thirty-One, Nazi camp experiments, Soviet political psychiatry, and abuses in democratic institutions to ask whether these were isolated outrages or manifestations of a repeatable process - and what the existing medical and legal frameworks did or did not prevent.

Person: Dietrich Bonhoeffer
Event: discovery of notebook in Phnom Penh prison, 1978
Case: Unit Seven Thirty-One (1937-1945), up to 10,000 killed
Period: Nazi medical experiments prosecuted at Nuremberg after World War II
Location: Lake Alice psychiatric hospital, New Zealand (1972-1978)

- The Phnom Penh notebook documents procedures performed on at least 17 detainees and was kept by someone with medical training.
- Unit Seven Thirty-One operated from 1937 to 1945 in Japanese-occupied Manchuria and involved deliberate infection and vivisection, with estimates of victims up to 10,000.
- Nazi physicians such as Josef Mengele conducted non-consensual twin studies; some medical personnel were convicted and executed at Nuremberg.
- Soviet psychiatry created the diagnosis "sluggish schizophrenia" to detain dissenters and used neuroleptic drugs as chemical punishment without observable symptom requirements.
- Lake Alice admitted 362 children and young people between 1972 and 1978; a Royal Commission later found unmodified ECT without anesthesia and paraldehyde injections amounted to torture.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090428Fri, 09 Oct 2026 08:00:03 +0000Creator at ObomediaWhen Doctors Became Executioners: The Notebook That Proves It The notebook found in 1978 at a former prison in Phnom Penh records clinical procedures on at least seventeen detainees and names the Khmer Rouge term pisaot menuh - human experiments -...
The notebook found in 1978 at a former prison in Phnom Penh records clinical procedures on at least seventeen detainees and names the Khmer Rouge term pisaot menuh - human experiments - raising the chilling possibility that medical training was repurposed as a tool of systematic harm. How did professionals sworn to care become architects or enablers of torture and experimentation across the twentieth century?

In this episode, we trace a line from the Tuol Sleng notebook through Unit Seven Thirty-One, Nazi camp experiments, Soviet political psychiatry, and abuses in democratic institutions to ask whether these were isolated outrages or manifestations of a repeatable process - and what the existing medical and legal frameworks did or did not prevent.

Person: Dietrich Bonhoeffer
Event: discovery of notebook in Phnom Penh prison, 1978
Case: Unit Seven Thirty-One (1937-1945), up to 10,000 killed
Period: Nazi medical experiments prosecuted at Nuremberg after World War II
Location: Lake Alice psychiatric hospital, New Zealand (1972-1978)

- The Phnom Penh notebook documents procedures performed on at least 17 detainees and was kept by someone with medical training.
- Unit Seven Thirty-One operated from 1937 to 1945 in Japanese-occupied Manchuria and involved deliberate infection and vivisection, with estimates of victims up to 10,000.
- Nazi physicians such as Josef Mengele conducted non-consensual twin studies; some medical personnel were convicted and executed at Nuremberg.
- Soviet psychiatry created the diagnosis "sluggish schizophrenia" to detain dissenters and used neuroleptic drugs as chemical punishment without observable symptom requirements.
- Lake Alice admitted 362 children and young people between 1972 and 1978; a Royal Commission later found unmodified ECT without anesthesia and paraldehyde injections amounted to torture.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1902falsefullhttps://www.spreaker.com/episode/why-doctors-tortured-the-unsettling-notebook-from-tuol-sleng--73090427
The notebook found in Tuol Sleng in 1978 recorded human experiments on at least seventeen detainees and was deliberately preserved, forcing a confrontation with how physicians used medical skill to harm. If international law after World War II spelled out clear prohibitions, why did trained doctors continue to perform and document torture under institutional sanction?

In this episode, we explore that preserved record and the wider pattern across the twentieth century that links physicians, institutions, and state-sanctioned harm, asking how legal and ethical protections failed to stop medicalized brutality.

Person: Josef Mengele
Person: Hermann Fischer-Hüllstrung
Date: 1978
Event: Discovery of a notebook documenting human experiments at Tuol Sleng
Instrument: Declaration of Geneva replaced the Hippocratic Oath

- The Tuol Sleng notebook documented procedures performed on at least 17 detainees.
- The Nuremberg Doctors' Trial in 1947 convicted 16 of 23 defendants and executed 7.
- Six international legal instruments were built between 1945 and 1982 addressing medical ethics and torture.
- The 1975 Declaration of Tokyo stated a doctor shall not participate in torture.
- Beginning in the 1960s Soviet psychiatry used the diagnosis "sluggish schizophrenia" to pathologize dissent.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090427Thu, 08 Oct 2026 08:00:03 +0000Creator at ObomediaWhy Doctors Tortured: The Unsettling Notebook from Tuol Sleng The notebook found in Tuol Sleng in 1978 recorded human experiments on at least seventeen detainees and was deliberately preserved, forcing a confrontation with how physicians used...
The notebook found in Tuol Sleng in 1978 recorded human experiments on at least seventeen detainees and was deliberately preserved, forcing a confrontation with how physicians used medical skill to harm. If international law after World War II spelled out clear prohibitions, why did trained doctors continue to perform and document torture under institutional sanction?

In this episode, we explore that preserved record and the wider pattern across the twentieth century that links physicians, institutions, and state-sanctioned harm, asking how legal and ethical protections failed to stop medicalized brutality.

Person: Josef Mengele
Person: Hermann Fischer-Hüllstrung
Date: 1978
Event: Discovery of a notebook documenting human experiments at Tuol Sleng
Instrument: Declaration of Geneva replaced the Hippocratic Oath

- The Tuol Sleng notebook documented procedures performed on at least 17 detainees.
- The Nuremberg Doctors' Trial in 1947 convicted 16 of 23 defendants and executed 7.
- Six international legal instruments were built between 1945 and 1982 addressing medical ethics and torture.
- The 1975 Declaration of Tokyo stated a doctor shall not participate in torture.
- Beginning in the 1960s Soviet psychiatry used the diagnosis "sluggish schizophrenia" to pathologize dissent.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1544falsefullhttps://www.spreaker.com/episode/when-healers-became-executioners-the-notebook-that-proved-it--73090426
Cold professional care flipped into organized harm: in 1978 a medical-trained author methodically recorded human experiments inside a former Phnom Penh school-turned-prison, filing the notebook as official paperwork rather than hiding it. Across the twentieth century, trained physicians from Unit 731 to Soviet psychiatry documented procedures that reclassified people as non-patients - so why did prosecution and accountability so often never follow?

In this episode, we lay out the documented cases and institutional instruments that turned medical practice into state violence, showing how codes like the Nuremberg Code, the Declaration of Geneva, and the Declaration of Tokyo were written in response to such breaches - and yet violations continued. How did documentation, professional habit, and changing diagnostic criteria enable healers to become executioners?

Person: Josef Mengele
Event: Unit Seven Thirty-One operations (1937-1945)
Date: 1978 notebook entries
Topic: Soviet diagnosis "sluggish schizophrenia" applied to dissent
Instrument: Declaration of Tokyo (1975) stating physician must not participate in torture

- The 1978 notebook was written inside a former Phnom Penh school converted into a prison and was officially filed rather than hidden.
- Unit Seven Thirty-One operated from 1937 to 1945 and is reported to have tortured and killed up to 10,000 prisoners.
- The Nuremberg Trials in the 1940s exposed physician-led experiments such as those by Josef Mengele at Auschwitz.
- The Declaration of Tokyo was issued in 1975 by the World Medical Association asserting doctors shall not participate in torture.
- Soviet psychiatrists invented the diagnosis "sluggish schizophrenia" to detain political dissidents without trial, using high-dose neuroleptics as "treatment."

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090426Wed, 07 Oct 2026 08:00:03 +0000Creator at ObomediaWhen Healers Became Executioners: The Notebook That Proved It Cold professional care flipped into organized harm: in 1978 a medical-trained author methodically recorded human experiments inside a former Phnom Penh school-turned-prison, filing the...
Cold professional care flipped into organized harm: in 1978 a medical-trained author methodically recorded human experiments inside a former Phnom Penh school-turned-prison, filing the notebook as official paperwork rather than hiding it. Across the twentieth century, trained physicians from Unit 731 to Soviet psychiatry documented procedures that reclassified people as non-patients - so why did prosecution and accountability so often never follow?

In this episode, we lay out the documented cases and institutional instruments that turned medical practice into state violence, showing how codes like the Nuremberg Code, the Declaration of Geneva, and the Declaration of Tokyo were written in response to such breaches - and yet violations continued. How did documentation, professional habit, and changing diagnostic criteria enable healers to become executioners?

Person: Josef Mengele
Event: Unit Seven Thirty-One operations (1937-1945)
Date: 1978 notebook entries
Topic: Soviet diagnosis "sluggish schizophrenia" applied to dissent
Instrument: Declaration of Tokyo (1975) stating physician must not participate in torture

- The 1978 notebook was written inside a former Phnom Penh school converted into a prison and was officially filed rather than hidden.
- Unit Seven Thirty-One operated from 1937 to 1945 and is reported to have tortured and killed up to 10,000 prisoners.
- The Nuremberg Trials in the 1940s exposed physician-led experiments such as those by Josef Mengele at Auschwitz.
- The Declaration of Tokyo was issued in 1975 by the World Medical Association asserting doctors shall not participate in torture.
- Soviet psychiatrists invented the diagnosis "sluggish schizophrenia" to detain political dissidents without trial, using high-dose neuroleptics as "treatment."

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1642falsefullhttps://www.spreaker.com/episode/the-medical-records-that-exposed-decades-of-human-experimentation--73090424
The ordinary ledger can become a ledger of atrocity: a notebook found in 1978 at Tuol Sleng listed human experiments under a Khmer phrase translated as "pisaot menuh," and clinical charts from a New Zealand child psychiatric ward recorded electric shocks given as punishment. How did routine medical paperwork become the clearest proof that trained healers were ordered to harm - and who was ever held accountable?

In this episode, we follow the paper trail that links medical records from Tuol Sleng to Lake Alice and to earlier wartime programs, showing how dates, signatures, and clinical detail reveal practices labeled "human experiments" and "torture." What does the persistence of those records tell us about how medicine was repurposed across different countries and decades?

Person: Dietrich Bonhoeffer
Date: 1978
Location: Tuol Sleng (S-21), Phnom Penh
Event: Human experiments recorded under the phrase "pisaot menuh"
Case: Lake Alice child and adolescent unit (1972-1978)

- Investigators found the Tuol Sleng notebook in 1978 inside the ruins of S-21 with pages documenting human experiments.
- The Khmer phrase recorded for at least seventeen people in the Tuol Sleng notebook translates as "pisaot menuh" (human experiments).
- Unit 731 operated from 1937 to 1945 with estimated death tolls reaching ten thousand people due to organized medical experiments.
- Lake Alice admitted 362 patients to its child and adolescent unit between 1972 and 1978, many without diagnosed mental illness.
- The Royal Commission of Inquiry found practices at Lake Alice amounted to torture, yet clinicians faced no criminal accountability.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090424Tue, 06 Oct 2026 08:00:03 +0000Creator at ObomediaThe Medical Records That Exposed Decades of Human Experimentation The ordinary ledger can become a ledger of atrocity: a notebook found in 1978 at Tuol Sleng listed human experiments under a Khmer phrase translated as "pisaot menuh," and clinical...
The ordinary ledger can become a ledger of atrocity: a notebook found in 1978 at Tuol Sleng listed human experiments under a Khmer phrase translated as "pisaot menuh," and clinical charts from a New Zealand child psychiatric ward recorded electric shocks given as punishment. How did routine medical paperwork become the clearest proof that trained healers were ordered to harm - and who was ever held accountable?

In this episode, we follow the paper trail that links medical records from Tuol Sleng to Lake Alice and to earlier wartime programs, showing how dates, signatures, and clinical detail reveal practices labeled "human experiments" and "torture." What does the persistence of those records tell us about how medicine was repurposed across different countries and decades?

Person: Dietrich Bonhoeffer
Date: 1978
Location: Tuol Sleng (S-21), Phnom Penh
Event: Human experiments recorded under the phrase "pisaot menuh"
Case: Lake Alice child and adolescent unit (1972-1978)

- Investigators found the Tuol Sleng notebook in 1978 inside the ruins of S-21 with pages documenting human experiments.
- The Khmer phrase recorded for at least seventeen people in the Tuol Sleng notebook translates as "pisaot menuh" (human experiments).
- Unit 731 operated from 1937 to 1945 with estimated death tolls reaching ten thousand people due to organized medical experiments.
- Lake Alice admitted 362 patients to its child and adolescent unit between 1972 and 1978, many without diagnosed mental illness.
- The Royal Commission of Inquiry found practices at Lake Alice amounted to torture, yet clinicians faced no criminal accountability.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1641falsefullhttps://www.spreaker.com/episode/when-healers-harm-doctors-who-turned-medicine-into-torture--73090421
Trust in healers can be shattered by the fact that physicians have, in documented cases from Tuol Sleng to Lake Alice, deliberately used clinical skills to inflict suffering; how did oaths and ethics fail to stop human experiments and institutionalized harm? What allowed doctors to turn medical procedure into torture across continents and decades?

In this episode, we lay out the documented pattern linking medical training to deliberate harm and trace how international frameworks responded - and why those responses left gaps. We map cases from World War II-era atrocities to later institutional abuses to ask: how did medicine become an instrument of cruelty?

Person: Josef Mengele
Event: Discovery of a Tuol Sleng notebook documenting human experiments
Period: 1937-1978 (cases referenced span these years)
Location: Tuol Sleng security prison, Phnom Penh
Case: Lake Alice Child and Adolescent Unit admissions (362 young people)

- The Tuol Sleng notebook recorded procedures performed on at least 17 human beings and named them "pisaot menuh" (human experiments).
- Unit 731 operated between 1937 and 1945 and is estimated to have tortured and killed about 10,000 prisoners.
- The Nuremberg Code established principles like informed consent and the right to withdraw after the 1939-1945 atrocities.
- New Zealand's Royal Commission reviewed records of 362 young people admitted to Lake Alice between 1972 and 1978, many without documented mental illness.
- Lake Alice administered unmodified electroconvulsive therapy to conscious children, applying current to induce convulsions without anesthesia or muscle relaxants.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090421Mon, 05 Oct 2026 08:00:02 +0000Creator at ObomediaWhen Healers Harm: Doctors Who Turned Medicine Into Torture Trust in healers can be shattered by the fact that physicians have, in documented cases from Tuol Sleng to Lake Alice, deliberately used clinical skills to inflict suffering; how did oaths...
Trust in healers can be shattered by the fact that physicians have, in documented cases from Tuol Sleng to Lake Alice, deliberately used clinical skills to inflict suffering; how did oaths and ethics fail to stop human experiments and institutionalized harm? What allowed doctors to turn medical procedure into torture across continents and decades?

In this episode, we lay out the documented pattern linking medical training to deliberate harm and trace how international frameworks responded - and why those responses left gaps. We map cases from World War II-era atrocities to later institutional abuses to ask: how did medicine become an instrument of cruelty?

Person: Josef Mengele
Event: Discovery of a Tuol Sleng notebook documenting human experiments
Period: 1937-1978 (cases referenced span these years)
Location: Tuol Sleng security prison, Phnom Penh
Case: Lake Alice Child and Adolescent Unit admissions (362 young people)

- The Tuol Sleng notebook recorded procedures performed on at least 17 human beings and named them "pisaot menuh" (human experiments).
- Unit 731 operated between 1937 and 1945 and is estimated to have tortured and killed about 10,000 prisoners.
- The Nuremberg Code established principles like informed consent and the right to withdraw after the 1939-1945 atrocities.
- New Zealand's Royal Commission reviewed records of 362 young people admitted to Lake Alice between 1972 and 1978, many without documented mental illness.
- Lake Alice administered unmodified electroconvulsive therapy to conscious children, applying current to induce convulsions without anesthesia or muscle relaxants.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1838falsefullhttps://www.spreaker.com/episode/he-faked-their-pregnancies-the-doctor-who-manufactured-hope--73090420
In this episode, we tell the record of that medical fraud from early claims about a baboon pregnancy through decades of patient care, the treatment protocol Jacobson used, and the legal outcome, asking how a respected title and a simple hormone injection allowed this scheme to operate in plain sight.

Person: Cecil Byran Jacobson
Date of conviction: 1992
Counts: 52
Location: Fairfax County, Virginia
Birth date: October 2, 1936

- Jacobson administered human chorionic gonadotropin (hCG) injections as a fertility treatment that cause positive pregnancy tests.
- Experts testified that ultrasound images Jacobson showed patients contained nearby organs or fecal matter, not fetuses.
- Jacobson claimed in the 1960s to have implanted his sperm into a baboon that carried a pregnancy for four months; this claim was never published or peer reviewed.
- He held the title Chief of the Reproductive Genetics Unit at George Washington University Medical School but had no specialist training in infertility medicine.
- The fraud operated over years in a legitimate medical practice in Fairfax County before his 1992 conviction on 52 counts.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090420Sun, 04 Oct 2026 08:00:03 +0000Creator at ObomediaHe Faked Their Pregnancies: The Doctor Who Manufactured Hope In this episode, we tell the record of that medical fraud from early claims about a baboon pregnancy through decades of patient care, the treatment protocol Jacobson used, and the legal...
In this episode, we tell the record of that medical fraud from early claims about a baboon pregnancy through decades of patient care, the treatment protocol Jacobson used, and the legal outcome, asking how a respected title and a simple hormone injection allowed this scheme to operate in plain sight.

Person: Cecil Byran Jacobson
Date of conviction: 1992
Counts: 52
Location: Fairfax County, Virginia
Birth date: October 2, 1936

- Jacobson administered human chorionic gonadotropin (hCG) injections as a fertility treatment that cause positive pregnancy tests.
- Experts testified that ultrasound images Jacobson showed patients contained nearby organs or fecal matter, not fetuses.
- Jacobson claimed in the 1960s to have implanted his sperm into a baboon that carried a pregnancy for four months; this claim was never published or peer reviewed.
- He held the title Chief of the Reproductive Genetics Unit at George Washington University Medical School but had no specialist training in infertility medicine.
- The fraud operated over years in a legitimate medical practice in Fairfax County before his 1992 conviction on 52 counts.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1674falsefullhttps://www.spreaker.com/episode/the-doctor-who-faked-pregnancies-inside-jacobson-s-deception--73090419
The shock of trusted medicine turned to betrayal: a doctor used injections of human chorionic gonadotropin to create positive pregnancy tests while ultrasound images shown to patients were actually organs or fecal matter. How did a respected reproductive geneticist convince at least fifteen women that they were bearing children when DNA and expert testimony later proved otherwise?

In this episode, we tell the story of Cecil Bryan Jacobson and the clinic in Fairfax County, Virginia, where patients came after other options failed, the biological mechanism he exploited, the courtroom revelations that followed, and the unresolved questions about medical oversight and trust that remain.

Person: Cecil Bryan Jacobson
Date of birth: October 2, 1936
Location: Fairfax County, Virginia
Institution: George Washington University (Reproductive Genetics Unit)
Confirmed children by DNA: at least 15

- Jacobson claimed to have implanted a male baboon’s sperm into a female, resulting in a four-month pregnancy that was never published or independently verified.
- He injected patients with human chorionic gonadotropin to produce positive home and clinical pregnancy tests.
- Expert witnesses testified that ultrasound images Jacobson showed patients were actually nearby organs or fecal matter, not fetal tissue.
- Jacobson had led the Reproductive Genetics Unit at George Washington University before opening a private clinic in the 1980s without documented specialized infertility training.
- Investigations included DNA testing and federal grand jury proceedings that revealed a donor program investigators say never existed.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090419Sat, 03 Oct 2026 08:00:03 +0000Creator at ObomediaThe Doctor Who Faked Pregnancies: Inside Jacobson's Deception The shock of trusted medicine turned to betrayal: a doctor used injections of human chorionic gonadotropin to create positive pregnancy tests while ultrasound images shown to patients...
The shock of trusted medicine turned to betrayal: a doctor used injections of human chorionic gonadotropin to create positive pregnancy tests while ultrasound images shown to patients were actually organs or fecal matter. How did a respected reproductive geneticist convince at least fifteen women that they were bearing children when DNA and expert testimony later proved otherwise?

In this episode, we tell the story of Cecil Bryan Jacobson and the clinic in Fairfax County, Virginia, where patients came after other options failed, the biological mechanism he exploited, the courtroom revelations that followed, and the unresolved questions about medical oversight and trust that remain.

Person: Cecil Bryan Jacobson
Date of birth: October 2, 1936
Location: Fairfax County, Virginia
Institution: George Washington University (Reproductive Genetics Unit)
Confirmed children by DNA: at least 15

- Jacobson claimed to have implanted a male baboon’s sperm into a female, resulting in a four-month pregnancy that was never published or independently verified.
- He injected patients with human chorionic gonadotropin to produce positive home and clinical pregnancy tests.
- Expert witnesses testified that ultrasound images Jacobson showed patients were actually nearby organs or fecal matter, not fetal tissue.
- Jacobson had led the Reproductive Genetics Unit at George Washington University before opening a private clinic in the 1980s without documented specialized infertility training.
- Investigations included DNA testing and federal grand jury proceedings that revealed a donor program investigators say never existed.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1525falsefullhttps://www.spreaker.com/episode/he-built-babies-out-of-hope-the-fairfax-fertility-fraud-revealed--73090418
Hope turned into proof on blurry ultrasound prints and positive pregnancy tests-until the third month when the pregnancies vanished and investigators later found no donor program at all. Fifty-two convictions and at least fifteen confirmed children would follow; how did a respected reproductive genetics chief turn medical tools into instruments of loss?

In this episode, we trace the arc of Cecil Byran Jacobson's Fairfax County clinic, the treatments he offered, the injections and ultrasound images patients trusted, and the federal probe that exposed the fraud-what exactly did investigators uncover about the donor program and the ultrasound evidence?

Person: Cecil Byran Jacobson
Date of birth: October 2, 1936
Location: Fairfax County, Virginia
Convictions: 52
Confirmed children: at least 15

- Jacobson served as Chief of the Reproductive Genetics Unit at George Washington University Medical School by the 1960s.
- Investigators found no evidence that the promised anonymous donor insemination program ever existed.
- Trial experts testified many ultrasound images Jacobson identified as fetuses were actually anatomical structures or, in some cases, fecal matter.
- Jacobson injected patients with human chorionic gonadotropin (hCG), the hormone detected by pregnancy tests.
- The suspected total number of affected children reached as high as 75.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090418Fri, 02 Oct 2026 08:00:03 +0000Creator at ObomediaHe Built Babies Out of Hope: The Fairfax Fertility Fraud Revealed Hope turned into proof on blurry ultrasound prints and positive pregnancy tests-until the third month when the pregnancies vanished and investigators later found no donor program at...
Hope turned into proof on blurry ultrasound prints and positive pregnancy tests-until the third month when the pregnancies vanished and investigators later found no donor program at all. Fifty-two convictions and at least fifteen confirmed children would follow; how did a respected reproductive genetics chief turn medical tools into instruments of loss?

In this episode, we trace the arc of Cecil Byran Jacobson's Fairfax County clinic, the treatments he offered, the injections and ultrasound images patients trusted, and the federal probe that exposed the fraud-what exactly did investigators uncover about the donor program and the ultrasound evidence?

Person: Cecil Byran Jacobson
Date of birth: October 2, 1936
Location: Fairfax County, Virginia
Convictions: 52
Confirmed children: at least 15

- Jacobson served as Chief of the Reproductive Genetics Unit at George Washington University Medical School by the 1960s.
- Investigators found no evidence that the promised anonymous donor insemination program ever existed.
- Trial experts testified many ultrasound images Jacobson identified as fetuses were actually anatomical structures or, in some cases, fecal matter.
- Jacobson injected patients with human chorionic gonadotropin (hCG), the hormone detected by pregnancy tests.
- The suspected total number of affected children reached as high as 75.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1532falsefullhttps://www.spreaker.com/episode/the-doctor-who-created-pregnancies-that-never-existed--73090416
The idea that a single hormone injection and a grainy ultrasound could manufacture months of real hope and real grief is chilling: patients received hCG that made pregnancy tests positive and felt pregnancy symptoms, while ultrasounds Jacobson pointed to showed organs or fecal matter, not fetuses. How did one physician turn diagnostic signals into fabricated pregnancies and secretly father children in the same clinic?

In this episode, we outline the two schemes that unfolded in a Fairfax County reproductive practice, laying out the hormone-based false pregnancies and the donor insemination program that produced unexpected paternity. What did the clinical record, expert testimony, and DNA results reveal about trust, authority, and the boundaries of medical practice?

Person: Cecil Byran Jacobson
Date of birth: October 2, 1936
Location: Fairfax County, Virginia
Education: Brown University; George Washington University Medical School (Chief of the Reproductive Genetics Unit)
Hormone used: hCG (human chorionic gonadotropin)

- Jacobson opened his Fairfax County practice in the 1980s and held the title Chief of the Reproductive Genetics Unit at George Washington University Medical School.
- He injected patients with hCG, which caused home pregnancy tests to turn positive and produced pregnancy-like symptoms without an actual fetus.
- Expert testimony in federal court identified ultrasound images Jacobson presented as consistent with organs or fecal matter, not fetuses.
- Near the end of the third month, patients were often told their "fetus had died" after months of believing they were pregnant.
- DNA testing revealed at least one child conceived via the clinic's donor program was biologically fathered by Cecil Jacobson.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090416Thu, 01 Oct 2026 08:00:03 +0000Creator at ObomediaThe Doctor Who Created Pregnancies That Never Existed The idea that a single hormone injection and a grainy ultrasound could manufacture months of real hope and real grief is chilling: patients received hCG that made pregnancy tests positive and...
The idea that a single hormone injection and a grainy ultrasound could manufacture months of real hope and real grief is chilling: patients received hCG that made pregnancy tests positive and felt pregnancy symptoms, while ultrasounds Jacobson pointed to showed organs or fecal matter, not fetuses. How did one physician turn diagnostic signals into fabricated pregnancies and secretly father children in the same clinic?

In this episode, we outline the two schemes that unfolded in a Fairfax County reproductive practice, laying out the hormone-based false pregnancies and the donor insemination program that produced unexpected paternity. What did the clinical record, expert testimony, and DNA results reveal about trust, authority, and the boundaries of medical practice?

Person: Cecil Byran Jacobson
Date of birth: October 2, 1936
Location: Fairfax County, Virginia
Education: Brown University; George Washington University Medical School (Chief of the Reproductive Genetics Unit)
Hormone used: hCG (human chorionic gonadotropin)

- Jacobson opened his Fairfax County practice in the 1980s and held the title Chief of the Reproductive Genetics Unit at George Washington University Medical School.
- He injected patients with hCG, which caused home pregnancy tests to turn positive and produced pregnancy-like symptoms without an actual fetus.
- Expert testimony in federal court identified ultrasound images Jacobson presented as consistent with organs or fecal matter, not fetuses.
- Near the end of the third month, patients were often told their "fetus had died" after months of believing they were pregnant.
- DNA testing revealed at least one child conceived via the clinic's donor program was biologically fathered by Cecil Jacobson.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1465falsefullhttps://www.spreaker.com/episode/he-claimed-babies-not-donors-the-doctor-who-fathered-dozens--73090414
Heard certainty can be more convincing than evidence: a chief of a university reproductive genetics unit showed patients grainy ultrasound images and gave injections that made pregnancy tests positive, while expert testimony later said the images were likely organs or fecal matter. How did a respected doctor turn late-20th-century infertility care into a decade-long pattern of false pregnancies - and what did DNA testing reveal afterward?

In this episode, we present the story of Cecil Bryan Jacobson and the care he provided at a private clinic in Fairfax County, Virginia, covering his background, the methods he used to produce false positive pregnancies, and the emergence of DNA evidence that reframed the case. What changed when families began to doubt his diagnoses?

Person: Cecil Bryan Jacobson
Date of birth: October 2, 1936
Location: Fairfax County, Virginia
Institution: George Washington University (former Chief of the Reproductive Genetics Unit)
Period: 1960s-1980s

- Jacobson was chief of the Reproductive Genetics Unit at George Washington University before opening a private clinic in Fairfax County.
- He reportedly claimed in the 1960s to have implanted his own sperm into a female baboon, a claim never published or independently verified.
- Federal investigators documented a pattern of false pregnancies across the 1980s in his private clinic.
- Jacobson injected patients with hCG, the hormone that causes standard pregnancy tests to read positive.
- At least 15 families - and possibly as many as 75 - were affected as the case shifted from false pregnancies to questions answered by DNA testing.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090414Wed, 30 Sep 2026 08:00:04 +0000Creator at ObomediaHe Claimed Babies, Not Donors: The Doctor Who Fathered Dozens Heard certainty can be more convincing than evidence: a chief of a university reproductive genetics unit showed patients grainy ultrasound images and gave injections that made pregnancy...
Heard certainty can be more convincing than evidence: a chief of a university reproductive genetics unit showed patients grainy ultrasound images and gave injections that made pregnancy tests positive, while expert testimony later said the images were likely organs or fecal matter. How did a respected doctor turn late-20th-century infertility care into a decade-long pattern of false pregnancies - and what did DNA testing reveal afterward?

In this episode, we present the story of Cecil Bryan Jacobson and the care he provided at a private clinic in Fairfax County, Virginia, covering his background, the methods he used to produce false positive pregnancies, and the emergence of DNA evidence that reframed the case. What changed when families began to doubt his diagnoses?

Person: Cecil Bryan Jacobson
Date of birth: October 2, 1936
Location: Fairfax County, Virginia
Institution: George Washington University (former Chief of the Reproductive Genetics Unit)
Period: 1960s-1980s

- Jacobson was chief of the Reproductive Genetics Unit at George Washington University before opening a private clinic in Fairfax County.
- He reportedly claimed in the 1960s to have implanted his own sperm into a female baboon, a claim never published or independently verified.
- Federal investigators documented a pattern of false pregnancies across the 1980s in his private clinic.
- Jacobson injected patients with hCG, the hormone that causes standard pregnancy tests to read positive.
- At least 15 families - and possibly as many as 75 - were affected as the case shifted from false pregnancies to questions answered by DNA testing.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1641falsefullhttps://www.spreaker.com/episode/he-faked-their-pregnancies-the-doctor-who-stole-motherhood--73090413
The idea that a trusted doctor could manufacture pregnancies and steal biological parenthood sparks a specific, cold dread: your most private hope turned into someone else’s secret. This episode reveals how ultrasound images, hormone injections and coded “donor” files were used to create convincing false pregnancies - and asks how so many red flags were missed until DNA proved paternity.

In this episode, you’ll hear the story of Cecil Byran Jacobson, the reproductive genetics doctor whose clinic in Fairfax County offered certainty to women who had struggled to conceive, and whose methods concealed a deeper betrayal. How did credentials, confident readings and a few documented successes shield a pattern of deception that only DNA and trial testimony later exposed?

Person: Cecil Byran Jacobson
Location: Fairfax County, Virginia
Period: 1980s
Event: False pregnancies produced by hormone injections and misleading ultrasounds
Evidence: DNA confirmed at least 15 children fathered by Jacobson

- Born October 2, 1936, in Salt Lake City, Utah, Cecil Byran Jacobson held the title Chief of the Reproductive Genetics Unit at George Washington University Medical School.
- Jacobson opened a reproductive genetics center in Fairfax County in the 1980s without specialist training in infertility medicine.
- Investigators found no evidence that the coded anonymous donor program Jacobson claimed to run ever existed.
- Trial experts testified that ultrasound images Jacobson showed patients were actually nearby organs or fecal matter, not fetuses.
- DNA evidence confirmed that at least 15 children, possibly up to 75, were fathered by Jacobson, including one case where a woman had specifically requested her husband’s sperm.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090413Tue, 29 Sep 2026 08:00:03 +0000Creator at ObomediaHe Faked Their Pregnancies - The Doctor Who Stole Motherhood The idea that a trusted doctor could manufacture pregnancies and steal biological parenthood sparks a specific, cold dread: your most private hope turned into someone else’s secret. This...
The idea that a trusted doctor could manufacture pregnancies and steal biological parenthood sparks a specific, cold dread: your most private hope turned into someone else’s secret. This episode reveals how ultrasound images, hormone injections and coded “donor” files were used to create convincing false pregnancies - and asks how so many red flags were missed until DNA proved paternity.

In this episode, you’ll hear the story of Cecil Byran Jacobson, the reproductive genetics doctor whose clinic in Fairfax County offered certainty to women who had struggled to conceive, and whose methods concealed a deeper betrayal. How did credentials, confident readings and a few documented successes shield a pattern of deception that only DNA and trial testimony later exposed?

Person: Cecil Byran Jacobson
Location: Fairfax County, Virginia
Period: 1980s
Event: False pregnancies produced by hormone injections and misleading ultrasounds
Evidence: DNA confirmed at least 15 children fathered by Jacobson

- Born October 2, 1936, in Salt Lake City, Utah, Cecil Byran Jacobson held the title Chief of the Reproductive Genetics Unit at George Washington University Medical School.
- Jacobson opened a reproductive genetics center in Fairfax County in the 1980s without specialist training in infertility medicine.
- Investigators found no evidence that the coded anonymous donor program Jacobson claimed to run ever existed.
- Trial experts testified that ultrasound images Jacobson showed patients were actually nearby organs or fecal matter, not fetuses.
- DNA evidence confirmed that at least 15 children, possibly up to 75, were fathered by Jacobson, including one case where a woman had specifically requested her husband’s sperm.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1607falsefullhttps://www.spreaker.com/episode/manufacturers-quitting-the-question-about-meaning-of-payouts--73090412
A federal program had paid out $4.2 billion by October 2019 to American families - a number that sounds like a confession but records show the payouts responded to rare, documented injuries such as anaphylaxis and febrile seizures. Why did 5,636 families file autism-related claims with the Vaccine Injury Compensation Program and receive only one compensation?

In this episode, we trace how manufacturers withdrawing from vaccine production in the early 1980s led Congress to create a no-fault federal compensation system, how the Vaccine Injury Compensation works, and why the gap between public belief and federal record about vaccine harm became so wide. What does the $4.2 billion total actually mean about risk, responsibility, and the program’s original purpose?

Person: families who filed claims
Date: October 2019
Event: $4.2 billion in payouts by the VICP
Case: 5,636 autism-related claims filed (1988-March 2011)
Claim outcome: 1 autism claim compensated

- By mid-1980s, only a single domestic vaccine manufacturer remained for certain critical vaccines due to litigation pressure.
- The National Childhood Vaccine Injury Act was passed in 1986 and the VICP took effect in 1988 as a no-fault federal system.
- Anaphylaxis occurs at approximately 1 per 1,000,000 doses across all vaccines, and some cases are linked to gelatin in MMR.
- Retroactive claims filed for injuries before 1988 totaled 4,264; 1,189 were compensated with $903,000,000 awarded.
- Between 1988 and March 2011, 5,636 families filed vaccine-autism claims with the VICP, resulting in one compensated autism-related award.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090412Mon, 28 Sep 2026 08:00:02 +0000Creator at Obomedia+ manufacturers quitting + the question about meaning of payouts A federal program had paid out $4.2 billion by October 2019 to American families - a number that sounds like a confession but records show the payouts responded to rare, documented...
A federal program had paid out $4.2 billion by October 2019 to American families - a number that sounds like a confession but records show the payouts responded to rare, documented injuries such as anaphylaxis and febrile seizures. Why did 5,636 families file autism-related claims with the Vaccine Injury Compensation Program and receive only one compensation?

In this episode, we trace how manufacturers withdrawing from vaccine production in the early 1980s led Congress to create a no-fault federal compensation system, how the Vaccine Injury Compensation works, and why the gap between public belief and federal record about vaccine harm became so wide. What does the $4.2 billion total actually mean about risk, responsibility, and the program’s original purpose?

Person: families who filed claims
Date: October 2019
Event: $4.2 billion in payouts by the VICP
Case: 5,636 autism-related claims filed (1988-March 2011)
Claim outcome: 1 autism claim compensated

- By mid-1980s, only a single domestic vaccine manufacturer remained for certain critical vaccines due to litigation pressure.
- The National Childhood Vaccine Injury Act was passed in 1986 and the VICP took effect in 1988 as a no-fault federal system.
- Anaphylaxis occurs at approximately 1 per 1,000,000 doses across all vaccines, and some cases are linked to gelatin in MMR.
- Retroactive claims filed for injuries before 1988 totaled 4,264; 1,189 were compensated with $903,000,000 awarded.
- Between 1988 and March 2011, 5,636 families filed vaccine-autism claims with the VICP, resulting in one compensated autism-related award.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1881falsefullhttps://www.spreaker.com/episode/the-pill-that-broke-minds-mefloquine-s-untold-military-legacy--73090408
A routine anti-malarial pill given to healthy troops and travelers carried a molecular secret: it was a chiral racemate with four stereoisomers and a half-life of two to four weeks, and it acts on the serotonin 5-HT2A receptor - the same target as classic psychedelics. How much did those who distributed millions of doses know about its effects on the brain, and what happened when large-scale use outpaced rigorous safety trials?

In this episode, we trace the drug from Walter Reed’s screening of 250,000 compounds to its use across decades, outlining the gaps in testing and regulatory oversight and asking whether the harms documented later could have been foreseen.

Person: Walter Reed Army Institute of Research
Event: Screening of 250,000 chemical compounds
Compound: 142,490 (mefloquine)
Date: 1984 Swiss approval; 1989 FDA approval; 2001 first randomized controlled trial published
Population: 16,000 Canadian soldiers received mefloquine between 2001 and 2012

- 250,000 chemical compounds were screened at Walter Reed to find an anti-malarial.
- Compound 142,490 (mefloquine) cleared early testing and was later transferred to Hoffmann‑LaRoche and SmithKline.
- Switzerland approved mefloquine in 1984 and the FDA approved it in 1989, prior to a mixed-population randomized controlled trial.
- Mefloquine has a half-life of two to four weeks and contains four stereoisomers sold as a racemate.
- Between 2001 and 2012, 16,000 Canadian soldiers in Afghanistan received mefloquine.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090408Sun, 27 Sep 2026 08:00:02 +0000Creator at ObomediaThe Pill That Broke Minds: Mefloquine's Untold Military Legacy A routine anti-malarial pill given to healthy troops and travelers carried a molecular secret: it was a chiral racemate with four stereoisomers and a half-life of two to four weeks, and...
A routine anti-malarial pill given to healthy troops and travelers carried a molecular secret: it was a chiral racemate with four stereoisomers and a half-life of two to four weeks, and it acts on the serotonin 5-HT2A receptor - the same target as classic psychedelics. How much did those who distributed millions of doses know about its effects on the brain, and what happened when large-scale use outpaced rigorous safety trials?

In this episode, we trace the drug from Walter Reed’s screening of 250,000 compounds to its use across decades, outlining the gaps in testing and regulatory oversight and asking whether the harms documented later could have been foreseen.

Person: Walter Reed Army Institute of Research
Event: Screening of 250,000 chemical compounds
Compound: 142,490 (mefloquine)
Date: 1984 Swiss approval; 1989 FDA approval; 2001 first randomized controlled trial published
Population: 16,000 Canadian soldiers received mefloquine between 2001 and 2012

- 250,000 chemical compounds were screened at Walter Reed to find an anti-malarial.
- Compound 142,490 (mefloquine) cleared early testing and was later transferred to Hoffmann‑LaRoche and SmithKline.
- Switzerland approved mefloquine in 1984 and the FDA approved it in 1989, prior to a mixed-population randomized controlled trial.
- Mefloquine has a half-life of two to four weeks and contains four stereoisomers sold as a racemate.
- Between 2001 and 2012, 16,000 Canadian soldiers in Afghanistan received mefloquine.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1575falsefullhttps://www.spreaker.com/episode/the-watch-on-the-drug-how-4-6m-reports-hid-millions-more-harmed--73090407
A single database in Uppsala had 4.6 million reports of medicines doing the wrong thing - but experts estimate the true number of adverse drug events was 10-20 times larger, meaning up to 92 million harms went unrecorded. How did a global watch over medicines become both meticulous and massively incomplete, and what exactly did the system choose to see or ignore?

In this episode, we walk through how the WHO programme placed a pharmacovigilance hub in Uppsala, how VigiBase collected reports from over 150 countries, and why the difference between an adverse event and an adverse drug reaction decided whether suffering entered the official record. Can a surveillance system built on human judgments ever capture the real scale of medicine-related harm?

Person: Uppsala Monitoring Centre
Date: January 2009
Location: Uppsala, Sweden
Event: 4.6 million records in VigiBase
Country: more than 150 member nations

- VigiBase contained 4.6 million records as of January 2009.
- Experts estimated actual adverse drug events were between 10 and 20 times the recorded number (46 million to 92 million).
- Severe, unexpected reactions were reported at a rate of 80-90%.
- Mild or common reactions were reported at a rate of 5-10% or lower.
- A valid report required four elements: an identifiable patient, an identifiable reporter, a suspected drug, and an adverse event.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090407Sat, 26 Sep 2026 08:00:02 +0000Creator at ObomediaThe Watch on the Drug: How 4.6M Reports Hid Millions More Harmed A single database in Uppsala had 4.6 million reports of medicines doing the wrong thing - but experts estimate the true number of adverse drug events was 10-20 times larger, meaning...
A single database in Uppsala had 4.6 million reports of medicines doing the wrong thing - but experts estimate the true number of adverse drug events was 10-20 times larger, meaning up to 92 million harms went unrecorded. How did a global watch over medicines become both meticulous and massively incomplete, and what exactly did the system choose to see or ignore?

In this episode, we walk through how the WHO programme placed a pharmacovigilance hub in Uppsala, how VigiBase collected reports from over 150 countries, and why the difference between an adverse event and an adverse drug reaction decided whether suffering entered the official record. Can a surveillance system built on human judgments ever capture the real scale of medicine-related harm?

Person: Uppsala Monitoring Centre
Date: January 2009
Location: Uppsala, Sweden
Event: 4.6 million records in VigiBase
Country: more than 150 member nations

- VigiBase contained 4.6 million records as of January 2009.
- Experts estimated actual adverse drug events were between 10 and 20 times the recorded number (46 million to 92 million).
- Severe, unexpected reactions were reported at a rate of 80-90%.
- Mild or common reactions were reported at a rate of 5-10% or lower.
- A valid report required four elements: an identifiable patient, an identifiable reporter, a suspected drug, and an adverse event.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1781falsefullhttps://www.spreaker.com/episode/the-joke-that-became-his-epitaph-rodney-dangerfield-s-hidden-wounds--73090406
He built the "I don't get no respect" persona from a life of abandonment, a $20,000 debt, and nights selling aluminum siding between sets - and the same joke that defined him became his epitaph within hours of his death. How did a boy named Jacob Cohen from Babylon turn decades of invisible failures into one of the most recognizable comic identities of the twentieth century?

In this episode, we tell the arc of his life from Jacob Cohen to Jack Roy to Rodney Dangerfield, following the personal losses, the nine years of grinding failure, the return to the Catskills, and the pivotal moment a club owner gave him his stage name - could a name and a punchline finally make him seen?

Person: Jacob Cohen / Rodney Dangerfield
Date: November 22, 1921 (birth)
Event: Website auto-generated Joke of the Day became his epitaph on October 5, 2004
Location: Babylon, New York; Catskill resorts; Inwood Lounge, Manhattan
Debt: Roughly $20,000 carried over nine years

- He began writing jokes at age 15.
- He legally changed his name to Jack Roy at age 19.
- He accumulated roughly $20,000 in debt over nine years of trying and failing.
- He worked selling aluminum siding while performing at night in his late 30s and early 40s.
- George McFadden of the Inwood Lounge gave him the stage name "Rodney Dangerfield."

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090406Fri, 25 Sep 2026 08:00:02 +0000Creator at ObomediaThe Joke That Became His Epitaph: Rodney Dangerfield's Hidden Wounds He built the "I don't get no respect" persona from a life of abandonment, a $20,000 debt, and nights selling aluminum siding between sets - and the same joke that defined him...
He built the "I don't get no respect" persona from a life of abandonment, a $20,000 debt, and nights selling aluminum siding between sets - and the same joke that defined him became his epitaph within hours of his death. How did a boy named Jacob Cohen from Babylon turn decades of invisible failures into one of the most recognizable comic identities of the twentieth century?

In this episode, we tell the arc of his life from Jacob Cohen to Jack Roy to Rodney Dangerfield, following the personal losses, the nine years of grinding failure, the return to the Catskills, and the pivotal moment a club owner gave him his stage name - could a name and a punchline finally make him seen?

Person: Jacob Cohen / Rodney Dangerfield
Date: November 22, 1921 (birth)
Event: Website auto-generated Joke of the Day became his epitaph on October 5, 2004
Location: Babylon, New York; Catskill resorts; Inwood Lounge, Manhattan
Debt: Roughly $20,000 carried over nine years

- He began writing jokes at age 15.
- He legally changed his name to Jack Roy at age 19.
- He accumulated roughly $20,000 in debt over nine years of trying and failing.
- He worked selling aluminum siding while performing at night in his late 30s and early 40s.
- George McFadden of the Inwood Lounge gave him the stage name "Rodney Dangerfield."

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1446falsefullhttps://www.spreaker.com/episode/the-altar-boy-who-became-the-world-s-scholar-of-fascism--73090405
Fear and awe: a Jewish child baptized and serving as an altar boy in Kraków would later map how the very ideologies that destroyed his family formed - arguing fascism’s roots in 1880s France and surviving a pipe bomb attack at age 73. How did a boy who learned to be invisible become the scholar who named fascism’s intellectual DNA, and why did that work make him a target?

In this episode, we follow the life and career of Zeev Sternhell from his birth in Przemyśl through wartime survival, migration to France, arrival in Israel, military service, and decades of scholarship that linked Maurice Barrès and French nationalism to the origins of fascism - and ask how those claims led to an assassination attempt on September 25, 2008.

Person: Zeev Sternhell
Date of birth: April 10, 1935
Event: Pipe bomb detonated at his Jerusalem home on September 25, 2008
Education: Bachelor's degree from Hebrew University (1957-1960); doctoral thesis at Institut d'études politiques, Paris
Awards: Léon Blum Chair (1989); Chevalier de l'Ordre des Arts et des Lettres (1991)

- He was seven years old when his mother and sister were killed and he was given false Aryan papers and the name Zbigniew Orolski.
- He served as an altar boy at the Cathedral of Kraków after being baptized to conceal his Jewish identity.
- In 1946, at age 11, a Red Cross train carried him from Poland to France, where he lived in Avignon and learned French.
- He arrived in Israel aboard the ship Artza in the winter of 1951 at age 16 and later served as a platoon commander in the Golani brigade during the Sinai War.
- On September 25, 2008, a pipe bomb exploded at his front door amid fliers offering over one million shekels to kill members of Peace Now.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090405Thu, 24 Sep 2026 08:00:03 +0000Creator at ObomediaThe Altar Boy Who Became the World's Scholar of Fascism Fear and awe: a Jewish child baptized and serving as an altar boy in Kraków would later map how the very ideologies that destroyed his family formed - arguing fascism’s roots in 1880s France...
Fear and awe: a Jewish child baptized and serving as an altar boy in Kraków would later map how the very ideologies that destroyed his family formed - arguing fascism’s roots in 1880s France and surviving a pipe bomb attack at age 73. How did a boy who learned to be invisible become the scholar who named fascism’s intellectual DNA, and why did that work make him a target?

In this episode, we follow the life and career of Zeev Sternhell from his birth in Przemyśl through wartime survival, migration to France, arrival in Israel, military service, and decades of scholarship that linked Maurice Barrès and French nationalism to the origins of fascism - and ask how those claims led to an assassination attempt on September 25, 2008.

Person: Zeev Sternhell
Date of birth: April 10, 1935
Event: Pipe bomb detonated at his Jerusalem home on September 25, 2008
Education: Bachelor's degree from Hebrew University (1957-1960); doctoral thesis at Institut d'études politiques, Paris
Awards: Léon Blum Chair (1989); Chevalier de l'Ordre des Arts et des Lettres (1991)

- He was seven years old when his mother and sister were killed and he was given false Aryan papers and the name Zbigniew Orolski.
- He served as an altar boy at the Cathedral of Kraków after being baptized to conceal his Jewish identity.
- In 1946, at age 11, a Red Cross train carried him from Poland to France, where he lived in Avignon and learned French.
- He arrived in Israel aboard the ship Artza in the winter of 1951 at age 16 and later served as a platoon commander in the Golani brigade during the Sinai War.
- On September 25, 2008, a pipe bomb exploded at his front door amid fliers offering over one million shekels to kill members of Peace Now.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1692falsefullhttps://www.spreaker.com/episode/the-king-who-refused-to-sign-their-last-papers-mohammed-v-revealed--73090403
A Muslim king who survived exile, occupation, and a collapsing order died after a routine nasal operation at age 51 - yet two hundred thousand Moroccan Jews mourned him in Rabat. He signed Vichy decrees that curtailed Jewish rights but reportedly refused to sign deportation orders; was he protector, passive ruler, or something in between?

In this episode, we tell the life story and political choices of Mohammed V of Morocco, tracing key moments from his birth in Fes to the funeral in Rabat, and probing the unresolved question of why deportation orders under Vichy were not signed.

Person: Mohammed al-Khamis bin Yusef bin Hassan al-Alawi
Date (birth): 10 August 1909
Date (death): 26 February 1961
Location (death): Lausanne, Switzerland
Event: Signed two Vichy decrees restricting Jewish life; reportedly did not sign deportation orders

- He died on 26 February 1961 at age 51 after a nasal septum correction in Lausanne.
- He was placed on the throne at age 17 in 1927 following Sultan Yusef’s death.
- On 16 May 1930 he signed the Berber Dahir, restructuring Berber communities under French civil courts.
- Approximately 250,000 Jews lived under Vichy jurisdiction in Morocco during the wartime directives.
- In January 1943 Mohammed attended the Casablanca conference dinner where Roosevelt reportedly told him “ten years from now, your country will be independent.”

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090403Wed, 23 Sep 2026 08:00:03 +0000Creator at ObomediaThe King Who Refused to Sign Their Last Papers: Mohammed V Revealed A Muslim king who survived exile, occupation, and a collapsing order died after a routine nasal operation at age 51 - yet two hundred thousand Moroccan Jews mourned him in Rabat....
A Muslim king who survived exile, occupation, and a collapsing order died after a routine nasal operation at age 51 - yet two hundred thousand Moroccan Jews mourned him in Rabat. He signed Vichy decrees that curtailed Jewish rights but reportedly refused to sign deportation orders; was he protector, passive ruler, or something in between?

In this episode, we tell the life story and political choices of Mohammed V of Morocco, tracing key moments from his birth in Fes to the funeral in Rabat, and probing the unresolved question of why deportation orders under Vichy were not signed.

Person: Mohammed al-Khamis bin Yusef bin Hassan al-Alawi
Date (birth): 10 August 1909
Date (death): 26 February 1961
Location (death): Lausanne, Switzerland
Event: Signed two Vichy decrees restricting Jewish life; reportedly did not sign deportation orders

- He died on 26 February 1961 at age 51 after a nasal septum correction in Lausanne.
- He was placed on the throne at age 17 in 1927 following Sultan Yusef’s death.
- On 16 May 1930 he signed the Berber Dahir, restructuring Berber communities under French civil courts.
- Approximately 250,000 Jews lived under Vichy jurisdiction in Morocco during the wartime directives.
- In January 1943 Mohammed attended the Casablanca conference dinner where Roosevelt reportedly told him “ten years from now, your country will be independent.”

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1649falsefullhttps://www.spreaker.com/episode/the-tangerine-revolution-how-an-election-rotten-at-the-border-won--73090402
Rotting tangerines sat in wooden crates at a border checkpoint while two sides froze a dispute that began with a disputed vote; a court first found Sergei Bagapsh had won with 50.3% and then reversed itself under pressure - how did fruit become the symbol of a revolution? What really happened in the forty-eight hours that flipped an election and triggered a standoff at the border?

In this episode, we lay out the timeline and key events of the 2004 Abkhazian presidential race, Bagapsh’s rise from sovkhoz manager to president-elect, and the political crisis that left perishable cargo and a contested verdict at the center of a geopolitical standoff. What did Bagapsh’s narrow 50.3% ruling - and its reversal after a protest at the Supreme Court - mean for a republic that existed in limbo?

Person: Sergei Uasyl-ipa Bagapsh
Date: March 4, 1949 (birth)
Date: November 1995 (seriously wounded in an attack)
Event: 2004 presidential election
Location: Sukhumi, Abkhazia
Topic: Tangerine Revolution / disputed election

- Bagapsh was born on March 4, 1949, in Sukhumi.
- The Supreme Court ruled Bagapsh had won 50.3% of the vote before reversing the decision after protesters entered the court.
- Thirty thousand Georgian civilians fled across the border during the May 1998 attack on CIS peacekeepers.
- Bagapsh served as Prime Minister in 1997 and became Managing Director of Chernomorenergo by 2000.
- Bagapsh died eight days after surgeons declared an operation successful.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090402Tue, 22 Sep 2026 08:00:03 +0000Creator at ObomediaThe Tangerine Revolution: How an Election Rotten at the Border Won Rotting tangerines sat in wooden crates at a border checkpoint while two sides froze a dispute that began with a disputed vote; a court first found Sergei Bagapsh had won with 50.3%...
Rotting tangerines sat in wooden crates at a border checkpoint while two sides froze a dispute that began with a disputed vote; a court first found Sergei Bagapsh had won with 50.3% and then reversed itself under pressure - how did fruit become the symbol of a revolution? What really happened in the forty-eight hours that flipped an election and triggered a standoff at the border?

In this episode, we lay out the timeline and key events of the 2004 Abkhazian presidential race, Bagapsh’s rise from sovkhoz manager to president-elect, and the political crisis that left perishable cargo and a contested verdict at the center of a geopolitical standoff. What did Bagapsh’s narrow 50.3% ruling - and its reversal after a protest at the Supreme Court - mean for a republic that existed in limbo?

Person: Sergei Uasyl-ipa Bagapsh
Date: March 4, 1949 (birth)
Date: November 1995 (seriously wounded in an attack)
Event: 2004 presidential election
Location: Sukhumi, Abkhazia
Topic: Tangerine Revolution / disputed election

- Bagapsh was born on March 4, 1949, in Sukhumi.
- The Supreme Court ruled Bagapsh had won 50.3% of the vote before reversing the decision after protesters entered the court.
- Thirty thousand Georgian civilians fled across the border during the May 1998 attack on CIS peacekeepers.
- Bagapsh served as Prime Minister in 1997 and became Managing Director of Chernomorenergo by 2000.
- Bagapsh died eight days after surgeons declared an operation successful.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1430falsefullhttps://www.spreaker.com/episode/when-the-generator-kept-running-eight-lives-silenced-by-invisible-gas--73090401
A single machine ran through the night and eight nineteen-year-olds stopped breathing without a struggle; carbon monoxide-colorless, odorless, and silently deadly-filled a winter cottage near Mount Radovan. How did a generator placed in an adjacent room and an open window become the last facts of eight lives that had just begun?

In this episode, we tell who those eight students were, where and how they spent the night, and the sequence of events that led to their deaths; what happened when neighbors heard the generator still running and forced a window to find the bodies will be answered as the story unfolds.

Person: Marija Pavković
Person: Žana Pavković
Person: Stipe Pavković
Person: Mia Soldo
Person: Stjepan Jukić
Person: Ivan Miličević
Person: Stipe Romić
Person: Mirela Rezo

- Date: January 1, 2021
- Location: cottage near Mount Radovan, municipality of Posušje, Bosnia and Herzegovina
- Age: all eight victims born in 2001 (nineteen years old)
- Time neighbors checked the cottage: around 10:00 AM
- Monument inaugurated on the cottage site: August 3, 2024

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090401Mon, 21 Sep 2026 08:00:03 +0000Creator at ObomediaWhen the Generator Kept Running: Eight Lives Silenced by Invisible Gas A single machine ran through the night and eight nineteen-year-olds stopped breathing without a struggle; carbon monoxide-colorless, odorless, and silently deadly-filled a...
A single machine ran through the night and eight nineteen-year-olds stopped breathing without a struggle; carbon monoxide-colorless, odorless, and silently deadly-filled a winter cottage near Mount Radovan. How did a generator placed in an adjacent room and an open window become the last facts of eight lives that had just begun?

In this episode, we tell who those eight students were, where and how they spent the night, and the sequence of events that led to their deaths; what happened when neighbors heard the generator still running and forced a window to find the bodies will be answered as the story unfolds.

Person: Marija Pavković
Person: Žana Pavković
Person: Stipe Pavković
Person: Mia Soldo
Person: Stjepan Jukić
Person: Ivan Miličević
Person: Stipe Romić
Person: Mirela Rezo

- Date: January 1, 2021
- Location: cottage near Mount Radovan, municipality of Posušje, Bosnia and Herzegovina
- Age: all eight victims born in 2001 (nineteen years old)
- Time neighbors checked the cottage: around 10:00 AM
- Monument inaugurated on the cottage site: August 3, 2024

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1551falsefullhttps://www.spreaker.com/episode/bhopal-s-midnight-leak-how-industry-law-and-silence-killed-thousands--73090396
A concrete slab cracked at 12:20 AM on December 3, 1984, releasing 42 tons of methyl isocyanate into a sleeping city where half a million people were exposed within two hours. Alarms had been switched off, the refrigeration system was dismantled months earlier, and a safety report describing this exact scenario never left the United States - so who, if anyone, was ever meant to be protected?

In this episode, we lay out the sequence of decisions, mechanical failures, and ignored warnings that led to the worst industrial disaster in history, and ask whether regulatory oversight and corporate responsibility were ever designed to include the people living downwind.

Person: Rajkumar Keswani
Date: December 3, 1984
Location: Bhopal, India
Company: Union Carbide / Union Carbide India Limited
Chemical: Methyl isocyanate (MIC)

- 12:20 AM on December 3, 1984: a concrete slab above an underground MIC storage tank cracked and leaked.
- 42 tons of methyl isocyanate were held in the tank, exceeding the company’s prescribed 30-ton storage cap.
- Refrigeration for the MIC tanks was shut down in January 1982 and refrigerant removed in June 1984.
- A 1982 Union Carbide safety audit identified 61 hazards, 30 major, with 11 concentrated in phosgene and MIC units.
- Within two hours of the leak, more than 500,000 people were breathing the gas; the plant’s scrubber had no caustic soda and the temperature alarm was disconnected.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090396Sun, 20 Sep 2026 08:00:03 +0000Creator at ObomediaBhopal's Midnight Leak: How Industry, Law, and Silence Killed Thousands A concrete slab cracked at 12:20 AM on December 3, 1984, releasing 42 tons of methyl isocyanate into a sleeping city where half a million people were exposed within two hours....
A concrete slab cracked at 12:20 AM on December 3, 1984, releasing 42 tons of methyl isocyanate into a sleeping city where half a million people were exposed within two hours. Alarms had been switched off, the refrigeration system was dismantled months earlier, and a safety report describing this exact scenario never left the United States - so who, if anyone, was ever meant to be protected?

In this episode, we lay out the sequence of decisions, mechanical failures, and ignored warnings that led to the worst industrial disaster in history, and ask whether regulatory oversight and corporate responsibility were ever designed to include the people living downwind.

Person: Rajkumar Keswani
Date: December 3, 1984
Location: Bhopal, India
Company: Union Carbide / Union Carbide India Limited
Chemical: Methyl isocyanate (MIC)

- 12:20 AM on December 3, 1984: a concrete slab above an underground MIC storage tank cracked and leaked.
- 42 tons of methyl isocyanate were held in the tank, exceeding the company’s prescribed 30-ton storage cap.
- Refrigeration for the MIC tanks was shut down in January 1982 and refrigerant removed in June 1984.
- A 1982 Union Carbide safety audit identified 61 hazards, 30 major, with 11 concentrated in phosgene and MIC units.
- Within two hours of the leak, more than 500,000 people were breathing the gas; the plant’s scrubber had no caustic soda and the temperature alarm was disconnected.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1760falsefullhttps://www.spreaker.com/episode/who-put-needles-in-our-strawberries-the-unsolved-contamination-mystery--73090394
A small, invisible violence turned ordinary punnets into objects of fear: a needle pressed inside a strawberry led to 186 contamination reports, eight brands implicated, and half a million plants burned - yet no convictions. Who inserted the first needle, and why did the investigation collapse before answers were found?

In this episode, we tell the story of the 2018 Australian strawberry needle crisis, following the timeline from the first hospitalisation on 9 September through the rapid spread of reports across states and brands, and the critical delays in response that worsened the fallout. What combination of supply-chain access, human error, and institutional failure allowed this to become a national emergency?

Date: 9 September 2018
Location: Moreton Bay, Queensland
Reports: 186 contamination reports
Brands: 8 brands affected
Plants destroyed: 500,000 strawberry plants burned

- First public warning post about contaminated strawberries appeared the same evening as the first hospital incident.
- Two separate reports had been made before Woolworths withdrew any product, creating a three-day response gap.
- Contaminated punnets moved into New South Wales, South Australia, Victoria, and Tasmania by 12 September.
- A typical punnet contained roughly 250 grams of fruit and was sealed with plastic film and a sticker.
- My Ut Trinh, a 50-year-old picking supervisor from Caboolture, worked at the farm supplying Berry Obsession and Berry Obsession.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090394Sat, 19 Sep 2026 08:00:02 +0000Creator at ObomediaWho Put Needles in Our Strawberries? The Unsolved Contamination Mystery A small, invisible violence turned ordinary punnets into objects of fear: a needle pressed inside a strawberry led to 186 contamination reports, eight brands implicated, and...
A small, invisible violence turned ordinary punnets into objects of fear: a needle pressed inside a strawberry led to 186 contamination reports, eight brands implicated, and half a million plants burned - yet no convictions. Who inserted the first needle, and why did the investigation collapse before answers were found?

In this episode, we tell the story of the 2018 Australian strawberry needle crisis, following the timeline from the first hospitalisation on 9 September through the rapid spread of reports across states and brands, and the critical delays in response that worsened the fallout. What combination of supply-chain access, human error, and institutional failure allowed this to become a national emergency?

Date: 9 September 2018
Location: Moreton Bay, Queensland
Reports: 186 contamination reports
Brands: 8 brands affected
Plants destroyed: 500,000 strawberry plants burned

- First public warning post about contaminated strawberries appeared the same evening as the first hospital incident.
- Two separate reports had been made before Woolworths withdrew any product, creating a three-day response gap.
- Contaminated punnets moved into New South Wales, South Australia, Victoria, and Tasmania by 12 September.
- A typical punnet contained roughly 250 grams of fruit and was sealed with plastic film and a sticker.
- My Ut Trinh, a 50-year-old picking supervisor from Caboolture, worked at the farm supplying Berry Obsession and Berry Obsession.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1668falsefullhttps://www.spreaker.com/episode/the-secret-second-death-toll-what-the-dust-knew-and-who-said-so--73090389
Fear that the air that filled Lower Manhattan after September 11 was itself lethal - and that officials knew enough to warn colleagues while publicly saying the opposite - opens this episode. More than 5,000 people enrolled in the federal health program have since died of attack-related illness, surpassing the September 11 death toll by 2023; who decided the public message, and why, remains unanswered.

In this episode, we lay out the timeline of warnings and reassurances, the people who kept working and breathing for months, and the mounting death toll tied to exposure - asking again what was known, when, and who chose to say otherwise.

Person: Edwin M. Kilbourne
Date: September 12, 2001
Event: Internal CDC memo warning against returning to Lower Manhattan buildings
Case: James Zadroga - death ruled related to September 11 by Dr. Gerard Breton
Status: More than 5,000 enrolled program deaths by 2023

- The fires at Ground Zero burned for three months after the attacks.
- Investigators catalogued more than 2,500 distinct contaminants in dust samples from the site.
- Dust composition was roughly 50% construction debris, 40% glass fibers, 9.2% cellulose, and 0.8% asbestos.
- By 2020, 247 NYPD officers had died of nine-eleven-related illness; by September 2022, 299 FDNY firefighters had died.
- Felicia Dunn-Jones died on February 10, 2002, five months after the attacks, of sarcoidosis attributed by the NYC chief medical examiner to the dust cloud.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090389Fri, 18 Sep 2026 08:00:03 +0000Creator at ObomediaThe Secret Second Death Toll: What the Dust Knew and Who Said So Fear that the air that filled Lower Manhattan after September 11 was itself lethal - and that officials knew enough to warn colleagues while publicly saying the opposite - opens this...
Fear that the air that filled Lower Manhattan after September 11 was itself lethal - and that officials knew enough to warn colleagues while publicly saying the opposite - opens this episode. More than 5,000 people enrolled in the federal health program have since died of attack-related illness, surpassing the September 11 death toll by 2023; who decided the public message, and why, remains unanswered.

In this episode, we lay out the timeline of warnings and reassurances, the people who kept working and breathing for months, and the mounting death toll tied to exposure - asking again what was known, when, and who chose to say otherwise.

Person: Edwin M. Kilbourne
Date: September 12, 2001
Event: Internal CDC memo warning against returning to Lower Manhattan buildings
Case: James Zadroga - death ruled related to September 11 by Dr. Gerard Breton
Status: More than 5,000 enrolled program deaths by 2023

- The fires at Ground Zero burned for three months after the attacks.
- Investigators catalogued more than 2,500 distinct contaminants in dust samples from the site.
- Dust composition was roughly 50% construction debris, 40% glass fibers, 9.2% cellulose, and 0.8% asbestos.
- By 2020, 247 NYPD officers had died of nine-eleven-related illness; by September 2022, 299 FDNY firefighters had died.
- Felicia Dunn-Jones died on February 10, 2002, five months after the attacks, of sarcoidosis attributed by the NYC chief medical examiner to the dust cloud.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1603falsefullhttps://www.spreaker.com/episode/he-filmed-a-man-dying-how-kevorkian-forced-america-s-choice--73090388
Sixty million Americans watched a real man die on television on November 22, 1998 - not a dramatization, but a fifty-two-year-old receiving a lethal injection filmed by Jack Kevorkian and mailed to CBS. How did a single videotape, after eight years of assisted deaths and four failed prosecutions, force a nation to confront who decides when a suffering person dies?

In this episode, we trace Kevorkian’s path from the son of an Armenian survivor to a trained pathologist who operated outside medicine’s institutions, his development of the Thanatron and assisted-suicide practice, and the legal gaps that allowed him to assist an estimated 130 deaths - culminating in the broadcast that led to his conviction. What choices did the law, medicine, and society leave open for him to close?

Person: Jack Kevorkian
Date: November 22, 1998
Event: Broadcast of a filmed assisted death on CBS's 60 Minutes
Period: 1988-1998 (eight years of assisted deaths)
Case: Janet Adkins - died June 4, 1990

- 60,000,000 Americans watched the televised death on November 22, 1998.
- Kevorkian claimed to have assisted in 130 deaths over eight years.
- He faced four criminal trials before the 1998 broadcast and was acquitted or not convicted in each.
- Janet Adkins, age 54, died on June 4, 1990 using Kevorkian’s device, the Thanatron.
- Kevorkian entered University of Michigan Medical School in 1948 and graduated in 1952.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090388Thu, 17 Sep 2026 08:00:03 +0000Creator at ObomediaHe Filmed a Man Dying: How Kevorkian Forced America's Choice Sixty million Americans watched a real man die on television on November 22, 1998 - not a dramatization, but a fifty-two-year-old receiving a lethal injection filmed by Jack Kevorkian and...
Sixty million Americans watched a real man die on television on November 22, 1998 - not a dramatization, but a fifty-two-year-old receiving a lethal injection filmed by Jack Kevorkian and mailed to CBS. How did a single videotape, after eight years of assisted deaths and four failed prosecutions, force a nation to confront who decides when a suffering person dies?

In this episode, we trace Kevorkian’s path from the son of an Armenian survivor to a trained pathologist who operated outside medicine’s institutions, his development of the Thanatron and assisted-suicide practice, and the legal gaps that allowed him to assist an estimated 130 deaths - culminating in the broadcast that led to his conviction. What choices did the law, medicine, and society leave open for him to close?

Person: Jack Kevorkian
Date: November 22, 1998
Event: Broadcast of a filmed assisted death on CBS's 60 Minutes
Period: 1988-1998 (eight years of assisted deaths)
Case: Janet Adkins - died June 4, 1990

- 60,000,000 Americans watched the televised death on November 22, 1998.
- Kevorkian claimed to have assisted in 130 deaths over eight years.
- He faced four criminal trials before the 1998 broadcast and was acquitted or not convicted in each.
- Janet Adkins, age 54, died on June 4, 1990 using Kevorkian’s device, the Thanatron.
- Kevorkian entered University of Michigan Medical School in 1948 and graduated in 1952.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1581falsefullhttps://www.spreaker.com/episode/hidden-gold-poisoned-blood-the-man-who-sold-italy-s-medicines--73090386
A nation trusted one office to keep its medicines safe - and inside the modest apartments of its chief regulator investigators found gold ingots, jewels, ancient coins and a Swiss account with more than fifteen billion lire. How did the man who decided which drugs entered Italy's formulary become the conduit for fortunes hidden in sofa linings, and what cost did that betrayal impose on patients?

In this episode, we trace the career and discoveries that followed the autumn 1993 search of Duilio Poggiolini's apartments, following the hidden assets, the flow of payments through his wife, and the approval of medicines that later proved dangerous. What links the buried treasure to contaminated blood products and the victims who received them?

Person: Duilio Poggiolini
Date (birth): 25 July 1929
Period (corruption window): 1982-1992
Asset seizure: 29 billion lire (connected to Poggiolini) and 10 billion lire (connected to his wife)
Swiss account amount: more than 15 billion lire

- Investigators spent twelve hours cataloging items hidden in Poggiolini's apartment in autumn 1993.
- The apartment contained gold ingots, jewels, paintings, and coins including Tsar Nicholas II gold rubles and South African Krugerrands.
- Poggiolini was Director General of the pharmaceutical department at Italy's Ministry of Health and decided formulary admissions and drug pricing.
- Between 1982 and 1992 Maria Di Pierr Poggiolini received payments from pharmaceutical companies that sought formulary access.
- Sandoglobuline, made from pooled human plasma supplied by the Marcucci group, was not subjected to viral inactivation before distribution.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090386Wed, 16 Sep 2026 08:00:03 +0000Creator at ObomediaHidden Gold, Poisoned Blood: The Man Who Sold Italy's Medicines A nation trusted one office to keep its medicines safe - and inside the modest apartments of its chief regulator investigators found gold ingots, jewels, ancient coins and a Swiss...
A nation trusted one office to keep its medicines safe - and inside the modest apartments of its chief regulator investigators found gold ingots, jewels, ancient coins and a Swiss account with more than fifteen billion lire. How did the man who decided which drugs entered Italy's formulary become the conduit for fortunes hidden in sofa linings, and what cost did that betrayal impose on patients?

In this episode, we trace the career and discoveries that followed the autumn 1993 search of Duilio Poggiolini's apartments, following the hidden assets, the flow of payments through his wife, and the approval of medicines that later proved dangerous. What links the buried treasure to contaminated blood products and the victims who received them?

Person: Duilio Poggiolini
Date (birth): 25 July 1929
Period (corruption window): 1982-1992
Asset seizure: 29 billion lire (connected to Poggiolini) and 10 billion lire (connected to his wife)
Swiss account amount: more than 15 billion lire

- Investigators spent twelve hours cataloging items hidden in Poggiolini's apartment in autumn 1993.
- The apartment contained gold ingots, jewels, paintings, and coins including Tsar Nicholas II gold rubles and South African Krugerrands.
- Poggiolini was Director General of the pharmaceutical department at Italy's Ministry of Health and decided formulary admissions and drug pricing.
- Between 1982 and 1992 Maria Di Pierr Poggiolini received payments from pharmaceutical companies that sought formulary access.
- Sandoglobuline, made from pooled human plasma supplied by the Marcucci group, was not subjected to viral inactivation before distribution.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1708falsefullhttps://www.spreaker.com/episode/the-phone-call-that-skipped-argentina-s-deadly-vaccine-queue--73090384
A single radio confession revealed a clandestine shortcut through Argentina’s vaccine scarcity: a journalist received Sputnik V inside the Health Ministry after phoning the minister, while elderly patients and health workers kept waiting - who else bypassed the line? What did that one phone call expose about power, privilege, and protocol during a crisis?

In this episode, we lay out the timeline and the players involved, showing how one on-air admission triggered resignations, prosecutions, and raids - and we ask whether this was an isolated favor or evidence of wider irregularities in the vaccine rollout.

Person: Horacio Verbitsky
Person: Ginés González García
Date: February 19, 2021
Event: Journalist vaccinated inside the Ministry of Health after private phone call
Location: Ministry of Health (Argentina)

- Verbitsky publicly stated on radio that he received a Sputnik V dose on February 19, 2021.
- Verbitsky was 69 years old at the time of vaccination.
- Within 24 hours of the broadcast, the Health Minister resigned.
- Federal prosecutors opened formal charges and a list of 70 names surfaced of people vaccinated under Ministry direction.
- A judicial raid seized documents and security footage from the Ministry headquarters.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090384Tue, 15 Sep 2026 08:00:02 +0000Creator at ObomediaThe Phone Call That Skipped Argentina's Deadly Vaccine Queue A single radio confession revealed a clandestine shortcut through Argentina’s vaccine scarcity: a journalist received Sputnik V inside the Health Ministry after phoning the minister,...
A single radio confession revealed a clandestine shortcut through Argentina’s vaccine scarcity: a journalist received Sputnik V inside the Health Ministry after phoning the minister, while elderly patients and health workers kept waiting - who else bypassed the line? What did that one phone call expose about power, privilege, and protocol during a crisis?

In this episode, we lay out the timeline and the players involved, showing how one on-air admission triggered resignations, prosecutions, and raids - and we ask whether this was an isolated favor or evidence of wider irregularities in the vaccine rollout.

Person: Horacio Verbitsky
Person: Ginés González García
Date: February 19, 2021
Event: Journalist vaccinated inside the Ministry of Health after private phone call
Location: Ministry of Health (Argentina)

- Verbitsky publicly stated on radio that he received a Sputnik V dose on February 19, 2021.
- Verbitsky was 69 years old at the time of vaccination.
- Within 24 hours of the broadcast, the Health Minister resigned.
- Federal prosecutors opened formal charges and a list of 70 names surfaced of people vaccinated under Ministry direction.
- A judicial raid seized documents and security footage from the Ministry headquarters.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1667falsefullhttps://www.spreaker.com/episode/the-doctor-who-diagnosed-freedom-as-madness-drapetomania-explained--73090383
Freedom was recast as a disease when a Louisiana physician named Samuel A. Cartwright declared in May 1851 that "walking away" was a psychiatric symptom called drapetomania. The diagnosis spread from a medical lecture into plantation policy and print-how did a single paper turn escape into pathology, and who pushed back?

In this episode, we trace the paper Cartwright presented to the Medical Association of Louisiana, its publication in the New Orleans Medical and Surgical Journal and reprint in De Bow's Review, and the social and therapeutic prescriptions he recommended - including "proper governance" and whipping - to answer the question: how did medicine become a tool to justify slavery?

Person: Samuel A. Cartwright
Date: May 1851
Publication: New Orleans Medical and Surgical Journal (pages 691-715)
Reprint: De Bow's Review
Later reference: Stedman's Practical Medical Dictionary (1914)

- Cartwright named the condition drapetomania, built from Greek drapetēs (fugitive slave) + mania (madness).
- His paper was titled "Report on the Diseases and Physical Peculiarities of the Negro Race" and presented to the Medical Association of Louisiana.
- The paper was published in 1851 on pages 691-715 of the New Orleans Medical and Surgical Journal and reprinted in De Bow's Review.
- Cartwright prescribed "proper governance" measures (no traveling after dark, maintained family units, limited visits, no alcohol) and recommended whipping as treatment.
- Drapetomania appeared in Stedman's Practical Medical Dictionary as late as 1914, 63 years after Cartwright's lecture.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090383Mon, 14 Sep 2026 08:00:02 +0000Creator at ObomediaThe Doctor Who Diagnosed Freedom as Madness: Drapetomania Explained Freedom was recast as a disease when a Louisiana physician named Samuel A. Cartwright declared in May 1851 that "walking away" was a psychiatric symptom called drapetomania. The...
Freedom was recast as a disease when a Louisiana physician named Samuel A. Cartwright declared in May 1851 that "walking away" was a psychiatric symptom called drapetomania. The diagnosis spread from a medical lecture into plantation policy and print-how did a single paper turn escape into pathology, and who pushed back?

In this episode, we trace the paper Cartwright presented to the Medical Association of Louisiana, its publication in the New Orleans Medical and Surgical Journal and reprint in De Bow's Review, and the social and therapeutic prescriptions he recommended - including "proper governance" and whipping - to answer the question: how did medicine become a tool to justify slavery?

Person: Samuel A. Cartwright
Date: May 1851
Publication: New Orleans Medical and Surgical Journal (pages 691-715)
Reprint: De Bow's Review
Later reference: Stedman's Practical Medical Dictionary (1914)

- Cartwright named the condition drapetomania, built from Greek drapetēs (fugitive slave) + mania (madness).
- His paper was titled "Report on the Diseases and Physical Peculiarities of the Negro Race" and presented to the Medical Association of Louisiana.
- The paper was published in 1851 on pages 691-715 of the New Orleans Medical and Surgical Journal and reprinted in De Bow's Review.
- Cartwright prescribed "proper governance" measures (no traveling after dark, maintained family units, limited visits, no alcohol) and recommended whipping as treatment.
- Drapetomania appeared in Stedman's Practical Medical Dictionary as late as 1914, 63 years after Cartwright's lecture.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1506falsefullhttps://www.spreaker.com/episode/how-jawan-rebuilt-indian-cinema-medicine-memory-and-mass-spectacle--73090382
A film shot its first scene in a Pune metro station on 30 August 2021 with Shah Rukh Khan sitting still-a single image that later millions would associate with a film that then had no name. Built during a pandemic, conceived over Zoom, and featuring a 135-foot studio train and a 300 crore rupee budget, how did a gamble of scale turn into a 1,148 crore worldwide phenomenon?

In this episode, we trace the production choices, creative collaborations, and political impulses that shaped the film from a video-call pitch to global box-office success. How did decisions-casting a Tamil director for a Hindi debut, a composer making his solo Bollywood debut, and a storyline rooted in real-life crises-combine to remake mainstream Indian cinema?

Person: Shah Rukh Khan
Director: Atlee
Production budget: 300 crore rupees
Worldwide gross: 1,148 crore rupees
Music rights sale: 36 crore rupees

- First cameras arrived at Sant Tukaram Nagar metro station, Pune on 30 August 2021 and the shoot there lasted 16 days.
- The train built for the film measured 135 feet and was constructed inside a studio because no real track would do.
- The original collaboration between Khan and Atlee was announced in October 2019 and the script was pitched over Zoom during 2020.
- Post-production ran for six months from January to August 2023 following two years of shooting across five cities.
- The music rights sold to T-Series for 36 crore rupees and composer Anirudh Ravichander made his solo Hindi film debut.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090382Sun, 13 Sep 2026 08:00:02 +0000Creator at ObomediaHow Jawan Rebuilt Indian Cinema: Medicine, Memory, and Mass Spectacle A film shot its first scene in a Pune metro station on 30 August 2021 with Shah Rukh Khan sitting still-a single image that later millions would associate with a film that then...
A film shot its first scene in a Pune metro station on 30 August 2021 with Shah Rukh Khan sitting still-a single image that later millions would associate with a film that then had no name. Built during a pandemic, conceived over Zoom, and featuring a 135-foot studio train and a 300 crore rupee budget, how did a gamble of scale turn into a 1,148 crore worldwide phenomenon?

In this episode, we trace the production choices, creative collaborations, and political impulses that shaped the film from a video-call pitch to global box-office success. How did decisions-casting a Tamil director for a Hindi debut, a composer making his solo Bollywood debut, and a storyline rooted in real-life crises-combine to remake mainstream Indian cinema?

Person: Shah Rukh Khan
Director: Atlee
Production budget: 300 crore rupees
Worldwide gross: 1,148 crore rupees
Music rights sale: 36 crore rupees

- First cameras arrived at Sant Tukaram Nagar metro station, Pune on 30 August 2021 and the shoot there lasted 16 days.
- The train built for the film measured 135 feet and was constructed inside a studio because no real track would do.
- The original collaboration between Khan and Atlee was announced in October 2019 and the script was pitched over Zoom during 2020.
- Post-production ran for six months from January to August 2023 following two years of shooting across five cities.
- The music rights sold to T-Series for 36 crore rupees and composer Anirudh Ravichander made his solo Hindi film debut.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1643falsefullhttps://www.spreaker.com/episode/the-anesthetic-that-killed-a-king-inside-michael-jackson-s-final-hours--73090381
Fear and fascination collide: a powerful surgical anesthetic called propofol was being used as a sleep aid in a rented Los Angeles mansion, and Michael Jackson was dead less than 14 hours after a late-night rehearsal. How did a drug that requires operating-room monitoring become part of a private bedtime routine, and why was there nearly an hour and a half before anyone dialed 9-1-1?

In this episode, we lay out the documented timeline from the Staples Center rehearsal past midnight to the coroner's homicide ruling and the criminal conviction that followed, using medical reports, police documents, and witness accounts to track propofol, personnel, and phone calls. What gaps between toxicology, official findings, and charges still need answering?

Date: June 25, 2009
Person: Michael Jackson
Location: 100 North Carolwood Drive, Holmby Hills, Los Angeles
Drug: Propofol (intravenous anesthetic)
Verdict: Coroner ruled homicide; doctor convicted and served two years

- Jackson rehearsed at the Staples Center the evening of June 24, arriving around 6:30 p.m. and beginning rehearsals at 9:00 p.m.
- Jackson went to bed at approximately 1:30 a.m, on June 25 after returning to the Carolwood house.
- A gap of nearly 1 hour and 30 minutes elapsed between when Jackson stopped breathing and when anyone called for emergency help.
- Conrad Murray was contracted in May 2009 as Jackson's personal physician at $150,000 per month and was employed by AEG Live.
- Police documents state Jackson had previously consumed up to 40 alprazolam tablets per night at one point.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090381Sat, 12 Sep 2026 08:00:03 +0000Creator at ObomediaThe Anesthetic That Killed a King: Inside Michael Jackson's Final Hours Fear and fascination collide: a powerful surgical anesthetic called propofol was being used as a sleep aid in a rented Los Angeles mansion, and Michael Jackson was dead less...
Fear and fascination collide: a powerful surgical anesthetic called propofol was being used as a sleep aid in a rented Los Angeles mansion, and Michael Jackson was dead less than 14 hours after a late-night rehearsal. How did a drug that requires operating-room monitoring become part of a private bedtime routine, and why was there nearly an hour and a half before anyone dialed 9-1-1?

In this episode, we lay out the documented timeline from the Staples Center rehearsal past midnight to the coroner's homicide ruling and the criminal conviction that followed, using medical reports, police documents, and witness accounts to track propofol, personnel, and phone calls. What gaps between toxicology, official findings, and charges still need answering?

Date: June 25, 2009
Person: Michael Jackson
Location: 100 North Carolwood Drive, Holmby Hills, Los Angeles
Drug: Propofol (intravenous anesthetic)
Verdict: Coroner ruled homicide; doctor convicted and served two years

- Jackson rehearsed at the Staples Center the evening of June 24, arriving around 6:30 p.m. and beginning rehearsals at 9:00 p.m.
- Jackson went to bed at approximately 1:30 a.m, on June 25 after returning to the Carolwood house.
- A gap of nearly 1 hour and 30 minutes elapsed between when Jackson stopped breathing and when anyone called for emergency help.
- Conrad Murray was contracted in May 2009 as Jackson's personal physician at $150,000 per month and was employed by AEG Live.
- Police documents state Jackson had previously consumed up to 40 alprazolam tablets per night at one point.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1738falsefullhttps://www.spreaker.com/episode/the-night-a-handwritten-negative-nearly-spread-hiv-through-transplants--73090380
Trust is the currency of elite sport - and Lawrence Nassar spent decades converting it into access to girls as young as six. More than 265 women and girls were harmed across MSU, the U.S. Olympic Training Center, and the Karolyi Ranch; institutions saw warnings and still let him keep practicing. How did so many checkpoints fail for so long?

In this episode, we lay out the timeline of Nassar’s career, the environments that enabled him, and the institutional decisions that allowed abuse to continue - from early reports in 2015 to the athletes who kept seeing him afterward. What choices let a trusted team doctor go unchecked for more than twenty years?

Person: Lawrence Nassar Nassar
Date of birth: August 16, 1963
Location: Michigan State University; U.S. Olympic Training Center; Karolyi Ranch, Huntsville, Texas
Case: At least 265 victims reported; 70 additional athletes abused after federal investigators first learned his name
Period: Abuse described from approximately 1988 through 2016

- Nassar was hired by Michigan State University as an assistant professor and team physician in 1997 at $100,000 per year.
- He served as USA Gymnastics national medical coordinator for 18 years, beginning in 1996.
- At least six peer-reviewed papers on gymnastics injuries list Nassar as a co-author.
- Maggie Nichols reported concerns to USA Gymnastics on June 17, 2015, but USAG did not notify police or suspend Nassar.
- Between June 2015 and September 2016, Nassar continued treating athletes while an outside law firm conducted an internal review, during which parents often sat in the same room.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090380Fri, 11 Sep 2026 08:00:02 +0000Creator at ObomediaThe Night a Handwritten "Negative" Nearly Spread HIV Through Transplants Trust is the currency of elite sport - and Lawrence Nassar spent decades converting it into access to girls as young as six. More than 265 women and girls were harmed across...
Trust is the currency of elite sport - and Lawrence Nassar spent decades converting it into access to girls as young as six. More than 265 women and girls were harmed across MSU, the U.S. Olympic Training Center, and the Karolyi Ranch; institutions saw warnings and still let him keep practicing. How did so many checkpoints fail for so long?

In this episode, we lay out the timeline of Nassar’s career, the environments that enabled him, and the institutional decisions that allowed abuse to continue - from early reports in 2015 to the athletes who kept seeing him afterward. What choices let a trusted team doctor go unchecked for more than twenty years?

Person: Lawrence Nassar Nassar
Date of birth: August 16, 1963
Location: Michigan State University; U.S. Olympic Training Center; Karolyi Ranch, Huntsville, Texas
Case: At least 265 victims reported; 70 additional athletes abused after federal investigators first learned his name
Period: Abuse described from approximately 1988 through 2016

- Nassar was hired by Michigan State University as an assistant professor and team physician in 1997 at $100,000 per year.
- He served as USA Gymnastics national medical coordinator for 18 years, beginning in 1996.
- At least six peer-reviewed papers on gymnastics injuries list Nassar as a co-author.
- Maggie Nichols reported concerns to USA Gymnastics on June 17, 2015, but USAG did not notify police or suspend Nassar.
- Between June 2015 and September 2016, Nassar continued treating athletes while an outside law firm conducted an internal review, during which parents often sat in the same room.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1624falsefullhttps://www.spreaker.com/episode/x-e3-cubierto-head-fake-mirando-sues-not-knowing-mackay-existed--73090379
A young man in Seoul bled three and a half liters after a cosmetic jawline operation while nursing staff mopped the operating room floor more than a dozen times and the advertised surgeon was absent; how did security camera footage later reveal the truth, and what does that silence hide about decades-long practices in surgery? This episode connects a 2016 death in Seoul to a 1975 New York hip operation that lasted ten hours with an uncredentialed company manager at the table - could these be symptoms of the same hidden system?

In this episode, we tell the parallel stories recorded in hospital corridors and security footage: the case of Kwon Dae-hee at Center A clinic in Seoul and the 1975 operation of Franklin Mirando in New York, and we trace the questions that tie them together - who was actually performing surgery, and why were they allowed into the operating room?

Person: Kwon Dae-hee
Date: October 2016
Location: Center A clinic, Seoul
Person: Franklin Mirando
Date: 1975

- Kwon Dae-hee was 24 years old when he underwent a jawline procedure in 2016.
- Kwon lost 3.5 liters of blood during or after the procedure; the official report recorded less than one-third of that amount.
- The operating room floor at Center A clinic was mopped more than a dozen times on the day of Kwon’s surgery.
- Franklin Mirando, age 43 in 1975, had a hip replacement that lasted ten hours.
- William MacKay, a prosthetics company general sales manager with no medical training, spent an additional 3.5 hours working on Mirando’s hip after leaving and returning.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090379Thu, 10 Sep 2026 08:00:03 +0000Creator at Obomedia- [x] E3 cubierto: head fake - Mirando sues not knowing MacKay existed A young man in Seoul bled three and a half liters after a cosmetic jawline operation while nursing staff mopped the operating room floor more than a dozen times and the...
A young man in Seoul bled three and a half liters after a cosmetic jawline operation while nursing staff mopped the operating room floor more than a dozen times and the advertised surgeon was absent; how did security camera footage later reveal the truth, and what does that silence hide about decades-long practices in surgery? This episode connects a 2016 death in Seoul to a 1975 New York hip operation that lasted ten hours with an uncredentialed company manager at the table - could these be symptoms of the same hidden system?

In this episode, we tell the parallel stories recorded in hospital corridors and security footage: the case of Kwon Dae-hee at Center A clinic in Seoul and the 1975 operation of Franklin Mirando in New York, and we trace the questions that tie them together - who was actually performing surgery, and why were they allowed into the operating room?

Person: Kwon Dae-hee
Date: October 2016
Location: Center A clinic, Seoul
Person: Franklin Mirando
Date: 1975

- Kwon Dae-hee was 24 years old when he underwent a jawline procedure in 2016.
- Kwon lost 3.5 liters of blood during or after the procedure; the official report recorded less than one-third of that amount.
- The operating room floor at Center A clinic was mopped more than a dozen times on the day of Kwon’s surgery.
- Franklin Mirando, age 43 in 1975, had a hip replacement that lasted ten hours.
- William MacKay, a prosthetics company general sales manager with no medical training, spent an additional 3.5 hours working on Mirando’s hip after leaving and returning.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1691falsefullhttps://www.spreaker.com/episode/the-shot-that-shouldn-t-have-killed-a-president-doctors-did--73090377
A presidential wound that doctors called survivable nonetheless produced death after seventy-nine days - and the bullet never struck the spinal cord. This episode tells how a $14 .442 Webley British Bulldog, a wood grip chosen because ivory cost one dollar more, and a series of medical choices turned a single shot into one of the most documented medical catastrophes in American history. How did the physicians' responses change the outcome that seemed obvious in the first hours?

In this episode, we follow the events from the purchase of the revolver through the shooting at the Baltimore and Potomac Railroad Station and the medical care that followed, tracing how decisions by those around James Abram Garfield shaped the final result. What do the details of the wound, the assassin, and the medical response reveal about why Garfield died?

Person: James Abram Garfield
Date: July 2, 1881
Assassin: Charles Julius Julius
Weapon: .442 Webley British Bulldog revolver
Survival interval: 79 days

- The revolver cost $14 and the killer chose a wood grip because ivory cost $1 more.
- The bullet entered Garfield's back and lodged behind his pancreas, missing the spinal cord.
- Every physician who examined Garfield in the first hours declared the wound survivable.
- Charles Julius was 39 years old and had been banned from the White House waiting room on May 13, 1881.
- Garfield won the 1880 election by fewer than 2,000 popular votes and was inaugurated March 4, 1881.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090377Wed, 09 Sep 2026 08:00:02 +0000Creator at ObomediaThe Shot That Shouldn't Have Killed a President - Doctors Did A presidential wound that doctors called survivable nonetheless produced death after seventy-nine days - and the bullet never struck the spinal cord. This episode tells how a $14 .442...
A presidential wound that doctors called survivable nonetheless produced death after seventy-nine days - and the bullet never struck the spinal cord. This episode tells how a $14 .442 Webley British Bulldog, a wood grip chosen because ivory cost one dollar more, and a series of medical choices turned a single shot into one of the most documented medical catastrophes in American history. How did the physicians' responses change the outcome that seemed obvious in the first hours?

In this episode, we follow the events from the purchase of the revolver through the shooting at the Baltimore and Potomac Railroad Station and the medical care that followed, tracing how decisions by those around James Abram Garfield shaped the final result. What do the details of the wound, the assassin, and the medical response reveal about why Garfield died?

Person: James Abram Garfield
Date: July 2, 1881
Assassin: Charles Julius Julius
Weapon: .442 Webley British Bulldog revolver
Survival interval: 79 days

- The revolver cost $14 and the killer chose a wood grip because ivory cost $1 more.
- The bullet entered Garfield's back and lodged behind his pancreas, missing the spinal cord.
- Every physician who examined Garfield in the first hours declared the wound survivable.
- Charles Julius was 39 years old and had been banned from the White House waiting room on May 13, 1881.
- Garfield won the 1880 election by fewer than 2,000 popular votes and was inaugurated March 4, 1881.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1514falsefullhttps://www.spreaker.com/episode/when-the-or-floor-needed-mopping-the-hidden-toll-of-ghost-surgery--73090375
The idea that a clinic's operating room needed mopping more than a dozen times is chillingly concrete: CCTV showed repeated blood cleanup while the official record listed just over one liter of blood loss. How did a twenty-two-year-old patient end up under different hands, and what did the footage reveal that the medical report did not?

In this episode, we follow the case of Kwon Dae-hee and the sequence of events after his jawline procedure at a Seoul cosmetic clinic that led his mother to review CCTV footage frame by frame. We lay out what the footage, the clinic’s staffing practices, and the official report each say - and ask how widespread practices like double-booking and unauthorized substitutes reshape responsibility for surgical outcomes.

Person: Kwon Dae-hee
Date: October 2016
Location: Seoul
Event: jawline cosmetic surgery
Status: died seven weeks after procedure

- The operating room floor had to be mopped more than a dozen times according to CCTV footage.
- The clinic’s official medical report recorded blood loss during the procedure as just over one liter.
- Kwon was 22 years old at the time and had not told his family he was having surgery.
- The surgeon whose name was on the advertising was double-booked; much of the operation was performed by a general doctor and nursing assistants.
- The Korean Society of Plastic Surgeons estimated about 100,000 patients were subjected to similar substitute-practitioner practices between 2008 and 2014.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090375Tue, 08 Sep 2026 08:00:03 +0000Creator at ObomediaWhen the OR Floor Needed Mopping: The Hidden Toll of Ghost Surgery The idea that a clinic's operating room needed mopping more than a dozen times is chillingly concrete: CCTV showed repeated blood cleanup while the official record listed just over...
The idea that a clinic's operating room needed mopping more than a dozen times is chillingly concrete: CCTV showed repeated blood cleanup while the official record listed just over one liter of blood loss. How did a twenty-two-year-old patient end up under different hands, and what did the footage reveal that the medical report did not?

In this episode, we follow the case of Kwon Dae-hee and the sequence of events after his jawline procedure at a Seoul cosmetic clinic that led his mother to review CCTV footage frame by frame. We lay out what the footage, the clinic’s staffing practices, and the official report each say - and ask how widespread practices like double-booking and unauthorized substitutes reshape responsibility for surgical outcomes.

Person: Kwon Dae-hee
Date: October 2016
Location: Seoul
Event: jawline cosmetic surgery
Status: died seven weeks after procedure

- The operating room floor had to be mopped more than a dozen times according to CCTV footage.
- The clinic’s official medical report recorded blood loss during the procedure as just over one liter.
- Kwon was 22 years old at the time and had not told his family he was having surgery.
- The surgeon whose name was on the advertising was double-booked; much of the operation was performed by a general doctor and nursing assistants.
- The Korean Society of Plastic Surgeons estimated about 100,000 patients were subjected to similar substitute-practitioner practices between 2008 and 2014.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1648falsefullhttps://www.spreaker.com/episode/how-doctors-killed-a-surviving-president-the-garfield-failure--73090374
A president shot in a crowded train station should have survived; every surgeon since agrees the wound was survivable, yet James Garfield died after seventy-nine days of public, confident medical care. What went so wrong under the hands of doctors who believed they were saving him?

In this episode, we trace the moments before and after the shooting, the personal history that brought Garfield to power, and the actions of the man who pulled the trigger, all leading to the central question: once Garfield survived the night, how did he still end up dead?

Person: James Abram Garfield
Date: July 2, 1881
Location: Baltimore and Potomac Railroad Station, Washington
Assailant: Charles Guiteau
Weapon: .442 Webley British Bulldog revolver

- Garfield was inaugurated on March 4, 1881 and had been president fewer than 200 days at the time of the shooting.
- Garfield was born in November 1831 in Orange Township, Ohio, and graduated from Williams College in 1856.
- Charles Guiteau arrived at the station at approximately 9:30 AM on July 2, 1881 and had borrowed $15 to buy the gun.
- Guiteau stopped to have his shoes shined and had prearranged a cab to take him to the police after the shooting.
- Medical observers agree the bullet wound was survivable, but Garfield died after 79 days of treatment.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090374Mon, 07 Sep 2026 08:00:02 +0000Creator at ObomediaHow Doctors Killed a Surviving President: The Garfield Failure A president shot in a crowded train station should have survived; every surgeon since agrees the wound was survivable, yet James Garfield died after seventy-nine days of public,...
A president shot in a crowded train station should have survived; every surgeon since agrees the wound was survivable, yet James Garfield died after seventy-nine days of public, confident medical care. What went so wrong under the hands of doctors who believed they were saving him?

In this episode, we trace the moments before and after the shooting, the personal history that brought Garfield to power, and the actions of the man who pulled the trigger, all leading to the central question: once Garfield survived the night, how did he still end up dead?

Person: James Abram Garfield
Date: July 2, 1881
Location: Baltimore and Potomac Railroad Station, Washington
Assailant: Charles Guiteau
Weapon: .442 Webley British Bulldog revolver

- Garfield was inaugurated on March 4, 1881 and had been president fewer than 200 days at the time of the shooting.
- Garfield was born in November 1831 in Orange Township, Ohio, and graduated from Williams College in 1856.
- Charles Guiteau arrived at the station at approximately 9:30 AM on July 2, 1881 and had borrowed $15 to buy the gun.
- Guiteau stopped to have his shoes shined and had prearranged a cab to take him to the police after the shooting.
- Medical observers agree the bullet wound was survivable, but Garfield died after 79 days of treatment.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1676falsefullhttps://www.spreaker.com/episode/when-the-surgeon-killed-patients-inside-doctor-death-duntsch-s-trail--73090373
Danger hides in credentials: a neurosurgeon trained for 15 years injured 33 of 38 patients in less than two years, permanently maiming 31 and killing 2 on the table. How did Christopher Duntsch, with a 12-page CV and a $600,000 salary, operate across four Dallas-Fort Worth hospitals while colleagues later described him as dangerous - and what let him slip through the system until a criminal conviction in 2017?

In this episode, we tell the sequence of events, the surgical errors, the colleagues and patients who raised alarms, and the legal outcome that ended with a life sentence; we ask how the medical and legal systems failed until prosecutors secured a conviction, and whether that gap has really been closed.

Person: Christopher Duntsch Duntsch
Date: February 20, 2017 (conviction deliberation and verdict)
Location: Dallas-Fort Worth area
Event: Neurosurgeon operated in four hospitals and harmed 33 of 38 patients
Status: Sentenced to life in prison, parole eligibility July 2045

- 33 of 38 patients were injured by Duntsch in under two years.
- 31 patients were permanently maimed; 2 died on the operating table.
- Jury deliberated for four hours to convict him and one hour to sentence him to life.
- Duntsch was born April 3, 1971, and finished his neurosurgery training in 2010.
- He earned an MD in 2001 and a PhD in 2002, but falsely claimed a magna cum laude doctorate program from St. Jude that did not exist.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090373Sun, 06 Sep 2026 08:00:02 +0000Creator at ObomediaWhen the Surgeon Killed Patients: Inside "Doctor Death" Duntsch's Trail Danger hides in credentials: a neurosurgeon trained for 15 years injured 33 of 38 patients in less than two years, permanently maiming 31 and killing 2 on the table. How did...
Danger hides in credentials: a neurosurgeon trained for 15 years injured 33 of 38 patients in less than two years, permanently maiming 31 and killing 2 on the table. How did Christopher Duntsch, with a 12-page CV and a $600,000 salary, operate across four Dallas-Fort Worth hospitals while colleagues later described him as dangerous - and what let him slip through the system until a criminal conviction in 2017?

In this episode, we tell the sequence of events, the surgical errors, the colleagues and patients who raised alarms, and the legal outcome that ended with a life sentence; we ask how the medical and legal systems failed until prosecutors secured a conviction, and whether that gap has really been closed.

Person: Christopher Duntsch Duntsch
Date: February 20, 2017 (conviction deliberation and verdict)
Location: Dallas-Fort Worth area
Event: Neurosurgeon operated in four hospitals and harmed 33 of 38 patients
Status: Sentenced to life in prison, parole eligibility July 2045

- 33 of 38 patients were injured by Duntsch in under two years.
- 31 patients were permanently maimed; 2 died on the operating table.
- Jury deliberated for four hours to convict him and one hour to sentence him to life.
- Duntsch was born April 3, 1971, and finished his neurosurgery training in 2010.
- He earned an MD in 2001 and a PhD in 2002, but falsely claimed a magna cum laude doctorate program from St. Jude that did not exist.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1802falsefullhttps://www.spreaker.com/episode/the-nurse-who-made-monitors-fall-silent-inside-hogel-s-ward--73090372
A single shelf held four empty vials of ajmaline in Ward Four of the Delmenhorst Clinic - a cardiac drug powerful enough to stop a heart - and supervisors did nothing. By the time anyone stopped him the death toll had been climbing for six years across two hospitals; how did hospital paperwork and promotions let a nurse accused of killing dozens keep moving through the system?

In this episode, we lay out the documented sequence of events, personnel actions, and data that followed Niels Högel from ward to ward, and trace how meetings, reports, and a glowing reference letter failed to halt him - what does that official paper trail reveal about institutional responsibility?

Person: Niels Högel
Date of birth: December 30, 1976
Event: Four empty ajmaline vials found in 2004 at Delmenhorst Clinic Ward Four
Case: Estimated 300 victims, 85 proven in court
Document: Reference letter dated October 10, 2002 from director of nursing

- 58% of all resuscitations and patient deaths on Ward Four-Eleven occurred on Högel's shifts (noted in August 2001 meeting).
- Högel called in sick for three weeks after the August 2001 meeting; only two deaths occurred on the ward during that period.
- Transfer options after a September 2002 confrontation were resignation with continued pay or reassignment to logistics; no police referral was made.
- Director of nursing issued an unqualified, positive reference letter for Högel on October 10, 2002.
- Investigators estimated up to 300 victims across two hospitals and two German cities; 85 deaths were proven in court.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090372Sat, 05 Sep 2026 08:00:02 +0000Creator at ObomediaThe Nurse Who Made Monitors Fall Silent: Inside Högel's Ward A single shelf held four empty vials of ajmaline in Ward Four of the Delmenhorst Clinic - a cardiac drug powerful enough to stop a heart - and supervisors did nothing. By the time anyone...
A single shelf held four empty vials of ajmaline in Ward Four of the Delmenhorst Clinic - a cardiac drug powerful enough to stop a heart - and supervisors did nothing. By the time anyone stopped him the death toll had been climbing for six years across two hospitals; how did hospital paperwork and promotions let a nurse accused of killing dozens keep moving through the system?

In this episode, we lay out the documented sequence of events, personnel actions, and data that followed Niels Högel from ward to ward, and trace how meetings, reports, and a glowing reference letter failed to halt him - what does that official paper trail reveal about institutional responsibility?

Person: Niels Högel
Date of birth: December 30, 1976
Event: Four empty ajmaline vials found in 2004 at Delmenhorst Clinic Ward Four
Case: Estimated 300 victims, 85 proven in court
Document: Reference letter dated October 10, 2002 from director of nursing

- 58% of all resuscitations and patient deaths on Ward Four-Eleven occurred on Högel's shifts (noted in August 2001 meeting).
- Högel called in sick for three weeks after the August 2001 meeting; only two deaths occurred on the ward during that period.
- Transfer options after a September 2002 confrontation were resignation with continued pay or reassignment to logistics; no police referral was made.
- Director of nursing issued an unqualified, positive reference letter for Högel on October 10, 2002.
- Investigators estimated up to 300 victims across two hospitals and two German cities; 85 deaths were proven in court.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1680falsefullhttps://www.spreaker.com/episode/when-the-caregiver-killed-inside-ward-211-s-quiet-murders--73090369
A ward where 58% of resuscitation events and deaths fell to one nurse sounds like a statistical alarm - but in Ward Two-Eleven those numbers met polite explanations and a glowing recommendation instead of handcuffs. How did routine drugs, failing systems, and a young nurse’s need to be needed combine to let more than two hundred people die before anyone stopped him?

In this episode, we follow the timeline and institutional choices around the cardiac surgery ICU known as Ward Two-Eleven, tracing Niels Högel’s movements between clinics, the drugs he used, and the meetings that failed to stop him. What happened inside those wards, and how did medical systems keep turning while patients continued to die?

Person: Niels Högel
Date: 22 June 2005
Location: Ward Two-Eleven, Klinikum Delmenhorst / Klinikum Oldenburg
Period: 1999-2005
Event: First witnessed adjustment of a patient’s syringe pump without an order

- In 2001 administrators recorded that 58% of all resuscitation events and patient deaths on Ward Two-Eleven occurred during the shifts of a single 24-year-old nurse.
- On 22 June 2005 a nurse at Klinikum Delmenhorst was seen adjusting a patient’s syringe pump without a doctor’s order or an alarm sounding.
- Investigators later concluded Niels Högel had killed more than two hundred people over several years.
- Högel arrived at Oldenburg in 1999 at age 22 after vocational training at Sankt-Willehad Hospital in Wilhelmshaven.
- Confirmed victims ranged in age from 34 to 96 and included people from Germany, Poland, and Turkey.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090369Fri, 04 Sep 2026 08:00:02 +0000Creator at ObomediaWhen the Caregiver Killed: Inside Ward 211's Quiet Murders A ward where 58% of resuscitation events and deaths fell to one nurse sounds like a statistical alarm - but in Ward Two-Eleven those numbers met polite explanations and a glowing...
A ward where 58% of resuscitation events and deaths fell to one nurse sounds like a statistical alarm - but in Ward Two-Eleven those numbers met polite explanations and a glowing recommendation instead of handcuffs. How did routine drugs, failing systems, and a young nurse’s need to be needed combine to let more than two hundred people die before anyone stopped him?

In this episode, we follow the timeline and institutional choices around the cardiac surgery ICU known as Ward Two-Eleven, tracing Niels Högel’s movements between clinics, the drugs he used, and the meetings that failed to stop him. What happened inside those wards, and how did medical systems keep turning while patients continued to die?

Person: Niels Högel
Date: 22 June 2005
Location: Ward Two-Eleven, Klinikum Delmenhorst / Klinikum Oldenburg
Period: 1999-2005
Event: First witnessed adjustment of a patient’s syringe pump without an order

- In 2001 administrators recorded that 58% of all resuscitation events and patient deaths on Ward Two-Eleven occurred during the shifts of a single 24-year-old nurse.
- On 22 June 2005 a nurse at Klinikum Delmenhorst was seen adjusting a patient’s syringe pump without a doctor’s order or an alarm sounding.
- Investigators later concluded Niels Högel had killed more than two hundred people over several years.
- Högel arrived at Oldenburg in 1999 at age 22 after vocational training at Sankt-Willehad Hospital in Wilhelmshaven.
- Confirmed victims ranged in age from 34 to 96 and included people from Germany, Poland, and Turkey.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1734falsefullhttps://www.spreaker.com/episode/how-a-reference-letter-hid-a-serial-killer-nurse-for-years--73090367
Fear of betrayal by those we trust is the first thing that grabs you here: a single signed reference kept a nurse employed after 58% of emergencies on his ward happened during his shifts. The word "reference" appears in official files while four empty vials of ajmaline sat in a break room - so how did that one document let him move and keep killing? What else was hidden behind routine hospital paperwork?

In this episode, we lay out the sequence of events that moved a nurse from ward to ward, the decisions made inside hospital meetings, and the small but decisive documents and actions that allowed the pattern to continue. We follow the timeline from the August meeting with damning mortality data to the October reference letter - and ask how a single piece of paper changed everything.

Person: Niels Högel
Date: June 22, 2005
Location: Delmenhorst clinic
Period: 1997-2005
Event: Reference letter signed October 10, 2002

- 58% of the emergencies and deaths on Ward 211 occurred during Högel's shifts, presented in an August 2001 meeting.
- Högel disappeared on sick leave for three weeks after the August 2001 meeting; only two patients died on the ward during that absence.
- The general director confronted Högel in September 2002 and offered resignation with three months' salary or transfer to logistics; no criminal report was filed.
- On October 10, 2002, the nursing director at Oldenburg signed a glowing letter of reference that omitted mortality data and the prior confrontation.
- Four empty vials of ajmaline were found in Högel's break room at Delmenhorst, logged but not followed by disciplinary action.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090367Thu, 03 Sep 2026 08:00:02 +0000Creator at ObomediaHow a Reference Letter Hid a Serial Killer Nurse for Years Fear of betrayal by those we trust is the first thing that grabs you here: a single signed reference kept a nurse employed after 58% of emergencies on his ward happened during his shifts....
Fear of betrayal by those we trust is the first thing that grabs you here: a single signed reference kept a nurse employed after 58% of emergencies on his ward happened during his shifts. The word "reference" appears in official files while four empty vials of ajmaline sat in a break room - so how did that one document let him move and keep killing? What else was hidden behind routine hospital paperwork?

In this episode, we lay out the sequence of events that moved a nurse from ward to ward, the decisions made inside hospital meetings, and the small but decisive documents and actions that allowed the pattern to continue. We follow the timeline from the August meeting with damning mortality data to the October reference letter - and ask how a single piece of paper changed everything.

Person: Niels Högel
Date: June 22, 2005
Location: Delmenhorst clinic
Period: 1997-2005
Event: Reference letter signed October 10, 2002

- 58% of the emergencies and deaths on Ward 211 occurred during Högel's shifts, presented in an August 2001 meeting.
- Högel disappeared on sick leave for three weeks after the August 2001 meeting; only two patients died on the ward during that absence.
- The general director confronted Högel in September 2002 and offered resignation with three months' salary or transfer to logistics; no criminal report was filed.
- On October 10, 2002, the nursing director at Oldenburg signed a glowing letter of reference that omitted mortality data and the prior confrontation.
- Four empty vials of ajmaline were found in Högel's break room at Delmenhorst, logged but not followed by disciplinary action.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1577falsefullhttps://www.spreaker.com/episode/the-nurse-who-turned-resuscitation-into-murder-the-hogel-files--73090365
58% of all cardiac emergencies on Ward Two Eleven happened during one nurse’s shifts, and when he stayed home for three weeks only two patients died - yet he received a glowing reference and continued working. How did routine drugs, routine care, and routine paperwork let suspected murders across three countries go unnoticed for years?

In this episode, we tell the story contained in hospital records and investigations: the rise in resuscitations on a cardiac ICU, the meeting where the statistic was presented with the accused nurse in the room, the decision that followed, and the transfers that carried him onward. What choices by colleagues and institutions allowed the deaths to continue?

Person: Niels Högel
Date of birth: 30 December 1976
Location: Oldenburg Clinic, Ward Two Eleven
Event: 58% of cardiac emergencies on one nurse’s shifts (August 2001)
Confirmed murders: 85

- In August 2001 a projector showed that 58% of all cardiac emergencies on Ward Two Eleven had occurred during one nurse’s shifts.
- After that meeting the nurse called in sick and stayed home for three weeks; during those three weeks only two patients died.
- On 10 October 2002 the hospital issued a written reference letter describing him as diligent and prudent.
- Investigators later exhumed bodies in 67 cemeteries across three countries.
- The final confirmed murder count reached 85, with suspected total up to 300.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090365Wed, 02 Sep 2026 08:00:02 +0000Creator at ObomediaThe Nurse Who Turned Resuscitation Into Murder: The Högel Files 58% of all cardiac emergencies on Ward Two Eleven happened during one nurse’s shifts, and when he stayed home for three weeks only two patients died - yet he received a glowing...
58% of all cardiac emergencies on Ward Two Eleven happened during one nurse’s shifts, and when he stayed home for three weeks only two patients died - yet he received a glowing reference and continued working. How did routine drugs, routine care, and routine paperwork let suspected murders across three countries go unnoticed for years?

In this episode, we tell the story contained in hospital records and investigations: the rise in resuscitations on a cardiac ICU, the meeting where the statistic was presented with the accused nurse in the room, the decision that followed, and the transfers that carried him onward. What choices by colleagues and institutions allowed the deaths to continue?

Person: Niels Högel
Date of birth: 30 December 1976
Location: Oldenburg Clinic, Ward Two Eleven
Event: 58% of cardiac emergencies on one nurse’s shifts (August 2001)
Confirmed murders: 85

- In August 2001 a projector showed that 58% of all cardiac emergencies on Ward Two Eleven had occurred during one nurse’s shifts.
- After that meeting the nurse called in sick and stayed home for three weeks; during those three weeks only two patients died.
- On 10 October 2002 the hospital issued a written reference letter describing him as diligent and prudent.
- Investigators later exhumed bodies in 67 cemeteries across three countries.
- The final confirmed murder count reached 85, with suspected total up to 300.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1511falsefullhttps://www.spreaker.com/episode/he-used-his-own-sperm-the-doctor-who-hid-94-children--73090361
Curiosity turned into a legal reckoning when a consumer DNA test revealed that at least 94 people in Indiana shared a biological father they never knew. How could a reproductive endocrinologist with a thirty-year practice have fathered dozens of children using his own sperm while his clinic formally barred donors with autoimmune conditions - and what does it mean that the law had no answer?

In this episode, we tell the sequence of events from a kitchen-table DNA kit to a voicemail confession and the ensuing gaps left by the legal system. Listen as the story traces how patterns in matches, clinic records, and a single recorded message reshaped a case that prosecutors initially declined to pursue.

Person: Dr. Donald Lee Lee
Location: Indianapolis, Indiana
Period: 1979-2009 (practice years)
Case: at least 94 donor-conceived children confirmed
Event: consumer DNA test led to complaint filed in 2015

- A consumer DNA test taken in 2014 by Jacoba Ballard produced matches to eight previously unknown half-siblings.
- Dr. Lee opened his practice at 2020 West 86th Street in Indianapolis in 1979 and retired in 2009 after roughly thirty years.
- Clinic rules explicitly disqualified donors with autoimmune conditions; Lee himself had rheumatoid arthritis.
- Ballard filed a complaint with the Indiana Attorney General’s office in 2015; prosecutors declined to charge because no state law criminalized the conduct.
- Lee reportedly told investigators he used his own sperm "nine or ten times," while confirmed children linked to him number at least 94.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090361Tue, 01 Sep 2026 08:00:02 +0000Creator at ObomediaHe Used His Own Sperm: The Doctor Who Hid 94 Children Curiosity turned into a legal reckoning when a consumer DNA test revealed that at least 94 people in Indiana shared a biological father they never knew. How could a reproductive endocrinologist...
Curiosity turned into a legal reckoning when a consumer DNA test revealed that at least 94 people in Indiana shared a biological father they never knew. How could a reproductive endocrinologist with a thirty-year practice have fathered dozens of children using his own sperm while his clinic formally barred donors with autoimmune conditions - and what does it mean that the law had no answer?

In this episode, we tell the sequence of events from a kitchen-table DNA kit to a voicemail confession and the ensuing gaps left by the legal system. Listen as the story traces how patterns in matches, clinic records, and a single recorded message reshaped a case that prosecutors initially declined to pursue.

Person: Dr. Donald Lee Lee
Location: Indianapolis, Indiana
Period: 1979-2009 (practice years)
Case: at least 94 donor-conceived children confirmed
Event: consumer DNA test led to complaint filed in 2015

- A consumer DNA test taken in 2014 by Jacoba Ballard produced matches to eight previously unknown half-siblings.
- Dr. Lee opened his practice at 2020 West 86th Street in Indianapolis in 1979 and retired in 2009 after roughly thirty years.
- Clinic rules explicitly disqualified donors with autoimmune conditions; Lee himself had rheumatoid arthritis.
- Ballard filed a complaint with the Indiana Attorney General’s office in 2015; prosecutors declined to charge because no state law criminalized the conduct.
- Lee reportedly told investigators he used his own sperm "nine or ten times," while confirmed children linked to him number at least 94.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1453falsefullhttps://www.spreaker.com/episode/the-doctor-who-stole-hundreds-of-families-dna-secrets--73090360
Curiosity turned to betrayal: a consumer DNA test in 2014 connected an adopted woman to eight half-siblings - and every genetic thread led to her fertility doctor. How did a respected Indianapolis physician become the center of a network of at least ninety-four children conceived with his DNA, and why did the law fail to stop him?

In this episode, we tell the sequence of events from a 2014 DNA kit to the growing group of matches, the role of genetic genealogy, the Indiana Attorney General's conclusion that "there was no law," the broadcast that produced a voicemail admission, and the expanding tally of suspected victims - but how did investigators finally piece together the full scope?

Person: Donald Lee Cline
Date: 1974-1987
Location: Indianapolis
Event: fertility fraud involving physician's own genetic material
Status: at least 94 biological children confirmed by May 2022

- A 2014 consumer DNA test first linked Jacoba Ballard to eight half-siblings sharing the same paternal line.
- Donald Lee Cline was born December 10, 1938, and opened a reproductive practice at 2020 West 86th Street by 1979.
- The alleged misconduct spanned roughly 1974 to 1987, according to the pattern of genetic matches.
- Indiana Attorney General Tim DeLaney concluded in 2015 that "there was no law" criminalizing fertility fraud in the state.
- After a Fox59 broadcast contradicted his statements, Cline left Ballard a voicemail admitting he had donated his own samples "nine or ten times."

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090360Mon, 31 Aug 2026 08:00:02 +0000Creator at ObomediaThe Doctor Who Stole Hundreds of Families' DNA Secrets Curiosity turned to betrayal: a consumer DNA test in 2014 connected an adopted woman to eight half-siblings - and every genetic thread led to her fertility doctor. How did a respected...
Curiosity turned to betrayal: a consumer DNA test in 2014 connected an adopted woman to eight half-siblings - and every genetic thread led to her fertility doctor. How did a respected Indianapolis physician become the center of a network of at least ninety-four children conceived with his DNA, and why did the law fail to stop him?

In this episode, we tell the sequence of events from a 2014 DNA kit to the growing group of matches, the role of genetic genealogy, the Indiana Attorney General's conclusion that "there was no law," the broadcast that produced a voicemail admission, and the expanding tally of suspected victims - but how did investigators finally piece together the full scope?

Person: Donald Lee Cline
Date: 1974-1987
Location: Indianapolis
Event: fertility fraud involving physician's own genetic material
Status: at least 94 biological children confirmed by May 2022

- A 2014 consumer DNA test first linked Jacoba Ballard to eight half-siblings sharing the same paternal line.
- Donald Lee Cline was born December 10, 1938, and opened a reproductive practice at 2020 West 86th Street by 1979.
- The alleged misconduct spanned roughly 1974 to 1987, according to the pattern of genetic matches.
- Indiana Attorney General Tim DeLaney concluded in 2015 that "there was no law" criminalizing fertility fraud in the state.
- After a Fox59 broadcast contradicted his statements, Cline left Ballard a voicemail admitting he had donated his own samples "nine or ten times."

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1740falsefullhttps://www.spreaker.com/episode/he-fathered-94-children-without-consent-the-doctor-who-lied--73090358
Curiosity turns to outrage when you learn one fertility doctor’s secret created 94 biological children who never consented to, or were informed of, his actions-how did a trusted physician father nearly a hundred offspring and avoid prison? Who bears responsibility for lives altered at their root?

In this episode, we present the record of what happened at a single Indianapolis fertility clinic, the discovery that unfolded after a consumer DNA test, and the legal gaps that left victims without criminal recourse. What led investigators to a guilty plea but zero days behind bars?

Person: Donald Lee Cline
Person: Jacoba Ballard
Location: 2020 West 86th Street, Indianapolis
Period: 1974-1987
Date of consumer DNA test purchase: 2014

- 94 people later confirmed to share Donald Cline’s DNA without consent
- 99.99997% probability confirming the biological link reported for the case
- Cline practiced at the Indianapolis clinic for 30 years and retired in 2009
- Ballard’s consumer DNA test in 2014 initially revealed eight previously unknown half-siblings
- Indiana Attorney General Tim DeLaney reviewed the evidence in 2015 and closed the file citing no applicable criminal statute

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090358Sun, 30 Aug 2026 08:00:03 +0000Creator at ObomediaHe Fathered 94 Children Without Consent - The Doctor Who Lied Curiosity turns to outrage when you learn one fertility doctor’s secret created 94 biological children who never consented to, or were informed of, his actions-how did a trusted...
Curiosity turns to outrage when you learn one fertility doctor’s secret created 94 biological children who never consented to, or were informed of, his actions-how did a trusted physician father nearly a hundred offspring and avoid prison? Who bears responsibility for lives altered at their root?

In this episode, we present the record of what happened at a single Indianapolis fertility clinic, the discovery that unfolded after a consumer DNA test, and the legal gaps that left victims without criminal recourse. What led investigators to a guilty plea but zero days behind bars?

Person: Donald Lee Cline
Person: Jacoba Ballard
Location: 2020 West 86th Street, Indianapolis
Period: 1974-1987
Date of consumer DNA test purchase: 2014

- 94 people later confirmed to share Donald Cline’s DNA without consent
- 99.99997% probability confirming the biological link reported for the case
- Cline practiced at the Indianapolis clinic for 30 years and retired in 2009
- Ballard’s consumer DNA test in 2014 initially revealed eight previously unknown half-siblings
- Indiana Attorney General Tim DeLaney reviewed the evidence in 2015 and closed the file citing no applicable criminal statute

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1351falsefullhttps://www.spreaker.com/episode/the-first-patient-mdma-a-therapist-s-cuddle-and-betrayal--73090357
A video from 2015 shows a therapist cuddling a woman under the effects of MDMA - and the man had no active medical license since 2009. How did a Phase Two MAPS trial allow an unlicensed co-therapist into recorded dosing sessions, and what did that structural gap cost the first patient?

In this episode, we tell the episode’s account of Meaghan Buisson’s enrollment in a MAPS MDMA-assisted therapy trial, the recorded dosing sessions on Cortes Island, and the timelines that followed, asking whether the system’s design enabled the harm described.

Person: Meaghan Buisson
Person: Gabor Maté
Person: Richard Yensen
Person: Donna Dryer
Organization: MAPS

- Buisson enrolled in the MDMA-assisted therapy trial in December 2014 as the first of a planned twelve participants.
- Richard Yensen had not held an active medical license since 2009, five years before Buisson entered care.
- The final dosing session was recorded in October 2015 and the final formal follow-up visit was recorded in June 2016.
- Buisson lived near the Yensens on Cortes Island from June 2015 until May 2017, a period described as further therapy.
- Buisson published a piece in Mad in America in October 2016 describing her experience positively and did not publicly disclose abuse at that time.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090357Sat, 29 Aug 2026 08:00:02 +0000Creator at ObomediaThe First Patient: MDMA, a Therapist's Cuddle, and Betrayal A video from 2015 shows a therapist cuddling a woman under the effects of MDMA - and the man had no active medical license since 2009. How did a Phase Two MAPS trial allow an unlicensed...
A video from 2015 shows a therapist cuddling a woman under the effects of MDMA - and the man had no active medical license since 2009. How did a Phase Two MAPS trial allow an unlicensed co-therapist into recorded dosing sessions, and what did that structural gap cost the first patient?

In this episode, we tell the episode’s account of Meaghan Buisson’s enrollment in a MAPS MDMA-assisted therapy trial, the recorded dosing sessions on Cortes Island, and the timelines that followed, asking whether the system’s design enabled the harm described.

Person: Meaghan Buisson
Person: Gabor Maté
Person: Richard Yensen
Person: Donna Dryer
Organization: MAPS

- Buisson enrolled in the MDMA-assisted therapy trial in December 2014 as the first of a planned twelve participants.
- Richard Yensen had not held an active medical license since 2009, five years before Buisson entered care.
- The final dosing session was recorded in October 2015 and the final formal follow-up visit was recorded in June 2016.
- Buisson lived near the Yensens on Cortes Island from June 2015 until May 2017, a period described as further therapy.
- Buisson published a piece in Mad in America in October 2016 describing her experience positively and did not publicly disclose abuse at that time.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1420falsefullhttps://www.spreaker.com/episode/the-surgeon-without-a-license-the-tijuana-amputation-that-killed-bondy--73090356
Hundreds of tubes of super glue sat alongside blood-soaked linens, surgical instruments, and anesthetic drugs in an unlicensed room where a seventy-five-year-old surgeon claimed to have performed roughly six hundred operations. How did a man barred from practice in multiple jurisdictions keep operating across the Mexican border, and what exactly happened to Philip Bondy after his trip to Tijuana?

In this episode, we tell the episode’s narrative using only the facts on record, following Bondy’s search for an amputation for body integrity identity disorder and John Ronald Brown’s long, contentious career that persisted despite revoked licenses. What choices led a retired satellite engineer to cross the border for a surgeon with no recognized surgical certifications?

Person: John Ronald Brown
Person: Philip Bondy
Event: Tijuana amputation, spring 1998
Period: 1947-1998 (career span referenced)
Status: Licenses revoked in California, Hawaii, Alaska, and Saint Lucia

- Brown claimed to have performed roughly 600 surgeries over his career.
- Brown was born July 4, 1922, and graduated from the University of Utah School of Medicine in 1947.
- The California Medical Board revoked Brown’s license in 1977 for gross negligence, incompetence, moral turpitude, using patients as unqualified surgical assistants, failing to hospitalize an infected patient, and falsifying insurance forms.
- Brown was arrested in 1990 and served 19 months in prison for an operation performed on a 30-year-old transgender woman in Orange County.
- Philip Bondy was a 79-year-old retired satellite engineer from New York who traveled to Tijuana in spring 1998 seeking amputation for body integrity identity disorder and was found dead after the surgery.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090356Fri, 28 Aug 2026 08:00:02 +0000Creator at ObomediaThe Surgeon Without a License: The Tijuana Amputation That Killed Bondy Hundreds of tubes of super glue sat alongside blood-soaked linens, surgical instruments, and anesthetic drugs in an unlicensed room where a seventy-five-year-old surgeon...
Hundreds of tubes of super glue sat alongside blood-soaked linens, surgical instruments, and anesthetic drugs in an unlicensed room where a seventy-five-year-old surgeon claimed to have performed roughly six hundred operations. How did a man barred from practice in multiple jurisdictions keep operating across the Mexican border, and what exactly happened to Philip Bondy after his trip to Tijuana?

In this episode, we tell the episode’s narrative using only the facts on record, following Bondy’s search for an amputation for body integrity identity disorder and John Ronald Brown’s long, contentious career that persisted despite revoked licenses. What choices led a retired satellite engineer to cross the border for a surgeon with no recognized surgical certifications?

Person: John Ronald Brown
Person: Philip Bondy
Event: Tijuana amputation, spring 1998
Period: 1947-1998 (career span referenced)
Status: Licenses revoked in California, Hawaii, Alaska, and Saint Lucia

- Brown claimed to have performed roughly 600 surgeries over his career.
- Brown was born July 4, 1922, and graduated from the University of Utah School of Medicine in 1947.
- The California Medical Board revoked Brown’s license in 1977 for gross negligence, incompetence, moral turpitude, using patients as unqualified surgical assistants, failing to hospitalize an infected patient, and falsifying insurance forms.
- Brown was arrested in 1990 and served 19 months in prison for an operation performed on a 30-year-old transgender woman in Orange County.
- Philip Bondy was a 79-year-old retired satellite engineer from New York who traveled to Tijuana in spring 1998 seeking amputation for body integrity identity disorder and was found dead after the surgery.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1037falsefullhttps://www.spreaker.com/episode/super-glue-next-to-the-scalpel-the-john-ronald-brown-case--73090352
Hundreds of tubes of super glue beside scalpels in a ground-floor apartment - a single image that captures the unease of unregulated medicine. Investigators found blood-soaked linens, anesthetizing drugs, videotapes of operations, and a revoked-license surgeon who had been operating for decades; how did it come to this, and why were adhesive tubes there next to surgical instruments?

In this episode, we trace the life and practice of John Ronald Brown from his 1947 medical school graduation to the 1998 search of his San Ysidro apartment, exploring his surgeries in San Ysidro and Tijuana, the victims who sought him out, and the legal and medical consequences that followed. What does the collision at the edges of medicine reveal about patients, practitioners, and the law?

Person: John Ronald Brown
Date of conviction: 1998 (convicted of second-degree murder at age 75)
Date of death: May 16, 2010 (died at age 87 of pneumonia)
Victim: Philip Bondy (aged 79; died after left leg amputation in May 1998)
Education: University of Utah School of Medicine, graduated 1947

- Investigators found hundreds of tubes of adhesive, scalpels, clamps, anesthetizing drugs, videotapes, and blood-soaked towels, sheets, and mattresses in Brown's San Ysidro apartment in 1998.
- Brown's medical license was revoked by the California Medical Board in 1977 for gross negligence, incompetence, and moral turpitude after a patient death and documented failures.
- He claimed to have performed roughly 600 surgeries, including gender-affirming operations beginning in the early 1970s, often operating in offices and motel rooms without board certification.
- Philip Bondy traveled to Tijuana in May 1998 for a left leg amputation performed by Brown and was dead the next morning from a bacterial infection in tissue with inadequate blood supply.
- Brown was convicted of second-degree murder at age 75 and died in prison on May 16, 2010, at age 87 from pneumonia that did not respond to antibiotics.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090352Thu, 27 Aug 2026 08:00:03 +0000Creator at ObomediaSuper Glue Next to the Scalpel: The John Ronald Brown Case Hundreds of tubes of super glue beside scalpels in a ground-floor apartment - a single image that captures the unease of unregulated medicine. Investigators found blood-soaked linens,...
Hundreds of tubes of super glue beside scalpels in a ground-floor apartment - a single image that captures the unease of unregulated medicine. Investigators found blood-soaked linens, anesthetizing drugs, videotapes of operations, and a revoked-license surgeon who had been operating for decades; how did it come to this, and why were adhesive tubes there next to surgical instruments?

In this episode, we trace the life and practice of John Ronald Brown from his 1947 medical school graduation to the 1998 search of his San Ysidro apartment, exploring his surgeries in San Ysidro and Tijuana, the victims who sought him out, and the legal and medical consequences that followed. What does the collision at the edges of medicine reveal about patients, practitioners, and the law?

Person: John Ronald Brown
Date of conviction: 1998 (convicted of second-degree murder at age 75)
Date of death: May 16, 2010 (died at age 87 of pneumonia)
Victim: Philip Bondy (aged 79; died after left leg amputation in May 1998)
Education: University of Utah School of Medicine, graduated 1947

- Investigators found hundreds of tubes of adhesive, scalpels, clamps, anesthetizing drugs, videotapes, and blood-soaked towels, sheets, and mattresses in Brown's San Ysidro apartment in 1998.
- Brown's medical license was revoked by the California Medical Board in 1977 for gross negligence, incompetence, and moral turpitude after a patient death and documented failures.
- He claimed to have performed roughly 600 surgeries, including gender-affirming operations beginning in the early 1970s, often operating in offices and motel rooms without board certification.
- Philip Bondy traveled to Tijuana in May 1998 for a left leg amputation performed by Brown and was dead the next morning from a bacterial infection in tissue with inadequate blood supply.
- Brown was convicted of second-degree murder at age 75 and died in prison on May 16, 2010, at age 87 from pneumonia that did not respond to antibiotics.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1538falsefullhttps://www.spreaker.com/episode/the-butcher-surgeon-how-john-ronald-brown-killed-a-patient-for-hire--73090351
A retired satellite engineer traveled seeking a surgeon willing to amputate a healthy limb, and he died of gas gangrene less than 24 hours after the operation - performed by a man with no board certification who kept hundreds of tubes of super glue and videotapes of motel-room surgeries in his San Ysidro apartment. How did John Ronald Brown continue operating across decades, borders, and license revocations until a patient died?

In this episode, we trace Brown's trajectory from a 1947 medical graduate to a practitioner banned by multiple licensing boards, and we follow the case of Philip Bondy, a 79-year-old patient with Body Integrity Identity Disorder, whose elective amputation ended in fatal infection - what led Bondy to choose Brown and how did the system allow it?

Person: John Ronald Brown
Date: 1947 (medical school graduation)
Event: Amputation and death by gas gangrene within 24 hours
Location: surgery performed in rented space across the Mexican border; patient found dead in a National City hotel room
Status: license revoked by California Medical Board in 1977; barred in Hawaii, Alaska, and Saint Lucia

- Brown claimed to have performed 600 gender-affirming surgeries, a figure never independently verified.
- Johns Hopkins approved surgery for 24 out of the first 2,000 applicants (24/2000).
- Investigators found hundreds of tubes of super glue, blood-soaked mattresses, surgical instruments, and videotapes in Brown's San Ysidro apartment.
- Brown served 19 months in prison after a 1990 arrest for practicing medicine without a license, then drove a taxi for one year before returning to operate.
- Philip Bondy was 79 years old and died of gas gangrene less than 24 hours after his left leg was amputated by Brown.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090351Wed, 26 Aug 2026 08:00:02 +0000Creator at ObomediaThe Butcher Surgeon: How John Ronald Brown Killed a Patient for Hire A retired satellite engineer traveled seeking a surgeon willing to amputate a healthy limb, and he died of gas gangrene less than 24 hours after the operation - performed by a man...
A retired satellite engineer traveled seeking a surgeon willing to amputate a healthy limb, and he died of gas gangrene less than 24 hours after the operation - performed by a man with no board certification who kept hundreds of tubes of super glue and videotapes of motel-room surgeries in his San Ysidro apartment. How did John Ronald Brown continue operating across decades, borders, and license revocations until a patient died?

In this episode, we trace Brown's trajectory from a 1947 medical graduate to a practitioner banned by multiple licensing boards, and we follow the case of Philip Bondy, a 79-year-old patient with Body Integrity Identity Disorder, whose elective amputation ended in fatal infection - what led Bondy to choose Brown and how did the system allow it?

Person: John Ronald Brown
Date: 1947 (medical school graduation)
Event: Amputation and death by gas gangrene within 24 hours
Location: surgery performed in rented space across the Mexican border; patient found dead in a National City hotel room
Status: license revoked by California Medical Board in 1977; barred in Hawaii, Alaska, and Saint Lucia

- Brown claimed to have performed 600 gender-affirming surgeries, a figure never independently verified.
- Johns Hopkins approved surgery for 24 out of the first 2,000 applicants (24/2000).
- Investigators found hundreds of tubes of super glue, blood-soaked mattresses, surgical instruments, and videotapes in Brown's San Ysidro apartment.
- Brown served 19 months in prison after a 1990 arrest for practicing medicine without a license, then drove a taxi for one year before returning to operate.
- Philip Bondy was 79 years old and died of gas gangrene less than 24 hours after his left leg was amputated by Brown.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1419falsefullhttps://www.spreaker.com/episode/the-surgeon-who-used-hundreds-of-super-glue-tubes-to-operate--73090350
Anxious fascination: investigators in 1998 found hundreds of tubes of super glue stacked in a San Ysidro apartment alongside surgical instruments, anesthetizing drugs, and blood-soaked mattresses - and the man who lived there had a medical degree and a decades-long history of operating outside licensed facilities. How did a physician who failed a single oral exam in 1947 end up using hardware-store adhesive by the case and causing a patient’s death within twenty-four hours?

In this episode, we tell the story of John Ronald Brown’s medical career from his 1947 graduation to the 1998 investigation, outline the failures of licensing systems that pushed him to operate in motel rooms and garages, and follow the case of seventy-nine-year-old Philip Bondy who traveled for an elective amputation that proved fatal - what does this reveal about medical oversight and patient desperation?

Person: John Ronald Brown
Date: 1947 oral exam failure
Event: 1998 investigation finding hundreds of super glue tubes
Case: Philip Bondy, 79-year-old patient dead within 24 hours
Status: California medical license revoked in 1977 (gross negligence, incompetence, moral turpitude)

- Born July 4, 1922, John Ronald Brown graduated from the University of Utah School of Medicine in 1947.
- Brown passed written components of the American Board of Plastic Surgery but failed the oral assessment in 1947.
- In 1977 the California Board revoked Brown’s license for gross negligence, incompetence, and moral turpitude following one patient death and one lawsuit.
- Brown claimed to have performed six hundred gender-affirming surgeries over his career, a figure the record cannot independently verify.
- In 1998 investigators found hundreds of tubes of super glue, surgical instruments, anesthetizing drugs, and blood-soaked mattresses in Brown’s San Ysidro apartment.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090350Tue, 25 Aug 2026 08:00:03 +0000Creator at ObomediaThe Surgeon Who Used Hundreds of Super Glue Tubes to Operate Anxious fascination: investigators in 1998 found hundreds of tubes of super glue stacked in a San Ysidro apartment alongside surgical instruments, anesthetizing drugs, and blood-soaked...
Anxious fascination: investigators in 1998 found hundreds of tubes of super glue stacked in a San Ysidro apartment alongside surgical instruments, anesthetizing drugs, and blood-soaked mattresses - and the man who lived there had a medical degree and a decades-long history of operating outside licensed facilities. How did a physician who failed a single oral exam in 1947 end up using hardware-store adhesive by the case and causing a patient’s death within twenty-four hours?

In this episode, we tell the story of John Ronald Brown’s medical career from his 1947 graduation to the 1998 investigation, outline the failures of licensing systems that pushed him to operate in motel rooms and garages, and follow the case of seventy-nine-year-old Philip Bondy who traveled for an elective amputation that proved fatal - what does this reveal about medical oversight and patient desperation?

Person: John Ronald Brown
Date: 1947 oral exam failure
Event: 1998 investigation finding hundreds of super glue tubes
Case: Philip Bondy, 79-year-old patient dead within 24 hours
Status: California medical license revoked in 1977 (gross negligence, incompetence, moral turpitude)

- Born July 4, 1922, John Ronald Brown graduated from the University of Utah School of Medicine in 1947.
- Brown passed written components of the American Board of Plastic Surgery but failed the oral assessment in 1947.
- In 1977 the California Board revoked Brown’s license for gross negligence, incompetence, and moral turpitude following one patient death and one lawsuit.
- Brown claimed to have performed six hundred gender-affirming surgeries over his career, a figure the record cannot independently verify.
- In 1998 investigators found hundreds of tubes of super glue, surgical instruments, anesthetizing drugs, and blood-soaked mattresses in Brown’s San Ysidro apartment.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1729falsefullhttps://www.spreaker.com/episode/hundreds-of-super-glue-tubes-the-doctor-who-amputated-healthy-legs--73090349
Amazement and dread collide: investigators found hundreds of tubes of super glue next to blood-soaked mattresses, surgical instruments, vials of anesthetic, and videotapes of surgeries performed inside a San Ysidro apartment - surgeries done outside any licensed hospital. How did an MD who graduated in 1947 come to amputate a healthy 79-year-old’s leg in Tijuana, with the patient dead the next morning?

In this episode, we tell the documented story of John Ronald Brown and of Philip Bondy and Gregg Furth, two men with Body Integrity Identity Disorder who traveled seeking a surgeon willing to perform elective amputations; we trace Brown’s rise from a legitimate MD to a controversial outsider surgeon and ask how medical boundaries were crossed.

Person: John Ronald Brown
Person: Philip Bondy
Person: Gregg Furth
Date: 1947 (medical degree)
Event: Elective amputation of a healthy leg in Tijuana leading to patient’s death the following morning

- Investigators found hundreds of tubes of super glue inside Brown’s San Ysidro apartment.
- Brown earned his MD from the University of Utah School of Medicine in 1947.
- Brown claimed to have performed approximately 600 gender reassignment procedures in the 1970s.
- Brown’s California medical license was revoked in 1977 on six grounds including gross negligence and moral turpitude.
- Philip Bondy was 79 years old in spring 1998 when he sought Brown for an elective amputation.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090349Mon, 24 Aug 2026 08:00:03 +0000Creator at ObomediaHundreds of Super Glue Tubes: The Doctor Who Amputated Healthy Legs Amazement and dread collide: investigators found hundreds of tubes of super glue next to blood-soaked mattresses, surgical instruments, vials of anesthetic, and videotapes of...
Amazement and dread collide: investigators found hundreds of tubes of super glue next to blood-soaked mattresses, surgical instruments, vials of anesthetic, and videotapes of surgeries performed inside a San Ysidro apartment - surgeries done outside any licensed hospital. How did an MD who graduated in 1947 come to amputate a healthy 79-year-old’s leg in Tijuana, with the patient dead the next morning?

In this episode, we tell the documented story of John Ronald Brown and of Philip Bondy and Gregg Furth, two men with Body Integrity Identity Disorder who traveled seeking a surgeon willing to perform elective amputations; we trace Brown’s rise from a legitimate MD to a controversial outsider surgeon and ask how medical boundaries were crossed.

Person: John Ronald Brown
Person: Philip Bondy
Person: Gregg Furth
Date: 1947 (medical degree)
Event: Elective amputation of a healthy leg in Tijuana leading to patient’s death the following morning

- Investigators found hundreds of tubes of super glue inside Brown’s San Ysidro apartment.
- Brown earned his MD from the University of Utah School of Medicine in 1947.
- Brown claimed to have performed approximately 600 gender reassignment procedures in the 1970s.
- Brown’s California medical license was revoked in 1977 on six grounds including gross negligence and moral turpitude.
- Philip Bondy was 79 years old in spring 1998 when he sought Brown for an elective amputation.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1726falsefullhttps://www.spreaker.com/episode/the-hotel-amputation-how-a-retired-engineer-died-in-tijuana--73090348
Fear and fascination meet at the border: a 79-year-old retired satellite engineer crossed into Tijuana to have a healthy limb removed and was dead the next morning in a National City hotel room-his left leg amputated the day before by a surgeon whose license had been revoked in 1977. How did a man with a lifetime of precision end up under the knife of a doctor known as "Butcher Brown," and what single decision at a hotel doorway decided who lived and who died?

In this episode, we tell the story of Philip Bondy, the surgeon John Ronald Brown, and Gregg M. Furth, and we follow the events from Bondy’s years-long search for amputation to the crossing into Tijuana and the aftermath found in San Ysidro. What did investigators discover that linked the operation to death, and what was seen at the threshold that stopped one man from entering?

Person: Philip Bondy
Age: 79
Person: John Ronald Brown
Date: May 10, 1998
Location: National City, California

- Bondy’s left leg was amputated in Tijuana the day before he was found dead on May 10, 1998.
- John Ronald Brown had his California medical license revoked in 1977 for gross negligence and related charges.
- Police searching Brown’s San Ysidro apartment found blood-soaked towels, sheets, and a mattress saturated with blood.
- Investigators also found anaesthetizing drugs, surgical instruments, videotapes of operations, and hundreds of tubes of super glue.
- Gregg M. Furth, who traveled with Bondy and also sought amputation, turned back because he saw an assistant carrying a large knife into the operating room.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090348Sun, 23 Aug 2026 08:00:02 +0000Creator at ObomediaThe Hotel Amputation: How a Retired Engineer Died in Tijuana Fear and fascination meet at the border: a 79-year-old retired satellite engineer crossed into Tijuana to have a healthy limb removed and was dead the next morning in a National City...
Fear and fascination meet at the border: a 79-year-old retired satellite engineer crossed into Tijuana to have a healthy limb removed and was dead the next morning in a National City hotel room-his left leg amputated the day before by a surgeon whose license had been revoked in 1977. How did a man with a lifetime of precision end up under the knife of a doctor known as "Butcher Brown," and what single decision at a hotel doorway decided who lived and who died?

In this episode, we tell the story of Philip Bondy, the surgeon John Ronald Brown, and Gregg M. Furth, and we follow the events from Bondy’s years-long search for amputation to the crossing into Tijuana and the aftermath found in San Ysidro. What did investigators discover that linked the operation to death, and what was seen at the threshold that stopped one man from entering?

Person: Philip Bondy
Age: 79
Person: John Ronald Brown
Date: May 10, 1998
Location: National City, California

- Bondy’s left leg was amputated in Tijuana the day before he was found dead on May 10, 1998.
- John Ronald Brown had his California medical license revoked in 1977 for gross negligence and related charges.
- Police searching Brown’s San Ysidro apartment found blood-soaked towels, sheets, and a mattress saturated with blood.
- Investigators also found anaesthetizing drugs, surgical instruments, videotapes of operations, and hundreds of tubes of super glue.
- Gregg M. Furth, who traveled with Bondy and also sought amputation, turned back because he saw an assistant carrying a large knife into the operating room.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1700falsefullhttps://www.spreaker.com/episode/invisible-pharmacology-at-a-public-event--73090345
Calmness can be manufactured: a cardiac drug patented in 1962 and approved in 1964 was later found to concentrate in the brain up to 33 times more than in blood, altering memory, fear and performance in ways no regulator had anticipated. How did a medicine meant for failing hearts become an invisible influence on minds and public life?

In this episode, we trace the history, chemistry and unexpected journeys of propranolol from its invention to widespread use, and ask where medicine ends and other forms of control begin.

Person: James W. Black
Date: 1962 (patent), 1964 (approval)
Location: Alderley Park, Cheshire
Topic: Propranolol pharmacokinetics and uses
Event: 1964 Tokyo pistol shooting (arm stillness observed)

- Propranolol was patented in 1962 and approved for human use in 1964.
- The drug was marketed under the trade name Inderal one year after approval.
- Only about 25% of an oral dose survives first-pass metabolism to circulate systemically.
- Propranolol accumulates in the brain at 15 to 33 times the concentration found in blood.
- In a single year it reached number 69 on the US prescription list and was dispensed over nine million times.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090345Sat, 22 Aug 2026 08:00:03 +0000Creator at Obomediainvisible pharmacology at a public event Calmness can be manufactured: a cardiac drug patented in 1962 and approved in 1964 was later found to concentrate in the brain up to 33 times more than in blood, altering memory, fear and performance in ways...
Calmness can be manufactured: a cardiac drug patented in 1962 and approved in 1964 was later found to concentrate in the brain up to 33 times more than in blood, altering memory, fear and performance in ways no regulator had anticipated. How did a medicine meant for failing hearts become an invisible influence on minds and public life?

In this episode, we trace the history, chemistry and unexpected journeys of propranolol from its invention to widespread use, and ask where medicine ends and other forms of control begin.

Person: James W. Black
Date: 1962 (patent), 1964 (approval)
Location: Alderley Park, Cheshire
Topic: Propranolol pharmacokinetics and uses
Event: 1964 Tokyo pistol shooting (arm stillness observed)

- Propranolol was patented in 1962 and approved for human use in 1964.
- The drug was marketed under the trade name Inderal one year after approval.
- Only about 25% of an oral dose survives first-pass metabolism to circulate systemically.
- Propranolol accumulates in the brain at 15 to 33 times the concentration found in blood.
- In a single year it reached number 69 on the US prescription list and was dispensed over nine million times.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1704falsefullhttps://www.spreaker.com/episode/a-blood-pressure-pill-stripped-an-olympic-athlete-of-two-medals-in-beijing-2008--73090344
Fear and fascination collide: a common blood pressure drug, propranolol, taken by millions, silenced the physical tremors of performers and quietly altered how traumatic memories are stored - and it cost an Olympic shooter his medals in Beijing. How did a heart medicine become a disqualifying performance aid and a tool to soften trauma?

In this episode, we trace the journey of propranolol from James Whyte Whyte’s lab to the Olympic podium and to studies of memory reconsolidation. We explain what the drug does in the body and brain, why it steadied hands for musicians, and how that same effect led to Kim Jong-su losing two Olympic medals - and we ask what this means for medicine, sport, and memory.

Person: Kim Jong-su
Event: 2008 Olympic Games
Medals: Silver (10m air pistol), Bronze (50m pistol) - subsequently stripped
Drug: Propranolol
Scientist: James Whyte Whyte

- Propranolol reached the market in the early 1960s under the brand name Inderal.
- By 1977, 27% of surveyed UK performers had used beta blockers before performances.
- Propranolol’s brain-to-blood ratio can be as high as 15:1 to 33:1, far higher than atenolol’s ~0.2:1.
- James Whyte Whyte received the Nobel Prize in Physiology or Medicine in 1988 in part for developing propranolol.
- Memory reconsolidation is a roughly six-hour window after an experience during which norepinephrine is required to stabilize memories.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090344Fri, 21 Aug 2026 08:00:03 +0000Creator at ObomediaA blood pressure pill stripped an Olympic athlete of two medals in Beijing 2008 Fear and fascination collide: a common blood pressure drug, propranolol, taken by millions, silenced the physical tremors of performers and quietly altered how...
Fear and fascination collide: a common blood pressure drug, propranolol, taken by millions, silenced the physical tremors of performers and quietly altered how traumatic memories are stored - and it cost an Olympic shooter his medals in Beijing. How did a heart medicine become a disqualifying performance aid and a tool to soften trauma?

In this episode, we trace the journey of propranolol from James Whyte Whyte’s lab to the Olympic podium and to studies of memory reconsolidation. We explain what the drug does in the body and brain, why it steadied hands for musicians, and how that same effect led to Kim Jong-su losing two Olympic medals - and we ask what this means for medicine, sport, and memory.

Person: Kim Jong-su
Event: 2008 Olympic Games
Medals: Silver (10m air pistol), Bronze (50m pistol) - subsequently stripped
Drug: Propranolol
Scientist: James Whyte Whyte

- Propranolol reached the market in the early 1960s under the brand name Inderal.
- By 1977, 27% of surveyed UK performers had used beta blockers before performances.
- Propranolol’s brain-to-blood ratio can be as high as 15:1 to 33:1, far higher than atenolol’s ~0.2:1.
- James Whyte Whyte received the Nobel Prize in Physiology or Medicine in 1988 in part for developing propranolol.
- Memory reconsolidation is a roughly six-hour window after an experience during which norepinephrine is required to stabilize memories.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1638falsefullhttps://www.spreaker.com/episode/the-heart-drug-that-quieted-fear-and-shocked-the-world--73090342
Fear feels conquerable when the body stops betraying you: a heart-slowing tablet from 1964 eventually reached 9 million dispensings in the U.S. and the WHO Essential Medicines List - yet its most startling effect was discovered in the brain. How did a drug meant for failing hearts come to erase the physical signature of fear, and what did that mean for athletes, performers, and medicine?

In this episode, we trace the drug's path from Alderley Park labs to global use, describe its mechanism in heart and brain, and unpack the clinical and ethical questions that emerged as propranolol spread into new indications and public life. What happens when a cardiovascular medicine also quiets the body's alarm system?

Person: James W. Black
Date: 1962 (patent filed), 1964 (approval), 1965 (market)
Location: Alderley Park, Cheshire, England
Topic: Propranolol mechanism and clinical history
Event: 1987 study by the International Conference of Symphony and Opera Musicians

- Propranolol was patented in 1962, approved for medical use in 1964, and marketed as Inderal in 1965.
- By 2023, propranolol had been dispensed more than 9,000,000 times in the United States.
- Propranolol reaches the brain at 15 to 33 times its blood concentration, versus atenolol at roughly 0.2 times.
- The molecule blocks beta-1 receptors in the heart and beta-2 receptors in the airways, interrupting the adenylate cyclase → cAMP → protein kinase A → calcium influx cascade.
- A 1987 study by the International Conference of Symphony and Opera Musicians reported a relevant finding involving performance and propranolol with a 27% figure mentioned.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090342Thu, 20 Aug 2026 08:00:03 +0000Creator at ObomediaThe Heart Drug That Quieted Fear - And Shocked the World Fear feels conquerable when the body stops betraying you: a heart-slowing tablet from 1964 eventually reached 9 million dispensings in the U.S. and the WHO Essential Medicines List - yet its...
Fear feels conquerable when the body stops betraying you: a heart-slowing tablet from 1964 eventually reached 9 million dispensings in the U.S. and the WHO Essential Medicines List - yet its most startling effect was discovered in the brain. How did a drug meant for failing hearts come to erase the physical signature of fear, and what did that mean for athletes, performers, and medicine?

In this episode, we trace the drug's path from Alderley Park labs to global use, describe its mechanism in heart and brain, and unpack the clinical and ethical questions that emerged as propranolol spread into new indications and public life. What happens when a cardiovascular medicine also quiets the body's alarm system?

Person: James W. Black
Date: 1962 (patent filed), 1964 (approval), 1965 (market)
Location: Alderley Park, Cheshire, England
Topic: Propranolol mechanism and clinical history
Event: 1987 study by the International Conference of Symphony and Opera Musicians

- Propranolol was patented in 1962, approved for medical use in 1964, and marketed as Inderal in 1965.
- By 2023, propranolol had been dispensed more than 9,000,000 times in the United States.
- Propranolol reaches the brain at 15 to 33 times its blood concentration, versus atenolol at roughly 0.2 times.
- The molecule blocks beta-1 receptors in the heart and beta-2 receptors in the airways, interrupting the adenylate cyclase → cAMP → protein kinase A → calcium influx cascade.
- A 1987 study by the International Conference of Symphony and Opera Musicians reported a relevant finding involving performance and propranolol with a 27% figure mentioned.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1526falsefullhttps://www.spreaker.com/episode/the-accidental-birth-control-how-a-testosterone-mistake-changed-medicine--73090341
A single lab error in 1938 produced a molecule that doctors prescribed to women for sixty-one years and that helped make oral hormone therapy possible - but it was born from a mistaken aim and carried a hidden chemical tension that later shaped contraception. How did a tweak meant to make testosterone swallowable become a progestogenic drug that fueled the contraceptive revolution?

In this episode, we trace the creation, commercial rollout, and clinical use of ethisterone, from the four chemists who synthesized it at Schering AG to the dosing and potency issues that revealed its androgenic origins - and we ask how that molecular accident changed medical practice and contraception.

Person: Hans Herloff Inhoffen, Willy Logemann, Walter Hohlweg, Arthur Serini
Date: 1938 (synthesis); 1939 (Proluton C); 1945 (Pranone US)
Location: Schering AG, Berlin
Topic: ethinyltestosterone / ethisterone oral progestogen
Period: 1938-late 20th century clinical use

- The molecule synthesized in 1938 was named ethinyltestosterone and later renamed ethisterone.
- Ethisterone bound to progesterone receptors with roughly 44% of the affinity of natural progesterone.
- To produce progestogenic effects physicians prescribed between 200 and 700 milligrams of ethisterone over 10-14 days.
- Tablets were manufactured in 5, 10, and 25 mg; capsules reached 50, 100, and 250 mg strengths.
- Norethisterone, the later replacement, proved approximately 20 times more potent than ethisterone.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090341Wed, 19 Aug 2026 08:00:03 +0000Creator at ObomediaThe Accidental Birth Control: How a Testosterone Mistake Changed Medicine A single lab error in 1938 produced a molecule that doctors prescribed to women for sixty-one years and that helped make oral hormone therapy possible - but it was born from...
A single lab error in 1938 produced a molecule that doctors prescribed to women for sixty-one years and that helped make oral hormone therapy possible - but it was born from a mistaken aim and carried a hidden chemical tension that later shaped contraception. How did a tweak meant to make testosterone swallowable become a progestogenic drug that fueled the contraceptive revolution?

In this episode, we trace the creation, commercial rollout, and clinical use of ethisterone, from the four chemists who synthesized it at Schering AG to the dosing and potency issues that revealed its androgenic origins - and we ask how that molecular accident changed medical practice and contraception.

Person: Hans Herloff Inhoffen, Willy Logemann, Walter Hohlweg, Arthur Serini
Date: 1938 (synthesis); 1939 (Proluton C); 1945 (Pranone US)
Location: Schering AG, Berlin
Topic: ethinyltestosterone / ethisterone oral progestogen
Period: 1938-late 20th century clinical use

- The molecule synthesized in 1938 was named ethinyltestosterone and later renamed ethisterone.
- Ethisterone bound to progesterone receptors with roughly 44% of the affinity of natural progesterone.
- To produce progestogenic effects physicians prescribed between 200 and 700 milligrams of ethisterone over 10-14 days.
- Tablets were manufactured in 5, 10, and 25 mg; capsules reached 50, 100, and 250 mg strengths.
- Norethisterone, the later replacement, proved approximately 20 times more potent than ethisterone.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1580falsefullhttps://www.spreaker.com/episode/the-forgotten-pill-that-began-the-birth-control-revolution-one-atom-away--73090340
A tiny chemical tweak in a Berlin lab in 1938 produced an oral hormone that erased the need for injections-and yet the molecule that opened the door, ethisterone, vanished from medicine's memory decades later. How did a drug prescribed under multiple brand names from 1939 to 2000 persist without scandal and then disappear so completely, and what changed when a single carbon atom was removed to create its more famous successor?

In this episode, we tell the story of four chemists at Schering AG whose routine modification of testosterone accidentally created the first orally active progestogen, and follow that compound's journey from Proluton C/Pranone across continents and decades. What did ethisterone actually do in patients, why did dosing vary so widely, and how did one atom make the difference between a footnote and a revolution?

Person: Hans Herloff Inhoffen, Willy Logemann, Walter Hohlweg, Arthur Serini
Date: 1938 (synthesis), 1939 (appearance in Germany), 1945 (arrived in United States), 2000 (off market)
Location: Berlin, Germany
Compound: Ethisterone (marketed as Proluton C and Pranone)
Dose range: 5 mg, 10 mg, 25 mg; full course 200-700 mg over 10-14 days

- Ethisterone was synthesized in 1938 by four chemists at Schering AG in Berlin.
- The compound reached the German market in 1939 and the U.S. market in 1945 under the name Pranone.
- Tablets were produced in 5 mg, 10 mg, and 25 mg strengths with full endometrial courses of 200-700 mg over 10-14 days.
- Ethisterone bound progesterone receptors at roughly 44% of progesterone's affinity.
- Ethisterone remained on the market until the year 2000, forty-three years after its successor had arrived.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090340Tue, 18 Aug 2026 08:00:04 +0000Creator at ObomediaThe Forgotten Pill That Began the Birth-Control Revolution-One Atom Away A tiny chemical tweak in a Berlin lab in 1938 produced an oral hormone that erased the need for injections-and yet the molecule that opened the door, ethisterone, vanished...
A tiny chemical tweak in a Berlin lab in 1938 produced an oral hormone that erased the need for injections-and yet the molecule that opened the door, ethisterone, vanished from medicine's memory decades later. How did a drug prescribed under multiple brand names from 1939 to 2000 persist without scandal and then disappear so completely, and what changed when a single carbon atom was removed to create its more famous successor?

In this episode, we tell the story of four chemists at Schering AG whose routine modification of testosterone accidentally created the first orally active progestogen, and follow that compound's journey from Proluton C/Pranone across continents and decades. What did ethisterone actually do in patients, why did dosing vary so widely, and how did one atom make the difference between a footnote and a revolution?

Person: Hans Herloff Inhoffen, Willy Logemann, Walter Hohlweg, Arthur Serini
Date: 1938 (synthesis), 1939 (appearance in Germany), 1945 (arrived in United States), 2000 (off market)
Location: Berlin, Germany
Compound: Ethisterone (marketed as Proluton C and Pranone)
Dose range: 5 mg, 10 mg, 25 mg; full course 200-700 mg over 10-14 days

- Ethisterone was synthesized in 1938 by four chemists at Schering AG in Berlin.
- The compound reached the German market in 1939 and the U.S. market in 1945 under the name Pranone.
- Tablets were produced in 5 mg, 10 mg, and 25 mg strengths with full endometrial courses of 200-700 mg over 10-14 days.
- Ethisterone bound progesterone receptors at roughly 44% of progesterone's affinity.
- Ethisterone remained on the market until the year 2000, forty-three years after its successor had arrived.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1563falsefullhttps://www.spreaker.com/episode/the-pill-that-wasn-t-how-a-testosterone-mistake-made-birth-control-possible--73090338
A single lab accident in 1938 produced the first orally active progestogen, turning a failed testosterone experiment into a quiet revolution that let women take hormone therapy at home instead of getting injections. How did a molecule that began as a testosterone derivative become the swallowable precursor to modern oral birth control, and what limits did its chemistry impose?

In this episode, we trace the path from a Schering AG bench in Berlin to clinics around the world, following the chemists who ethynylated testosterone and unexpectedly created an orally active progestogen; we explore its clinical uses and the chemical ceiling that shaped subsequent developments and asks what that ceiling meant for doses, side effects, and future drugs.

Person: Hans Herloff Inhoffen, Willy Logemann, Walter Hohlweg, Arthur Serini
Date: 1938
Location: Schering AG, Berlin
Event: Creation of ethisterone (first orally active progestogen)
Status: Introduced to German clinics in 1939 as Proluton C

- Progesterone became available by injection in 1934 and degraded when taken orally due to stomach acid and liver enzymes.
- The ethynyl modification at C-17 alpha had previously produced orally active ethinylestradiol.
- Schering’s compound was introduced in Germany in 1939 as Proluton C and reached the U.S, by 1945 as Pranone.
- The molecule was sold under at least eight brand names across France, Germany, Italy, Japan, the U.K., and the U.S.
- Ethisterone had 44% binding affinity at the progesterone receptor compared to progesterone and was about 20 times less potent than the compound that later replaced it.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090338Mon, 17 Aug 2026 08:00:03 +0000Creator at ObomediaThe Pill That Wasn't: How a Testosterone Mistake Made Birth Control Possible A single lab accident in 1938 produced the first orally active progestogen, turning a failed testosterone experiment into a quiet revolution that let women take hormone...
A single lab accident in 1938 produced the first orally active progestogen, turning a failed testosterone experiment into a quiet revolution that let women take hormone therapy at home instead of getting injections. How did a molecule that began as a testosterone derivative become the swallowable precursor to modern oral birth control, and what limits did its chemistry impose?

In this episode, we trace the path from a Schering AG bench in Berlin to clinics around the world, following the chemists who ethynylated testosterone and unexpectedly created an orally active progestogen; we explore its clinical uses and the chemical ceiling that shaped subsequent developments and asks what that ceiling meant for doses, side effects, and future drugs.

Person: Hans Herloff Inhoffen, Willy Logemann, Walter Hohlweg, Arthur Serini
Date: 1938
Location: Schering AG, Berlin
Event: Creation of ethisterone (first orally active progestogen)
Status: Introduced to German clinics in 1939 as Proluton C

- Progesterone became available by injection in 1934 and degraded when taken orally due to stomach acid and liver enzymes.
- The ethynyl modification at C-17 alpha had previously produced orally active ethinylestradiol.
- Schering’s compound was introduced in Germany in 1939 as Proluton C and reached the U.S, by 1945 as Pranone.
- The molecule was sold under at least eight brand names across France, Germany, Italy, Japan, the U.K., and the U.S.
- Ethisterone had 44% binding affinity at the progesterone receptor compared to progesterone and was about 20 times less potent than the compound that later replaced it.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1606falsefullhttps://www.spreaker.com/episode/the-pill-that-wasn-t-how-a-1938-drug-masculinized-babies--73090336
Fear and astonishment: a single failed testosterone experiment in 1938 produced the world's first oral progestin, ethisterone, and over sixty-one years millions of women swallowed doses between 200 and 700 mg per course-so how did a drug meant to replace injections quietly carry a built-in flaw that only became obvious decades later?

In this episode, we trace how four Schering AG chemists in Berlin turned a commercial goal into a medical breakthrough and how that breakthrough later revealed its limits; what followed when a far more potent compound arrived in 1957, and why those dosage charts raise a troubling question about early hormonal therapy.

Person: Hans Herloff Inhoffen, Willy Logemann, Walter Hohlweg, Arthur Serini
Date: 1938
Compound: ethisterone
Market entry (Germany): 1939 (Proluton C)
Comparison compound: norethisterone (1957)

- The four chemists at Schering AG aimed to make oral testosterone in 1938 and instead created ethisterone, the first synthetic oral progestin.
- Ethisterone had about 44% of the receptor affinity of natural progesterone.
- Schering marketed the compound in Germany in 1939 as Proluton C and in the U.S, in 1945 as Pranone.
- Therapeutic courses required between 200 and 700 milligrams of ethisterone over ten to fourteen days, often 25 mg up to four times daily.
- In 1957 norethisterone was introduced and proved to be 20 times more potent at the progesterone receptor than ethisterone.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090336Sun, 16 Aug 2026 08:00:03 +0000Creator at ObomediaThe Pill That Wasn't: How a 1938 Drug Masculinized Babies Fear and astonishment: a single failed testosterone experiment in 1938 produced the world's first oral progestin, ethisterone, and over sixty-one years millions of women swallowed doses...
Fear and astonishment: a single failed testosterone experiment in 1938 produced the world's first oral progestin, ethisterone, and over sixty-one years millions of women swallowed doses between 200 and 700 mg per course-so how did a drug meant to replace injections quietly carry a built-in flaw that only became obvious decades later?

In this episode, we trace how four Schering AG chemists in Berlin turned a commercial goal into a medical breakthrough and how that breakthrough later revealed its limits; what followed when a far more potent compound arrived in 1957, and why those dosage charts raise a troubling question about early hormonal therapy.

Person: Hans Herloff Inhoffen, Willy Logemann, Walter Hohlweg, Arthur Serini
Date: 1938
Compound: ethisterone
Market entry (Germany): 1939 (Proluton C)
Comparison compound: norethisterone (1957)

- The four chemists at Schering AG aimed to make oral testosterone in 1938 and instead created ethisterone, the first synthetic oral progestin.
- Ethisterone had about 44% of the receptor affinity of natural progesterone.
- Schering marketed the compound in Germany in 1939 as Proluton C and in the U.S, in 1945 as Pranone.
- Therapeutic courses required between 200 and 700 milligrams of ethisterone over ten to fourteen days, often 25 mg up to four times daily.
- In 1957 norethisterone was introduced and proved to be 20 times more potent at the progesterone receptor than ethisterone.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1650falsefullhttps://www.spreaker.com/episode/how-a-wwii-era-pill-accidentally-invented-oral-progestins--73090334
A pill that began as an experiment on testosterone became the first orally active progestin, offering women a way to avoid injections and clinic visits. But the molecule’s imperfect receptor affinity meant daily doses of hundreds of milligrams-so how did a wartime chemistry shortcut reshape reproductive medicine?

In this episode, we follow the lab work and clinical rollout that turned a structural tweak into a marketed hormone pill, and we ask how a drug with only 44% receptor affinity changed treatment practices despite high-dose requirements.

Person: Hans Herloff Inhoffen; Willy Logemann; Walter Hohlweg; Arthur Serini
Date: 1938-1939
Location: Berlin; Schering AG
Event: Introduction of ethisterone (Proluton C) to the German market
Topic: First orally active progestin; development from ethynylated testosterone

- Chemists applied an ethynyl group at the C17α position of testosterone in 1938.
- The resulting compound bound progesterone receptors with roughly 44% of natural progesterone’s affinity.
- Clinical regimens documented effective endometrial response with 200-700 milligrams taken over 10-14 days.
- Schering marketed the drug in 1939 under the brand name Proluton C.
- Tablets were packaged in 5, 10, and 25 milligram strengths with directions allowing multiple tablets per day, sometimes exceeding 100 milligrams on heavy days.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090334Sat, 15 Aug 2026 08:00:03 +0000Creator at ObomediaHow a WWII-Era Pill Accidentally Invented Oral Progestins A pill that began as an experiment on testosterone became the first orally active progestin, offering women a way to avoid injections and clinic visits. But the molecule’s imperfect receptor...
A pill that began as an experiment on testosterone became the first orally active progestin, offering women a way to avoid injections and clinic visits. But the molecule’s imperfect receptor affinity meant daily doses of hundreds of milligrams-so how did a wartime chemistry shortcut reshape reproductive medicine?

In this episode, we follow the lab work and clinical rollout that turned a structural tweak into a marketed hormone pill, and we ask how a drug with only 44% receptor affinity changed treatment practices despite high-dose requirements.

Person: Hans Herloff Inhoffen; Willy Logemann; Walter Hohlweg; Arthur Serini
Date: 1938-1939
Location: Berlin; Schering AG
Event: Introduction of ethisterone (Proluton C) to the German market
Topic: First orally active progestin; development from ethynylated testosterone

- Chemists applied an ethynyl group at the C17α position of testosterone in 1938.
- The resulting compound bound progesterone receptors with roughly 44% of natural progesterone’s affinity.
- Clinical regimens documented effective endometrial response with 200-700 milligrams taken over 10-14 days.
- Schering marketed the drug in 1939 under the brand name Proluton C.
- Tablets were packaged in 5, 10, and 25 milligram strengths with directions allowing multiple tablets per day, sometimes exceeding 100 milligrams on heavy days.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1676falsefullhttps://www.spreaker.com/episode/when-chemists-aimed-for-testosterone-and-accidentally-invented-progesterone--73090333
Astonishment and unease: four chemists in Berlin added a single ethynyl group to testosterone in 1938 and produced a compound that acted like a female hormone, not an androgen-creating the first oral progestin that would reshape reproductive medicine. How did a deliberate modification intended to make an oral androgen become the founding drug of oral progestins, and what costs emerged as its hidden androgenic nature revealed itself?

In this episode, we follow the team at Schering AG from the laboratory decision to add an ethynyl group through the clinical rollout of ethisterone, and we trace the practical consequences for patients and fetuses that only became clear after widespread use. What the chemists thought they were making, and what the molecule actually did, raises the question of how chemical structure can hide dangerous dual actions.

Person: Hans Herloff Inhoffen; Willy Logemann; Walter Hohlweg; Arthur Serini
Date: 1938 (synthesis); 1939 (Germany market); 1945 (United States)
Location: Berlin
Event: Synthesis and clinical introduction of ethisterone (Proluton C / Pranone)
Dose: 25 mg up to 4 times daily maintenance; 200-700 mg over 10-14 days transformation

- Four chemists at Schering AG added an ethynyl group to testosterone in 1938 and synthesized ethisterone.
- Ethisterone reached the German market in 1939 as Proluton C and the U.S, in 1945 as Pranone.
- Ethisterone's progestogenic affinity measured about 44% of natural progesterone by potency.
- Maintenance dosing was 25 mg up to four times daily; transformation dosing ranged 200-700 mg across 10-14 days.
- At clinical doses patients experienced acne and hirsutism, and exposure during pregnancy caused masculinization of female fetuses.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090333Fri, 14 Aug 2026 08:00:03 +0000Creator at ObomediaWhen Chemists Aimed for Testosterone and Accidentally Invented Progesterone Astonishment and unease: four chemists in Berlin added a single ethynyl group to testosterone in 1938 and produced a compound that acted like a female hormone, not an...
Astonishment and unease: four chemists in Berlin added a single ethynyl group to testosterone in 1938 and produced a compound that acted like a female hormone, not an androgen-creating the first oral progestin that would reshape reproductive medicine. How did a deliberate modification intended to make an oral androgen become the founding drug of oral progestins, and what costs emerged as its hidden androgenic nature revealed itself?

In this episode, we follow the team at Schering AG from the laboratory decision to add an ethynyl group through the clinical rollout of ethisterone, and we trace the practical consequences for patients and fetuses that only became clear after widespread use. What the chemists thought they were making, and what the molecule actually did, raises the question of how chemical structure can hide dangerous dual actions.

Person: Hans Herloff Inhoffen; Willy Logemann; Walter Hohlweg; Arthur Serini
Date: 1938 (synthesis); 1939 (Germany market); 1945 (United States)
Location: Berlin
Event: Synthesis and clinical introduction of ethisterone (Proluton C / Pranone)
Dose: 25 mg up to 4 times daily maintenance; 200-700 mg over 10-14 days transformation

- Four chemists at Schering AG added an ethynyl group to testosterone in 1938 and synthesized ethisterone.
- Ethisterone reached the German market in 1939 as Proluton C and the U.S, in 1945 as Pranone.
- Ethisterone's progestogenic affinity measured about 44% of natural progesterone by potency.
- Maintenance dosing was 25 mg up to four times daily; transformation dosing ranged 200-700 mg across 10-14 days.
- At clinical doses patients experienced acne and hirsutism, and exposure during pregnancy caused masculinization of female fetuses.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1482falsefullhttps://www.spreaker.com/episode/how-a-child-resistant-cap-stopped-500-toddlers-deaths-a-year--73090332
Five hundred children aged five and under were dying each year from everyday household products like aspirin, furniture polish and turpentine until a simple mechanical cap changed that toll-so why did it take thirteen years of counting dead children before policy caught up? Discover how labels failed, how the true victims were often invisible to the records, and what single change finally cut those deaths.

In this episode, we tell the story of the data, the laws, and the everyday objects involved, outlining the period from the 1957 creation of the National Clearinghouse for Poison Control Centers to the 1960 Hazardous Substances Labeling Act, and ask how a barrier rather than a warning became the decisive solution.

Person: National Clearinghouse for Poison Control Centers
Date: 1957
Event: Hazardous Substances Labeling Act passed in 1960
Period: thirteen years of documented deaths before a decisive solution
Topic: childhood poisoning deaths from household products

- Approximately 500 children aged five and under died each year from household substances in the early 1960s.
- The National Clearinghouse for Poison Control Centers began aggregating hospital poisoning data in 1957.
- The Hazardous Substances Labeling Act requiring cautionary warnings was passed in 1960.
- The 500 annual deaths counted only cases that reached hospitals and were entered into federal documentation.
- Toddlers most affected were typically between one and three years old, at peak oral exploration.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090332Thu, 13 Aug 2026 08:00:36 +0000Creator at ObomediaHow a Child-Resistant Cap Stopped 500 Toddlers' Deaths a Year Five hundred children aged five and under were dying each year from everyday household products like aspirin, furniture polish and turpentine until a simple mechanical cap changed that...
Five hundred children aged five and under were dying each year from everyday household products like aspirin, furniture polish and turpentine until a simple mechanical cap changed that toll-so why did it take thirteen years of counting dead children before policy caught up? Discover how labels failed, how the true victims were often invisible to the records, and what single change finally cut those deaths.

In this episode, we tell the story of the data, the laws, and the everyday objects involved, outlining the period from the 1957 creation of the National Clearinghouse for Poison Control Centers to the 1960 Hazardous Substances Labeling Act, and ask how a barrier rather than a warning became the decisive solution.

Person: National Clearinghouse for Poison Control Centers
Date: 1957
Event: Hazardous Substances Labeling Act passed in 1960
Period: thirteen years of documented deaths before a decisive solution
Topic: childhood poisoning deaths from household products

- Approximately 500 children aged five and under died each year from household substances in the early 1960s.
- The National Clearinghouse for Poison Control Centers began aggregating hospital poisoning data in 1957.
- The Hazardous Substances Labeling Act requiring cautionary warnings was passed in 1960.
- The 500 annual deaths counted only cases that reached hospitals and were entered into federal documentation.
- Toddlers most affected were typically between one and three years old, at peak oral exploration.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1728falsefullhttps://www.spreaker.com/episode/when-paper-vanished-how-ectd-quietly-rewrote-drug-history--73090331
On May 5, 2017 entire rooms of binders - hundreds of volumes and years of clinical data - became unnecessary overnight when the FDA’s paper deadline expired; why did a single file called index.xml end up dictating how every medicine’s dossier is read around the world?

In this episode, we trace how a technical specification turned into a global operational standard, moving drug submissions from printed binders to a digital architecture, and we ask how a quiet, fifteen-year rollout reshaped regulatory work and review efficiency.

Person: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
Date: May 5, 2017
Event: FDA deadline to abandon paper submissions
Date: February 12, 2002
Date: October 8, 2002

- 24 months was the window given by the FDA for the industry to abandon paper.
- The eCTD’s index file was named index.xml and served as both metadata manager and table of contents.
- Version 2.0 of the eCTD specification was finalized on February 12, 2002.
- Version 3.0 of the eCTD specification was finalized on October 8, 2002.
- The last major markets confirmed compliance in December 2017.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090331Wed, 12 Aug 2026 08:00:03 +0000Creator at ObomediaWhen Paper Vanished: How eCTD Quietly Rewrote Drug History On May 5, 2017 entire rooms of binders - hundreds of volumes and years of clinical data - became unnecessary overnight when the FDA’s paper deadline expired; why did a single file called...
On May 5, 2017 entire rooms of binders - hundreds of volumes and years of clinical data - became unnecessary overnight when the FDA’s paper deadline expired; why did a single file called index.xml end up dictating how every medicine’s dossier is read around the world?

In this episode, we trace how a technical specification turned into a global operational standard, moving drug submissions from printed binders to a digital architecture, and we ask how a quiet, fifteen-year rollout reshaped regulatory work and review efficiency.

Person: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
Date: May 5, 2017
Event: FDA deadline to abandon paper submissions
Date: February 12, 2002
Date: October 8, 2002

- 24 months was the window given by the FDA for the industry to abandon paper.
- The eCTD’s index file was named index.xml and served as both metadata manager and table of contents.
- Version 2.0 of the eCTD specification was finalized on February 12, 2002.
- Version 3.0 of the eCTD specification was finalized on October 8, 2002.
- The last major markets confirmed compliance in December 2017.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1677falsefullhttps://www.spreaker.com/episode/dwayne-mcduffie-s-last-draft-a-birthday-a-death-a-legacy--73090329
A comic released one day after its writer died and one day after his forty-ninth birthday: Dwayne McDuffie’s final screenplay hit shelves with All-Star Superman in Burbank on February 22, 2011. How did a Detroit-born physicist-turned-writer build a career that reshaped representation in comics and leave a legacy that still reveals surprises?

In this episode, we trace McDuffie’s life from his birth in Detroit to his education at Roeper School and the University of Michigan, his early work at Marvel and investment journalism, and the founding of Milestone Media - asking how his insistence on real representation changed the industry.

Person: Dwayne Glenn McDuffie
Date: February 20, 1962 (birth)
Event: Release of All-Star Superman comic on February 22, 2011
Person: Leroy McDuffie and Edna Hawkins McDuffie Gardner (parents)
Organization: Milestone Media founded in 1993

- McDuffie’s final screenplay for All-Star Superman was on a comic placed on a Burbank shelf on February 22, 2011, the day after he died.
- He was born on February 20, 1962, in Detroit and turned 49 the day before his death.
- He earned a Bachelor of Arts in English in 1983 and a Master of Science in Physics from the University of Michigan.
- He left Marvel staff in 1990 and freelanced for Marvel, DC, Archie, and Harvey thereafter.
- Milestone Media launched in 1993 through DC distribution with McDuffie as editor-in-chief, creating characters such as Static, Icon, Hardware, Xombi, and Blood Syndicate.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090329Tue, 11 Aug 2026 08:00:03 +0000Creator at ObomediaDwayne McDuffie's Last Draft: A Birthday, A Death, A Legacy A comic released one day after its writer died and one day after his forty-ninth birthday: Dwayne McDuffie’s final screenplay hit shelves with All-Star Superman in Burbank on February 22,...
A comic released one day after its writer died and one day after his forty-ninth birthday: Dwayne McDuffie’s final screenplay hit shelves with All-Star Superman in Burbank on February 22, 2011. How did a Detroit-born physicist-turned-writer build a career that reshaped representation in comics and leave a legacy that still reveals surprises?

In this episode, we trace McDuffie’s life from his birth in Detroit to his education at Roeper School and the University of Michigan, his early work at Marvel and investment journalism, and the founding of Milestone Media - asking how his insistence on real representation changed the industry.

Person: Dwayne Glenn McDuffie
Date: February 20, 1962 (birth)
Event: Release of All-Star Superman comic on February 22, 2011
Person: Leroy McDuffie and Edna Hawkins McDuffie Gardner (parents)
Organization: Milestone Media founded in 1993

- McDuffie’s final screenplay for All-Star Superman was on a comic placed on a Burbank shelf on February 22, 2011, the day after he died.
- He was born on February 20, 1962, in Detroit and turned 49 the day before his death.
- He earned a Bachelor of Arts in English in 1983 and a Master of Science in Physics from the University of Michigan.
- He left Marvel staff in 1990 and freelanced for Marvel, DC, Archie, and Harvey thereafter.
- Milestone Media launched in 1993 through DC distribution with McDuffie as editor-in-chief, creating characters such as Static, Icon, Hardware, Xombi, and Blood Syndicate.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1185falsefullhttps://www.spreaker.com/episode/he-outlived-his-lungs-the-congressman-who-breathed-borrowed-time--73090328
A Congressman lived thirteen years on a double lung transplant and died while those very lungs were still working-raising an unsettling question about survival and identity: what does it mean to outlast the thing that saved you? This episode reveals how a medical first became a prolonged, quiet experiment in endurance that intersected with shifting Southern politics.

In this episode, you will hear the life story of Floyd Davidson Davidson, from his Lexington County roots and long Navy Reserve career to the 1988 double lung transplant that allowed him to return to Congress and serve fourteen terms; what follows is the strange overlap of medical precedent and political longevity, and the moment one form of endurance finally gave out.

Person: Floyd Davidson Davidson
Date of birth: April 9, 1928
Date of transplant: 1988
Age at transplant: 60
Hospital: University of Mississippi Medical Center

- He was admitted to St. Dominic Memorial Hospital in Jackson, Mississippi, in August 2001 and died there three weeks later.
- He received a standalone double lung transplant in 1988 and was the oldest patient at that time to undergo that procedure at age 60.
- He served in the United States Navy Reserve, retiring in 1988 with the rank of captain.
- He represented his congressional district for fourteen terms and faced no major-party opponent in several election cycles in the 1990s.
- After the 1990 census redistricting, most of his African-American constituents were moved into the new Sixth Congressional District won by Jim Clyburn.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090328Mon, 10 Aug 2026 08:00:06 +0000Creator at ObomediaHe Outlived His Lungs: The Congressman Who Breathed Borrowed Time A Congressman lived thirteen years on a double lung transplant and died while those very lungs were still working-raising an unsettling question about survival and identity: what...
A Congressman lived thirteen years on a double lung transplant and died while those very lungs were still working-raising an unsettling question about survival and identity: what does it mean to outlast the thing that saved you? This episode reveals how a medical first became a prolonged, quiet experiment in endurance that intersected with shifting Southern politics.

In this episode, you will hear the life story of Floyd Davidson Davidson, from his Lexington County roots and long Navy Reserve career to the 1988 double lung transplant that allowed him to return to Congress and serve fourteen terms; what follows is the strange overlap of medical precedent and political longevity, and the moment one form of endurance finally gave out.

Person: Floyd Davidson Davidson
Date of birth: April 9, 1928
Date of transplant: 1988
Age at transplant: 60
Hospital: University of Mississippi Medical Center

- He was admitted to St. Dominic Memorial Hospital in Jackson, Mississippi, in August 2001 and died there three weeks later.
- He received a standalone double lung transplant in 1988 and was the oldest patient at that time to undergo that procedure at age 60.
- He served in the United States Navy Reserve, retiring in 1988 with the rank of captain.
- He represented his congressional district for fourteen terms and faced no major-party opponent in several election cycles in the 1990s.
- After the 1990 census redistricting, most of his African-American constituents were moved into the new Sixth Congressional District won by Jim Clyburn.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1541falsefullhttps://www.spreaker.com/episode/the-49-days-that-almost-started-world-war-ii-moltke-s-madrid-cipher--73090327
Fear that a single dispatch could tip Europe into war: Hans-Adolf von Moltke warned Berlin that Poland would fight over Danzig, sent a precise cable on 28 March 1939, and three weeks later found himself in Madrid where a night-time embassy meeting waited on one document - but did that message change anything or get suppressed?

In this episode, we follow the trajectory of Moltke’s career from his birth in 1884 through his posts in Warsaw and Madrid, and trace the cable he sent after Józef Beck’s 28 March reply that Poland would treat a return of Danzig as an act of war; what happened after that cable, and why a 5 April order from State Secretary Ernst von Weizsäcker mattered, frame the central question.

Person: Hans-Adolf von Moltke
Date: 28 March 1939
Event: Józef Beck’s reply that Poland would treat a return of Danzig as an act of war
Date: 5 April 1939
Person: Ernst von Weizsäcker

- Moltke was born 29 November 1884 in Oppeln, Upper Silesia.
- He entered the Auswärtiges Amt in January 1913 after meeting a private income requirement of 15,000 marks per year.
- Moltke served as Germany’s minister to Warsaw from February 1931 and joined the Nazi Party in October 1937.
- On 25 March 1939 Poland rejected Germany’s demand over Danzig; on 28 March Beck told Moltke Poland would fight.
- On 5 April 1939 State Secretary Ernst von Weizsäcker ordered Moltke not to negotiate, probe, or explore concessions.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090327Sun, 09 Aug 2026 08:00:02 +0000Creator at ObomediaThe 49 Days That Almost Started World War II: Moltke's Madrid Cipher Fear that a single dispatch could tip Europe into war: Hans-Adolf von Moltke warned Berlin that Poland would fight over Danzig, sent a precise cable on 28 March 1939, and three...
Fear that a single dispatch could tip Europe into war: Hans-Adolf von Moltke warned Berlin that Poland would fight over Danzig, sent a precise cable on 28 March 1939, and three weeks later found himself in Madrid where a night-time embassy meeting waited on one document - but did that message change anything or get suppressed?

In this episode, we follow the trajectory of Moltke’s career from his birth in 1884 through his posts in Warsaw and Madrid, and trace the cable he sent after Józef Beck’s 28 March reply that Poland would treat a return of Danzig as an act of war; what happened after that cable, and why a 5 April order from State Secretary Ernst von Weizsäcker mattered, frame the central question.

Person: Hans-Adolf von Moltke
Date: 28 March 1939
Event: Józef Beck’s reply that Poland would treat a return of Danzig as an act of war
Date: 5 April 1939
Person: Ernst von Weizsäcker

- Moltke was born 29 November 1884 in Oppeln, Upper Silesia.
- He entered the Auswärtiges Amt in January 1913 after meeting a private income requirement of 15,000 marks per year.
- Moltke served as Germany’s minister to Warsaw from February 1931 and joined the Nazi Party in October 1937.
- On 25 March 1939 Poland rejected Germany’s demand over Danzig; on 28 March Beck told Moltke Poland would fight.
- On 5 April 1939 State Secretary Ernst von Weizsäcker ordered Moltke not to negotiate, probe, or explore concessions.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1728falsefullhttps://www.spreaker.com/episode/how-carman-packed-stadiums-and-survived-a-failed-goodbye--73090325
Awe at scale: a casino dropout from Trenton filled Texas Stadium with 71,132 people - every ticket free - and went on to sell over ten million records as the most attended solo Christian concert act in American history. How did a teenager trained in Atlantic City rooms and Las Vegas showmanship turn into a gospel phenomenon whose final collapse came not from cancer but a surgical complication?

In this episode, we tell the life story of Carman Domenic Licciardello, tracing his journey from a musical Italian-American household in Trenton to Atlantic City casinos, Las Vegas stages, and stadiums like Texas Stadium, and we ask how the showman-language of casinos translated into unprecedented evangelical audiences.

Person: Carman Domenic Licciardello
Date of birth: January 19, 1956
Event: Texas Stadium concert - October 22, 1994
Attendance: 71,132 (all free tickets)
Career sales: over 10,000,000 records sold

- Carman left high school at 17 and immediately performed in Atlantic City casino rooms.
- By age 5 he played drums; by 15 he played guitar; he began singing at 16.
- His 1980 debut album was titled God's Not Finished with Me.
- His third album, Sunday's on the Way, debuted at No, 13 on the Billboard Top Christian Albums chart in 1983.
- He was inducted into the Gospel Music Hall of Fame in 2018 and performed on stage on January 16, 2021, thirty days before his death.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090325Sat, 08 Aug 2026 08:00:05 +0000Creator at ObomediaHow Carman Packed Stadiums - and Survived a Failed Goodbye Awe at scale: a casino dropout from Trenton filled Texas Stadium with 71,132 people - every ticket free - and went on to sell over ten million records as the most attended solo Christian...
Awe at scale: a casino dropout from Trenton filled Texas Stadium with 71,132 people - every ticket free - and went on to sell over ten million records as the most attended solo Christian concert act in American history. How did a teenager trained in Atlantic City rooms and Las Vegas showmanship turn into a gospel phenomenon whose final collapse came not from cancer but a surgical complication?

In this episode, we tell the life story of Carman Domenic Licciardello, tracing his journey from a musical Italian-American household in Trenton to Atlantic City casinos, Las Vegas stages, and stadiums like Texas Stadium, and we ask how the showman-language of casinos translated into unprecedented evangelical audiences.

Person: Carman Domenic Licciardello
Date of birth: January 19, 1956
Event: Texas Stadium concert - October 22, 1994
Attendance: 71,132 (all free tickets)
Career sales: over 10,000,000 records sold

- Carman left high school at 17 and immediately performed in Atlantic City casino rooms.
- By age 5 he played drums; by 15 he played guitar; he began singing at 16.
- His 1980 debut album was titled God's Not Finished with Me.
- His third album, Sunday's on the Way, debuted at No, 13 on the Billboard Top Christian Albums chart in 1983.
- He was inducted into the Gospel Music Hall of Fame in 2018 and performed on stage on January 16, 2021, thirty days before his death.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1640falsefullhttps://www.spreaker.com/episode/the-corvair-conspiracy-how-a-cheap-decision-killed-a-legend--73090324
Danger and design clash: the Chevrolet Corvair arrived in 1959 with its engine in the back, 26,000 orders in 48 hours, and a suspension quirk that some say made it deadly - was a few-dollar anti-roll bar the difference between safety and catastrophe?

In this episode, we tell how a single engineering choice, corporate cost decisions, and a consumer advocate's file shaped the Corvair's fate, and we ask whether the car was intrinsically defective or simply misunderstood by drivers.

Person: Ed Cole
Date: October 2, 1959
Location: Willow Run (production began July 1959)
Event: Publication of Unsafe at Any Speed (1965) - first chapter "The Sporty Corvair"
Case: over 100 pending lawsuits connected to Corvair crashes

- 26,000 Corvairs were ordered within 48 hours of the October 2, 1959 launch.
- 35% of all GM sales across all models during the Corvair’s opening window came from the Corvair.
- The Monza trim sold nearly 12,000 units in its first partial year and accounted for 80% of Corvairs by 1963.
- Management rejected a front anti-roll bar citing cost; it became optional in 1962 and standard in 1964.
- Ralph Nader, age 29, compiled over 100 pending lawsuits and technical specifications before publishing Unsafe at Any Speed in 1965.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090324Fri, 07 Aug 2026 08:00:04 +0000Creator at ObomediaThe Corvair Conspiracy: How a Cheap Decision Killed a Legend Danger and design clash: the Chevrolet Corvair arrived in 1959 with its engine in the back, 26,000 orders in 48 hours, and a suspension quirk that some say made it deadly - was a...
Danger and design clash: the Chevrolet Corvair arrived in 1959 with its engine in the back, 26,000 orders in 48 hours, and a suspension quirk that some say made it deadly - was a few-dollar anti-roll bar the difference between safety and catastrophe?

In this episode, we tell how a single engineering choice, corporate cost decisions, and a consumer advocate's file shaped the Corvair's fate, and we ask whether the car was intrinsically defective or simply misunderstood by drivers.

Person: Ed Cole
Date: October 2, 1959
Location: Willow Run (production began July 1959)
Event: Publication of Unsafe at Any Speed (1965) - first chapter "The Sporty Corvair"
Case: over 100 pending lawsuits connected to Corvair crashes

- 26,000 Corvairs were ordered within 48 hours of the October 2, 1959 launch.
- 35% of all GM sales across all models during the Corvair’s opening window came from the Corvair.
- The Monza trim sold nearly 12,000 units in its first partial year and accounted for 80% of Corvairs by 1963.
- Management rejected a front anti-roll bar citing cost; it became optional in 1962 and standard in 1964.
- Ralph Nader, age 29, compiled over 100 pending lawsuits and technical specifications before publishing Unsafe at Any Speed in 1965.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1344falsefullhttps://www.spreaker.com/episode/the-bakery-that-almost-killed-a-colony-the-1857-arsenic-loaf--73090322
Panic rippled through Hong Kong when a single bakery’s loaves sickened 300-500 people on January 15, 1857 - tests later found about 62-64 grains of arsenic trioxide per pound, a concentration lethal many times over, yet no one died. How could arsenic so concentrated force mass vomiting and spare lives, and who slipped poison into finished loaves minutes before they were baked?

In this episode, we tell the story of that morning, the bakery at the center of the crisis, the tests and the emergency response, and the unanswered questions that followed: why the poison failed to kill and why the accused man walked free.

Person: Cheong Ah-lum
Date: January 15, 1857
Location: Hong Kong
Event: Mass arsenic poisoning from Esing Bakery loaves
Analysts: Murray and Liebig

- Between 300 and 500 European residents were violently ill by the end of January 15, 1857.
- Chemist Murray measured 62.3 grains of arsenic trioxide per pound of bread.
- Analyst Liebig measured 64 grains of arsenic trioxide per pound of bread.
- Surgeon General Aurelius Harland ordered inducing vomiting and consuming raw eggs as emergency treatment.
- Cheong Ah-lum left for Macau the morning of January 15, was arrested and later acquitted, and died in 1900 without ever being convicted.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090322Thu, 06 Aug 2026 08:00:04 +0000Creator at ObomediaThe Bakery That Almost Killed a Colony: The 1857 Arsenic Loaf Panic rippled through Hong Kong when a single bakery’s loaves sickened 300-500 people on January 15, 1857 - tests later found about 62-64 grains of arsenic trioxide per pound, a...
Panic rippled through Hong Kong when a single bakery’s loaves sickened 300-500 people on January 15, 1857 - tests later found about 62-64 grains of arsenic trioxide per pound, a concentration lethal many times over, yet no one died. How could arsenic so concentrated force mass vomiting and spare lives, and who slipped poison into finished loaves minutes before they were baked?

In this episode, we tell the story of that morning, the bakery at the center of the crisis, the tests and the emergency response, and the unanswered questions that followed: why the poison failed to kill and why the accused man walked free.

Person: Cheong Ah-lum
Date: January 15, 1857
Location: Hong Kong
Event: Mass arsenic poisoning from Esing Bakery loaves
Analysts: Murray and Liebig

- Between 300 and 500 European residents were violently ill by the end of January 15, 1857.
- Chemist Murray measured 62.3 grains of arsenic trioxide per pound of bread.
- Analyst Liebig measured 64 grains of arsenic trioxide per pound of bread.
- Surgeon General Aurelius Harland ordered inducing vomiting and consuming raw eggs as emergency treatment.
- Cheong Ah-lum left for Macau the morning of January 15, was arrested and later acquitted, and died in 1900 without ever being convicted.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1811falsefullhttps://www.spreaker.com/episode/a-frozen-croquette-tested-positive-for-pork-chicken-and-it-said-100-beef--73090321
Trust in Japan’s food labels was nearly absolute in the 1990s and 2000s, yet one DNA test in spring 2007 revealed a frozen croquette labeled “100% beef” contained pork and chicken. How did nearly 9,838 tons of fraudulent ground beef move through 22 prefectures while whistleblowers were ignored?

In this episode, we lay out the sequence of events from a factory floor in Tomakomai to anonymous complaints, a named whistleblower, and a lab result that cracked open a national scandal - and ask why official channels repeatedly failed to act.

Person: Kiroku Akahane
Company: Meat Hope Inc
Location: Tomakomai, Hokkaido
Date: spring 2007
Quantity: 9,838 tons

- The DNA test in spring 2007 found pork and chicken in a croquette labeled “100% beef.”
- Kiroku Akahane was born in 1935 and retired from hotel management in 1995 before joining Meat Hope that year.
- By the mid-1990s Meat Hope employed roughly 100 people directly and about 500 through associated companies.
- Between July 2006 and June 2007, 9,838 tons of fraudulent ground beef were distributed across 22 prefectures.
- The Whistleblower Protection Act took effect on April 1, 2006, the same month Akahane resigned and revealed his identity.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090321Wed, 05 Aug 2026 08:00:03 +0000Creator at ObomediaA frozen croquette tested positive for pork, chicken - and it said 100% beef Trust in Japan’s food labels was nearly absolute in the 1990s and 2000s, yet one DNA test in spring 2007 revealed a frozen croquette labeled “100% beef” contained pork and...
Trust in Japan’s food labels was nearly absolute in the 1990s and 2000s, yet one DNA test in spring 2007 revealed a frozen croquette labeled “100% beef” contained pork and chicken. How did nearly 9,838 tons of fraudulent ground beef move through 22 prefectures while whistleblowers were ignored?

In this episode, we lay out the sequence of events from a factory floor in Tomakomai to anonymous complaints, a named whistleblower, and a lab result that cracked open a national scandal - and ask why official channels repeatedly failed to act.

Person: Kiroku Akahane
Company: Meat Hope Inc
Location: Tomakomai, Hokkaido
Date: spring 2007
Quantity: 9,838 tons

- The DNA test in spring 2007 found pork and chicken in a croquette labeled “100% beef.”
- Kiroku Akahane was born in 1935 and retired from hotel management in 1995 before joining Meat Hope that year.
- By the mid-1990s Meat Hope employed roughly 100 people directly and about 500 through associated companies.
- Between July 2006 and June 2007, 9,838 tons of fraudulent ground beef were distributed across 22 prefectures.
- The Whistleblower Protection Act took effect on April 1, 2006, the same month Akahane resigned and revealed his identity.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1385falsefullhttps://www.spreaker.com/episode/when-the-bulldozers-came-the-lost-parrots-of-rafah-2004--73090320
A dense refugee camp, a civilian zoo eight hundred meters from the Egyptian border, and bulldozers that erased both - along with the African parrots its owner said soldiers took and never returned. How did an operation that destroyed 254 homes and razed 70 hectares of farmland produce a single tunnel and no publicly accounted-for missiles - and what became of those parrots?

In this episode, we tell the story of Operation Rainbow over ten days in May 2004, detailing the demolitions, the military claims, and the human consequences in Rafah; what did the operation accomplish, and what questions did it leave unanswered?

Person: Mohammed Juma
Date: May 21, 2004
Location: Rafah refugee camp
Event: Operation Rainbow
Homes demolished: 254

- The Rafah zoo was leveled by Israeli military bulldozers on Tuesday, May 21, 2004.
- The zoo sat 800 meters from the Egyptian border and its owner reported that soldiers took his African parrots, which were never publicly accounted for.
- From May 12 to May 24, 2004, 254 homes were demolished in the Rafah refugee camp.
- Seventy hectares of farmland were razed during the operation and nearly 3,800 people lost their shelter.
- Investigators found one smuggling tunnel on May 23, 2004, twenty-five feet deep, while no anti-aircraft missiles cited as justification were found.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090320Tue, 04 Aug 2026 08:00:03 +0000Creator at ObomediaWhen the Bulldozers Came: The Lost Parrots of Rafah 2004 A dense refugee camp, a civilian zoo eight hundred meters from the Egyptian border, and bulldozers that erased both - along with the African parrots its owner said soldiers took and never...
A dense refugee camp, a civilian zoo eight hundred meters from the Egyptian border, and bulldozers that erased both - along with the African parrots its owner said soldiers took and never returned. How did an operation that destroyed 254 homes and razed 70 hectares of farmland produce a single tunnel and no publicly accounted-for missiles - and what became of those parrots?

In this episode, we tell the story of Operation Rainbow over ten days in May 2004, detailing the demolitions, the military claims, and the human consequences in Rafah; what did the operation accomplish, and what questions did it leave unanswered?

Person: Mohammed Juma
Date: May 21, 2004
Location: Rafah refugee camp
Event: Operation Rainbow
Homes demolished: 254

- The Rafah zoo was leveled by Israeli military bulldozers on Tuesday, May 21, 2004.
- The zoo sat 800 meters from the Egyptian border and its owner reported that soldiers took his African parrots, which were never publicly accounted for.
- From May 12 to May 24, 2004, 254 homes were demolished in the Rafah refugee camp.
- Seventy hectares of farmland were razed during the operation and nearly 3,800 people lost their shelter.
- Investigators found one smuggling tunnel on May 23, 2004, twenty-five feet deep, while no anti-aircraft missiles cited as justification were found.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1677falsefullhttps://www.spreaker.com/episode/ten-million-people-every-single-year-by-2050--73090317
Antibiotic resistance will kill an estimated ten million people every year by 2050, and the choices that built that future began with a petri dish in 1928. What happens when a wonder drug stops working, and who paid the price for decades of small, repeated decisions?

In this episode, we trace the history from Alexander Fleming's discovery of penicillin to global practices in medicine and agriculture, showing how clinical and livestock antibiotic use created a reservoir of resistant bacteria - and asking how that reservoir crossed from farms into kitchens and hospitals.

Person: Alexander Fleming
Date: 1928
Event: Industrial-scale penicillin production in the early 1940s
Program: NARMS established in 1996 by FDA, CDC, and USDA
Evidence: Over 150 peer-reviewed articles linking antibiotic use in food animals to resistant strains

- Up to 75% of acute respiratory infections were treated with antibiotics despite most being viral.
- By the 1940s, penicillin was manufactured at industrial scale for Allied forces.
- In 1996, FDA, CDC, and USDA created NARMS to monitor antimicrobial resistance in the food supply.
- NARMS data contributed to more than 150 peer-reviewed articles documenting transmission of resistant bacteria from food animals to humans.
- In the 1980s, medically important antibiotics were added to livestock feed and water for prevention and growth promotion on a scale that dwarfed clinical use.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090317Mon, 03 Aug 2026 08:00:03 +0000Creator at ObomediaTen million people, every single year, by 2050 Antibiotic resistance will kill an estimated ten million people every year by 2050, and the choices that built that future began with a petri dish in 1928. What happens when a wonder drug stops...
Antibiotic resistance will kill an estimated ten million people every year by 2050, and the choices that built that future began with a petri dish in 1928. What happens when a wonder drug stops working, and who paid the price for decades of small, repeated decisions?

In this episode, we trace the history from Alexander Fleming's discovery of penicillin to global practices in medicine and agriculture, showing how clinical and livestock antibiotic use created a reservoir of resistant bacteria - and asking how that reservoir crossed from farms into kitchens and hospitals.

Person: Alexander Fleming
Date: 1928
Event: Industrial-scale penicillin production in the early 1940s
Program: NARMS established in 1996 by FDA, CDC, and USDA
Evidence: Over 150 peer-reviewed articles linking antibiotic use in food animals to resistant strains

- Up to 75% of acute respiratory infections were treated with antibiotics despite most being viral.
- By the 1940s, penicillin was manufactured at industrial scale for Allied forces.
- In 1996, FDA, CDC, and USDA created NARMS to monitor antimicrobial resistance in the food supply.
- NARMS data contributed to more than 150 peer-reviewed articles documenting transmission of resistant bacteria from food animals to humans.
- In the 1980s, medically important antibiotics were added to livestock feed and water for prevention and growth promotion on a scale that dwarfed clinical use.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1732falsefullhttps://www.spreaker.com/episode/three-grains-of-morphine-the-nurse-who-rewrote-a-will--73090313
Fear that a quiet household hid a deliberate plan: more than three grains of morphine were found across five organs in a body hours from the crematorium, and a newly rewritten will diverted £1,600 to the nurse running the home. Who signed that death certificate, why did a municipal clerk order a post-mortem, and could a forged “dying” request have been the final act in a calculated scheme?

In this episode, we walk through the sequence of events that followed Ada Baguley’s death in September 1935 at a nursing home on Devon Drive, showing how one bureaucrat’s doubt led to a lab report that changed everything. What exactly linked a supply of morphine, a non‑qualified “nurse,” and a sudden change in Ada’s testamentary plans?

Person: Ada Baguley
Date: September 1935
Location: 32 Devon Drive, Nottingham, England
Amount: £1,600
Other Person: Dorothea Nancy Nancy (Nurse Nancy)

- Ada Baguley was 51 years old and had been diagnosed with “creeping paralysis” (now recognised as multiple sclerosis).
- Three grains of morphine were reported found in a stomach, liver, a pair of kidneys, and a heart.
- Louisa Baguley was 88 years old and died in May 1935 after Ada rewrote her will earlier that month.
- The rewritten will left Ada and Louisa’s entire estate to Dorothea Nancy and Ronald Sullivan after both deaths, replacing cousins Lawrence Baguley and Fred Gilbert.
- Dorothea Nancy Nancy was 35 years old, had no nursing qualifications, had served two prison sentences for fraud and theft, and lived with her partner Ronald Sullivan Sullivan at Devon Drive.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090313Sun, 02 Aug 2026 08:00:02 +0000Creator at ObomediaThree Grains of Morphine: The Nurse Who Rewrote a Will Fear that a quiet household hid a deliberate plan: more than three grains of morphine were found across five organs in a body hours from the crematorium, and a newly rewritten will diverted...
Fear that a quiet household hid a deliberate plan: more than three grains of morphine were found across five organs in a body hours from the crematorium, and a newly rewritten will diverted £1,600 to the nurse running the home. Who signed that death certificate, why did a municipal clerk order a post-mortem, and could a forged “dying” request have been the final act in a calculated scheme?

In this episode, we walk through the sequence of events that followed Ada Baguley’s death in September 1935 at a nursing home on Devon Drive, showing how one bureaucrat’s doubt led to a lab report that changed everything. What exactly linked a supply of morphine, a non‑qualified “nurse,” and a sudden change in Ada’s testamentary plans?

Person: Ada Baguley
Date: September 1935
Location: 32 Devon Drive, Nottingham, England
Amount: £1,600
Other Person: Dorothea Nancy Nancy (Nurse Nancy)

- Ada Baguley was 51 years old and had been diagnosed with “creeping paralysis” (now recognised as multiple sclerosis).
- Three grains of morphine were reported found in a stomach, liver, a pair of kidneys, and a heart.
- Louisa Baguley was 88 years old and died in May 1935 after Ada rewrote her will earlier that month.
- The rewritten will left Ada and Louisa’s entire estate to Dorothea Nancy and Ronald Sullivan after both deaths, replacing cousins Lawrence Baguley and Fred Gilbert.
- Dorothea Nancy Nancy was 35 years old, had no nursing qualifications, had served two prison sentences for fraud and theft, and lived with her partner Ronald Sullivan Sullivan at Devon Drive.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1579falsefullhttps://www.spreaker.com/episode/when-trust-killed-the-canadian-blood-scandal-that-failed-children--73090311
Trust in a humanitarian emblem hid a system that chose convenience over safety: by the time a heat-treated Factor VIII batch failed in 1986, seven children were infected and the Canadian Red Cross refused to withdraw the remaining supply. How did an institution that set safety standards for decades allow pooled plasma, paid American donors, and delayed testing to become a national catastrophe?

In this episode, we lay out the sequence of decisions, institutional roles, and scientific choices that led to the largest preventable public health disaster in Canadian history, and ask why legal accountability bore almost no relation to the scale of the harm.

Person: Canadian Red Cross Society
Event: Arrival of heat-treated Factor VIII in 1986 that failed to kill HIV
Case: Seven children infected from that batch
Period: Red Cross oversight of standards until 1989
Projected deaths: more than 8,000 Canadians dead or projected to die from contaminated blood products

- Heat-treated Factor VIII approved by government arrived in 1986 and nonetheless failed to inactivate HIV.
- Seven children were infected from that single 1986 batch.
- The Red Cross refused the Canadian Hemophilia Society’s demand to withdraw the remaining supply.
- The Red Cross set health and safety standards for the national blood system until 1989 while also operating the system.
- The final criminal fine related to the scandal was five thousand dollars.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090311Sat, 01 Aug 2026 08:00:03 +0000Creator at ObomediaWhen Trust Killed: The Canadian Blood Scandal That Failed Children Trust in a humanitarian emblem hid a system that chose convenience over safety: by the time a heat-treated Factor VIII batch failed in 1986, seven children were infected and the...
Trust in a humanitarian emblem hid a system that chose convenience over safety: by the time a heat-treated Factor VIII batch failed in 1986, seven children were infected and the Canadian Red Cross refused to withdraw the remaining supply. How did an institution that set safety standards for decades allow pooled plasma, paid American donors, and delayed testing to become a national catastrophe?

In this episode, we lay out the sequence of decisions, institutional roles, and scientific choices that led to the largest preventable public health disaster in Canadian history, and ask why legal accountability bore almost no relation to the scale of the harm.

Person: Canadian Red Cross Society
Event: Arrival of heat-treated Factor VIII in 1986 that failed to kill HIV
Case: Seven children infected from that batch
Period: Red Cross oversight of standards until 1989
Projected deaths: more than 8,000 Canadians dead or projected to die from contaminated blood products

- Heat-treated Factor VIII approved by government arrived in 1986 and nonetheless failed to inactivate HIV.
- Seven children were infected from that single 1986 batch.
- The Red Cross refused the Canadian Hemophilia Society’s demand to withdraw the remaining supply.
- The Red Cross set health and safety standards for the national blood system until 1989 while also operating the system.
- The final criminal fine related to the scandal was five thousand dollars.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1430falsefullhttps://www.spreaker.com/episode/bloodied-dawn-at-pearl-roundabout-how-four-lives-vanished--73090309
Fear of sudden, unjust violence: at 3:00 AM on February 17, 2011, an unarmed encampment of roughly three thousand people was attacked at Pearl Roundabout, leaving four men dead and raising unresolved questions about blocked ambulances, acquitted officers, and a government commission that contradicted its own findings. How did a festival-like protest become a pre-dawn massacre, and who has been held accountable?

In this episode, we present the events and testimonies from Bloody Thursday, describing who was in the tents, how the operation unfolded, and the contradictions between official claims and independent evidence that leave the central questions open.

Person: Ali Mansour Ahmed Khudair
Person: Mahmoud Makki Abutaki
Person: Isa Abdulhasan Ali Hussain
Person: Ali Ahmed Moumen
Event: Bloody Thursday, Pearl Roundabout raid

- Time: roughly 3:00 AM on February 17, 2011, when the assault began.
- Attendance: between 1,500 and 3,000 people were inside the roundabout tents that night.
- Weapons recovered: ninety-one birdshot pellets were recovered from Ali Mansour Ahmed Khudair’s body.
- Ages: Mahmoud Makki Abutaki was 22; Ali Ahmed Moumen was 22; Isa Abdulhasan Ali Hussain was 60; Ali Mansour Ahmed Khudair was either 53 or 58.
- Legal outcome: the policeman charged with Isa Abdulhasan Ali Hussain’s murder was acquitted on September 27, 2012.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090309Fri, 31 Jul 2026 08:00:03 +0000Creator at ObomediaBloodied Dawn at Pearl Roundabout: How Four Lives Vanished Fear of sudden, unjust violence: at 3:00 AM on February 17, 2011, an unarmed encampment of roughly three thousand people was attacked at Pearl Roundabout, leaving four men dead and raising...
Fear of sudden, unjust violence: at 3:00 AM on February 17, 2011, an unarmed encampment of roughly three thousand people was attacked at Pearl Roundabout, leaving four men dead and raising unresolved questions about blocked ambulances, acquitted officers, and a government commission that contradicted its own findings. How did a festival-like protest become a pre-dawn massacre, and who has been held accountable?

In this episode, we present the events and testimonies from Bloody Thursday, describing who was in the tents, how the operation unfolded, and the contradictions between official claims and independent evidence that leave the central questions open.

Person: Ali Mansour Ahmed Khudair
Person: Mahmoud Makki Abutaki
Person: Isa Abdulhasan Ali Hussain
Person: Ali Ahmed Moumen
Event: Bloody Thursday, Pearl Roundabout raid

- Time: roughly 3:00 AM on February 17, 2011, when the assault began.
- Attendance: between 1,500 and 3,000 people were inside the roundabout tents that night.
- Weapons recovered: ninety-one birdshot pellets were recovered from Ali Mansour Ahmed Khudair’s body.
- Ages: Mahmoud Makki Abutaki was 22; Ali Ahmed Moumen was 22; Isa Abdulhasan Ali Hussain was 60; Ali Mansour Ahmed Khudair was either 53 or 58.
- Legal outcome: the policeman charged with Isa Abdulhasan Ali Hussain’s murder was acquitted on September 27, 2012.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1195falsefullhttps://www.spreaker.com/episode/the-bulletproof-vest-he-refused-medicine-murder-and-moral-theft--73090306
A dead man with a bulletproof vest he refused and a memory card sewn into its lining becomes the hinge of a Tamil thriller that asks how medicine can be turned into a weapon of profit. The film Thani Oruvan premiered on 28 August 2015 after seven years of stalled development, a rejected distribution deal, and a crew who forfeited salaries-so how did it still become one of the most discussed Tamil films of its decade?

In this episode, we trace the film’s journey from a conversation between two brothers to a finished film shot on celluloid, and we follow its story of corruption and scientific theft to ask: how does a society look when medicine, money, and governance collide?

Person: Mohan Raja
Person: Ravi Mohan (Jayam Ravi)
Person: Arvind Swamy
Date: 28 August 2015
Budget: 15 crore rupees

- Principal photography began on 6 December 2013.
- The project endured seven years of blocked development before release.
- The budget was initially set at 15 crore rupees but increased during production.
- The film was shot on physical celluloid and is documented as possibly the last major Indian production to do so.
- The production house AGS Entertainment committed financing in 2008 and included Kalpathi S. Aghoram, S. Ganesh, and S. Suresh.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090306Thu, 30 Jul 2026 08:00:02 +0000Creator at ObomediaThe Bulletproof Vest He Refused: Medicine, Murder, and Moral Theft A dead man with a bulletproof vest he refused and a memory card sewn into its lining becomes the hinge of a Tamil thriller that asks how medicine can be turned into a weapon of...
A dead man with a bulletproof vest he refused and a memory card sewn into its lining becomes the hinge of a Tamil thriller that asks how medicine can be turned into a weapon of profit. The film Thani Oruvan premiered on 28 August 2015 after seven years of stalled development, a rejected distribution deal, and a crew who forfeited salaries-so how did it still become one of the most discussed Tamil films of its decade?

In this episode, we trace the film’s journey from a conversation between two brothers to a finished film shot on celluloid, and we follow its story of corruption and scientific theft to ask: how does a society look when medicine, money, and governance collide?

Person: Mohan Raja
Person: Ravi Mohan (Jayam Ravi)
Person: Arvind Swamy
Date: 28 August 2015
Budget: 15 crore rupees

- Principal photography began on 6 December 2013.
- The project endured seven years of blocked development before release.
- The budget was initially set at 15 crore rupees but increased during production.
- The film was shot on physical celluloid and is documented as possibly the last major Indian production to do so.
- The production house AGS Entertainment committed financing in 2008 and included Kalpathi S. Aghoram, S. Ganesh, and S. Suresh.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1789falsefullhttps://www.spreaker.com/episode/they-gave-incarcerated-men-lsd-every-day-what-happened-next--73090305
Fear of losing control: seven incarcerated men were given LSD every morning for seventy-seven consecutive days, and by day three the drug "stopped working" so doctors quadrupled the dose-what did that do to their minds and bodies? This episode traces how daily LSD dosing at a federal hospital intersected with addiction science, CIA funding, and unsettled ethics-who benefited, and who paid the cost?

In this episode, we tell the story of Harris Isbell and the Addiction Research Center in Lexington, outlining the institution's dual role as a treatment facility and a research laboratory, the daily LSD experiments beginning in 1956, and the unanswered questions about consent and harm that followed-what did the seven men's experiences reveal about dependence and research ethics?

Person: Harris Isbell
Location: Lexington, Kentucky
Institution: United States Public Health Service Hospital / Addiction Research Center
Start date of LSD dosing: 1956
Duration of LSD regimen: 77 consecutive days

- Seven incarcerated men on a locked federal ward received LSD every morning for seventy-seven consecutive days.
- The initial LSD dose was roughly 1.5 micrograms per kilogram (about 140 micrograms for a 200-pound man).
- By day three the LSD "stopped working" and researchers quadrupled the dose.
- Funding for the LSD research came in part through the CIA's MKUltra program, which requested and helped pay for the work.
- Over eighteen years Isbell and his team published more than 125 peer-reviewed papers, while the LSD experiments later drew historical review calling them difficult or impossible to justify under current human subjects standards.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090305Wed, 29 Jul 2026 08:00:02 +0000Creator at ObomediaThey Gave Incarcerated Men LSD Every Day - What Happened Next? Fear of losing control: seven incarcerated men were given LSD every morning for seventy-seven consecutive days, and by day three the drug "stopped working" so doctors quadrupled the...
Fear of losing control: seven incarcerated men were given LSD every morning for seventy-seven consecutive days, and by day three the drug "stopped working" so doctors quadrupled the dose-what did that do to their minds and bodies? This episode traces how daily LSD dosing at a federal hospital intersected with addiction science, CIA funding, and unsettled ethics-who benefited, and who paid the cost?

In this episode, we tell the story of Harris Isbell and the Addiction Research Center in Lexington, outlining the institution's dual role as a treatment facility and a research laboratory, the daily LSD experiments beginning in 1956, and the unanswered questions about consent and harm that followed-what did the seven men's experiences reveal about dependence and research ethics?

Person: Harris Isbell
Location: Lexington, Kentucky
Institution: United States Public Health Service Hospital / Addiction Research Center
Start date of LSD dosing: 1956
Duration of LSD regimen: 77 consecutive days

- Seven incarcerated men on a locked federal ward received LSD every morning for seventy-seven consecutive days.
- The initial LSD dose was roughly 1.5 micrograms per kilogram (about 140 micrograms for a 200-pound man).
- By day three the LSD "stopped working" and researchers quadrupled the dose.
- Funding for the LSD research came in part through the CIA's MKUltra program, which requested and helped pay for the work.
- Over eighteen years Isbell and his team published more than 125 peer-reviewed papers, while the LSD experiments later drew historical review calling them difficult or impossible to justify under current human subjects standards.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1330falsefullhttps://www.spreaker.com/episode/when-consent-broke-the-shocking-case-that-shaped-medical-law--73090304
Fear and legal shock: a voluntary patient at Friern Hospital suffered bilateral acetabular fractures during electro-convulsive therapy after being neither warned nor given muscle relaxants or restraints - and the jury still found no negligence. How did one 1957 courtroom decision become the rule that governed consent and medical practice for fifty years?

In this episode, we tell the story of Mr Bolam and the case that followed, tracing the treatment at a north London Victorian psychiatric hospital, the clinical debates over muscle relaxants and restraints, and the legal question about what patients must be told before agreeing to risk. What did the jury accept, and why did that acceptance reshape patient rights?

Person: Mr Bolam
Date: 1957
Location: Friern Hospital, north London
Event: Electro-convulsive therapy causing bilateral acetabular fractures
Period: 1950s

- Mr Bolam was a voluntary patient who agreed to electro-convulsive therapy without being warned of the risks.
- Friern Hospital gave no muscle relaxants, applied no restraints, and provided no warning before ECT.
- The ECT-induced grand mal seizure caused both acetabula (hip socket bones) to fracture.
- Medical experts testified there was a recognized school of thought opposing routine use of muscle relaxants in ECT due to their risks.
- Expert testimony also held that physical restraints could increase fracture risk by creating fixed resistance during convulsions.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090304Tue, 28 Jul 2026 08:00:24 +0000Creator at ObomediaWhen Consent Broke: The Shocking Case That Shaped Medical Law Fear and legal shock: a voluntary patient at Friern Hospital suffered bilateral acetabular fractures during electro-convulsive therapy after being neither warned nor given muscle...
Fear and legal shock: a voluntary patient at Friern Hospital suffered bilateral acetabular fractures during electro-convulsive therapy after being neither warned nor given muscle relaxants or restraints - and the jury still found no negligence. How did one 1957 courtroom decision become the rule that governed consent and medical practice for fifty years?

In this episode, we tell the story of Mr Bolam and the case that followed, tracing the treatment at a north London Victorian psychiatric hospital, the clinical debates over muscle relaxants and restraints, and the legal question about what patients must be told before agreeing to risk. What did the jury accept, and why did that acceptance reshape patient rights?

Person: Mr Bolam
Date: 1957
Location: Friern Hospital, north London
Event: Electro-convulsive therapy causing bilateral acetabular fractures
Period: 1950s

- Mr Bolam was a voluntary patient who agreed to electro-convulsive therapy without being warned of the risks.
- Friern Hospital gave no muscle relaxants, applied no restraints, and provided no warning before ECT.
- The ECT-induced grand mal seizure caused both acetabula (hip socket bones) to fracture.
- Medical experts testified there was a recognized school of thought opposing routine use of muscle relaxants in ECT due to their risks.
- Expert testimony also held that physical restraints could increase fracture risk by creating fixed resistance during convulsions.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1519falsefullhttps://www.spreaker.com/episode/the-dollar-that-turned-children-into-patients-the-duplessis-fraud--73090302
Fear and outrage: thousands of children in Quebec were reclassified as psychiatric patients in 1949 because one spreadsheet turned a $1.25 subsidy into $2.75 - a $1.50 daily difference that filled church coffers and emptied truth. How did a single administrative order turn orphanages into mental hospitals with no medical exams, and what remains unexcavated in Montreal?

In this episode, we tell the story of the Duplessis Orphans, tracing the 1949 provincial order that reclassified educational orphanages as psychiatric hospitals, the federal funding that followed, and the survivors’ fight decades later to demand answers. What did that reclassification change about the children’s lives, and why did institutions never repudiate the gains?

Person: Maurice Duplessis
Date: 1949
Location: Quebec, Canada
Law: Loi sur les Asiles d'aliénés (since 1909)
Funding differential: $1.50 per child per day

- The federal rate for an orphan in an educational institution was $1.25 per day.
- The federal rate for a psychiatric patient was $2.75 per day.
- The provincial order-in-council in 1949 reclassified orphanages as hospitals for the mentally ill without medical examinations.
- The 1909 Law on Asylums for the Insane allowed internment for "maintaining social order" with no independent review.
- Survivors organized and demanded answers in the 1990s about conditions like electroshock, restraints, and experimental procedures.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090302Mon, 27 Jul 2026 08:00:03 +0000Creator at ObomediaThe Dollar That Turned Children Into Patients: The Duplessis Fraud Fear and outrage: thousands of children in Quebec were reclassified as psychiatric patients in 1949 because one spreadsheet turned a $1.25 subsidy into $2.75 - a $1.50 daily...
Fear and outrage: thousands of children in Quebec were reclassified as psychiatric patients in 1949 because one spreadsheet turned a $1.25 subsidy into $2.75 - a $1.50 daily difference that filled church coffers and emptied truth. How did a single administrative order turn orphanages into mental hospitals with no medical exams, and what remains unexcavated in Montreal?

In this episode, we tell the story of the Duplessis Orphans, tracing the 1949 provincial order that reclassified educational orphanages as psychiatric hospitals, the federal funding that followed, and the survivors’ fight decades later to demand answers. What did that reclassification change about the children’s lives, and why did institutions never repudiate the gains?

Person: Maurice Duplessis
Date: 1949
Location: Quebec, Canada
Law: Loi sur les Asiles d'aliénés (since 1909)
Funding differential: $1.50 per child per day

- The federal rate for an orphan in an educational institution was $1.25 per day.
- The federal rate for a psychiatric patient was $2.75 per day.
- The provincial order-in-council in 1949 reclassified orphanages as hospitals for the mentally ill without medical examinations.
- The 1909 Law on Asylums for the Insane allowed internment for "maintaining social order" with no independent review.
- Survivors organized and demanded answers in the 1990s about conditions like electroshock, restraints, and experimental procedures.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1733falsefullhttps://www.spreaker.com/episode/the-pediatrician-who-hid-horrific-abuse-behind-carnival-rides--73090301
Trust and terror sat side-by-side in a waiting room that smelled of cotton candy and motor oil, where Volkswagen Beetle rides and a Buzz Lightyear statue masked a predator trusted by a coastal community. More than thirteen hours of hidden camera footage would later be described by a Harvard pediatric expert as the worst case of physician abuse he'd seen - so how did warnings over fifteen years fail to stop him?

In this episode, we tell how a pediatrician built a comforting, theatrical practice while multiple sealed complaints, family reports, and peer concerns accumulated for years, and how one recorded tape finally changed everything. What did the footage show that decades of reports and failed warrants could not?

Person: Earl Brian Bradley
Location: Lewes, Delaware
Practice: BayBees Pediatrics
Patients served: estimated 7,000
Footage recorded: more than 13 hours

- Bradley was born May 10, 1953, in Philadelphia, Pennsylvania.
- He earned his medical degree from Temple University School of Medicine in 1983.
- Two sealed complaints were filed against him in 1994 and 1995 before he moved to Lewes.
- In 2004 his sister, Lynda Barnes, reported complaints including inappropriate touching and alleged abuse of his son.
- In 2005 a warrant request based on peer reports was denied by the attorney general's office for insufficient evidence.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090301Sun, 26 Jul 2026 08:00:03 +0000Creator at ObomediaThe Pediatrician Who Hid Horrific Abuse Behind Carnival Rides Trust and terror sat side-by-side in a waiting room that smelled of cotton candy and motor oil, where Volkswagen Beetle rides and a Buzz Lightyear statue masked a predator trusted by a...
Trust and terror sat side-by-side in a waiting room that smelled of cotton candy and motor oil, where Volkswagen Beetle rides and a Buzz Lightyear statue masked a predator trusted by a coastal community. More than thirteen hours of hidden camera footage would later be described by a Harvard pediatric expert as the worst case of physician abuse he'd seen - so how did warnings over fifteen years fail to stop him?

In this episode, we tell how a pediatrician built a comforting, theatrical practice while multiple sealed complaints, family reports, and peer concerns accumulated for years, and how one recorded tape finally changed everything. What did the footage show that decades of reports and failed warrants could not?

Person: Earl Brian Bradley
Location: Lewes, Delaware
Practice: BayBees Pediatrics
Patients served: estimated 7,000
Footage recorded: more than 13 hours

- Bradley was born May 10, 1953, in Philadelphia, Pennsylvania.
- He earned his medical degree from Temple University School of Medicine in 1983.
- Two sealed complaints were filed against him in 1994 and 1995 before he moved to Lewes.
- In 2004 his sister, Lynda Barnes, reported complaints including inappropriate touching and alleged abuse of his son.
- In 2005 a warrant request based on peer reports was denied by the attorney general's office for insufficient evidence.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1658falsefullhttps://www.spreaker.com/episode/the-carnival-doctor-how-seven-thousand-parents-were-betrayed--73090300
A pediatrician whose office featured a Buzz Lightyear statue, a Volkswagen painted like a bumblebee, and a small theatre recorded more than thirteen hours of abuse-yet he kept seeing an estimated seven thousand children before being stopped. How could complaints from his sister, nurses, and other physicians all fail to halt him?

In this episode, we tell the story of Earl Brian Bradley and the sequence of warnings, reports, and official decisions that allowed his practice to continue in Lewes, Delaware. What went wrong across hospitals, police, and medical review boards that let him keep his appointment book open?

Person: Earl Brian Bradley
Date of birth: May 10, 1953
Education: Temple University School of Medicine (MD, 1983)
Residency: Pediatrics at Thomas Jefferson University Hospital (completed 1986)
Practice location: BayBees Pediatrics, Lewes, Delaware

- More than thirteen hours of videotaped abuse were recorded inside Bradley’s pediatric office.
- Bradley was estimated to have a patient base of approximately seven thousand children in Lewes.
- Two complaints were filed against him at Thomas Jefferson University Hospital in 1994 and 1995; both remained unverified and records were sealed.
- In 2004 Bradley’s sister, Lynda Barnes, reported allegations including inappropriate touching, stolen antidepressants, and abuse of his son to the Delaware state medical society.
- In 2005 a nurse reported Bradley had been videotaping children; police sought an arrest warrant but the state attorney general’s office found insufficient evidence for prosecution.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090300Sat, 25 Jul 2026 08:00:03 +0000Creator at ObomediaThe Carnival Doctor: How Seven Thousand Parents Were Betrayed A pediatrician whose office featured a Buzz Lightyear statue, a Volkswagen painted like a bumblebee, and a small theatre recorded more than thirteen hours of abuse-yet he kept seeing an...
A pediatrician whose office featured a Buzz Lightyear statue, a Volkswagen painted like a bumblebee, and a small theatre recorded more than thirteen hours of abuse-yet he kept seeing an estimated seven thousand children before being stopped. How could complaints from his sister, nurses, and other physicians all fail to halt him?

In this episode, we tell the story of Earl Brian Bradley and the sequence of warnings, reports, and official decisions that allowed his practice to continue in Lewes, Delaware. What went wrong across hospitals, police, and medical review boards that let him keep his appointment book open?

Person: Earl Brian Bradley
Date of birth: May 10, 1953
Education: Temple University School of Medicine (MD, 1983)
Residency: Pediatrics at Thomas Jefferson University Hospital (completed 1986)
Practice location: BayBees Pediatrics, Lewes, Delaware

- More than thirteen hours of videotaped abuse were recorded inside Bradley’s pediatric office.
- Bradley was estimated to have a patient base of approximately seven thousand children in Lewes.
- Two complaints were filed against him at Thomas Jefferson University Hospital in 1994 and 1995; both remained unverified and records were sealed.
- In 2004 Bradley’s sister, Lynda Barnes, reported allegations including inappropriate touching, stolen antidepressants, and abuse of his son to the Delaware state medical society.
- In 2005 a nurse reported Bradley had been videotaping children; police sought an arrest warrant but the state attorney general’s office found insufficient evidence for prosecution.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1592falsefullhttps://www.spreaker.com/episode/000-dead-17-000-lawsuits-who-pays-for-hospital-deaths--73090298
Every year an estimated 400,000 people die in American hospitals from causes those hospitals introduced or failed to prevent - including 75,000 who die from infections acquired on supposedly clean wards. Why do roughly 17,000 malpractice lawsuits follow a crisis that numbers in the hundreds of thousands, and who, if anyone, is held accountable?

In this episode, we lay out the numbers and studies behind preventable hospital deaths, legal claims, and the economic flows that follow, showing how patient harm and malpractice compensation move on different tracks. Can the math of deaths, claims, and payouts explain why so few families receive justice?

Person: John T. James, PhD
Date: 1984 (first major estimate) and updated studies through 2011
Event: Landmark reform and largest study of 3.8 million records
Topic: Preventable hospital deaths, malpractice claims, and compensation flows
Country: United States

- 400,000 unnecessary hospital deaths per year attributed to hospital-introduced or unprevented causes, per John T. James.
- 75,000 deaths per year from hospital-acquired infections, according to CDC figures.
- ~17,000 malpractice lawsuits filed in the same year when 400,000 deaths were estimated.
- 1.14 million patient safety incidents identified in 37 million Medicare hospitalizations from 2000-2002.
- 54% of malpractice payouts went to administrative costs, leaving 46% to patients or families, per a 2006 study.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090298Fri, 24 Jul 2026 08:00:06 +0000Creator at Obomedia,000 Dead, 17,000 Lawsuits: Who Pays for Hospital Deaths? Every year an estimated 400,000 people die in American hospitals from causes those hospitals introduced or failed to prevent - including 75,000 who die from infections acquired on supposedly...
Every year an estimated 400,000 people die in American hospitals from causes those hospitals introduced or failed to prevent - including 75,000 who die from infections acquired on supposedly clean wards. Why do roughly 17,000 malpractice lawsuits follow a crisis that numbers in the hundreds of thousands, and who, if anyone, is held accountable?

In this episode, we lay out the numbers and studies behind preventable hospital deaths, legal claims, and the economic flows that follow, showing how patient harm and malpractice compensation move on different tracks. Can the math of deaths, claims, and payouts explain why so few families receive justice?

Person: John T. James, PhD
Date: 1984 (first major estimate) and updated studies through 2011
Event: Landmark reform and largest study of 3.8 million records
Topic: Preventable hospital deaths, malpractice claims, and compensation flows
Country: United States

- 400,000 unnecessary hospital deaths per year attributed to hospital-introduced or unprevented causes, per John T. James.
- 75,000 deaths per year from hospital-acquired infections, according to CDC figures.
- ~17,000 malpractice lawsuits filed in the same year when 400,000 deaths were estimated.
- 1.14 million patient safety incidents identified in 37 million Medicare hospitalizations from 2000-2002.
- 54% of malpractice payouts went to administrative costs, leaving 46% to patients or families, per a 2006 study.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1261falsefullhttps://www.spreaker.com/episode/000-silent-deaths-why-hospitals-hide-the-true-toll--73090296
Four hundred thousand Americans die in hospitals each year from preventable harms-more than the CDC’s seventy-five thousand annual deaths from hospital-acquired infections-and only seventeen thousand malpractice cases proceed through the legal system; how does a system that produces that scale of harm also make most of it disappear from public redress? What forces turned these deaths into a statistical abstraction instead of named victims?

In this episode, we trace the research and records that produced rising estimates of hospital-caused deaths from 1984 onward, follow John T. James’s peer-reviewed tally of four hundred thousand preventable deaths, and unpack why the legal process resolves only a fraction of cases-raising the question of how structural features of medicine and law enable this gap.

Person: John T. James, PhD
Date: 1984 (first serious estimate) and 2013 (BMJ Open diagnostic-failure study)
Topic: Preventable deaths and patient-safety incidents in U.S. hospitals
Event: 2000-2002 study finding 1.14 million patient-safety incidents across 37 million Medicare hospitalizations
Case: 2006 closed-claims analysis of 1,452 claims

- 400,000 preventable hospital deaths per year measured in John T. James’s peer-reviewed study.
- 44,000-98,000 annual deaths estimated in the 1984 first serious attempt to count hospital-caused deaths.
- 75,000 annual deaths from hospital-acquired infections reported by the CDC.
- 1.14 million patient-safety incidents found across 37 million Medicare hospitalizations (2000-2002 study).
- 17,000 malpractice cases processed per year in the American legal system.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090296Thu, 23 Jul 2026 08:00:03 +0000Creator at Obomedia,000 Silent Deaths: Why Hospitals Hide the True Toll Four hundred thousand Americans die in hospitals each year from preventable harms-more than the CDC’s seventy-five thousand annual deaths from hospital-acquired infections-and only seventeen...
Four hundred thousand Americans die in hospitals each year from preventable harms-more than the CDC’s seventy-five thousand annual deaths from hospital-acquired infections-and only seventeen thousand malpractice cases proceed through the legal system; how does a system that produces that scale of harm also make most of it disappear from public redress? What forces turned these deaths into a statistical abstraction instead of named victims?

In this episode, we trace the research and records that produced rising estimates of hospital-caused deaths from 1984 onward, follow John T. James’s peer-reviewed tally of four hundred thousand preventable deaths, and unpack why the legal process resolves only a fraction of cases-raising the question of how structural features of medicine and law enable this gap.

Person: John T. James, PhD
Date: 1984 (first serious estimate) and 2013 (BMJ Open diagnostic-failure study)
Topic: Preventable deaths and patient-safety incidents in U.S. hospitals
Event: 2000-2002 study finding 1.14 million patient-safety incidents across 37 million Medicare hospitalizations
Case: 2006 closed-claims analysis of 1,452 claims

- 400,000 preventable hospital deaths per year measured in John T. James’s peer-reviewed study.
- 44,000-98,000 annual deaths estimated in the 1984 first serious attempt to count hospital-caused deaths.
- 75,000 annual deaths from hospital-acquired infections reported by the CDC.
- 1.14 million patient-safety incidents found across 37 million Medicare hospitalizations (2000-2002 study).
- 17,000 malpractice cases processed per year in the American legal system.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1386falsefullhttps://www.spreaker.com/episode/when-a-lab-vanished-the-simufilam-data-that-disappeared--73090294
Hope turned into doubt when a western blot printout showed identical background pixels across distinct wells - a kind of precision biology never makes - and the missing original data that could have explained it vanished. This episode unravels how a single lab's images helped secure $16 million in federal support and enroll 400 patients in a Phase III trial, and asks: what happens when the evidence that built a drug disappears?

In this episode, we trace the story of simufilam from early papers and NIH funding to conflicting biomarker results and federal investigations, following the questions left by images, labs, and late-night doors closing. What did the missing source data mean for a drug that promised to reset the protein FLNA and slow Alzheimer's?

Person: Hoau‑Yan Wang
Person: Lindsay Burns
Company: Cassava Sciences
Grant: more than $16,000,000
Trial enrollment: 400 patients

- A western blot printout showed identical background pixel regions where biological noise should have differed.
- The Journal of Neuroscience published a 2012 paper on the proposed mechanism involving filamin A (FLNA).
- Neurobiology of Aging published a 2017 paper reporting benefit in an Alzheimer's mouse model.
- The National Institutes of Health awarded a grant in 2018 that became part of over $16 million in federal support.
- In May 2020 a biomarker analysis indicated the drug was not working, and in September 2020 Cassava announced an outside lab found improvements.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090294Wed, 22 Jul 2026 08:00:03 +0000Creator at ObomediaWhen a Lab Vanished: The Simufilam Data That Disappeared Hope turned into doubt when a western blot printout showed identical background pixels across distinct wells - a kind of precision biology never makes - and the missing original data that...
Hope turned into doubt when a western blot printout showed identical background pixels across distinct wells - a kind of precision biology never makes - and the missing original data that could have explained it vanished. This episode unravels how a single lab's images helped secure $16 million in federal support and enroll 400 patients in a Phase III trial, and asks: what happens when the evidence that built a drug disappears?

In this episode, we trace the story of simufilam from early papers and NIH funding to conflicting biomarker results and federal investigations, following the questions left by images, labs, and late-night doors closing. What did the missing source data mean for a drug that promised to reset the protein FLNA and slow Alzheimer's?

Person: Hoau‑Yan Wang
Person: Lindsay Burns
Company: Cassava Sciences
Grant: more than $16,000,000
Trial enrollment: 400 patients

- A western blot printout showed identical background pixel regions where biological noise should have differed.
- The Journal of Neuroscience published a 2012 paper on the proposed mechanism involving filamin A (FLNA).
- Neurobiology of Aging published a 2017 paper reporting benefit in an Alzheimer's mouse model.
- The National Institutes of Health awarded a grant in 2018 that became part of over $16 million in federal support.
- In May 2020 a biomarker analysis indicated the drug was not working, and in September 2020 Cassava announced an outside lab found improvements.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1796falsefullhttps://www.spreaker.com/episode/the-drug-that-looked-real-simufilam-s-pixel-proofed-promise--73090293
Hope and doubt collided over a pattern of repeating pixels in a lab image, triggering retractions, sixteen million dollars in federal funding, and trials that enrolled hundreds of Alzheimer's patients - but what did those repeating pixels really mean for the people who took the drug? Which part of simufilam’s story was science, and which was something else?

In this episode, we trace the sequence of events that connected lab images, biomarker shifts, and clinical trials: how FLNA-based theory led to PTI-125 (renamed simufilam), why key experiments all came from a single research group, and how May 2020 biomarker failures were later reported as improvements - but by the same laboratory. What does that chain of evidence reveal about the drug and the trials?

Person: Hoau-Yan Wang
Company: Cassava Sciences
Drug: PTI-125 / simufilam
Funding: $16,000,000 federal
Date of confirmation: November 25, 2024

- Two scientific papers were retracted because the background pixels in western blot images looked too similar.
- Simufilam produced no clinical benefit and the program was discontinued as confirmed by Cassava Sciences on November 25, 2024.
- Sixteen million dollars in federal funding supported early clinical trials beginning after NIH funding in 2018.
- Biomarker results in May 2020 reported failure, then were reported as improved by September 2020, with the later results originating from the same laboratory.
- All key papers linking FLNA dysregulation and simufilam’s mechanism traced back to Hoau-Yan Wang's lab with no independent replication.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090293Tue, 21 Jul 2026 17:27:44 +0000Creator at ObomediaThe Drug That Looked Real: Simufilam's Pixel-Proofed Promise Hope and doubt collided over a pattern of repeating pixels in a lab image, triggering retractions, sixteen million dollars in federal funding, and trials that enrolled hundreds of...
Hope and doubt collided over a pattern of repeating pixels in a lab image, triggering retractions, sixteen million dollars in federal funding, and trials that enrolled hundreds of Alzheimer's patients - but what did those repeating pixels really mean for the people who took the drug? Which part of simufilam’s story was science, and which was something else?

In this episode, we trace the sequence of events that connected lab images, biomarker shifts, and clinical trials: how FLNA-based theory led to PTI-125 (renamed simufilam), why key experiments all came from a single research group, and how May 2020 biomarker failures were later reported as improvements - but by the same laboratory. What does that chain of evidence reveal about the drug and the trials?

Person: Hoau-Yan Wang
Company: Cassava Sciences
Drug: PTI-125 / simufilam
Funding: $16,000,000 federal
Date of confirmation: November 25, 2024

- Two scientific papers were retracted because the background pixels in western blot images looked too similar.
- Simufilam produced no clinical benefit and the program was discontinued as confirmed by Cassava Sciences on November 25, 2024.
- Sixteen million dollars in federal funding supported early clinical trials beginning after NIH funding in 2018.
- Biomarker results in May 2020 reported failure, then were reported as improved by September 2020, with the later results originating from the same laboratory.
- All key papers linking FLNA dysregulation and simufilam’s mechanism traced back to Hoau-Yan Wang's lab with no independent replication.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1420falsefullhttps://www.spreaker.com/episode/lab-printout-with-repeated-pixels-became-the-thread--73090292
The discovery that two western blot images were pixel-for-pixel identical - not similar, identical - triggered an unraveling that touched $16,000,000 in federal grants and sent hundreds of Alzheimer's patients into clinical trials. How could a microscopic flaw in image backgrounds help propel a drug to human trials, and what exactly remains unknown about the science behind it?

In this episode, we tell the sequence of events that followed that matched background pixels: the history of the academic collaboration, the drug candidate simufilam, the federal funding and clinical trials, and the unresolved questions left by conflicting expert opinions. How did a single laboratory's findings become the foundation for a treatment that showed no biomarker benefit in a phase IIb study?

Person: Hoau-Yan Wang
Person: Lindsay Burns
Company: Pain Therapeutics (later Cassava Sciences)
Compound: PTI-125 (simufilam)
Finding: phase IIb biomarker results failed two months after first patient dosing in March 2020

- The identical western blot pixels were detected in images that were supposed to represent different experiments on different days.
- $16,000,000 in federal grants were implicated as unraveling after the image discovery.
- Hundreds of Alzheimer's patients were enrolled in clinical trials of simufilam following the published research.
- All evidence supporting the filamin A - amyloid beta 42 mechanism came from Wang's laboratory at CUNY, with no independent replication reported.
- The phase IIb biomarker study reported results that did not show the expected biological improvement two months after dosing began in March 2020.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090292Tue, 21 Jul 2026 17:27:41 +0000Creator at Obomedialab printout with repeated pixels became the thread The discovery that two western blot images were pixel-for-pixel identical - not similar, identical - triggered an unraveling that touched $16,000,000 in federal grants and sent hundreds of...
The discovery that two western blot images were pixel-for-pixel identical - not similar, identical - triggered an unraveling that touched $16,000,000 in federal grants and sent hundreds of Alzheimer's patients into clinical trials. How could a microscopic flaw in image backgrounds help propel a drug to human trials, and what exactly remains unknown about the science behind it?

In this episode, we tell the sequence of events that followed that matched background pixels: the history of the academic collaboration, the drug candidate simufilam, the federal funding and clinical trials, and the unresolved questions left by conflicting expert opinions. How did a single laboratory's findings become the foundation for a treatment that showed no biomarker benefit in a phase IIb study?

Person: Hoau-Yan Wang
Person: Lindsay Burns
Company: Pain Therapeutics (later Cassava Sciences)
Compound: PTI-125 (simufilam)
Finding: phase IIb biomarker results failed two months after first patient dosing in March 2020

- The identical western blot pixels were detected in images that were supposed to represent different experiments on different days.
- $16,000,000 in federal grants were implicated as unraveling after the image discovery.
- Hundreds of Alzheimer's patients were enrolled in clinical trials of simufilam following the published research.
- All evidence supporting the filamin A - amyloid beta 42 mechanism came from Wang's laboratory at CUNY, with no independent replication reported.
- The phase IIb biomarker study reported results that did not show the expected biological improvement two months after dosing began in March 2020.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1279falsefullhttps://www.spreaker.com/episode/the-quipazine-puzzle-tiny-dose-giant-psychedelic-question--73090290
A single bracketed word - "[sic]" - appeared next to a reported dose of 0.5 mg, implying someone claimed a mescaline-like effect from less than a grain of salt. Quipazine has been studied since 1966, produced LSD-like substitution in animals, and provoked projectile vomiting in primates; so what exactly does it do in the human brain?

In this episode, we trace quipazine’s scientific trail from 1966 through rodent and primate studies, the shifting labels from antidepressant to psychedelic candidate, and the locked doctoral thesis that may hold part of the answer - can one molecule explain both psychedelic and emetic effects at similar doses?

Person: researchers (unnamed) who reported 0.5 mg dose marked "[sic]"
Date: 1966 (first appearance in literature)
Event: 1977 animal studies documenting psychedelic-like behaviors
Topic: serotonin 2-A receptor activation (head-twitch response, ketanserin blockade)
Status: doctoral thesis under embargo until 2030

- Reported dose printed next to the notation "[sic]": 0.5 mg
- First appearance of quipazine in scientific literature: 1966
- By 1971 quipazine described as an antidepressant-like agent
- 1977 animal studies showed head-twitch response indicative of serotonin 2-A activation
- Primate studies produced LSD-like behaviors plus projectile vomiting, linking psychedelic and emetic effects

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090290Tue, 21 Jul 2026 17:27:38 +0000Creator at ObomediaThe Quipazine Puzzle: Tiny Dose, Giant Psychedelic Question A single bracketed word - "[sic]" - appeared next to a reported dose of 0.5 mg, implying someone claimed a mescaline-like effect from less than a grain of salt. Quipazine has been studied...
A single bracketed word - "[sic]" - appeared next to a reported dose of 0.5 mg, implying someone claimed a mescaline-like effect from less than a grain of salt. Quipazine has been studied since 1966, produced LSD-like substitution in animals, and provoked projectile vomiting in primates; so what exactly does it do in the human brain?

In this episode, we trace quipazine’s scientific trail from 1966 through rodent and primate studies, the shifting labels from antidepressant to psychedelic candidate, and the locked doctoral thesis that may hold part of the answer - can one molecule explain both psychedelic and emetic effects at similar doses?

Person: researchers (unnamed) who reported 0.5 mg dose marked "[sic]"
Date: 1966 (first appearance in literature)
Event: 1977 animal studies documenting psychedelic-like behaviors
Topic: serotonin 2-A receptor activation (head-twitch response, ketanserin blockade)
Status: doctoral thesis under embargo until 2030

- Reported dose printed next to the notation "[sic]": 0.5 mg
- First appearance of quipazine in scientific literature: 1966
- By 1971 quipazine described as an antidepressant-like agent
- 1977 animal studies showed head-twitch response indicative of serotonin 2-A activation
- Primate studies produced LSD-like behaviors plus projectile vomiting, linking psychedelic and emetic effects

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1904falsefullhttps://www.spreaker.com/episode/the-0-5-mg-mystery-why-quipazine-s-psychedelic-secret-remains-locked--73090289
A single notation - "0.5 mg [sic]" - sits in a published paper as a tiny flag of doubt that has gone unexplained for sixty years, attached to a compound tested in humans, animals, and written about by a meticulous twentieth-century chemist; can a drug that reliably causes nausea also hide a psychedelic action at 5-HT2A? What keeps this answer sealed until 2030?

In this episode, we trace the scientific record of quipazine from its chemical synthesis and antidepressant hopes in the 1960s and 1970s through human dosing trials that stopped at 25 mg for gastrointestinal reasons, and the contrasting animal evidence that produced robust head-twitch responses linked to 5-HT2A - how did these two paths diverge and what remains locked away in an unread thesis?

Person: one author noted "0.5 mg [sic]" beside a reported figure
Date: first described in scientific literature in 1966
Date: by 1971 characterized as an antidepressant-like agent
Dose: 25 mg given orally in human subjects produced nausea and GI symptoms
Response: head-twitch response observed in mice, rats, and monkeys and blocked by ketanserin

- The transcript states there are exactly three human data points for quipazine.
- Quipazine's formal chemical name is one-(two-quinolinyl)piperazine and was shortened to two-QP in the lab.
- At 25 mg orally, human subjects reported nausea, flatulence, gastrointestinal discomfort, and diarrhea with no psychedelic effects.
- Animal studies by 1977 documented a head-twitch response in rodents linked to 5-HT2A activation.
- A doctoral thesis containing key data on the question cannot be read until 2030.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090289Tue, 21 Jul 2026 17:27:34 +0000Creator at ObomediaThe 0.5 mg Mystery: Why Quipazine's Psychedelic Secret Remains Locked A single notation - "0.5 mg [sic]" - sits in a published paper as a tiny flag of doubt that has gone unexplained for sixty years, attached to a compound tested in humans,...
A single notation - "0.5 mg [sic]" - sits in a published paper as a tiny flag of doubt that has gone unexplained for sixty years, attached to a compound tested in humans, animals, and written about by a meticulous twentieth-century chemist; can a drug that reliably causes nausea also hide a psychedelic action at 5-HT2A? What keeps this answer sealed until 2030?

In this episode, we trace the scientific record of quipazine from its chemical synthesis and antidepressant hopes in the 1960s and 1970s through human dosing trials that stopped at 25 mg for gastrointestinal reasons, and the contrasting animal evidence that produced robust head-twitch responses linked to 5-HT2A - how did these two paths diverge and what remains locked away in an unread thesis?

Person: one author noted "0.5 mg [sic]" beside a reported figure
Date: first described in scientific literature in 1966
Date: by 1971 characterized as an antidepressant-like agent
Dose: 25 mg given orally in human subjects produced nausea and GI symptoms
Response: head-twitch response observed in mice, rats, and monkeys and blocked by ketanserin

- The transcript states there are exactly three human data points for quipazine.
- Quipazine's formal chemical name is one-(two-quinolinyl)piperazine and was shortened to two-QP in the lab.
- At 25 mg orally, human subjects reported nausea, flatulence, gastrointestinal discomfort, and diarrhea with no psychedelic effects.
- Animal studies by 1977 documented a head-twitch response in rodents linked to 5-HT2A activation.
- A doctoral thesis containing key data on the question cannot be read until 2030.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1865falsefullhttps://www.spreaker.com/episode/the-sic-mark-at-0-5-mg-why-quipazine-haunted-science--73090286
A single bracketed "sic" beside the dose 0.5 mg has haunted nearly six decades of literature on quipazine, a compound that behaves like a psychedelic in animals yet produced only severe gastrointestinal effects in humans-what really happened at that dose and why did editors leave the doubt standing? This episode follows the molecule from its 1966 entry into the literature to the conflicting animal and human records and asks whether the unresolved 0.5 mg notation obscures a missing human response.

In this episode, we trace quipazine's path through receptor studies, animal behaviors, primate reports and a human trial to lay out the precise mismatch between preclinical signals and clinical outcomes, and we return to the unresolved 0.5 mg entry to ask whether the literature ever answered its own question.

Person: quipazine
Date: 1966 (entry into literature)
Receptor: 5-HT3 and 5-HT2A/2B/2C
Event: 1977 animal studies documenting head-twitch response
Dose: 25 mg (first human trial, oral)

- Quipazine entered the scientific literature no later than 1966.
- By 1971 researchers labeled it "antidepressant-like" but it was never developed as an antidepressant.
- In 1977 animal studies showed a consistent head-twitch response blocked by ketanserin, indicating 5-HT2A activation.
- Drug discrimination studies found quipazine fully substituted for LSD and DOM, and animals trained on quipazine generalized to LSD, mescaline, and psilocybin.
- A human oral trial at 25 mg produced only nausea, flatulence, gastrointestinal discomfort and diarrhea, with no LSD-like visual or perceptual effects.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090286Tue, 21 Jul 2026 17:27:30 +0000Creator at ObomediaThe Sic Mark at 0.5 mg: Why Quipazine Haunted Science A single bracketed "sic" beside the dose 0.5 mg has haunted nearly six decades of literature on quipazine, a compound that behaves like a psychedelic in animals yet produced only severe...
A single bracketed "sic" beside the dose 0.5 mg has haunted nearly six decades of literature on quipazine, a compound that behaves like a psychedelic in animals yet produced only severe gastrointestinal effects in humans-what really happened at that dose and why did editors leave the doubt standing? This episode follows the molecule from its 1966 entry into the literature to the conflicting animal and human records and asks whether the unresolved 0.5 mg notation obscures a missing human response.

In this episode, we trace quipazine's path through receptor studies, animal behaviors, primate reports and a human trial to lay out the precise mismatch between preclinical signals and clinical outcomes, and we return to the unresolved 0.5 mg entry to ask whether the literature ever answered its own question.

Person: quipazine
Date: 1966 (entry into literature)
Receptor: 5-HT3 and 5-HT2A/2B/2C
Event: 1977 animal studies documenting head-twitch response
Dose: 25 mg (first human trial, oral)

- Quipazine entered the scientific literature no later than 1966.
- By 1971 researchers labeled it "antidepressant-like" but it was never developed as an antidepressant.
- In 1977 animal studies showed a consistent head-twitch response blocked by ketanserin, indicating 5-HT2A activation.
- Drug discrimination studies found quipazine fully substituted for LSD and DOM, and animals trained on quipazine generalized to LSD, mescaline, and psilocybin.
- A human oral trial at 25 mg produced only nausea, flatulence, gastrointestinal discomfort and diarrhea, with no LSD-like visual or perceptual effects.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1528falsefullhttps://www.spreaker.com/episode/the-single-secret-human-trip-that-animal-tests-couldn-t-predict--73090285
A single anonymous human report in 2007 claims a full psychedelic experience from a compound never approved for human use, yet every controlled human trial since produced only severe nausea and gastrointestinal distress. How did decades of animal data-head-twitches in mice, LSD-like responses in monkeys-fail to predict that human outcome?

In this episode, we present the history of quipazine from its first reports in 1966 through behavioral pharmacology in the 1970s and the halted human dosing that followed, and we ask why animal models missed a crucial human effect: could a structural limitation in common laboratory species explain the disconnect?

Person: anonymous human reporter (2007)
Period: 1966-2007 (literature and single human report)
Event: animal head-twitch response documented (1977)
Dose: 25 mg oral human trial produced intolerable nausea
Status: doctoral thesis on quipazine sealed until 2030

- Quipazine first appeared in the literature in 1966 as one-(2-quinolinyl)piperazine (2-QP).
- In 1977 quipazine reliably produced the head-twitch response in mice and rats, a marker of 5-HT2A activation.
- Rodent drug discrimination tests showed quipazine generalized to LSD, DOM, mescaline, and psilocybin.
- Primate studies showed LSD-like behavioral disruption but also projectile vomiting in monkeys.
- A human oral dose of 25 mg produced severe nausea, flatulence, gastrointestinal discomfort, and diarrhea with no reported psychedelic effects.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090285Tue, 21 Jul 2026 17:27:26 +0000Creator at ObomediaThe Single Secret Human Trip That Animal Tests Couldn't Predict A single anonymous human report in 2007 claims a full psychedelic experience from a compound never approved for human use, yet every controlled human trial since produced only severe...
A single anonymous human report in 2007 claims a full psychedelic experience from a compound never approved for human use, yet every controlled human trial since produced only severe nausea and gastrointestinal distress. How did decades of animal data-head-twitches in mice, LSD-like responses in monkeys-fail to predict that human outcome?

In this episode, we present the history of quipazine from its first reports in 1966 through behavioral pharmacology in the 1970s and the halted human dosing that followed, and we ask why animal models missed a crucial human effect: could a structural limitation in common laboratory species explain the disconnect?

Person: anonymous human reporter (2007)
Period: 1966-2007 (literature and single human report)
Event: animal head-twitch response documented (1977)
Dose: 25 mg oral human trial produced intolerable nausea
Status: doctoral thesis on quipazine sealed until 2030

- Quipazine first appeared in the literature in 1966 as one-(2-quinolinyl)piperazine (2-QP).
- In 1977 quipazine reliably produced the head-twitch response in mice and rats, a marker of 5-HT2A activation.
- Rodent drug discrimination tests showed quipazine generalized to LSD, DOM, mescaline, and psilocybin.
- Primate studies showed LSD-like behavioral disruption but also projectile vomiting in monkeys.
- A human oral dose of 25 mg produced severe nausea, flatulence, gastrointestinal discomfort, and diarrhea with no reported psychedelic effects.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1663falsefullhttps://www.spreaker.com/episode/the-molecule-that-vomited-its-way-out-of-human-psychedelia--73090284
A single physiological reflex stood between decades of animal evidence and human confirmation: a molecule that triggered both psychedelic-linked behavior and uncontrollable vomiting. Quipazine activated the same serotonin receptor tied to psychedelic head-twitches in mice and LSD-like effects in monkeys - so why did human trials report sickness instead of altered consciousness?

In this episode, we tell the sequence of experiments, publications and unanswered gaps that surround quipazine, and we follow the thread from 1977 mouse studies to 2011 archival notes and a 2025 doctoral thesis that remains embargoed; what did the vomiting hide about quipazine's effects?

Person: Alexander Shulgin
Person: Yilun Yang
Date: 1977
Date: 2011
Event: human trials administering 25 mg of quipazine

- 1977: researchers first documented the head-twitch response in mice linked to psychedelic drug action.
- Quipazine fully substituted for LSD, mescaline and psilocybin in animal drug discrimination studies.
- In primate studies quipazine produced LSD-like agitation and disrupted behavior alongside projectile vomiting.
- 2011: Alexander Shulgin published a brief account of a 2007 experiment in The Shulgin Index with no subject name or institutional affiliation.
- 2025: a doctoral thesis by Yilun Yang on quipazine and its analogs was completed and will remain unavailable until 2030.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090284Tue, 21 Jul 2026 17:27:23 +0000Creator at ObomediaThe Molecule That Vomited Its Way Out of Human Psychedelia A single physiological reflex stood between decades of animal evidence and human confirmation: a molecule that triggered both psychedelic-linked behavior and uncontrollable vomiting....
A single physiological reflex stood between decades of animal evidence and human confirmation: a molecule that triggered both psychedelic-linked behavior and uncontrollable vomiting. Quipazine activated the same serotonin receptor tied to psychedelic head-twitches in mice and LSD-like effects in monkeys - so why did human trials report sickness instead of altered consciousness?

In this episode, we tell the sequence of experiments, publications and unanswered gaps that surround quipazine, and we follow the thread from 1977 mouse studies to 2011 archival notes and a 2025 doctoral thesis that remains embargoed; what did the vomiting hide about quipazine's effects?

Person: Alexander Shulgin
Person: Yilun Yang
Date: 1977
Date: 2011
Event: human trials administering 25 mg of quipazine

- 1977: researchers first documented the head-twitch response in mice linked to psychedelic drug action.
- Quipazine fully substituted for LSD, mescaline and psilocybin in animal drug discrimination studies.
- In primate studies quipazine produced LSD-like agitation and disrupted behavior alongside projectile vomiting.
- 2011: Alexander Shulgin published a brief account of a 2007 experiment in The Shulgin Index with no subject name or institutional affiliation.
- 2025: a doctoral thesis by Yilun Yang on quipazine and its analogs was completed and will remain unavailable until 2030.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1809falsefullhttps://www.spreaker.com/episode/the-psychedelic-that-vomited-its-way-out-of-science--73090283
A single three-character annotation - "0.5 mg (sic)" - sits in a scientific paper and betrays sixty years of pharmacology: a compound with consistent animal evidence for psychedelic action that never produced psychedelic effects in humans because it makes people violently ill. How did quipazine become a standard reference drug in animal studies yet remain effectively undtestable in people?

In this episode, we trace quipazine’s origin, its unexpected behavioral effects in rodents and primates, and the pharmacological barrier that stopped human research - and we ask whether a simple receptor blocker could have changed the course of study.

Person: Jerrold C. Winter
Period: 1966-1994 (key developments noted)
Compound: quipazine (one-(two-quinolinyl)piperazine; two-QP)
Trial Dose: 25 mg (human oral trial reported nausea and gastrointestinal effects)
Intervention Proposed: ondansetron (1994 hypothesis to block 5-HT3)

- Quipazine was first described in 1966 and by 1971 was characterized as an antidepressant-like agent.
- By 1977 mice, rats, and monkeys showed consistent head-twitch responses and monkeys displayed LSD-like behavior with projectile vomiting.
- Quipazine’s dominant action at practical oral doses is potent 5-HT3 receptor agonism, which causes nausea and vomiting rather than altered consciousness.
- A 25 mg human oral trial produced nausea, flatulence, gastrointestinal discomfort, and diarrhea with no LSD-like subjective effects observed.
- In 1994 Jerrold C. Winter proposed using ondansetron, a 5-HT3 antagonist, to block emesis and reveal quipazine’s potential 5-HT2A-mediated psychedelic effects, but no controlled human trial followed.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090283Tue, 21 Jul 2026 17:27:19 +0000Creator at ObomediaThe Psychedelic That Vomited Its Way Out of Science A single three-character annotation - "0.5 mg (sic)" - sits in a scientific paper and betrays sixty years of pharmacology: a compound with consistent animal evidence for psychedelic action that...
A single three-character annotation - "0.5 mg (sic)" - sits in a scientific paper and betrays sixty years of pharmacology: a compound with consistent animal evidence for psychedelic action that never produced psychedelic effects in humans because it makes people violently ill. How did quipazine become a standard reference drug in animal studies yet remain effectively undtestable in people?

In this episode, we trace quipazine’s origin, its unexpected behavioral effects in rodents and primates, and the pharmacological barrier that stopped human research - and we ask whether a simple receptor blocker could have changed the course of study.

Person: Jerrold C. Winter
Period: 1966-1994 (key developments noted)
Compound: quipazine (one-(two-quinolinyl)piperazine; two-QP)
Trial Dose: 25 mg (human oral trial reported nausea and gastrointestinal effects)
Intervention Proposed: ondansetron (1994 hypothesis to block 5-HT3)

- Quipazine was first described in 1966 and by 1971 was characterized as an antidepressant-like agent.
- By 1977 mice, rats, and monkeys showed consistent head-twitch responses and monkeys displayed LSD-like behavior with projectile vomiting.
- Quipazine’s dominant action at practical oral doses is potent 5-HT3 receptor agonism, which causes nausea and vomiting rather than altered consciousness.
- A 25 mg human oral trial produced nausea, flatulence, gastrointestinal discomfort, and diarrhea with no LSD-like subjective effects observed.
- In 1994 Jerrold C. Winter proposed using ondansetron, a 5-HT3 antagonist, to block emesis and reveal quipazine’s potential 5-HT2A-mediated psychedelic effects, but no controlled human trial followed.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1795falsefullhttps://www.spreaker.com/episode/the-drug-that-made-champions-and-secretly-gave-them-cancer--73090281
Fear and fascination collide: a drug that turned muscles into fat-burning engines and boosted endurance was also linked to widespread cancer in animal tests, yet it resurfaced on the black market for $1,000 per ten grams-how did it reach elite athletes despite an internal pharmaceutical shutdown? What happened in the six-year gap between GlaxoSmithKline’s 2007 discontinuation and WADA’s 2013 cancer warning that allowed GW501516 to spread through sport?

In this episode, we trace the compound’s path from a genetics lab to the podium and the grey market, charting the scientific breakthroughs, the unpublished cancer data, and the cases that reveal who paid the price for performance. How did a selective PPARδ agonist celebrated in Cell become a hidden public health threat?

Person: Ronald M. Evans
Date: 1992
Date: 2007
Event: Vuelta Ciclista a Costa Rica positive tests
Price: $1,000 per ten grams

- GW501516 had a binding affinity around one nanomolar and more than 1,000-fold selectivity over related receptors.
- GlaxoSmithKline discontinued development in 2007 after animal studies showed cancer at 3 mg/kg/day in mice and rats across multiple organs.
- A 2001 Phase One human trial and a 2001 PNAS paper were published; a Cell paper in 2007 reported extreme endurance gains in mice.
- By 2009 WADA had banned GW501516 before any athlete had been publicly caught using it.
- In December 2012 four Costa Rican cyclists tested positive for GW501516; three received two-year bans and one received a twelve-year ban.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090281Tue, 21 Jul 2026 17:27:15 +0000Creator at ObomediaThe Drug That Made Champions - and Secretly Gave Them Cancer Fear and fascination collide: a drug that turned muscles into fat-burning engines and boosted endurance was also linked to widespread cancer in animal tests, yet it resurfaced on the...
Fear and fascination collide: a drug that turned muscles into fat-burning engines and boosted endurance was also linked to widespread cancer in animal tests, yet it resurfaced on the black market for $1,000 per ten grams-how did it reach elite athletes despite an internal pharmaceutical shutdown? What happened in the six-year gap between GlaxoSmithKline’s 2007 discontinuation and WADA’s 2013 cancer warning that allowed GW501516 to spread through sport?

In this episode, we trace the compound’s path from a genetics lab to the podium and the grey market, charting the scientific breakthroughs, the unpublished cancer data, and the cases that reveal who paid the price for performance. How did a selective PPARδ agonist celebrated in Cell become a hidden public health threat?

Person: Ronald M. Evans
Date: 1992
Date: 2007
Event: Vuelta Ciclista a Costa Rica positive tests
Price: $1,000 per ten grams

- GW501516 had a binding affinity around one nanomolar and more than 1,000-fold selectivity over related receptors.
- GlaxoSmithKline discontinued development in 2007 after animal studies showed cancer at 3 mg/kg/day in mice and rats across multiple organs.
- A 2001 Phase One human trial and a 2001 PNAS paper were published; a Cell paper in 2007 reported extreme endurance gains in mice.
- By 2009 WADA had banned GW501516 before any athlete had been publicly caught using it.
- In December 2012 four Costa Rican cyclists tested positive for GW501516; three received two-year bans and one received a twelve-year ban.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1702falsefullhttps://www.spreaker.com/episode/the-sleeping-pill-that-vanished-the-molecule-no-pharma-could-explain--73090280
A legal drug derived from a poisonous mushroom promised deeper, more restorative sleep without morning sedation - yet it never reached a pharmacy shelf. Gaboxadol traced from Amanita muscaria to a synthetic analog with potency 30-100 times its parent, produced Phase Three hopes and then disappeared; what in the clinical record made companies walk away?

In this episode, we tell the sequence of events from discovery to late-stage trials, showing how a compound moved from forest lore to lab patent to multinational development and then to abandonment, and we ask whether the decision to stop was science, business, or something else.

Person: Povl Krogsgaard-Larsen
Date: 1977
Location: Denmark
Company: Lundbeck
Development code: MK-0928

- The active natural compound is muscimol from Amanita muscaria.
- Gaboxadol was synthesized in 1977 and patented in 1978, patent granted in 1981 with Lundbeck as assignee.
- Gaboxadol’s potency was estimated at 30 to 100 times greater than muscimol.
- In 1997 a human clinical sleep study showed 5-20 mg doses reduced sleep onset, increased slow wave activity, preserved REM, and produced no next-morning sedation.
- In Phase Three development with Merck (MK-0928), three-month trials showed initial improvement that faded by month three, and misuse-liability testing at higher doses produced concerning dose-response data.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090280Tue, 21 Jul 2026 17:27:12 +0000Creator at ObomediaThe Sleeping Pill That Vanished: The Molecule No Pharma Could Explain A legal drug derived from a poisonous mushroom promised deeper, more restorative sleep without morning sedation - yet it never reached a pharmacy shelf. Gaboxadol traced from...
A legal drug derived from a poisonous mushroom promised deeper, more restorative sleep without morning sedation - yet it never reached a pharmacy shelf. Gaboxadol traced from Amanita muscaria to a synthetic analog with potency 30-100 times its parent, produced Phase Three hopes and then disappeared; what in the clinical record made companies walk away?

In this episode, we tell the sequence of events from discovery to late-stage trials, showing how a compound moved from forest lore to lab patent to multinational development and then to abandonment, and we ask whether the decision to stop was science, business, or something else.

Person: Povl Krogsgaard-Larsen
Date: 1977
Location: Denmark
Company: Lundbeck
Development code: MK-0928

- The active natural compound is muscimol from Amanita muscaria.
- Gaboxadol was synthesized in 1977 and patented in 1978, patent granted in 1981 with Lundbeck as assignee.
- Gaboxadol’s potency was estimated at 30 to 100 times greater than muscimol.
- In 1997 a human clinical sleep study showed 5-20 mg doses reduced sleep onset, increased slow wave activity, preserved REM, and produced no next-morning sedation.
- In Phase Three development with Merck (MK-0928), three-month trials showed initial improvement that faded by month three, and misuse-liability testing at higher doses produced concerning dose-response data.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1655falsefullhttps://www.spreaker.com/episode/the-sleep-drug-that-came-from-a-poisonous-mushroom-and-vanished--73090279
A single molecule traced from a poisonous mushroom to a patent in 1981 promised a new kind of sleep drug with a novel target on GABA-A receptors, yet it never reached patients-why did a compound that decreased lethality by over 14-fold and increased affinity for the extrasynaptic delta-subunit disappear? What happened to gaboxadol between Danish labs, hundreds of trials, and abandoned pediatric studies?

In this episode, you will hear the story of gaboxadol from its discovery through decades of clinical trials, the companies and researchers involved, and the surprising clinical signals that alternately excited and stalled its development. We follow the chemistry from muscimol to THIP and track the key findings that kept reopening-and then closing-the molecule's pathways to market.

Person: Povl Krogsgaard-Larsen
Date: 1977 (origin of idea), 1978 (patent filed), 1981 (patent granted)
Author: H. Lundbeck A/S (patent assignee)
Topic: Gaboxadol (THIP), a direct GABA-A orthosteric agonist
Period: Trials spanning 1980s through 2021

- LD50 in mice for muscimol: 22 mg/kg
- LD50 in mice for gaboxadol: >320 mg/kg
- Gaboxadol had roughly 10x greater affinity for the extrasynaptic delta-subunit than existing drugs
- Patent filed in 1978 and granted in 1981 with Lundbeck as assignee
- Clinical programs tested gaboxadol for pain, anxiety, schizophrenia, epilepsy and sleep across hundreds of human trials

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090279Tue, 21 Jul 2026 17:27:08 +0000Creator at ObomediaThe Sleep Drug That Came From a Poisonous Mushroom-and Vanished A single molecule traced from a poisonous mushroom to a patent in 1981 promised a new kind of sleep drug with a novel target on GABA-A receptors, yet it never reached patients-why did...
A single molecule traced from a poisonous mushroom to a patent in 1981 promised a new kind of sleep drug with a novel target on GABA-A receptors, yet it never reached patients-why did a compound that decreased lethality by over 14-fold and increased affinity for the extrasynaptic delta-subunit disappear? What happened to gaboxadol between Danish labs, hundreds of trials, and abandoned pediatric studies?

In this episode, you will hear the story of gaboxadol from its discovery through decades of clinical trials, the companies and researchers involved, and the surprising clinical signals that alternately excited and stalled its development. We follow the chemistry from muscimol to THIP and track the key findings that kept reopening-and then closing-the molecule's pathways to market.

Person: Povl Krogsgaard-Larsen
Date: 1977 (origin of idea), 1978 (patent filed), 1981 (patent granted)
Author: H. Lundbeck A/S (patent assignee)
Topic: Gaboxadol (THIP), a direct GABA-A orthosteric agonist
Period: Trials spanning 1980s through 2021

- LD50 in mice for muscimol: 22 mg/kg
- LD50 in mice for gaboxadol: >320 mg/kg
- Gaboxadol had roughly 10x greater affinity for the extrasynaptic delta-subunit than existing drugs
- Patent filed in 1978 and granted in 1981 with Lundbeck as assignee
- Clinical programs tested gaboxadol for pain, anxiety, schizophrenia, epilepsy and sleep across hundreds of human trials

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1806falsefullhttps://www.spreaker.com/episode/the-urine-hormone-that-fooled-medicine-for-decades--73090277
Estrone, a hormone crystallized from pregnant women's urine in 1929, became a worldwide prescribed injection within months despite binding estrogen receptors at only about 4% the affinity of estradiol. How could a weak molecule produce dramatic restoration of tissue and symptoms - and why did its true mechanism remain hidden for decades?

In this episode, we tell how researchers moved from lab flasks to pharmacy ampoules in under two years, what clinicians observed in ovariectomized women after injection, and the unresolved question that kept medicine misled: if estrone was so weak at receptors, what was actually driving the clinical effects?

Person: Bernhard Zondek and Selmar Aschheim
Date: 1927-1929
Event: Isolation and commercialization of crystalline estrone
Product: Amniotin (Squibb), Progynon (Schering), Theelin (Parke-Davis)
Topic: Estrogen replacement after ovariectomy

- In 1927 Zondek and Aschheim discovered large quantities of estrogen in pregnant women's urine.
- Pure crystalline estrone was isolated by multiple teams in 1929 and characterized that same year.
- Three pharmaceutical companies launched estrone oil-solution ampoules for intramuscular injection in 1929.
- Clinical records from the early 1930s show restored breast, endometrial, and vaginal tissue and relief of hot flashes after estrone injections.
- Estrone binds estrogen receptors with about 4% of the affinity of estradiol, a discrepancy unexplained at the time.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090277Tue, 21 Jul 2026 17:27:04 +0000Creator at ObomediaThe Urine Hormone That Fooled Medicine for Decades Estrone, a hormone crystallized from pregnant women's urine in 1929, became a worldwide prescribed injection within months despite binding estrogen receptors at only about 4% the affinity of...
Estrone, a hormone crystallized from pregnant women's urine in 1929, became a worldwide prescribed injection within months despite binding estrogen receptors at only about 4% the affinity of estradiol. How could a weak molecule produce dramatic restoration of tissue and symptoms - and why did its true mechanism remain hidden for decades?

In this episode, we tell how researchers moved from lab flasks to pharmacy ampoules in under two years, what clinicians observed in ovariectomized women after injection, and the unresolved question that kept medicine misled: if estrone was so weak at receptors, what was actually driving the clinical effects?

Person: Bernhard Zondek and Selmar Aschheim
Date: 1927-1929
Event: Isolation and commercialization of crystalline estrone
Product: Amniotin (Squibb), Progynon (Schering), Theelin (Parke-Davis)
Topic: Estrogen replacement after ovariectomy

- In 1927 Zondek and Aschheim discovered large quantities of estrogen in pregnant women's urine.
- Pure crystalline estrone was isolated by multiple teams in 1929 and characterized that same year.
- Three pharmaceutical companies launched estrone oil-solution ampoules for intramuscular injection in 1929.
- Clinical records from the early 1930s show restored breast, endometrial, and vaginal tissue and relief of hot flashes after estrone injections.
- Estrone binds estrogen receptors with about 4% of the affinity of estradiol, a discrepancy unexplained at the time.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1603falsefullhttps://www.spreaker.com/episode/the-urine-cure-how-pregnant-vials-became-the-first-hormone-drug--73090276
A vial of urine from a pregnant woman became the world’s first commercial hormone medicine in 1929, and that drug worked well enough to restore menstruation, reverse atrophy, and stop hot flashes - but the active molecule was later measured at only about 4% the potency of the body’s main estrogen. How did a supposedly weak compound produce such clear clinical reversals, and what did that mismatch mean for patients and pharmaceuticals?

In this episode, we tell the episode’s story from laboratory observation to commercial product, following the scientists, surgeries, and medicines involved, and we ask how a treatment could function widely for decades when its biochemical explanation was wrong. What gap between chemistry and clinical effect went unrecognized for nearly a century?

Person: Selmar Aschheim
Person: Bernhard Zondek
Date: 1929
Event: Commercial release of Amniotin, Progynon, Theelin
Topic: Estrone isolated from pregnant urine

- 1929: a researcher in Berlin injected urine from a pregnant woman into a patient with no hormone production and observed symptom reversal.
- 1929: three commercial preparations reached the market the same year - Amniotin, Progynon, and Theelin.
- Approximately 4%: estrone’s measured estrogenic activity relative to estradiol.
- Surgical context: women who had undergone ovariectomy experienced abrupt hormonal deprivation and rapid onset of menopause-like symptoms.
- Clinical effects documented: return of menstruation, breast tissue response, and cessation of hot flashes after estrone administration.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090276Tue, 21 Jul 2026 17:27:01 +0000Creator at ObomediaThe Urine Cure: How Pregnant Vials Became the First Hormone Drug A vial of urine from a pregnant woman became the world’s first commercial hormone medicine in 1929, and that drug worked well enough to restore menstruation, reverse atrophy, and stop...
A vial of urine from a pregnant woman became the world’s first commercial hormone medicine in 1929, and that drug worked well enough to restore menstruation, reverse atrophy, and stop hot flashes - but the active molecule was later measured at only about 4% the potency of the body’s main estrogen. How did a supposedly weak compound produce such clear clinical reversals, and what did that mismatch mean for patients and pharmaceuticals?

In this episode, we tell the episode’s story from laboratory observation to commercial product, following the scientists, surgeries, and medicines involved, and we ask how a treatment could function widely for decades when its biochemical explanation was wrong. What gap between chemistry and clinical effect went unrecognized for nearly a century?

Person: Selmar Aschheim
Person: Bernhard Zondek
Date: 1929
Event: Commercial release of Amniotin, Progynon, Theelin
Topic: Estrone isolated from pregnant urine

- 1929: a researcher in Berlin injected urine from a pregnant woman into a patient with no hormone production and observed symptom reversal.
- 1929: three commercial preparations reached the market the same year - Amniotin, Progynon, and Theelin.
- Approximately 4%: estrone’s measured estrogenic activity relative to estradiol.
- Surgical context: women who had undergone ovariectomy experienced abrupt hormonal deprivation and rapid onset of menopause-like symptoms.
- Clinical effects documented: return of menstruation, breast tissue response, and cessation of hot flashes after estrone administration.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1520falsefullhttps://www.spreaker.com/episode/the-drug-that-never-left-how-one-injection-outlived-its-patients--73090275
A single intramuscular oil injection of one hundred milligrams could result in estradiol levels averaging 598 pg/mL at trough - roughly 17 times the normal male upper limit - and yet this compound was used for decades across Europe and Japan. How did a molecule designed to solve adherence become a lingering source of harm, and why did screened low-risk patients still suffer widespread cardiovascular complications?

In this episode, we narrate the clinical history and biochemical design of estradiol undecylate, outline its adoption in multiple countries and indications, and follow the Mainz Trial that revealed unexpected cardiovascular risk. What happened when a drug built to last simply would not leave?

Compound: estradiol undecylate
Inventor: Karl Junkmann
First clinical use: 1956
Patent filed: 1958, granted 1961
Mainz Trial enrollment: 191 men (subgroup of 42 men ages 51-84, mean age 68)

- A single 100 mg intramuscular dose was intended as a monthly injection but produced mean trough estradiol of 598 pg/mL.
- The normal male upper limit for estradiol cited in the records is 35 pg/mL.
- Estradiol undecylate was used clinically in France, Germany, the United Kingdom, Monaco, the Netherlands, Switzerland, and Japan.
- In one clinical trial run on medically screened cardiovascular low-risk men, 76% suffered cardiovascular complications.
- The Mainz Trial randomized 191 men with prostate cancer to 100 mg/month estradiol undecylate versus 300 mg/week cyproterone acetate, excluding patients with pre-existing cardiovascular disease.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090275Tue, 21 Jul 2026 17:26:57 +0000Creator at ObomediaThe Drug That Never Left: How One Injection Outlived Its Patients A single intramuscular oil injection of one hundred milligrams could result in estradiol levels averaging 598 pg/mL at trough - roughly 17 times the normal male upper limit - and yet...
A single intramuscular oil injection of one hundred milligrams could result in estradiol levels averaging 598 pg/mL at trough - roughly 17 times the normal male upper limit - and yet this compound was used for decades across Europe and Japan. How did a molecule designed to solve adherence become a lingering source of harm, and why did screened low-risk patients still suffer widespread cardiovascular complications?

In this episode, we narrate the clinical history and biochemical design of estradiol undecylate, outline its adoption in multiple countries and indications, and follow the Mainz Trial that revealed unexpected cardiovascular risk. What happened when a drug built to last simply would not leave?

Compound: estradiol undecylate
Inventor: Karl Junkmann
First clinical use: 1956
Patent filed: 1958, granted 1961
Mainz Trial enrollment: 191 men (subgroup of 42 men ages 51-84, mean age 68)

- A single 100 mg intramuscular dose was intended as a monthly injection but produced mean trough estradiol of 598 pg/mL.
- The normal male upper limit for estradiol cited in the records is 35 pg/mL.
- Estradiol undecylate was used clinically in France, Germany, the United Kingdom, Monaco, the Netherlands, Switzerland, and Japan.
- In one clinical trial run on medically screened cardiovascular low-risk men, 76% suffered cardiovascular complications.
- The Mainz Trial randomized 191 men with prostate cancer to 100 mg/month estradiol undecylate versus 300 mg/week cyproterone acetate, excluding patients with pre-existing cardiovascular disease.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1805falsefullhttps://www.spreaker.com/episode/the-vanishing-vial-did-3-000-frogs-ever-yield-epibatidine--73090273
A single vial held less than one milligram of residue after nearly 3,000 frogs and eighteen years of work - a sample claimed to contain a compound 2,900 times more potent than morphine and active on nicotinic receptors, not opioids. If that residue was real, it promised pain relief without addiction; if it was not, the entire story of epibatidine unravels - so what did that vial actually contain?

In this episode, we trace the field collections, lab delays, and the surprising pharmacology tied to that tiny sample, and ask whether the compound isolated from Epipedobates tricolor was a genuine breakthrough or an analytical artifact. How did one less-than-milligram vial become the fulcrum of an eighteen-year scientific mystery?

Person: John Daly
Location: Ecuador (western slopes of the Andes)
Species: Epipedobates tricolor
Quantity collected: approximately 3,000 specimens (1974-1979)
Residue remaining: less than one milligram

- 3,000 specimens of Epipedobates tricolor were collected between 1974 and 1979.
- The remaining lab sample from those collections measured less than one milligram.
- Reported analgesic potency required 2.5 micrograms per kilogram in rodents for complete analgesia.
- Morphine required 10 milligrams for the same effect in the comparison cited.
- The compound was reported to act on nicotinic acetylcholine receptors rather than opioid receptors.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090273Tue, 21 Jul 2026 17:26:53 +0000Creator at ObomediaThe Vanishing Vial: Did 3,000 Frogs Ever Yield Epibatidine? A single vial held less than one milligram of residue after nearly 3,000 frogs and eighteen years of work - a sample claimed to contain a compound 2,900 times more potent than morphine and...
A single vial held less than one milligram of residue after nearly 3,000 frogs and eighteen years of work - a sample claimed to contain a compound 2,900 times more potent than morphine and active on nicotinic receptors, not opioids. If that residue was real, it promised pain relief without addiction; if it was not, the entire story of epibatidine unravels - so what did that vial actually contain?

In this episode, we trace the field collections, lab delays, and the surprising pharmacology tied to that tiny sample, and ask whether the compound isolated from Epipedobates tricolor was a genuine breakthrough or an analytical artifact. How did one less-than-milligram vial become the fulcrum of an eighteen-year scientific mystery?

Person: John Daly
Location: Ecuador (western slopes of the Andes)
Species: Epipedobates tricolor
Quantity collected: approximately 3,000 specimens (1974-1979)
Residue remaining: less than one milligram

- 3,000 specimens of Epipedobates tricolor were collected between 1974 and 1979.
- The remaining lab sample from those collections measured less than one milligram.
- Reported analgesic potency required 2.5 micrograms per kilogram in rodents for complete analgesia.
- Morphine required 10 milligrams for the same effect in the comparison cited.
- The compound was reported to act on nicotinic acetylcholine receptors rather than opioid receptors.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1643falsefullhttps://www.spreaker.com/episode/the-molecule-that-should-have-ended-opioids-but-vanished--73090269
A tiny frog in Ecuador carried a molecule in 1974 that proved up to 2,900 times more potent than morphine and acted on alpha-4 beta-2 nicotinic receptors - yet less than one milligram was ever recovered. How did a compound with zero opioid activity and a binding affinity of 0.05 nM disappear between field trips, and did the frog ever make it at all?

In this episode, you will hear the story of John W. Daly and Charles Myers’ fieldwork, the laboratory findings about epibatidine’s potency and receptor activity, and the baffling gap between discovery and follow-up samples. What caused a previously record-setting analgesic to vanish from the same population two years later?

Person: John W. Daly
Person: Charles Myers
Species: Epipedobates anthonyi
Period: 1974-1979 (field collection) and 17-year storage gap
Potency comparison: up to 2,900:1 morphine (at 2.5 µg/kg vs ~10 mg/kg)

- Daly and Myers collected approximately 3,000 frog skins between 1974 and 1979.
- Total combined extract yielded less than one milligram of epibatidine.
- Early assays placed epibatidine’s analgesic dose at 2.5 micrograms per kilogram.
- Epibatidine bound alpha-4 beta-2 nicotinic receptors with an affinity of 0.05 nanomolars.
- A 1976 return to the original site produced zero detectable epibatidine in the same species.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090269Tue, 21 Jul 2026 17:26:50 +0000Creator at ObomediaThe Molecule That Should Have Ended Opioids - But Vanished A tiny frog in Ecuador carried a molecule in 1974 that proved up to 2,900 times more potent than morphine and acted on alpha-4 beta-2 nicotinic receptors - yet less than one milligram was...
A tiny frog in Ecuador carried a molecule in 1974 that proved up to 2,900 times more potent than morphine and acted on alpha-4 beta-2 nicotinic receptors - yet less than one milligram was ever recovered. How did a compound with zero opioid activity and a binding affinity of 0.05 nM disappear between field trips, and did the frog ever make it at all?

In this episode, you will hear the story of John W. Daly and Charles Myers’ fieldwork, the laboratory findings about epibatidine’s potency and receptor activity, and the baffling gap between discovery and follow-up samples. What caused a previously record-setting analgesic to vanish from the same population two years later?

Person: John W. Daly
Person: Charles Myers
Species: Epipedobates anthonyi
Period: 1974-1979 (field collection) and 17-year storage gap
Potency comparison: up to 2,900:1 morphine (at 2.5 µg/kg vs ~10 mg/kg)

- Daly and Myers collected approximately 3,000 frog skins between 1974 and 1979.
- Total combined extract yielded less than one milligram of epibatidine.
- Early assays placed epibatidine’s analgesic dose at 2.5 micrograms per kilogram.
- Epibatidine bound alpha-4 beta-2 nicotinic receptors with an affinity of 0.05 nanomolars.
- A 1976 return to the original site produced zero detectable epibatidine in the same species.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1652falsefullhttps://www.spreaker.com/episode/the-needle-size-molecule-that-rewrote-pain-then-vanished--73090268
A grain smaller than a sewing needle held a compound up to 2,900 times more potent than morphine, yet the frogs that yielded it never produced it again - where did it come from and why did it disappear? Discover the vanished molecule that forced scientists to rethink pain pathways and chemical ecology.

In this episode, we trace the decades-long arc from a single sub-milligram extract gathered in Ecuador to high-resolution spectrometry in 1991 that revealed a chlorinated alkaloid binding nicotinic acetylcholine receptors instead of opioid receptors. How could one tiny sample rewrite analgesic science and leave such unsolved questions about origin and stability?

Person: John W. Daly
Species: Epipedobates anthonyi
Date (first collection): 1974-1979
Analysis date: 1991
Status: Species protected by IUCN since 1984

- Total number of frogs collected: roughly 3,000
- Total extractable material from all frogs: less than 1 milligram
- Reported rodent analgesic potency: 2.5 micrograms/kg equaled 10 mg/kg morphine
- Estimated potency compared to morphine by weight: up to 2,900 times (conservative estimate 200×)
- Year Daly published his paper noting local absence of traditional use: 2000

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090268Tue, 21 Jul 2026 17:26:46 +0000Creator at ObomediaThe Needle-Size Molecule That Rewrote Pain - Then Vanished A grain smaller than a sewing needle held a compound up to 2,900 times more potent than morphine, yet the frogs that yielded it never produced it again - where did it come from and why did...
A grain smaller than a sewing needle held a compound up to 2,900 times more potent than morphine, yet the frogs that yielded it never produced it again - where did it come from and why did it disappear? Discover the vanished molecule that forced scientists to rethink pain pathways and chemical ecology.

In this episode, we trace the decades-long arc from a single sub-milligram extract gathered in Ecuador to high-resolution spectrometry in 1991 that revealed a chlorinated alkaloid binding nicotinic acetylcholine receptors instead of opioid receptors. How could one tiny sample rewrite analgesic science and leave such unsolved questions about origin and stability?

Person: John W. Daly
Species: Epipedobates anthonyi
Date (first collection): 1974-1979
Analysis date: 1991
Status: Species protected by IUCN since 1984

- Total number of frogs collected: roughly 3,000
- Total extractable material from all frogs: less than 1 milligram
- Reported rodent analgesic potency: 2.5 micrograms/kg equaled 10 mg/kg morphine
- Estimated potency compared to morphine by weight: up to 2,900 times (conservative estimate 200×)
- Year Daly published his paper noting local absence of traditional use: 2000

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1711falsefullhttps://www.spreaker.com/episode/the-molecule-that-vanished-doet-s-strange-split-second-fate--73090267
A single extra carbon atom turned DOM into DOET - and turned clinical promise into an unresolved mystery that would outpace the science around it. A compound patented by Dow in 1966, tested twice by colleagues with opposite results, and shelved before its final trial report was published - what exactly happened in between?

In this episode, we trace the sequence from Shulgin’s bench at Dow Chemical to the clinical program at Johns Hopkins and the quiet disappearance of a molecule called DOET, asking whether DOET was a mood elevator, a dangerous outlier, or simply a casualty of events outside the lab.

Person: Alexander Shulgin
Date: 1966
Location: Dow Chemical, California
Event: Patent filed for 4-ethyl-2,5-dimethoxyamphetamine (DOET)
Period: 1960s

- DOET differs from DOM by one structural change: a methyl group replaced with an ethyl group (one extra carbon).
- Shulgin reported onset between 1 and 1.5 hours, peak at 3-4 hours, and a 5-6 hour duration at lower doses.
- Patent for DOET was filed by Shulgin and Dow Chemical in 1966 under the name Hecate/DOET.
- One month after Shulgin’s self-test, a colleague at comparable dose experienced intense lethargy and prolonged depression.
- Solomon Snyder began controlled human trials for DOET at Johns Hopkins in 1968 with funding from Dow Chemical.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090267Tue, 21 Jul 2026 17:26:42 +0000Creator at ObomediaThe Molecule That Vanished: DOET's Strange Split‑Second Fate A single extra carbon atom turned DOM into DOET - and turned clinical promise into an unresolved mystery that would outpace the science around it. A compound patented by Dow in 1966,...
A single extra carbon atom turned DOM into DOET - and turned clinical promise into an unresolved mystery that would outpace the science around it. A compound patented by Dow in 1966, tested twice by colleagues with opposite results, and shelved before its final trial report was published - what exactly happened in between?

In this episode, we trace the sequence from Shulgin’s bench at Dow Chemical to the clinical program at Johns Hopkins and the quiet disappearance of a molecule called DOET, asking whether DOET was a mood elevator, a dangerous outlier, or simply a casualty of events outside the lab.

Person: Alexander Shulgin
Date: 1966
Location: Dow Chemical, California
Event: Patent filed for 4-ethyl-2,5-dimethoxyamphetamine (DOET)
Period: 1960s

- DOET differs from DOM by one structural change: a methyl group replaced with an ethyl group (one extra carbon).
- Shulgin reported onset between 1 and 1.5 hours, peak at 3-4 hours, and a 5-6 hour duration at lower doses.
- Patent for DOET was filed by Shulgin and Dow Chemical in 1966 under the name Hecate/DOET.
- One month after Shulgin’s self-test, a colleague at comparable dose experienced intense lethargy and prolonged depression.
- Solomon Snyder began controlled human trials for DOET at Johns Hopkins in 1968 with funding from Dow Chemical.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1833falsefullhttps://www.spreaker.com/episode/the-medicine-that-worked-buried-by-san-francisco-s-stp-panic--73090266
A Johns Hopkins neuroscientist ran controlled clinical trials for six years on a compound that produced no hallucinations, no cognitive impairment, and measurable mood elevation - yet the program was killed by a street drug crisis in San Francisco. The drug passed every test, the patent sat unused since 1966, and three peer‑reviewed papers survive; so how did a medicine that may have worked get buried under the wreckage of something it had nothing to do with?

In this episode, we trace the clinical record, corporate filings, and street history to show what the trials recorded, what Dow Chemical patented, and how a separate outbreak of high‑dose tablets in San Francisco changed the law and the science. What actually happened between laboratory notes, a 1966 patent, and the STP panic that ended the program?

Person: Alexander Shulgin
Person: Solomon Snyder
Event: STP distribution in San Francisco summer 1967
Date: 1966 (patent filed), 1968 (trials began)
Publication: Three peer‑reviewed papers

- The compound DOET was patented by Dow Chemical in 1966 and never developed into a pharmaceutical product.
- Controlled clinical trials on DOET began at Johns Hopkins in 1968 under neuroscientist Solomon Snyder.
- Three peer‑reviewed papers on the compound remain in the scientific literature authored by Snyder.
- Alexander Shulgin synthesized DOM in 1963 and created DOET by replacing a methyl group with an ethyl group.
- Owsley Stanley distributed high‑dose DOM tablets called STP in San Francisco in summer 1967, producing extended trips lasting 12-16 hours and hospitalizations.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090266Tue, 21 Jul 2026 17:26:38 +0000Creator at ObomediaThe Medicine That Worked - Buried by San Francisco's STP Panic A Johns Hopkins neuroscientist ran controlled clinical trials for six years on a compound that produced no hallucinations, no cognitive impairment, and measurable mood elevation - yet...
A Johns Hopkins neuroscientist ran controlled clinical trials for six years on a compound that produced no hallucinations, no cognitive impairment, and measurable mood elevation - yet the program was killed by a street drug crisis in San Francisco. The drug passed every test, the patent sat unused since 1966, and three peer‑reviewed papers survive; so how did a medicine that may have worked get buried under the wreckage of something it had nothing to do with?

In this episode, we trace the clinical record, corporate filings, and street history to show what the trials recorded, what Dow Chemical patented, and how a separate outbreak of high‑dose tablets in San Francisco changed the law and the science. What actually happened between laboratory notes, a 1966 patent, and the STP panic that ended the program?

Person: Alexander Shulgin
Person: Solomon Snyder
Event: STP distribution in San Francisco summer 1967
Date: 1966 (patent filed), 1968 (trials began)
Publication: Three peer‑reviewed papers

- The compound DOET was patented by Dow Chemical in 1966 and never developed into a pharmaceutical product.
- Controlled clinical trials on DOET began at Johns Hopkins in 1968 under neuroscientist Solomon Snyder.
- Three peer‑reviewed papers on the compound remain in the scientific literature authored by Snyder.
- Alexander Shulgin synthesized DOM in 1963 and created DOET by replacing a methyl group with an ethyl group.
- Owsley Stanley distributed high‑dose DOM tablets called STP in San Francisco in summer 1967, producing extended trips lasting 12-16 hours and hospitalizations.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1757falsefullhttps://www.spreaker.com/episode/hecate-the-lost-mood-drug-banned-before-it-was-proven--73090262
A forgotten psychiatric compound promised quiet, sustained mood elevation without hallucinations, yet it was placed on Schedule I before clinical results were published-how did a potentially safer mood drug become buried by a crisis it didn’t cause? Discover the strange link between a Dow patent, a Summer of Love emergency, and a scientist who kept testing after industry walked away.

In this episode, we trace the timeline from the 1966 Dow patent through the 1967 San Francisco crisis to the clinical trials that followed, describing who developed the molecule, what the early human data showed, and why the research program collapsed-was the drug outlawed because of science or because of circumstance?

Person: Alexander Shulgin
Person: Owsley Stanley
Person: Solomon Snyder
Date: 1966 (patent filed)
Event: San Francisco crisis, 1967

- Dow Chemical filed the DOET patent in 1966 describing a compound intended to elevate mood without producing hallucinations.
- California made LSD illegal in 1966, shifting underground chemists into criminal status and prompting changes in the drug market.
- Owsley Stanley distributed DOM as STP in 1967, with high-dose tablets that produced effects lasting three to four days and led to emergency room cases.
- Dow terminated the DOET clinical program in 1967; the patent was published in 1970 after the program had ended.
- Solomon Snyder conducted a DOET trial in 1968 administering 1.5 mg orally, with onset at 1-1.5 hours, peak at 3-4 hours, duration 5-6 hours, and reports of mild euphoria and heightened self-awareness without hallucinations.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090262Tue, 21 Jul 2026 17:26:35 +0000Creator at ObomediaHecate: The Lost Mood Drug Banned Before It Was Proven A forgotten psychiatric compound promised quiet, sustained mood elevation without hallucinations, yet it was placed on Schedule I before clinical results were published-how did a potentially...
A forgotten psychiatric compound promised quiet, sustained mood elevation without hallucinations, yet it was placed on Schedule I before clinical results were published-how did a potentially safer mood drug become buried by a crisis it didn’t cause? Discover the strange link between a Dow patent, a Summer of Love emergency, and a scientist who kept testing after industry walked away.

In this episode, we trace the timeline from the 1966 Dow patent through the 1967 San Francisco crisis to the clinical trials that followed, describing who developed the molecule, what the early human data showed, and why the research program collapsed-was the drug outlawed because of science or because of circumstance?

Person: Alexander Shulgin
Person: Owsley Stanley
Person: Solomon Snyder
Date: 1966 (patent filed)
Event: San Francisco crisis, 1967

- Dow Chemical filed the DOET patent in 1966 describing a compound intended to elevate mood without producing hallucinations.
- California made LSD illegal in 1966, shifting underground chemists into criminal status and prompting changes in the drug market.
- Owsley Stanley distributed DOM as STP in 1967, with high-dose tablets that produced effects lasting three to four days and led to emergency room cases.
- Dow terminated the DOET clinical program in 1967; the patent was published in 1970 after the program had ended.
- Solomon Snyder conducted a DOET trial in 1968 administering 1.5 mg orally, with onset at 1-1.5 hours, peak at 3-4 hours, duration 5-6 hours, and reports of mild euphoria and heightened self-awareness without hallucinations.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1688falsefullhttps://www.spreaker.com/episode/the-drug-that-didn-t-trip-why-ariadne-s-trial-vanished-in-1974--73090258
Alerting clarity without hallucinations: Ariadne, code BL-3912, produced measurable antidepressant, antimanic and Parkinsonian benefits across a wide dose range - and yet its phase three human trial data were never published. Why did Bristol Laboratories halt public release despite completed multi-clinic trials and no safety crisis?

In this episode, we follow the path from Alexander Shulgin’s 1968 synthesis to Bristol Laboratories’ decision to have every board member ingest the drug before approving human testing, and we track the unpublished phase three program around 1974. What can the sealed trial results tell us about a molecule that woke subjects without tripping them into hallucination?

Person: Alexander Shulgin
Date: 1968 (synthesis), 1974 (board dosing and phase three start)
Company: Bristol Laboratories
Compound: Ariadne (internal code BL-3912, active enantiomer BL-3912A; proposed brand Dimoxamine)
Status: Phase three completed; results unpublished

- Bristol board members each swallowed Ariadne themselves before authorizing human trials in 1974.
- At 25-50 mg BL-3912A produced alertness and measurable well-being, placing it in antidepressant range.
- At 50-100 mg the compound produced effects relevant to manic depression in psychotic individuals.
- At 100 mg daily Ariadne reversed motor deficits in animal Parkinson’s models at rates comparable to levodopa.
- At 300 mg (ten times minimum active dose) no subject reported hallucinations.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090258Tue, 21 Jul 2026 17:26:31 +0000Creator at ObomediaThe Drug That Didn't Trip: Why Ariadne's Trial Vanished in 1974 Alerting clarity without hallucinations: Ariadne, code BL-3912, produced measurable antidepressant, antimanic and Parkinsonian benefits across a wide dose range - and yet its phase...
Alerting clarity without hallucinations: Ariadne, code BL-3912, produced measurable antidepressant, antimanic and Parkinsonian benefits across a wide dose range - and yet its phase three human trial data were never published. Why did Bristol Laboratories halt public release despite completed multi-clinic trials and no safety crisis?

In this episode, we follow the path from Alexander Shulgin’s 1968 synthesis to Bristol Laboratories’ decision to have every board member ingest the drug before approving human testing, and we track the unpublished phase three program around 1974. What can the sealed trial results tell us about a molecule that woke subjects without tripping them into hallucination?

Person: Alexander Shulgin
Date: 1968 (synthesis), 1974 (board dosing and phase three start)
Company: Bristol Laboratories
Compound: Ariadne (internal code BL-3912, active enantiomer BL-3912A; proposed brand Dimoxamine)
Status: Phase three completed; results unpublished

- Bristol board members each swallowed Ariadne themselves before authorizing human trials in 1974.
- At 25-50 mg BL-3912A produced alertness and measurable well-being, placing it in antidepressant range.
- At 50-100 mg the compound produced effects relevant to manic depression in psychotic individuals.
- At 100 mg daily Ariadne reversed motor deficits in animal Parkinson’s models at rates comparable to levodopa.
- At 300 mg (ten times minimum active dose) no subject reported hallucinations.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1531falsefullhttps://www.spreaker.com/episode/the-girl-who-broke-hormones-how-a-seizure-drug-revealed-cancer-therapy--73090257
A child in 1963 collapsed not from a seizure but from adrenal failure after taking aminoglutethimide, an anticonvulsant not designed to touch steroid production - a reaction that later redirected cancer pharmacology. How did a single adverse event with a pediatric epilepsy drug lead to an entirely new therapeutic pathway?

In this episode, we tell the story of that drug's unexpected effect and its aftermath. You will hear how aminoglutethimide, approved for petit mal epilepsy, produced widespread toxicity, was withdrawn in 1966, and yet planted the seed for drugs treating hormone-sensitive cancers - but how exactly did that accidental discovery survive near-erasure?

Person: unnamed girl patient
Date: 1963 (collapse); 1960 (approval); 1966 (withdrawal)
Drug: aminoglutethimide (brand name Elipten)
Condition: adrenal insufficiency consistent with Addison's disease
Adverse effect rates: 45-85% experienced at least one adverse effect

- Aminoglutethimide was approved in 1960 for petit mal epilepsy and prescribed as an oral anticonvulsant.
- The 1963 patient developed life-threatening adrenal failure while taking the drug, resembling Addison's disease.
- Across observations, 45-85% of patients experienced at least one adverse effect from aminoglutethimide.
- Lethargy occurred in 31-70% of cases; skin rash and low blood pressure in roughly 15% of patients.
- Approximately 10% of patients experienced severe toxicity, including circulatory instability and adrenal failure, leading to the drug's market withdrawal in 1966.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090257Tue, 21 Jul 2026 17:26:27 +0000Creator at ObomediaThe Girl Who Broke Hormones: How a Seizure Drug Revealed Cancer Therapy A child in 1963 collapsed not from a seizure but from adrenal failure after taking aminoglutethimide, an anticonvulsant not designed to touch steroid production - a reaction...
A child in 1963 collapsed not from a seizure but from adrenal failure after taking aminoglutethimide, an anticonvulsant not designed to touch steroid production - a reaction that later redirected cancer pharmacology. How did a single adverse event with a pediatric epilepsy drug lead to an entirely new therapeutic pathway?

In this episode, we tell the story of that drug's unexpected effect and its aftermath. You will hear how aminoglutethimide, approved for petit mal epilepsy, produced widespread toxicity, was withdrawn in 1966, and yet planted the seed for drugs treating hormone-sensitive cancers - but how exactly did that accidental discovery survive near-erasure?

Person: unnamed girl patient
Date: 1963 (collapse); 1960 (approval); 1966 (withdrawal)
Drug: aminoglutethimide (brand name Elipten)
Condition: adrenal insufficiency consistent with Addison's disease
Adverse effect rates: 45-85% experienced at least one adverse effect

- Aminoglutethimide was approved in 1960 for petit mal epilepsy and prescribed as an oral anticonvulsant.
- The 1963 patient developed life-threatening adrenal failure while taking the drug, resembling Addison's disease.
- Across observations, 45-85% of patients experienced at least one adverse effect from aminoglutethimide.
- Lethargy occurred in 31-70% of cases; skin rash and low blood pressure in roughly 15% of patients.
- Approximately 10% of patients experienced severe toxicity, including circulatory instability and adrenal failure, leading to the drug's market withdrawal in 1966.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1585falsefullhttps://www.spreaker.com/episode/the-truth-about-expired-drugs-military-tests-that-changed-nothing--73090255
Nearly 90% of over 100 tested drugs remained effective up to fifteen years past their printed expiration dates, yet the findings were kept from hospitals, state health departments, and foreign governments-so why did nothing change for the public? What did the military do differently after learning that most expiration dates are conservative estimates?

In this episode, we lay out the Shelf Life Extension Program and the FDA tests it funded for the Department of Defense, describing what the study covered and how its conclusions contradicted common assumptions about expiration dates. How did a formal, fifteen-year-spanning body of research lead to a practice that saved the military money while remaining largely invisible to everyone else?

Person: Joel Davis
Organization: Food and Drug Administration
Program: Shelf Life Extension Program
Scope: more than 100 drugs tested
Result: roughly 90% effective up to 15 years past expiration

- The Department of Defense commissioned the FDA to test military stockpiles beginning in the mid-1980s.
- The FDA tested more than 100 prescription and over-the-counter drugs under proper storage conditions.
- Roughly 90% of those drugs were found safe and effective up to 15 years past their official expiration dates.
- Ciprofloxacin was found effective nine years past its official shelf life under proper storage conditions.
- The Shelf Life Extension Program continues to operate, allowing the military to extend usable life of tested stockpiles.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090255Tue, 21 Jul 2026 17:26:23 +0000Creator at ObomediaThe Truth About "Expired" Drugs: Military Tests That Changed Nothing Nearly 90% of over 100 tested drugs remained effective up to fifteen years past their printed expiration dates, yet the findings were kept from hospitals, state health...
Nearly 90% of over 100 tested drugs remained effective up to fifteen years past their printed expiration dates, yet the findings were kept from hospitals, state health departments, and foreign governments-so why did nothing change for the public? What did the military do differently after learning that most expiration dates are conservative estimates?

In this episode, we lay out the Shelf Life Extension Program and the FDA tests it funded for the Department of Defense, describing what the study covered and how its conclusions contradicted common assumptions about expiration dates. How did a formal, fifteen-year-spanning body of research lead to a practice that saved the military money while remaining largely invisible to everyone else?

Person: Joel Davis
Organization: Food and Drug Administration
Program: Shelf Life Extension Program
Scope: more than 100 drugs tested
Result: roughly 90% effective up to 15 years past expiration

- The Department of Defense commissioned the FDA to test military stockpiles beginning in the mid-1980s.
- The FDA tested more than 100 prescription and over-the-counter drugs under proper storage conditions.
- Roughly 90% of those drugs were found safe and effective up to 15 years past their official expiration dates.
- Ciprofloxacin was found effective nine years past its official shelf life under proper storage conditions.
- The Shelf Life Extension Program continues to operate, allowing the military to extend usable life of tested stockpiles.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1605falsefullhttps://www.spreaker.com/episode/the-iron-lung-doctor-who-built-the-world-s-drug-alert-system--73090254
Fear of hidden harm: a paralyzed Cambridge graduate who spent two years in an iron lung went on to create a worldwide drug-surveillance system after thalidomide, and a 2020 document alleges he destroyed case material during a government review-what really happened and why did he still feel his work was unfinished?

In this episode, we trace William Inman's life from polio in his early twenties to his role in government and industry, showing how his experiences shaped the yellow card system and the unresolved allegation that clouds parts of his legacy. How did a single yellow form become an international model, and what questions remain about the records he kept?

Person: William Howard Wallace Inman
Date of birth: 1 August 1929
Date of death: 20 October 2005
Event: Creation of the yellow card adverse drug reporting system
Period: 1950s-2000s

- Spent two years inside an iron lung after contracting polio at age 22
- Graduated as the first clinical medical graduate from the University of Cambridge in 1956
- Delivered approximately 50 babies from an adapted wheelchair while working at Addenbrooke's Hospital
- Worked five years as a medical adviser at ICI Pharmaceutical Division before joining the Department of Health
- A 2020 document alleged he destroyed case material during a government review, though he was never formally accused

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090254Tue, 21 Jul 2026 17:26:20 +0000Creator at ObomediaThe Iron Lung Doctor Who Built the World's Drug-Alert System Fear of hidden harm: a paralyzed Cambridge graduate who spent two years in an iron lung went on to create a worldwide drug-surveillance system after thalidomide, and a 2020 document...
Fear of hidden harm: a paralyzed Cambridge graduate who spent two years in an iron lung went on to create a worldwide drug-surveillance system after thalidomide, and a 2020 document alleges he destroyed case material during a government review-what really happened and why did he still feel his work was unfinished?

In this episode, we trace William Inman's life from polio in his early twenties to his role in government and industry, showing how his experiences shaped the yellow card system and the unresolved allegation that clouds parts of his legacy. How did a single yellow form become an international model, and what questions remain about the records he kept?

Person: William Howard Wallace Inman
Date of birth: 1 August 1929
Date of death: 20 October 2005
Event: Creation of the yellow card adverse drug reporting system
Period: 1950s-2000s

- Spent two years inside an iron lung after contracting polio at age 22
- Graduated as the first clinical medical graduate from the University of Cambridge in 1956
- Delivered approximately 50 babies from an adapted wheelchair while working at Addenbrooke's Hospital
- Worked five years as a medical adviser at ICI Pharmaceutical Division before joining the Department of Health
- A 2020 document alleged he destroyed case material during a government review, though he was never formally accused

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1720falsefullhttps://www.spreaker.com/episode/when-medicine-hurts-your-unborn-children-the-des-generation-reveal--73090253
A chilling gap between warning and withdrawal let harmful medicines persist for decades - Mrs. Winslow's Soothing Syrup was labeled "Baby Killers" in 1911 yet still sold in 1930 - and one drug, DES, carried damage into the next generation. How did a medication given to protect pregnancies end up increasing cancer and infertility risks two generations later?

In this episode, we trace the timeline and systems that allowed dangerous products to stay on shelves, outline who was affected by DES, and ask how regulatory processes and mislabeling shaped the outcomes for millions. Can a recall ever fully undo harm passed on before birth?

Person: American Medical Association
Event: "Baby Killers" article published
Date: 1911
Drug: diethylstilbestrol (DES)
Estimate: 5-10 million people exposed before 1971 recall

- Mrs. Winslow's Soothing Syrup was called "Baby Killers" in a medical journal in 1911 yet remained on sale in the UK in 1930.
- DES was given to women during pregnancy and an estimated 5-10 million people were exposed before its 1971 recall.
- Daughters exposed in utero to DES were more than twice as likely to develop breast cancer.
- DES-exposed daughters had a 2.4 times higher risk of infertility compared with the general population.
- In 2015, 42% of pharmaceutical recalls were due to misbranding, and 45 new drugs received approval that year.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090253Tue, 21 Jul 2026 17:26:16 +0000Creator at ObomediaWhen Medicine Hurts Your Unborn Children: The DES Generation Reveal A chilling gap between warning and withdrawal let harmful medicines persist for decades - Mrs. Winslow's Soothing Syrup was labeled "Baby Killers" in 1911 yet still sold in 1930 -...
A chilling gap between warning and withdrawal let harmful medicines persist for decades - Mrs. Winslow's Soothing Syrup was labeled "Baby Killers" in 1911 yet still sold in 1930 - and one drug, DES, carried damage into the next generation. How did a medication given to protect pregnancies end up increasing cancer and infertility risks two generations later?

In this episode, we trace the timeline and systems that allowed dangerous products to stay on shelves, outline who was affected by DES, and ask how regulatory processes and mislabeling shaped the outcomes for millions. Can a recall ever fully undo harm passed on before birth?

Person: American Medical Association
Event: "Baby Killers" article published
Date: 1911
Drug: diethylstilbestrol (DES)
Estimate: 5-10 million people exposed before 1971 recall

- Mrs. Winslow's Soothing Syrup was called "Baby Killers" in a medical journal in 1911 yet remained on sale in the UK in 1930.
- DES was given to women during pregnancy and an estimated 5-10 million people were exposed before its 1971 recall.
- Daughters exposed in utero to DES were more than twice as likely to develop breast cancer.
- DES-exposed daughters had a 2.4 times higher risk of infertility compared with the general population.
- In 2015, 42% of pharmaceutical recalls were due to misbranding, and 45 new drugs received approval that year.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1397falsefullhttps://www.spreaker.com/episode/the-man-lying-at-the-bottom-of-the-stairs-could-not-move-his-legs--73090252
He was told he would never walk again, yet he taught himself to walk in the dark at night - and later built a company that resolved $15 billion in consumer debt and employed 3,900 people. How did a one-time carnival worker and slaughterhouse employee turn five cents on the dollar into a Harvard Business School case and draw the ire of the Department of Justice?

In this episode, we tell the story of William R. Bartmann from his origins in Dubuque through the staircase that changed his life, his rise in debt collection using a novel repayment strategy, and the federal prosecution that failed on every count. What is the detail at the center of this case that reframes everything and makes the staircase the whole argument?

Person: William R. Bartmann
Location: Dubuque, Iowa
Date of birth: 1948
Event: Resolved $15 billion in consumer debt
Status: Federal jury rejected prosecution on every count

- Bartmann left school at age 14 and later earned a GED, college degrees, and a law degree.
- A fall down a staircase left him unable to move his legs until he retrained himself to walk in private.
- In 1986 he built a debt-buying company in Tulsa that eventually employed more than 3,900 people.
- His company’s approach bought charged-off accounts at five cents on the dollar and offered reasonable repayment options.
- The United States Department of Justice convened three grand juries and prosecuted him, but a federal jury rejected every count.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090252Tue, 21 Jul 2026 17:26:13 +0000Creator at ObomediaThe man lying at the bottom of the stairs could not move his legs He was told he would never walk again, yet he taught himself to walk in the dark at night - and later built a company that resolved $15 billion in consumer debt and employed 3,900...
He was told he would never walk again, yet he taught himself to walk in the dark at night - and later built a company that resolved $15 billion in consumer debt and employed 3,900 people. How did a one-time carnival worker and slaughterhouse employee turn five cents on the dollar into a Harvard Business School case and draw the ire of the Department of Justice?

In this episode, we tell the story of William R. Bartmann from his origins in Dubuque through the staircase that changed his life, his rise in debt collection using a novel repayment strategy, and the federal prosecution that failed on every count. What is the detail at the center of this case that reframes everything and makes the staircase the whole argument?

Person: William R. Bartmann
Location: Dubuque, Iowa
Date of birth: 1948
Event: Resolved $15 billion in consumer debt
Status: Federal jury rejected prosecution on every count

- Bartmann left school at age 14 and later earned a GED, college degrees, and a law degree.
- A fall down a staircase left him unable to move his legs until he retrained himself to walk in private.
- In 1986 he built a debt-buying company in Tulsa that eventually employed more than 3,900 people.
- His company’s approach bought charged-off accounts at five cents on the dollar and offered reasonable repayment options.
- The United States Department of Justice convened three grand juries and prosecuted him, but a federal jury rejected every count.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1455falsefullhttps://www.spreaker.com/episode/the-schoolteacher-who-saved-a-nation-then-lost-it-all--73090251
A tiny country with fewer than ten thousand people was kept standing by a schoolteacher-turned-prime minister who borrowed 1.5 million Swiss francs and secured a personal donation of 1,000,000 from the prince after the Alpine Rhine flood of 25 September 1927 - yet within a year roughly 4,000,000 francs were quietly removed from the National Bank by four men from his own party. How did the man who built Liechtenstein's emergency savings bank and anchored its currency lose everything he had fought to protect?

In this episode, we tell the story of Gustav Schädler’s rise from village teacher to Prime Minister and the sequence of events from the 1927 flood to the political crisis that ended his leadership. We cover his early life, key financial decisions during crisis, and the constitutional vacuum that left the nation without a procedure to remove a sitting prime minister - so what ultimately became of Schädler’s authority?

Person: Gustav Schädler
Date: 25 September 1927
Event: Alpine Rhine flood
Amount borrowed: 1,500,000 Swiss francs
Amount emptied: approximately 4,000,000 francs

- Schädler was born 18 November 1883 in Triesenberg and trained as a teacher at Bad Saulgau.
- He studied linguistics and history in Zurich from 1906 to 1912 and taught in Vaduz from 1914 to 1922.
- On 16 December 1918 he married Olga Real (born 29 July 1889); they had two children.
- As Prime Minister from 6 June 1922, he secured the first Swiss loan and the 1924 customs union adopting the Swiss franc.
- After the 1927 flood he borrowed 1,500,000 Swiss francs and obtained a 1,000,000 personal donation from the prince to build a state savings bank.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090251Tue, 21 Jul 2026 17:26:10 +0000Creator at ObomediaThe Schoolteacher Who Saved a Nation - Then Lost It All A tiny country with fewer than ten thousand people was kept standing by a schoolteacher-turned-prime minister who borrowed 1.5 million Swiss francs and secured a personal donation of 1,000,000...
A tiny country with fewer than ten thousand people was kept standing by a schoolteacher-turned-prime minister who borrowed 1.5 million Swiss francs and secured a personal donation of 1,000,000 from the prince after the Alpine Rhine flood of 25 September 1927 - yet within a year roughly 4,000,000 francs were quietly removed from the National Bank by four men from his own party. How did the man who built Liechtenstein's emergency savings bank and anchored its currency lose everything he had fought to protect?

In this episode, we tell the story of Gustav Schädler’s rise from village teacher to Prime Minister and the sequence of events from the 1927 flood to the political crisis that ended his leadership. We cover his early life, key financial decisions during crisis, and the constitutional vacuum that left the nation without a procedure to remove a sitting prime minister - so what ultimately became of Schädler’s authority?

Person: Gustav Schädler
Date: 25 September 1927
Event: Alpine Rhine flood
Amount borrowed: 1,500,000 Swiss francs
Amount emptied: approximately 4,000,000 francs

- Schädler was born 18 November 1883 in Triesenberg and trained as a teacher at Bad Saulgau.
- He studied linguistics and history in Zurich from 1906 to 1912 and taught in Vaduz from 1914 to 1922.
- On 16 December 1918 he married Olga Real (born 29 July 1889); they had two children.
- As Prime Minister from 6 June 1922, he secured the first Swiss loan and the 1924 customs union adopting the Swiss franc.
- After the 1927 flood he borrowed 1,500,000 Swiss francs and obtained a 1,000,000 personal donation from the prince to build a state savings bank.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1719falsefullhttps://www.spreaker.com/episode/the-unburied-president-why-edgar-lungu-s-coffin-never-came-home--73090249
Grief turned into a political standoff: former Zambian president Edgar Chagwa Lungu died on June 5, 2025, in Pretoria and his body was never returned home, while his explicit instruction barred sitting president Hakainde Hichilema from approaching the coffin - so why did a death spark an unburied dispute that outlasted the man? What did that written ban reveal about Lungu’s final power and the fractures in Zambian politics?

In this episode, we trace Lungu’s life from his birth in Ndola to his legal career, rise through the Patriotic Front, and contested presidency, and we follow the chain of events after his death that left his remains abroad and a nation divided - what did his documented final wish change about political rituals and power?

Person: Edgar Chagwa Lungu
Date of death: June 5, 2025
Location of death: Pretoria, South Africa
Instruction: Hakainde Hichilema forbidden from approaching remains
Birth date and place: November 11, 1956; Ndola Central Hospital

- Lungu left a documented instruction forbidding sitting president Hakainde Hichilema from being permitted near his remains.
- He died on June 5, 2025, on a surgical table in Pretoria, South Africa.
- Zambia declared seven days of mourning after his death.
- Lungu was born on November 11, 1956, in Ndola Central Hospital in then Northern Rhodesia.
- He won the January 20, 2015 presidential by-election by 27,757 votes out of more than 1.6 million cast (1.66% margin) with 32.36% nationwide participation.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090249Tue, 21 Jul 2026 17:26:06 +0000Creator at ObomediaThe Unburied President: Why Edgar Lungu's Coffin Never Came Home Grief turned into a political standoff: former Zambian president Edgar Chagwa Lungu died on June 5, 2025, in Pretoria and his body was never returned home, while his explicit...
Grief turned into a political standoff: former Zambian president Edgar Chagwa Lungu died on June 5, 2025, in Pretoria and his body was never returned home, while his explicit instruction barred sitting president Hakainde Hichilema from approaching the coffin - so why did a death spark an unburied dispute that outlasted the man? What did that written ban reveal about Lungu’s final power and the fractures in Zambian politics?

In this episode, we trace Lungu’s life from his birth in Ndola to his legal career, rise through the Patriotic Front, and contested presidency, and we follow the chain of events after his death that left his remains abroad and a nation divided - what did his documented final wish change about political rituals and power?

Person: Edgar Chagwa Lungu
Date of death: June 5, 2025
Location of death: Pretoria, South Africa
Instruction: Hakainde Hichilema forbidden from approaching remains
Birth date and place: November 11, 1956; Ndola Central Hospital

- Lungu left a documented instruction forbidding sitting president Hakainde Hichilema from being permitted near his remains.
- He died on June 5, 2025, on a surgical table in Pretoria, South Africa.
- Zambia declared seven days of mourning after his death.
- Lungu was born on November 11, 1956, in Ndola Central Hospital in then Northern Rhodesia.
- He won the January 20, 2015 presidential by-election by 27,757 votes out of more than 1.6 million cast (1.66% margin) with 32.36% nationwide participation.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1461falsefullhttps://www.spreaker.com/episode/a-30-km-h-crash-that-should-have-been-survived-the-airbag-was-the-weapon--73090246
A forty-two-year-old pregnant woman died in a collision at just thirty kilometers per hour when a metal fragment from her own dashboard severed her neck; the device meant to save her life detonated instead. How did a company that started making parachute cord end up filling hundreds of millions of cars with explosive inflators, and why were regulators and automakers still driving those cars years after engineers flagged the danger?

In this episode, we trace the path from a 1933 parachute-cord manufacturer to a global airbag supplier and the decisions in the 1990s that swapped stability for cost savings, the pattern of concealment across decades, and the lawsuit in Miami that began to pull the thread. What unfolded after three injury complaints triggered a regulatory file, and how did recalls grow from millions to the largest in U.S. history?

Person: Takezo Takada
Period: 1933-2014 (company history and crisis timeline)
Topic: Takata airbag inflator defect and concealment
Event: 2014 Honda City fatality in Malaysia
Status: Thirty-five confirmed deaths worldwide as of September 2024

- The crash speed was thirty kilometers per hour, described as barely faster than a bicycle.
- By 2014 Takata supplied roughly twenty percent of the global airbag market with manufacturing on four continents.
- Takata switched propellants in the 1990s to ammonium nitrate because it was cheaper and easier to manufacture.
- Ammonium nitrate degrades with repeated temperature and humidity cycling, causing inflators to detonate and send metal fragments outward.
- In April-May 2013 six manufacturers recalled 3.6 million cars tied to the Monclova Plant in Coahuila.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090246Tue, 21 Jul 2026 17:26:03 +0000Creator at ObomediaA 30-km/h crash that should have been survived - the airbag was the weapon A forty-two-year-old pregnant woman died in a collision at just thirty kilometers per hour when a metal fragment from her own dashboard severed her neck; the device meant to...
A forty-two-year-old pregnant woman died in a collision at just thirty kilometers per hour when a metal fragment from her own dashboard severed her neck; the device meant to save her life detonated instead. How did a company that started making parachute cord end up filling hundreds of millions of cars with explosive inflators, and why were regulators and automakers still driving those cars years after engineers flagged the danger?

In this episode, we trace the path from a 1933 parachute-cord manufacturer to a global airbag supplier and the decisions in the 1990s that swapped stability for cost savings, the pattern of concealment across decades, and the lawsuit in Miami that began to pull the thread. What unfolded after three injury complaints triggered a regulatory file, and how did recalls grow from millions to the largest in U.S. history?

Person: Takezo Takada
Period: 1933-2014 (company history and crisis timeline)
Topic: Takata airbag inflator defect and concealment
Event: 2014 Honda City fatality in Malaysia
Status: Thirty-five confirmed deaths worldwide as of September 2024

- The crash speed was thirty kilometers per hour, described as barely faster than a bicycle.
- By 2014 Takata supplied roughly twenty percent of the global airbag market with manufacturing on four continents.
- Takata switched propellants in the 1990s to ammonium nitrate because it was cheaper and easier to manufacture.
- Ammonium nitrate degrades with repeated temperature and humidity cycling, causing inflators to detonate and send metal fragments outward.
- In April-May 2013 six manufacturers recalled 3.6 million cars tied to the Monclova Plant in Coahuila.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1433falsefullhttps://www.spreaker.com/episode/how-a-fishing-town-s-babies-were-poisoned-by-invisible-industrial-mercury--73090245
Fear and disbelief swept a fishing town where cats convulsed, birds fell from the sky, and fishing yields plunged 91% - but why were infants who never ate fish also stricken? In Minamata, a factory’s unseen methylmercury turned bay sediment into an ore deposit at 2 kilograms per ton, and the answer to who was poisoned would take years to surface; what hidden pathway reached those children?

In this episode, we tell what happened in Minamata between 1956 and 1959: the arrival of patients with numbness, vision narrowing, convulsions and death, the town’s dependence on the Chisso Corporation, the discovery of extreme mercury contamination in bay sediment, and the company’s response that moved wastewater into the Minamata River - could that decision explain the spreading illness?

Person: Chisso Corporation
Location: Minamata, Kyūshū, Japan
Date: May 1, 1956 (first documented patient), November 4, 1956 (research finding), February 1959 (sediment measurement), September 1958 (wastewater rerouting)
Event: Discovery of methylmercury poisoning transmitted through fish and shellfish

- Fishing yields fell by 91% from earlier levels in the early 1950s.
- By October 1956, 40 people were identified with the disease and 14 were dead (case fatality rate 35%).
- Sediment sampling at the mouth of the wastewater canal measured 2 kilograms of mercury per ton of sediment in February 1959.
- Chisso began producing acetaldehyde in 1932 using mercury as a catalyst, which led to methylmercury discharge into Hyakken Harbour.
- In September 1958 Chisso rerouted its wastewater discharge from the bay to the Minamata River.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090245Tue, 21 Jul 2026 17:26:00 +0000Creator at ObomediaHow a Fishing Town's Babies Were Poisoned by Invisible Industrial Mercury Fear and disbelief swept a fishing town where cats convulsed, birds fell from the sky, and fishing yields plunged 91% - but why were infants who never ate fish also stricken?...
Fear and disbelief swept a fishing town where cats convulsed, birds fell from the sky, and fishing yields plunged 91% - but why were infants who never ate fish also stricken? In Minamata, a factory’s unseen methylmercury turned bay sediment into an ore deposit at 2 kilograms per ton, and the answer to who was poisoned would take years to surface; what hidden pathway reached those children?

In this episode, we tell what happened in Minamata between 1956 and 1959: the arrival of patients with numbness, vision narrowing, convulsions and death, the town’s dependence on the Chisso Corporation, the discovery of extreme mercury contamination in bay sediment, and the company’s response that moved wastewater into the Minamata River - could that decision explain the spreading illness?

Person: Chisso Corporation
Location: Minamata, Kyūshū, Japan
Date: May 1, 1956 (first documented patient), November 4, 1956 (research finding), February 1959 (sediment measurement), September 1958 (wastewater rerouting)
Event: Discovery of methylmercury poisoning transmitted through fish and shellfish

- Fishing yields fell by 91% from earlier levels in the early 1950s.
- By October 1956, 40 people were identified with the disease and 14 were dead (case fatality rate 35%).
- Sediment sampling at the mouth of the wastewater canal measured 2 kilograms of mercury per ton of sediment in February 1959.
- Chisso began producing acetaldehyde in 1932 using mercury as a catalyst, which led to methylmercury discharge into Hyakken Harbour.
- In September 1958 Chisso rerouted its wastewater discharge from the bay to the Minamata River.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1738falsefullhttps://www.spreaker.com/episode/the-luggage-sized-blast-that-shattered-al-ahli-s-silence--73090242
Hospitals are supposed to be sanctuaries; on October 17, 2023 a crater no larger than a carry-on suitcase appeared in Al-Ahli Arab Hospital’s courtyard and, according to the Gaza Health Organization, 471 people were killed-so how can such a small blast produce such a devastating death toll?

In this episode, we lay out the documented record: timelines, competing forensic claims, and the gaps where evidence ends. What each investigation found, where they contradict, and the single unresolved question-what actually detonated in that hospital courtyard-frames the narrative.

Person: Al-Ahli Arab Hospital staff and displaced civilians
Date: October 17, 2023
Location: Gaza City
Event: Courtyard explosion/crater roughly 1.0 m by 0.75 m and 0.3-0.4 m deep
Reported Death Toll: 471 (Gaza Health Organization), figures disputed

- Time of main strike recorded on Al Jazeera livestream: 18:59:55 local time
- Number of people inside hospital at time: roughly 600 patients and staff
- Number of displaced civilians sheltering in courtyard/parking lot: approximately 1,000
- Size of crater as measured by French intelligence: about 1 meter long, 75 centimeters wide, 30-40 centimeters deep
- Number of attacks on Gaza health facilities recorded by WHO from Oct 7-17: 51 attacks, with 15 healthcare workers killed and 27 injured

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090242Tue, 21 Jul 2026 17:25:55 +0000Creator at ObomediaThe Luggage-Sized Blast That Shattered Al-Ahli's Silence Hospitals are supposed to be sanctuaries; on October 17, 2023 a crater no larger than a carry-on suitcase appeared in Al-Ahli Arab Hospital’s courtyard and, according to the Gaza Health...
Hospitals are supposed to be sanctuaries; on October 17, 2023 a crater no larger than a carry-on suitcase appeared in Al-Ahli Arab Hospital’s courtyard and, according to the Gaza Health Organization, 471 people were killed-so how can such a small blast produce such a devastating death toll?

In this episode, we lay out the documented record: timelines, competing forensic claims, and the gaps where evidence ends. What each investigation found, where they contradict, and the single unresolved question-what actually detonated in that hospital courtyard-frames the narrative.

Person: Al-Ahli Arab Hospital staff and displaced civilians
Date: October 17, 2023
Location: Gaza City
Event: Courtyard explosion/crater roughly 1.0 m by 0.75 m and 0.3-0.4 m deep
Reported Death Toll: 471 (Gaza Health Organization), figures disputed

- Time of main strike recorded on Al Jazeera livestream: 18:59:55 local time
- Number of people inside hospital at time: roughly 600 patients and staff
- Number of displaced civilians sheltering in courtyard/parking lot: approximately 1,000
- Size of crater as measured by French intelligence: about 1 meter long, 75 centimeters wide, 30-40 centimeters deep
- Number of attacks on Gaza health facilities recorded by WHO from Oct 7-17: 51 attacks, with 15 healthcare workers killed and 27 injured

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1743falsefullhttps://www.spreaker.com/episode/the-hidden-crystals-that-turned-pet-food-into-poison--73090239
Fear and outrage: visible crystalline particles in wheat gluten shipped from China made their way into canned pet food on shelves across North America, Europe, and South Africa, and by the time anyone looked closely animals were already dying - why did the FDA receive roughly 8,500 reports of pet deaths but officially confirm only 14, and what deadly chemistry hid inside a bowl of gravy?

In this episode, we lay out the timeline and evidence from the spring of 2007, tracing how wheat gluten used as a thickener and protein source traveled from China to a Menu Foods factory in Ontario, was mixed into canned gravy products under roughly one hundred brand names, and was linked to sudden renal failure in household pets - could a chemical present at 6.6% explain the mass outbreak?

Person: Menu Foods
Event: Pet food recall in 2007
Date: March 16, 2007 (recall announced)
Location: Ontario factory, products on shelves in North America, Europe, and South Africa
Reports: FDA received roughly 8,500 reports of pet deaths; FDA officially confirmed 14

- Visible crystalline particles were present in a shipment of wheat gluten used for pet food gravy.
- The contaminated gluten contained a chemical measured at 6.6% in initial findings.
- Menu Foods manufactured wet pet food under approximately 100 brand names at its Streetsville, Ontario facility.
- The recall announced on March 16, 2007 pulled more than 5,300 products from shelves.
- A New York State lab reported finding aminopterin, but Cornell University and the FDA could not replicate that result.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090239Tue, 21 Jul 2026 17:25:50 +0000Creator at ObomediaThe Hidden Crystals That Turned Pet Food Into Poison Fear and outrage: visible crystalline particles in wheat gluten shipped from China made their way into canned pet food on shelves across North America, Europe, and South Africa, and by the time...
Fear and outrage: visible crystalline particles in wheat gluten shipped from China made their way into canned pet food on shelves across North America, Europe, and South Africa, and by the time anyone looked closely animals were already dying - why did the FDA receive roughly 8,500 reports of pet deaths but officially confirm only 14, and what deadly chemistry hid inside a bowl of gravy?

In this episode, we lay out the timeline and evidence from the spring of 2007, tracing how wheat gluten used as a thickener and protein source traveled from China to a Menu Foods factory in Ontario, was mixed into canned gravy products under roughly one hundred brand names, and was linked to sudden renal failure in household pets - could a chemical present at 6.6% explain the mass outbreak?

Person: Menu Foods
Event: Pet food recall in 2007
Date: March 16, 2007 (recall announced)
Location: Ontario factory, products on shelves in North America, Europe, and South Africa
Reports: FDA received roughly 8,500 reports of pet deaths; FDA officially confirmed 14

- Visible crystalline particles were present in a shipment of wheat gluten used for pet food gravy.
- The contaminated gluten contained a chemical measured at 6.6% in initial findings.
- Menu Foods manufactured wet pet food under approximately 100 brand names at its Streetsville, Ontario facility.
- The recall announced on March 16, 2007 pulled more than 5,300 products from shelves.
- A New York State lab reported finding aminopterin, but Cornell University and the FDA could not replicate that result.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1782falsefullhttps://www.spreaker.com/episode/the-grey-dust-that-killed-a-town-armley-s-asbestos-secret-revealed--73090237
Gray, invisible fibres settled on windowsills and children made snowballs from factory dust; decades later whole streets paid with their lives. Three hundred streets and a thousand homes lay downwind of blue asbestos, and when a court finally found for victims in 1995, the fifty people awarded compensation had all died - how did a company and a council keep this secret for so long?

In this episode, we lay out the timeline of exposure, corporate records, council surveys and legal outcomes to show what was known, when it was known, and what was done with that knowledge; could the contamination under Armley have been prevented or properly disclosed?

Person: R. D. Lunt
Company: Turner and Newall Ltd.
Factory: Midland Works (originally J. W. Roberts Ltd)
Period: 1855-1959 (factory operation and closure)
Event: Court ruling in 1995 awarding compensation to fifty people

- The Midland Works began manufacturing asbestos insulation mattresses in 1906 and processed blue asbestos, the most lethal variety.
- The factory’s peak workforce reached around 250 people who lived in streets immediately surrounding the site.
- Up to 50 years of latency existed between inhalation of asbestos fibres and diagnosis of mesothelioma.
- In 1978 Leeds City Council found “hundreds of tonnes of blue asbestos waste” mixed into the soil beneath the factory floor.
- Turner and Newall agreed to pay £15,000 for the factory clean-up in 1978 while excluding surrounding residential houses from the arrangement.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090237Tue, 21 Jul 2026 17:25:46 +0000Creator at ObomediaThe Grey Dust That Killed a Town: Armley's Asbestos Secret Revealed Gray, invisible fibres settled on windowsills and children made snowballs from factory dust; decades later whole streets paid with their lives. Three hundred streets and a thousand...
Gray, invisible fibres settled on windowsills and children made snowballs from factory dust; decades later whole streets paid with their lives. Three hundred streets and a thousand homes lay downwind of blue asbestos, and when a court finally found for victims in 1995, the fifty people awarded compensation had all died - how did a company and a council keep this secret for so long?

In this episode, we lay out the timeline of exposure, corporate records, council surveys and legal outcomes to show what was known, when it was known, and what was done with that knowledge; could the contamination under Armley have been prevented or properly disclosed?

Person: R. D. Lunt
Company: Turner and Newall Ltd.
Factory: Midland Works (originally J. W. Roberts Ltd)
Period: 1855-1959 (factory operation and closure)
Event: Court ruling in 1995 awarding compensation to fifty people

- The Midland Works began manufacturing asbestos insulation mattresses in 1906 and processed blue asbestos, the most lethal variety.
- The factory’s peak workforce reached around 250 people who lived in streets immediately surrounding the site.
- Up to 50 years of latency existed between inhalation of asbestos fibres and diagnosis of mesothelioma.
- In 1978 Leeds City Council found “hundreds of tonnes of blue asbestos waste” mixed into the soil beneath the factory floor.
- Turner and Newall agreed to pay £15,000 for the factory clean-up in 1978 while excluding surrounding residential houses from the arrangement.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1543falsefullhttps://www.spreaker.com/episode/the-doctor-who-turned-medicine-into-murder-karl-brandt-s-wake--73090235
The image of Karl Brandt speaking as the hood came down and the trapdoor opened captures a cold fusion of clinical expertise and engineered killing; he was Hitler's personal physician who specialized in head and spinal injuries and authorized the first infant killing that led to a program of medicalized murder. How did a trained surgeon, steeped in ideas that placed the “health of the social organism” above individuals, turn clinical knowledge into state-directed killing?

In this episode, we tell the story of Karl Brandt's rise from surgeon to Hitler's escort physician and the decisions that led from a single case to a systematized program of killing, and we ask the central question that emerged at Nuremberg: at what point does a physician become something else entirely?

Person: Karl Brandt
Date of birth: 8 January 1904
Event: Execution by hanging at Landsberg Prison on 2 June 1948
Case: Gerhard Kretschmar killed on 25 July 1939
Profession: Surgeon specializing in head and spinal injuries

- Brandt was hanged at Landsberg Prison on 2 June 1948 at age 44.
- He joined the Nazi Party in January 1932 at age 28 and joined the SS on 29 July 1934.
- Brandt examined and authorized the killing of five-month-old Gerhard Kretschmar on 25 July 1939.
- He completed his surgical training by 1928 with a specialty in injuries to the head and vertebral column.
- Brandt married Anni Rehborn on 17 March 1934 and their son Karl Brandt was born on 4 October 1935.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090235Tue, 21 Jul 2026 17:25:43 +0000Creator at ObomediaThe Doctor Who Turned Medicine into Murder: Karl Brandt's Wake The image of Karl Brandt speaking as the hood came down and the trapdoor opened captures a cold fusion of clinical expertise and engineered killing; he was Hitler's personal physician...
The image of Karl Brandt speaking as the hood came down and the trapdoor opened captures a cold fusion of clinical expertise and engineered killing; he was Hitler's personal physician who specialized in head and spinal injuries and authorized the first infant killing that led to a program of medicalized murder. How did a trained surgeon, steeped in ideas that placed the “health of the social organism” above individuals, turn clinical knowledge into state-directed killing?

In this episode, we tell the story of Karl Brandt's rise from surgeon to Hitler's escort physician and the decisions that led from a single case to a systematized program of killing, and we ask the central question that emerged at Nuremberg: at what point does a physician become something else entirely?

Person: Karl Brandt
Date of birth: 8 January 1904
Event: Execution by hanging at Landsberg Prison on 2 June 1948
Case: Gerhard Kretschmar killed on 25 July 1939
Profession: Surgeon specializing in head and spinal injuries

- Brandt was hanged at Landsberg Prison on 2 June 1948 at age 44.
- He joined the Nazi Party in January 1932 at age 28 and joined the SS on 29 July 1934.
- Brandt examined and authorized the killing of five-month-old Gerhard Kretschmar on 25 July 1939.
- He completed his surgical training by 1928 with a specialty in injuries to the head and vertebral column.
- Brandt married Anni Rehborn on 17 March 1934 and their son Karl Brandt was born on 4 October 1935.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1785falsefullhttps://www.spreaker.com/episode/the-judge-s-handwritten-plea-that-began-britain-s-blood-scandal--73090234
Fear that the state failed its most vulnerable: 962 haemophiliacs and their families were infected with HIV through NHS-prescribed clotting factor, and a High Court judge resorted to a handwritten plea because "the law had run out of instruments." What was in the 600 sealed files that the government refused to hand over, and why did a judge ask both sides to settle with no legal power to compel it?

In this episode, we follow the timeline from contaminated clotting factor in the late 1970s through the litigation that peaked in 1990, outlining who sued whom and what was at stake for families and children - and asking how much the state knew and when. Can a handwritten note from Mr Justice Ognall tell us where accountability begins?

Person: Mr Justice Ognall
Date: June 26, 1990
Case: 1,217 plaintiffs listed in litigation
Event: 600 files withheld covering 1972-1986
Status: 163 plaintiffs diagnosed with AIDS, 107 dead by November 1989

- 962 haemophiliacs and their families contracted HIV from NHS-prescribed clotting factor.
- Clotting factor was pooled from thousands of donors and used by the NHS from the late 1970s.
- By November 1989, 163 plaintiffs had developed AIDS and 107 were dead.
- The initial deadline to join proceedings was Feb 2, 1990, later extended to add 200 haemophiliac children.
- The government held 600 files covering 1972-1986 that were not handed over to plaintiffs.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090234Tue, 21 Jul 2026 17:25:39 +0000Creator at ObomediaThe Judge's Handwritten Plea That Began Britain's Blood Scandal Fear that the state failed its most vulnerable: 962 haemophiliacs and their families were infected with HIV through NHS-prescribed clotting factor, and a High Court judge resorted to a...
Fear that the state failed its most vulnerable: 962 haemophiliacs and their families were infected with HIV through NHS-prescribed clotting factor, and a High Court judge resorted to a handwritten plea because "the law had run out of instruments." What was in the 600 sealed files that the government refused to hand over, and why did a judge ask both sides to settle with no legal power to compel it?

In this episode, we follow the timeline from contaminated clotting factor in the late 1970s through the litigation that peaked in 1990, outlining who sued whom and what was at stake for families and children - and asking how much the state knew and when. Can a handwritten note from Mr Justice Ognall tell us where accountability begins?

Person: Mr Justice Ognall
Date: June 26, 1990
Case: 1,217 plaintiffs listed in litigation
Event: 600 files withheld covering 1972-1986
Status: 163 plaintiffs diagnosed with AIDS, 107 dead by November 1989

- 962 haemophiliacs and their families contracted HIV from NHS-prescribed clotting factor.
- Clotting factor was pooled from thousands of donors and used by the NHS from the late 1970s.
- By November 1989, 163 plaintiffs had developed AIDS and 107 were dead.
- The initial deadline to join proceedings was Feb 2, 1990, later extended to add 200 haemophiliac children.
- The government held 600 files covering 1972-1986 that were not handed over to plaintiffs.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1384falsefullhttps://www.spreaker.com/episode/the-factory-that-shouldn-t-have-died-al-shifa-s-missing-evidence--73090232
Half of Sudan’s medicines vanished in a single night: thirteen cruise missiles crossed the Red Sea on August 20, 1998 and destroyed the al-Shifa pharmaceutical factory that supplied more than 50% of the country’s pharmaceutical output. Yet the United States never allowed an on-site inspection, and the sole soil sample tying the site to VX precursor EMPTA came from a single Egyptian asset-so who really decided the factory’s fate?

In this episode, we trace the timeline from the soil sample and internal intelligence memos to the White House Small Group decision made twelve days after the East Africa embassy bombings, asking whether the strike was based on solid evidence or political urgency. Was al-Shifa targeted despite dissenting analysis, or was critical intelligence simply missing?

Person: Salah Idris
Date: August 20, 1998
Location: Khartoum, Sudan
Event: Operation Infinite Reach
Topic: EMPTA soil sample

- 13 cruise missiles struck the al-Shifa factory at 7:30 PM on August 20, 1998.
- The factory supplied more than 50% of Sudan’s pharmaceutical output and employed 300 workers.
- An Egyptian asset collected one soil sample in December 1997 that tested positive for EMPTA at 2.5 times trace levels.
- The factory held a United States Oil-for-Food contract worth $199,000 and had an assessed value of $30 million.
- A State Department Bureau of Intelligence and Research memo dated August 6, 1998 and a CIA report dated July 24, 1998 opposed the attack on al-Shifa.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090232Tue, 21 Jul 2026 17:25:36 +0000Creator at ObomediaThe Factory That Shouldn't Have Died: Al-Shifa's Missing Evidence Half of Sudan’s medicines vanished in a single night: thirteen cruise missiles crossed the Red Sea on August 20, 1998 and destroyed the al-Shifa pharmaceutical factory that supplied...
Half of Sudan’s medicines vanished in a single night: thirteen cruise missiles crossed the Red Sea on August 20, 1998 and destroyed the al-Shifa pharmaceutical factory that supplied more than 50% of the country’s pharmaceutical output. Yet the United States never allowed an on-site inspection, and the sole soil sample tying the site to VX precursor EMPTA came from a single Egyptian asset-so who really decided the factory’s fate?

In this episode, we trace the timeline from the soil sample and internal intelligence memos to the White House Small Group decision made twelve days after the East Africa embassy bombings, asking whether the strike was based on solid evidence or political urgency. Was al-Shifa targeted despite dissenting analysis, or was critical intelligence simply missing?

Person: Salah Idris
Date: August 20, 1998
Location: Khartoum, Sudan
Event: Operation Infinite Reach
Topic: EMPTA soil sample

- 13 cruise missiles struck the al-Shifa factory at 7:30 PM on August 20, 1998.
- The factory supplied more than 50% of Sudan’s pharmaceutical output and employed 300 workers.
- An Egyptian asset collected one soil sample in December 1997 that tested positive for EMPTA at 2.5 times trace levels.
- The factory held a United States Oil-for-Food contract worth $199,000 and had an assessed value of $30 million.
- A State Department Bureau of Intelligence and Research memo dated August 6, 1998 and a CIA report dated July 24, 1998 opposed the attack on al-Shifa.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1903falsefullhttps://www.spreaker.com/episode/when-diagnosis-becomes-a-prison-the-soviet-crime-of-sluggish-schizophrenia--73090231
Fear that a medical label can erase a life: Soviet psychiatry used a diagnosis called "sluggish schizophrenia" to confine dissenters, believers, and critics without trial. How did a diagnostic category with no hallucinations or conventional psychosis come to replace courts and prisons?

In this episode, we lay out the evidence brought to light by an American psychiatric delegation in February 1989 and earlier whistleblowers, showing how clinical records and human testimony diverged - and ask what it means when medicine is turned into a tool of repression.

Person: Vladimir Bukovsky
Person: Natalya Gorbanevskaya
Person: Pyotr Grigorenko
Event: American psychiatric delegation visit
Date: February 1989

- The American delegation arrived with a list of 48 names of people allegedly involuntarily committed to Soviet psychiatric hospitals.
- Roughly half of the 48 people were discharged in the two months between the list's submission and the Americans' arrival (about 24 people).
- Of the patients still in hospital, 15 were examined by the American team; one had an active schizophrenia diagnosis but showed no evidence of mental disorder.
- Twelve of the discharged individuals agreed to be examined; Americans found 9 of those 12 showed no evidence of current or past mental illness.
- The World Psychiatric Association formally condemned Soviet practices in 1977, and the Soviet psychiatric society withdrew from the WPA in 1983 before the vote.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090231Tue, 21 Jul 2026 17:25:31 +0000Creator at ObomediaWhen Diagnosis Becomes a Prison: The Soviet Crime of Sluggish Schizophrenia Fear that a medical label can erase a life: Soviet psychiatry used a diagnosis called "sluggish schizophrenia" to confine dissenters, believers, and critics without trial....
Fear that a medical label can erase a life: Soviet psychiatry used a diagnosis called "sluggish schizophrenia" to confine dissenters, believers, and critics without trial. How did a diagnostic category with no hallucinations or conventional psychosis come to replace courts and prisons?

In this episode, we lay out the evidence brought to light by an American psychiatric delegation in February 1989 and earlier whistleblowers, showing how clinical records and human testimony diverged - and ask what it means when medicine is turned into a tool of repression.

Person: Vladimir Bukovsky
Person: Natalya Gorbanevskaya
Person: Pyotr Grigorenko
Event: American psychiatric delegation visit
Date: February 1989

- The American delegation arrived with a list of 48 names of people allegedly involuntarily committed to Soviet psychiatric hospitals.
- Roughly half of the 48 people were discharged in the two months between the list's submission and the Americans' arrival (about 24 people).
- Of the patients still in hospital, 15 were examined by the American team; one had an active schizophrenia diagnosis but showed no evidence of mental disorder.
- Twelve of the discharged individuals agreed to be examined; Americans found 9 of those 12 showed no evidence of current or past mental illness.
- The World Psychiatric Association formally condemned Soviet practices in 1977, and the Soviet psychiatric society withdrew from the WPA in 1983 before the vote.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1897falsefullhttps://www.spreaker.com/episode/how-a-nail-riddled-dentist-escaped-asylum-and-haunted-small-town-medicine--73090229
A man drives down the highway with nails embedded in his skull, laughing and pulling a nail free to use as a toothpick - an image that opens and closes The Dentist 2. Why did a production made in five weeks, with one weekend of pre-production and a $700,000 budget, produce a film that earned a Sitges nomination while scoring zero percent on Rotten Tomatoes?

In this episode, we tell how a sequel was assembled from withheld scripts, Southern California stand-ins for a Missouri town, and a cast and crew who improvised their way through cramped schedules and practical effects. How did these choices shape a film built around a dentist who escaped a maximum-security psychiatric facility and assumed a new identity in a place called Paradise?

Person: Corbin Bernsen
Director: Brian Yuzna
Producer: Pierre David
Budget: $700,000
Principal photography: February 23, 1998 - March 1998

- The director had one weekend of pre-production and was not permitted to read the finished script before shooting began.
- Principal photography ran roughly five weeks, starting on February 23, 1998.
- The film premiered on HBO on December 11, 1998.
- Rotten Tomatoes scored the film at 0% from five critics with an average rating of 3.7/10.
- The production used locations in Southern California to portray Paradise, Missouri, including South Myrtle Avenue in Monrovia and the El Royale Motel on Rossmore Avenue.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090229Tue, 21 Jul 2026 17:25:27 +0000Creator at ObomediaHow a Nail‑Riddled Dentist Escaped Asylum and Haunted Small‑Town Medicine A man drives down the highway with nails embedded in his skull, laughing and pulling a nail free to use as a toothpick - an image that opens and closes The Dentist 2. Why did...
A man drives down the highway with nails embedded in his skull, laughing and pulling a nail free to use as a toothpick - an image that opens and closes The Dentist 2. Why did a production made in five weeks, with one weekend of pre-production and a $700,000 budget, produce a film that earned a Sitges nomination while scoring zero percent on Rotten Tomatoes?

In this episode, we tell how a sequel was assembled from withheld scripts, Southern California stand-ins for a Missouri town, and a cast and crew who improvised their way through cramped schedules and practical effects. How did these choices shape a film built around a dentist who escaped a maximum-security psychiatric facility and assumed a new identity in a place called Paradise?

Person: Corbin Bernsen
Director: Brian Yuzna
Producer: Pierre David
Budget: $700,000
Principal photography: February 23, 1998 - March 1998

- The director had one weekend of pre-production and was not permitted to read the finished script before shooting began.
- Principal photography ran roughly five weeks, starting on February 23, 1998.
- The film premiered on HBO on December 11, 1998.
- Rotten Tomatoes scored the film at 0% from five critics with an average rating of 3.7/10.
- The production used locations in Southern California to portray Paradise, Missouri, including South Myrtle Avenue in Monrovia and the El Royale Motel on Rossmore Avenue.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1462falsefullhttps://www.spreaker.com/episode/bound-and-breathless-how-restraints-killed-kelly-savage--73090228
A loved, 27-year-old dual citizen was strapped at five points to a hospital bed without having harmed anyone, then ten days later his heart stopped - what did paperwork, a holiday week and a nine percent statistic have to do with his death?

In this episode, we lay out the sequence of events, hospital records and family context from admission to aftermath, and ask how contradictory notes and a system already using restraints on thousands could end in a preventable death.

Person: Kelly Robert Savage
Date: April 30, 2017 (admission); ten days later (death)
Location: Yamato Hospital, Kanagawa Prefecture, Japan
Age: 27
Previous hospitalization: five weeks in 2012 for a psychotic episode

- Kelly Savage was placed in five-point restraints on admission: both wrists, both ankles and a waist belt.
- He had not harmed anyone or himself prior to being restrained on April 30, 2017.
- Kelly stopped taking psychiatric medication by April 2017 and developed a manic-psychotic state.
- Medical records from the same week contained contradictory entries describing him as both "calm" and at ongoing "risk."
- No criminal charges, independent investigation, or hospital acknowledgement of irregularity followed his death.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090228Tue, 21 Jul 2026 17:25:24 +0000Creator at ObomediaBound and Breathless: How Restraints Killed Kelly Savage A loved, 27-year-old dual citizen was strapped at five points to a hospital bed without having harmed anyone, then ten days later his heart stopped - what did paperwork, a holiday week and a...
A loved, 27-year-old dual citizen was strapped at five points to a hospital bed without having harmed anyone, then ten days later his heart stopped - what did paperwork, a holiday week and a nine percent statistic have to do with his death?

In this episode, we lay out the sequence of events, hospital records and family context from admission to aftermath, and ask how contradictory notes and a system already using restraints on thousands could end in a preventable death.

Person: Kelly Robert Savage
Date: April 30, 2017 (admission); ten days later (death)
Location: Yamato Hospital, Kanagawa Prefecture, Japan
Age: 27
Previous hospitalization: five weeks in 2012 for a psychotic episode

- Kelly Savage was placed in five-point restraints on admission: both wrists, both ankles and a waist belt.
- He had not harmed anyone or himself prior to being restrained on April 30, 2017.
- Kelly stopped taking psychiatric medication by April 2017 and developed a manic-psychotic state.
- Medical records from the same week contained contradictory entries describing him as both "calm" and at ongoing "risk."
- No criminal charges, independent investigation, or hospital acknowledgement of irregularity followed his death.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1775falsefullhttps://www.spreaker.com/episode/the-bodies-we-built-medicine-on-theft-silence-and-reckoning--73090227
Grief and outrage are threaded through medical history: a biopsy taken without consent became the HeLa cell line that powered vaccines and gene research, yet Henrietta Lacks’s family waited seventy-two years for formal acknowledgment-how did institutions normalize taking and displaying bodies as if they were data rather than people?

In this episode, we trace three linked stories across centuries to show how bodies were converted into specimens, artifacts, and cell lines without consent, and we ask how a pattern that began with public displays in nineteenth-century Europe led to modern laboratories still using tissues taken in secrecy.

Person: Henrietta Lacks
Date: 1951
Location: Johns Hopkins Hospital, Baltimore
Person: Sarah Baartman
Date: 1815
Person: James Marion Sims
Date: 1840s

- Henrietta Lacks arrived at Johns Hopkins in 1951 with vaginal bleeding and a malignant cervical tumor.
- Dr. George Gey labeled Lacks’s cells “immortal” after they survived and replicated outside the body, creating the HeLa cell line.
- HeLa cells were used in research on polio vaccine development, chemotherapy, gene mapping, cloning, and in vitro fertilization.
- Sarah Baartman was exhibited in London and Paris for five years and died in 1815; her brain, genitalia, and skeleton were preserved and displayed for over a century.
- James Marion Sims practiced in the American South in the 1840s and developed a technique for vesicovaginal fistula repair that is still taught in medical schools.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>https://api.spreaker.com/episode/73090227Tue, 21 Jul 2026 17:25:19 +0000Creator at ObomediaThe Bodies We Built Medicine On: Theft, Silence, and Reckoning Grief and outrage are threaded through medical history: a biopsy taken without consent became the HeLa cell line that powered vaccines and gene research, yet Henrietta Lacks’s family...
Grief and outrage are threaded through medical history: a biopsy taken without consent became the HeLa cell line that powered vaccines and gene research, yet Henrietta Lacks’s family waited seventy-two years for formal acknowledgment-how did institutions normalize taking and displaying bodies as if they were data rather than people?

In this episode, we trace three linked stories across centuries to show how bodies were converted into specimens, artifacts, and cell lines without consent, and we ask how a pattern that began with public displays in nineteenth-century Europe led to modern laboratories still using tissues taken in secrecy.

Person: Henrietta Lacks
Date: 1951
Location: Johns Hopkins Hospital, Baltimore
Person: Sarah Baartman
Date: 1815
Person: James Marion Sims
Date: 1840s

- Henrietta Lacks arrived at Johns Hopkins in 1951 with vaginal bleeding and a malignant cervical tumor.
- Dr. George Gey labeled Lacks’s cells “immortal” after they survived and replicated outside the body, creating the HeLa cell line.
- HeLa cells were used in research on polio vaccine development, chemotherapy, gene mapping, cloning, and in vitro fertilization.
- Sarah Baartman was exhibited in London and Paris for five years and died in 1815; her brain, genitalia, and skeleton were preserved and displayed for over a century.
- James Marion Sims practiced in the American South in the 1840s and developed a technique for vesicovaginal fistula repair that is still taught in medical schools.

To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.]]>1551falsefull